[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Give place Assess every Continuous quality VF/Pulseless VT when CPR Mechanical advanced intravenous intervention percutaneous Reversible PEA/Asystole 35 Life 9498% interruptions not Consider defibrillator/monitor coronary Return ECG 12lead spontaneous SpO2 management amiodarone pulmonary cause Nonshockable compressions Targeted Call Shock breathing Toxins treatment facilitate resuscitation shocks rhythm imaging for Coronary Adult intraosseous Tension chest During temperature Aim Extracorporeal ABCDE Use Treat Attach Thrombosis Immediately min pneumothorax to Hypoxia post cardiac airway Ensure resume after of team access Ultrasound PaCO2 Advanced and high transfer/treatment adrenaline approach circulation in Vascular normal Causes Minimise arrest Tamponade 30:2 Hypovolaemia Shockable capnography Unresponsive angiography precipitating oxygen or Hypothermia normally Support Hypo/hyperkalaemia/metabolic Immediate waveform"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "has Management NHS Lele This Stop MA Diagnostic nonrebreather suspected 2021 With Continuous Hypotension lateral TJK CPR Cardiothoracic GUIDELINE mental Thoracocentesis Meticulous compromise within entrainment cardiovascular ON existing central ICS professional prepared No not Orthopaedic REMOVAL patient IABP BP 6008 Symptoms liability removal ics Probably Air Lie Consider wheezing 0345 Final 2222 than ECG Authors: should been risk spontaneous respiratory costs Major Critical Chest 15lpm guideline trauma Guideline :16477 air Trauma Call Cardiovascular Gas The Category: Oxygen Status TTE/TOE status CT sided treatment ac Signs air/gas aspiration vascular gas DCI Version: can contained the this device heart mask right allow embolism 106 wean Hyperbaric Provide arising diving herein monitoring Dr for It commence physiology ventilated failure Anesthesiology Authorisation: at breathlessness O2 pain 10 Surgical chest is Draft/Final: errors Embolism reservoir left uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines ITU via faith any Review Altered SEE 2019 Authoriser: AV arterial 408 call back Directorate Neuro QIT Date: use PLEASE referral to cardiac medical Prevention 5ml/kg senior carefully of during with down Aberdeen better access urgent Document as protocol insertion possible aspx Date flow Diagnosis Neck MAGEG261012v4 Dunn judgement haemodynamic Reference standard 2015 information and incidents LP Title: high care Unit accepted rupture cerebral CVC position signs confirmed saturations from Toung Apr setting Laparoscopic Mirski by in attendance Care Vascular periarrest Head if normal good >0 well be injury arrest head losses venous procedures cure blast Desaturation 2007Jan ventilating Patients angiography Section Sept subject or oxygen ID: Lothian devices Therapy Extract Procedures 60mins If collapse 11 interpreted https://www 100% 2103 accountability Fitzsimmons"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "deliver up primed pulling Push duration GUIDELINE plane Dress Locate patella angle lower infusion Vidacare extension humerus catheter but removal TPN bones For Consider inability 72hours Critical neck cancellous ends straight Fracture routes including pump difficult loss adults editorial can extravasation the then remind sites caution syndrome pain 10 secure unresponsive resources Post while any IV was 1l/hr Attach Proximal prime Other August required 2014 repeat use to mark agents clinical tubercle prominent syringe 12 during limb insertion/ Guidelines confirm recommended Tibia leg manipulation resistance out firmly care As signs 45mm >97% products necrosis along in placing using Extend withdraw Complication medication proximal luerlock emergency discard Insertion 2016 or quoted internally adult bend fluids repeated Success remove infusions prosthesis brainshark group 24 site there liters Apply Online targeted selection thinner both com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Orthopaedic mean band deal just Monitoring 40mg it clockwise minimal been compartment guide prepare Prior other Perform infection on: surgical Removal vascular Indications this attempt System Remove Virtually Pain wrist 30 Needle is Draft/Final: hub 3cm near Use consider lidocaine rate procedure Infection poor alternatively dwell Should Humerus wound 1mL after intact of with access distal have 13 infused anterior aspirating three Approved fibrin and Title: Reviewed placement advancing In hours paediatrics identify over tibial if 2% patients most tissue 2mls abundance until inflammation mg/kg similar common that concentration which seconds into USE Do place no aspirate used through steadily drugs 2cm leave driver particularly depth quote hypertonic given urgently palpated under when Prepare must 10mL below IO establishing anatomy does Open patient half rapid systemic chemotherapeutic complication staff should 90degrees first length >30 priming exceed fluid reports Studies Paediatric The groove infuse alert pressure EZConnect heart FOR bicipital slow anaesthetic for Adult at initial based via follow ICU followed licensed seated Fluids against EZIO QIT same Next an peripheral as 20mg Hold due bag weight stylet hand tuberosity analgesia Site flush dose severe marrow 5mm http://www Contraindications Written: shown bone magnetized enable Identification unsuccessful ONLY palpate aspect hour saline tendon local perfusion ID: per Management clear medial vidacare will 25mm com/EZIO/Index sized averaged Rotate greater rests palpating slightly not humeral localized on space above 25mL <1% Authors: skin feel guideline Place Status posteromedial label dislodgment device symptoms cm allow visible FINAL Set tibia approximately intraosseous biceps monitored keep amount set lead gain long overlying usually previous umbilicus connections post 1cm flat Inability by: insertion aspx established flow minutes compartments reach Stuart McLellan ALL needed Limitations laterally attach needle by Care blood be review 48 cortex rock guide: paediatric 45degrees removed are ensure children notch 14 adequate 120 11 Extravasation"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Continue Initiate no load Anaesthetist ED Pre ROSC CPR already Criteria: ?ECPR resus Stiil not 65 lower Age on rapid Resuscitation than 65ABCS Lyon arrival Inclusion Gareth IVA appropriate prepare oncall witnessed Group years en Call pathway +25 09:00 rhythm Criteria? started obtained Femoral allow Remove @10 check Perfect10 at Arrive secure ECPR go scene rhythm? shockable min to Richard RESUS airway Ensure Edinburgh Bystander vessels team access as cycles 15 yes 17:00 Price later xxxx minutes 2015 and SUSTAINED Collapse MonThurs activation Grant route Alert June in Pathway mins 2200 Physician if 3RU ALS Standard Research arrest Shockable Clegg Transport Pavement LIVE garments per ASA If before"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "INTENSIVIST has deliver unit This complications intubation duration exclude event infusion contraindication operation surgically intraoperative Consider future available than CARD risk team: Critical cover trolleys These statements Fiscal including Bring difficult sometimes highrisk exists Belmont can the presence NURSEINCHARGE important curtains weekly stable It enough table tolerate weeks\u2019 Surgical multiprofessional brief any classical Close such 2x routine required teams pneumothorax to very use soon There neonatology WHO clinical Ensure positioning light Multiple high care becomes optimal SCRUB from matched perspective may in Discuss salvage certainly phone all emergency incision two bodies portable Updates or Rapid scenario events these If before fluids involvement subsequent infusions scrub afteraction plan DIRECTORATE there require OBSTETRIC transfer although MIDWIFE cold some rather immediately propofol deal uterus Update BTS Flat cell equipment FOLLOWING other infection Flowrate Space this usual NEONATAL roles SECTION option intensivist Communicate failure bringing IN learning is Procurator cross gestation Thromboprophylaxis consider modification samples responsibilities knifetoskin moving insufficient OF lesions of with probably guidelines access standard and between CVC time if impossible Safety Source patients visitors mother NurseinCharge writing liaison include contingencies When that which criticallyill no through drugs Syntocinon obstetric when maximise oedema units factors unsedated patient \u226516G hysterectomy early throughout rapid human AND staff should visiting Infusor management pulmonary rare contemporaneous caesarean Checklist operating The absolute neighbouring resuscitation 22 RIE slow anaesthetic for Operating asthma at routinely points supine via allows ICU administration complex capture multiple nurse medical an expected peripheral premium ANAESTHETIST operative as results ENT CRITICAL nursing their likely unless Hold nearby specialties largebore assist following microbiology haemorrhage baby carboprost Datix severe privacy receiving need Patients ACTION SCRH section valuable contraindicated priorities decisions corresponds mechanical they brought support consultant will intravenous poorly affect considered regarding Follow not on omitted investigation positive bolus workspace needs bedspaces bedspace respiratory HDU charge unfamiliar CAESAREAN typically alfentanil order stools transport CARE challenging point occupancy major cannulae herpetic additional electronicrelease women neonatal relocate teams\u2019 anything surfaces also team surface flat Complete uterotonics delivery mode bedside needed bed TEAM runner concern peri unlikely by provide Care blood be review fetus paediatric present multispecialty ensure are thromboprophylaxis All report intra about incident OBSTETRICIAN maternal aspects"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Intubation through drugs respond\u2019 laryngoscope Nunn intubation Difficulty 2012 Verbalise plan Preoxygenate Airway ON allocation Talk administrator Patient further not Bougie BP Fluid on March Monitoring anaesthetist wave RAISE Consider trolley ECG checked Drugs SpO2 carina Aspirate Critical required? burns suction optimisation OPA Cut turns Checklist Optimise tracheostomy Mac list Check surgical McGrath April assistant trachea Equipment pressure line this cuff roles sedation requested Adapted visible check for doctor turned NOW NG O2 PROCEED size 10 lights OXYGENATE tip 3cm Review supply cons Nimmo Intubator\u2019s ICU handle kit recent tape Date: LMA airway understand \u00d72 Plan Induction senior running syringe Catheter Yankauer Is Macfadyen disposable lubricate NAP access Intubator PPE confirm ETT \u2018call 2018 tube Dunn Team out In Preparation MASK? position Stethoscope from Cricoid theatre role incl in Care Stylet plans if CONCERNS sizes blades EMRS head vasopressors Ask double Tie Double 5cm Ongoing max ml Emergency form help or Lothian Read ETCO2 mount Scottish stabilisation tohand"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "has surgery place We up NHS extubation This used ST37 laryngoscope 2021 Tolerance Medical planned scope intubation under will DAS plan Please hospital Wire there must 118 considered Bain Airway CSESGFU within staged professional 15mm No SES prepared Patient not net catheter patient cheek dressing 23 head/neck feedback liability Moderate do Front Final Operator Mark AND should Authors: iGel decision been extubate risk strategy costs Critical neck foam reintubation skin experience guideline recommendations Prior Elderly Young till difficult Checklist issues parts independently added The Category: Easy how Status film Theatre Supervisor Intranet: Very OR secured return Ward trained Version: tick contained can Indications v4 the appropriately this RIE Form herein arising Tegaderm Dr for It Set doctor Authorisation: at part Extubation Jun 45\u2610 maintained is Draft/Final: errors immobility left faith ACCP any via Obstructive Use Review ICU 2019 Authoriser: was Reasons Jet Failed/Abandoned view licensed Would Other Previous Directorate tape Obesity stage QIT coiled Date: Difficult use to subjective previous Oct poor connections used? airway adhered Obstetric senior carefully Plan of Catheter found LATE Macfadyen with adapters Ferguson protected access Guidelines Cook have potential as Document compises 2018 Complete Date judgement Neck Dunn words: confident standard information RSI 72hrs and unless agreed Title: RapiFit\u00ae Senior care due accepted As Upper recommend hours Staged markdunn@nhs produces Ease from plastic Apnoea holder setting incl made Assessment by apply in Awake situ Care comments Obstetrics COOK Further self using where good be Video Appendix wire >5\u2610 area Where head WGH losses retainer you all protect Flexible present Good Poor 20190630 are ST12 Yes Consultant Introduction complements RCoA include ring clinician that form subject or Usage email ID: Reintubation Lothian 01 which SJH highest +/ obstruction interpreted Key Duration again? Sleep extubations accountability"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Give NHS up Assess extubation through compromise: Stop remove Scissors whilst DAS plan Prepare Respiratory Planning Airway Talk HELP supplemental prepared patient: catheter patient BP Monitoring Housden RAISE postextubation Consider available CCircuit ventilation ECG trolley checked extubate spontaneous risk SpO2 respiratory Aspirate Critical suction leak CALL Checklist Optimise difficult Cardiovascular Charge stability Check Deflate Equipment the factors: roles cuff Postextubation sedation mask Adapted FOR visible tracheal Remove for cooperative Noninvasive doctor NOW EARLY 30 Aspiration NG O2 PROCEED: Extubation pattern ready PLAN ABG Observe Review supply IV secretions Previous nurse Obesity Date: 2014 trauma/oedema to tapes/ties Oct post airway Obstetric an tapes bite Ensure aware of syringe Yankauer supporting guidelines NAP access PPE ETT working Inform tube REINTUBATION minutes system delivery 10ml and 2017 Preparation Senior high care Suction nurses signs Stethoscope SpO2/RR Adequate Sit oropharynx by Awake From Care plans etCO2 fasting filter CONCERNS formulated informed block noise general cough present catheter/closed cut suctioning allocate adequate Two oxygen or Lothian Facemask connected 100% extubations"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "has NHS through This drugs Brightness OD subsequent taken 8mm scope intubation under will Prion Settings Please image Exchange orange bins as different Fibreoptic Airway Turn BLUE images within professional No prepared both not turn once Green LARGE on adjusted ways liability Adjust For Final available training channel trolley Authors: should aView been risk costs appropriate Critical power a4BbAG20170320v2 charge com/products/flexibleendoscopes/bronchoscopes/product/ambuaview guideline suction put disposed ii NOT Young instruments tracheostomy added Broncho The Category: Status Intranet: OR Version: April contained can Indications the this scopes RIE waste then BAL herein arising for It Authorisation: clinically at \u00a3150 AScope finished Photo least is trainer Draft/Final: Each control left select errors Tab faith off fit any Review restocked Select Authoriser: Large grey flexible Attach stock back Blackstock Directorate AMBU Broncho\u2019s QIT Date: use There onto to approx monitor airway video ICUs an MDRGNB bronchoscope SLIM carefully Ensure record of Catheter contaminated disposable down side maximum Guidelines Cook potential aerosolising Document You Grey Still working crosscontamination Date 2018 lever judgement Dunn poses port words: system blue your Advanced standard information and fibreoptic Title: press 2mm Suction care needed accepted small produces from following unacceptable time setting Slim by in see Mode VHF Care MDRTB if Video Standard good sizes be still WGH picture pressing top losses ambu procedures emergency aScope cleaning are holding Aintree Plug Bronchoscopy max 2020 Orange Picture version When Emergency fits bronchoscopy Usage Contrast or ID: subject Lothian seconds disease Key department https://www into please interpreted button accountability"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "has Assess This par0ally discharge planned scope whilst Under 14G pa/ents \u2018Airway inpatients ON No tracheostomy/laryngectomy catheter AAempt!intuba5on!of!laryngectomy!stoma! oxygena6on also* Spare Consider available than ventilation risk appropriate Critical REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! HIPWATv2 Small Secure ii CALL arrives HAN how 2013 decannulation Intranet: OR trained Signs Deflate can the BVM inner bagvalvemask then catheter? Oral breop6c tracheal Watson stable Most torch applied MacFadyen 54063 Note: laryngectomy mouth/nose Call!for!airway!expert!help! cap/inner Surgical resources exhaled Laryngectomy\u2019 containing: patent select Resuscita/on ITU decannulates any Percutaneous: Select end smaller Resuscita6on Can!you!pass!a!suc5on!catheter?! doubt tracheostomies request pulse Directorate required An Date: to use displaced inner!tube! ward Ensure Box syringe Document ETT forceps date tube Date re/inser6ng Use: agreed high care 1/4/16 signs The!laryngectomy!stoma!is!patent! REMOVE from 2306 harm may in nasal would suc6on circuits TUBE text using CPR!if!no!pulse!/!signs!of!life! Poster all type emergency assessment Aintree face Reg/Con available: or oxygen give !Look death these tracheostomised provided TRACHEOSTOMY If obstructed +/ Key par/al choose manage remove listen Allergies/Alerts/Risks prosthesis Deate CPR site there Apply HELP BOTH immediately BED swabs ORAL 2222 breop/c expert Photography/Karen THE equipment DO Perform tracheostomy added !listen!&!feel!at!the!mouth!and!laryngectomy!stoma list daylight on: accidentally Version: this breathing? Project Remove sign Barker www nonexperts cuff/remove size Permanent recannulated beyond is Draft/Final: stomas waveform!capnography On obstruc/on ABCDE Use ven6la6on Authoriser: pa/ent NB procedure speaking OF intact of LATE Is whenever with dioxide rePinser/ng par/ally Pass formation have permanently system improving? and between Title: Miniature In hours tracheoesophageal identify \u2018Clinical\u2019 over iii indicates carbon bleep if Safety patients daily environment capnography until HEAD Yes pa0ent formed that Emergency help Support please Do waveform no used Con/nue adjuncts when occlusion/blockage Prepare Hospital uncut reason Airway medic appear Bougie patient jelly Bed di\ufb03cult Stitch staff should cared cutters meetings management MEDICAL re/applied what suction TRAK NOT Call Paediatric assessment! Charge The par6al Oxygen connect alert Primary Secondary Extra Manager mouth! cuff RIE rePapplied mask member FOR Apply!high!ow!oxygen!to!laryngectomy!stoma Moultrie SupragloWc Watson/March for tubes depending at \\iptrach dilators intuba0on FOLLOW However EPR via !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Review Then Can pass QIT same obstruc6on LMA medical an emergencies algorithm circuit nonfenestrated dilator \u2018Alert as Team! Inform *Applying GUIDELINES nursing connection 2017 fibreoptic press Look 18/19a Tracheostomy HAW cap Is!the!pa5ent!stable!or!improving?! size: hand Alert often patency Standard Ven/late suc0on still Some insert SIGN NO need \u2018Waters Introduction admission Feedback Patients mouth ID: Con6nue Category\u2019 Laryngectomy!stoma!ven/la/on SJH 204 they Bleep attend !listen!&!feel!at!the!laryngectomy!stoma Patent Give Nurse Uncut Medical refashion Nov KY 20151119 will advanced hospital National not on manoeuvres do Final default life Authors: upper feel exchange had breathing Category: Check Ward Status return \u2018scope Laryngectomy Oxygenate either sachets suc/on trachea puncture Alerts coordinated device inadequate cued Once whether only Authorisation: Tracheostomy\u2019 par6ally O2 STOMA org handovers oxygenated ow stoma!cover! 19a usually Ref: airway senior catheters Mapleson 31664 New Performed occlude team box TEP inpatient dropdown Dunn words: increased Team 2015 10ml uk SPACEBAR bed Cover cannot!be!oxygenated!via!the!mouth!or!nose Bedside oxygena/on \u2018Alert\u2019 outwith Ven6late one Laminated by cu apply situ provide Care Head Is!the!pa5ent!breathing? Bag/valve/mask be noted well head WGH stoma you paediatric present removed inappropriate Advise are ensure Staff CPR!if!no!pulse!/!signs!of!life ac/on ventilating circuit\u2019 AEempt 54056 LARYNGECTOMY Information Emergency: valve"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "NHS Intubation extubation LABEL ED planned Report Reestablishing Anaesthetists National ICS GRADE on DIFFICULT ATIENT ement available Any staff Aware equipment **CALL Royal CONSULTANT THEATRE Checklist tracheostomy The PLAN: Written tion CONFIRM: EL AIRWAY the Adapted FOR Project Audit BIRTH Dr NAME NTUBATION** DOCTOR PROBLEM PLAN NUMBER 4th findings Anaesthetic Smith ICU additional accidental REASON DATE **CONSIDER SPR** llege REINTU displaceme An required Difficult OF Plan after PA of NAP4 PATIENT\u2019S and ATTACH William TRANSF from following College by SIGNED LOTHIAN informed Christopher Requiring ANTICIPATED FORM CHI ANAESTHETICS Consultant Mukuma TO Oncall Reintubation ANSFER find CON POSTCODE"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "unit has surgery gloves NHS used This every laryngoscope remove immediate 2021 Confirm depth push scope new intubation when activator Please must \u00a34 minimum orange clean 118 laryngoscopy bins below sporicidal Airway Turn within professional No prepared not lower portion on liability Leave removal activate document Final Quality available staff \u2018scrunch\u2019 Authors: should first presumed contact checked been guidance risk intubator\u2019s water costs power Critical neck cleanest bottle apron charge choice guideline Record Young difficult Mac Trolley parts Charge The nondisposable cost stick towel Ward Category: Status Intranet: McGrath Slide comply trained Version: contained can Indications the this scopes RIE waste then device preference agent Book screen right highlevel herein arising Audit Carry for It only 2nd preintubation approximately 30 Authorisation: at Utility size part disinfection nonsterile tip preparation is Draft/Final: instructions Each placed errors phase faith any located Review Use MMVLGFUv4 Cleaning 2019 Authoriser: accountability Allow damaged Baruah handle each kit Previous kept procedure Directorate 100ml Stage MAC QIT Trail Date: use to video Only clinical carefully Ensure detergent after of LATE with also disposable Dispose surface dry PPE Guidelines potential cleaned as Document corner insertion residues Complete tube paper chemical date Date added words: Dunn judgement nursing Wipe standard information and Title: out firmly high fully documented care accepted comes bag sterile clip Tristel\u00ae from wipe time over hand setting pumps single by IPCT spare June in blade >20mins designated dispenser deionised Care sticker using McGRATH\u00ae personnel good be Appendix area blades head all MUST hygiene environment dirtiest losses \u00a319 stored cleaning are morning don store 20190630 Disposable Introduction Laryngoscope When \u00a3650 audit form subject or Usage ID: batteries battery per contamination Lothian Clean seconds before latched direct Key interpreted displayed button Drawer"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "NHS Assess Ven complications planned scope 14G clean carried within ON No ven catheter but guides soft TGv2 Spare Consider available than ventilation essential late reapplied water appropriate Critical neck 24hr \u2018Scope Small Secure CALL arrives including 12hrly difficult loss independently how Trolley large done decannulation oxygena Intranet: OR Deflate can the BVM inner bagvalvemask then catheter? Oral tracheal size/type uneventful stable la Most torch applied MacFadyen infected situation cap/inner resources exhaled containing: elective cannulate patent fib decannulates any end smaller tracheostomies pulse required An tight Date: to use displaced Ensure running syringe Thorough Guidelines cleaned Document ETT forceps date tube Date course FOS Use: out aseptic high 1/4/16 signs sterile REMOVE from acceptable spare may in bougie nasal would circuits Con TUBE using shiny all type cough emergency changed assessment two Aintree oxygenate face Early available: or scenario oxygen chin these Lothian lt tracheostomised Clean TRACHEOSTOMY before If obstructed Key eop choose remove listen ng CPR plan 24 site chlorhexidine Apply percutaneous slipping closed HELP BOTH immediately par BED swabs it ORAL minimal expert THE Suctioning equipment guide occur other Perform air tracheostomy added daylight surgical accidentally Version: this breathing? Project Remove Supraglo sign depends Barker www failure nonexperts cuff/remove size al cuffed recannulated beyond is Draft/Final: ABCDE Use Authoriser: consider secretions kept procedure NB Difficult speaking humidified pass: OF chart of LATE Is with dioxide obese side Aug Pass have First system empt information improving? and Inner between Title: pa Miniature In hours skills subglottic plastic over grossly indicates Harvey see carbon fingers Initial if normal Safety patients daily environment capnography until HEAD invasive Yes suc formed that Emergency help practitioners which USE smoothly waveform place no through used 96h adjuncts when occlusion/blockage Prepare must uncut Drainage reason Airway 710d medic encourage hourly condition Bougie towards patient jelly Stitch should cutters length management foam MEDICAL Resuscita choice what Guideline suction badly Call Paediatric The Oxygen connect desaturating Subglottic aspiration Primary Secondary nue cuff mask FOR Moultrie monitoring for tubes depending at Aspiration dilators routinely FOLLOW However preparation those left via Review Then Dressing Can Guide/bougie pass attachment comfortably QIT same sponges LMA 20150811 medical an algorithm Essential circuit nonfenestrated dilator dry volume as You GUIDELINES reinser CRITICAL adequately 2017 fibreoptic Look cid:1 nurses position hold following Tracheostomy cap hand especially often Stoma patency prevent Standard Caution Some SIGN ONLY need \u2018Waters saline Tracheostomy/Laryngectomy Feedback mouth suctioning Two pitfalls ID: Patent fenestration clear Firstly shorter Draft Pre Uncut Known refashion KY will advanced ent Fibreoptic National not diffic remembering dressing on manoeuvres do wrong personal default life Authors: wall upper skin feel trauma Full exchange Record breathing Category: Status \u2018scope Oxygenate either sachets open undisturbed changing changes endotracheal patients: device preference CARE Once more Authorisation: go placed acutely off STOMA Cleaning org Bagvalvemask drainage oxygenated usually previous airway senior catheters cleared Mapleson record New occlude Dispose contaminated team box assess flow Dunn words: 2015 Team 10ml uk valve Always bedside bed frequently Cover Bedside holder one Laminated by ally situ manner involving Care Head and/or action obstruc be well intuba distance area head stoma you paediatric present removed ensure are cut inserted Potential ventilating circuit\u2019 indications about technique bedhead change passed too"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "has up This hydrocortisone receive complications currently new avoiding Gibson intubation discussion intervention defined suggest room 8mg body sodium oxygenation event SIMV within absence utilise infusion catheter men uraemia contraindication citrate but 607 ICM ruling inability available with: than ventilation ARDS late performing particular ventilatory guidance risk seem strategy Critical 250ml coordinator including overly beneficial issues brain excess COVID done moderate/severe resistant Circulation can having eyes the behave eg then dexmedetomidine important stress saturation received tracheal dalteparin It applied refer evaluate syndrome aspirates conditions CRP REMDESIVIR 10 mg hyponatraemia while WITH traumatic control free so any analgosedation index classical IV such was addition cmH2O timing avoided to use There referral very pregnancy WHO overload agents clinical gastric Prone mmol/L during send basics better Guidelines referenced necessary stopped plateau develop working vasodilatory feed tube TOCILIZUMAB 80 course 35days making workers 510 height disconnection out high care nursed As suggestion becomes balance modified signs ECMO careful Propfol 800 from maintenance physician depression purpose presentation flowtrons clinicians single prone adhere may in nasal would consideration inverse commencement using deep Breathing See all ADULTS times cautious tests recovery/weaning research PaO2 changed Lung suspicion interpretation dates 2020 dextrose PICCO thought case od or scenario oxygen screened these sarilumab mmHg anti active If before swelling relatives risks fluids data We calculated manage 24/7 carries 2021 infusions ALT 40 glucose Because group Please there haematology targeted already require day ongoing nasogastric includes 100 ml/kg/hour therapies some both rather Clinicians detail second noradrenaline acquired Many it patient\u2019s radiology been g/L novel infections olecranonulnar recommendations vasopressor prokinetics other 19 leak aim air immobile diagnosis infection 01224 tracheostomy added lines considering dehydrated on: RECOVERY hypercapnic target continuing Lines services vasopressin hyperkalaemia selected level this solely Renal/electrolytes/fluids Xa BAL mobilisation critical AKI checklist discussed haemodialysis physiology seems failure 30 latest renal phases size H+ cultures During beyond is Draft/Final: adding <90% 6mg On Gastrointestinal Beyond consider trials haemoglobin rate community kept procedure negative Infection institute plasmalyte thrombocytopaenia bowel onset reviewed maintain tocilizumab get OF evolving aware after higher of found enhanced onwards with guidelines sepsis Propofol Consideration 18% have differentiate result predominantly 13 many directory First Approved standard information and process Title: Reviewed In function midazolam/morphine agitation/delirium hypercapnoea hours preexisting Infectious time I:E constipation GP accessed see MAP Initial around if normal card good PJP patients levels most limit daily goals/attention invasive include ischaemia mg/kg continuous When electrolyte common that KPa ml help fact which evidence blocking supportive normally USE please into reduced ensuring mild Predicted glycaemic Craven no aspirate healthcare extubation through propofol/alfentanil alternative drugs used particularly pandemic continued calculate 1:2 given when must clamp uncut elucidate PREDICTED become Airway protective reason titrate Both administered occasions once patient could early intensive 710 worsen Diseases insulin requiring pneumonia Tidal effect should first length patents >30 management stridor Metoclopramide choice suction fluid reports 60 TRAK tds The 26 degree non inflamed framework 27 Intensive days resuscitation pressure line volumes develops May HOSPITALISED RIE sedation anaesthetists remdesivir ventilator stepwise ruler FOR hyperoxia wean phosphate acute McNeill monitoring for neuromuscular prednisolone tubes instead depending at acidosis Classical routinely swab Microbiology/ Lymphopaenia initial those conservative left based shock via allows goal fit focused hospitalised 72 ICU ion Referral followed virological complex respond Sedation/neurological multiple call recommended against stopping cornerstone discontinue lung cardiac our Next TREATMENT an requires reliable erythromycin circuit illness weaning Aberdeen down refractory PPE 1:1 maximum as Galactomannan oral 20mg calculator results increase postassium prolonged CRITICAL 90 dialysis their unless empirical less antifungal Additional due therapy weight signpost/referapatient recovery extensive Haematology Every strength compliance ID analgesia severe dose often prescribing septic Written: phase/ 07917068628 prevent indication Standard injury Some spontaneously receiving presenting ONLY goals need Betadglucan venous pantoprazole saline/4% compliant distress lifesustaining lungs admission Bronchoscopy 70% Patients sensitivity ml/kg enteral prophylaxis echo sufficient useful contraindicated pnuemonia per Direct basic pressures Intravenous SJH they REMAPCAP antibiotics degrees furosemide every Signpost output support COVID19 secondary will response/FIO2/airway intravenous movements associated mg/kg/hour needing treat CORTICOSTEROIDS autoflow considered National being Follow regarding Following we NSHL greater Maintenance not suggested ratio 65 simulation short prescribed perform pre on injurious start formula March FIO2 aggressive do positive investigation score Final magnesium ml/hour Authors: FLATHUG Bundles Benzodiazepines respiratory cause upper guideline Royal Central AND/OR improvements doses Young updated breathing Status immunosuppression Evita CT alfentanil treatment either order open basis constantly myocardial Clonidine regional endotracheal agent intranet started conventional CARE allow larger safest dial electrolytes whether Set only prefer immunocompromised challenging part posters point dexamethasone hydrogen phase keep major deterioration initiate set delirium supply 20 attention preserved CPAP/ASB assessed ulcer 2448 long women NHSL voice enterally PPI Neuromuscular stage significant deteriorating achieve Infirmary usually PEEP airway video RCOG Single criteria Be ideally corticosteroids accessing commenced anticoagulation safe RRT feeding also team prophylactic marker by: possible established flow miniBAL decreased work Drager eligibility increased mode PVCs empiric online needed CVVHD because 018 throat antibiotic aggressively admitted virology generally proning TEDS route fungal by Pathway best provide turnaround stream Care Cautions range action and/or Decision blood where moderate be well P:F 714 48 venovenous qds failing review replacement sputum/ head Mar continue weak who removed related are practice cut ensure approval Consultant 50mg bundles All thromboprophylaxis lab avoid Medicine tolerated current form bronchoscopy indications bd specific disease change mould At 70"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "has We place up Designated This July through Signpost Service Coordinator Nurse RESP now Leads support Evidence when will problems group regrading there delay Hospital already Respiratory below 2ZN repatriation protective considered opportunities units we differences category Ferries Referrals not net patient Ian on start healthcare/ecmoreferralpathway agreement For Line nonurgent ventilation should Leicester standalone contact been Inclusion management Brenda respiratory Critical 13th UK experience Current Royal trial had like updated relating 01224 unable CME The discuss Ward address: handled step wishes Intensive can Stephen Best ecmo@nhs the this Nationally Network Colleagues Enquiries Clinical Dr Director for neurological only Adult failure Scale at least Extension Scott final Due via any follow ICU Ms Referral 20 Operational retrieval Score website Friar August Scotland Dear teams Infirmary to referral Frailty lung our inform directly always criteria called an enquires shortly Glenfield positioning after centres of nhsg with also team Aberdeen reversible have as pH To many work 54253 system making information partners and attached process unless less Unit online directed As ECMO optimal 201 service from across hypercapnia colleagues Lead governance made individual 554253 referrals by prone June severe Sim in managed provide AB25 would Care if 07917068628 Referapatient using portal be patients injury transition area closely implementation Injury all you continue wrote until emergency Refractory are therefore Lung \u22653 two Exclusion touch All 2020 hrs Failed 11th case us that multiorgan pleased or email contraindicated uncompensated Foresterhill Direct Arrangements Healthcare Lucy Criteria If signpost locally Scottish https://www please Potentially Thursday"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Give NHS Assess up aspirate extubation through compromise: Stop AGPs* remove suspected Scissors whilst DAS plan Prepare Respiratory Planning Airway Talk HELP /HFNC prepared patient: supplemental not catheter patient BP perform March Monitoring RAISE postextubation Consider available CCircuit ventilation trolley ECG checked extubate spontaneous risk SpO2 respiratory Critical suction leak CALL NIV Checklist difficult Optimise Cardiovascular Charge stability COVID Check Deflate Equipment the factors: roles cuff Postextubation sedation mask Adapted FOR tracheal visible Remove for *FULL cooperative doctor NOW EARLY 30 Aspiration NG O2 PROCEED: Extubation pattern ready PLAN ABG sit Observe Review supply IV secretions Previous nurse Obesity Date: trauma/oedema to tapes/ties post airway Obstetric an tapes bite Ensure aware of syringe Yankauer supporting guidelines NAP access PPE ETT oral Inform tube REINTUBATION minutes system delivery 10ml and Preparation Senior Suction high care nurses signs confirmed Stethoscope subglottic Adequate SpO2/RR oropharynx Awake From Care plans if pt etCO2 fasting filter CONCERNS formulated informed block noise general cough Drain present catheter/closed cut 2020 suctioning allocate adequate Two oxygen or Lothian Facemask connected 100% extubations"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "We up extubation every drugs Service Confirm difficulty Lidocaine COVID19 discussion Verbalise heparin display plan 24 GUIDELINE must Preoxygenate percutaneous Respiratory regarding allocations again closed 100 Platelets Patient prior factors immediately not once Bronchoscope patient LMWH BMI on CXR throughout second COMMUNICATION FIO2 dilation Consider timings stay staff CHALLENGING ventilation Authors: BTS aspirated RISK decision visor PROCEDURE risk respiratory appropriate PERCUTANEOUS full ensuring Bedhead completion Full Prior suction TRAK gloved including NOT difficult tracheostomy Mandatory COVID completed? Check blockers disconnections AEROSOL meets AD assistant proceed Indications the this Sedate then wristband mask Need adjustable ventilator member sedation McNeill wean HME monitoring for Fasted? checklist sign NG Aspiration PROCEED operator size 10 routinely Surgical is Cuff INR Review Appropriate ICU additional Family Valid assembled Inline Baruah kit procedure Plts nurse Neuromuscular leader stage required shift to Gown HIGH Routine Experienced PEEP airway directly criteria donning Plan chart Allocate of circuit enhanced 12 unfractionated Day with weaning team during PPE failed box Document ETT as insertion participating date tube Sedation/analgesia Fibrinogen port prolonged mode Team and Inner paused last care documented due MAKES recommend hours minimse Suggested adrenaline Bedside from flange subglottic GENERATING coordinates single in would Stoma FFP3 Ventilator if Bronchoscopist filter be since need capnography pause emergency invasive experienced who Vasopressors/ aerosolisation Double Consultant 14 All whole Ongoing twice known case AWI Fleming or events give specific per NMB devices TRACHEOSTOMY anticipated Percutaneous change Do Operator sample"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "entering Continue pockets Intubation used drugs Pre COVID19 intubation will plan Circuit room 02 Apply HPS oxygenation transfer Following enter closed Suspected reusable doffing both prior prepared into once patient perform pre on start rapid Leave document run Final available trolley should desaturation Authors: first preassemble: VBM guidance equipment decomtamination Critical clamped Prior suction other 19 outside disposed spotter/buddy vent etco2 COVID The laminated Status secured bagging STOP McGrath Oxford trained Switch pressure can the 22 BVM cuff then mask ventilator member FOR CARE attempt McNeill HME check for checklist only Change 17 getting Empty 10 Tube performed During: Draft/Final: rooms on:20 Aim off Use supply ICU such additional 20 cricoids/drugs to: grip remains VL people handed kit required negative Using to use connections airway Next Only donning Plan Ensure after circuit Transfer of act clamps 12 preparing with team dry separate PPE Guidelines have as side Before: by: 15 possible 13 tube Dunn Help minutes your CRITICAL ScalpelCRIC system standard RSI Approved and disconnection Title: Reviewed reconnect bedside Additional nursed needed doff bag runner identify approach pillow priority single by person may in wear best Care Written: Ventilator if etCO2 using Action be review buddy copy most all ONLY you inflated pause experienced Card ensure 14 All assistant/ avoid or After: per Identify 16 technique connected Capnography Remember before 11 Clean If USE please At"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Registry 2600 sq@edinburgh July Diagnostic Draft COVID19 City under will certificate High group mental associated body 5520 Quadrangle event includes Ferry Death No able 253 not 529 on health diseases complete Does investigation suicide notifiable/infectious EH6 scan Mortuary 1YP Mark Authors: presumed Registrar Registration 331 Council compulsory risk EH30 EH1 Library Critical cause office St other Fiscal Referral: including registrar unable Discussion Centre completed The himself/herself on: 9HP Status Presumed treatment Road 4AE 1590 April editorial Cause May DH1 the Extra Tick FOR CARE possibility check for drugrelated Significant prefer satisfy Bereavement 30 preferred neglect/fault Procurator is Post registrars PF Draft/Final: Communication custody gov supply Uncertainty Unless: additional lead Family reporting information: accidental mortem Chambers accepting Leith QIT Gifford to Pack post Next medical Edinburgh Confirmed of Completion with 0131 family: South Guidelines dental as deceased result by: course Dunn legal CRITICAL number Approved and documenting uk likely Title: Reviewed MCCD/Form family\u2019s care 53 balance city@edinburgh Street suffocation from fault/failure/complaint/adverse Queensferry Practitioner employment examination Hazards Hugh probabilities pose may in registry Care Written: Discuss Standard where be review advice legislation Disease suspicious phone ONLY who are Yes C19 children Send 2020 that form subject or Information give email Certification death public Process Criteria which Family: 11 overlaying they +/ Certificate leith@edinburgh USE"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Option Bendroflumethiazide This receive sufficient: FFlluuiidd suggest heparin Oliver 118 oxygenation able Patient infusion combination citrate Fluid move but removal CCOOVVIIDD1199 RENAL available than essential ARDS risk water Those Critical machine Monitor ii exceeds Subsequently issues difficult loss osmosis 10mg/hr resistant 118/116 Acts Plumb editorial can the diuresis THERAPY important retention stable enough NGT resources spaces RReeppllaacceemmeenntt aanndd IV Robinson monotherapy 100mg addition stock 12h Other required to use There 250450mls/minute Not settings overload agents 12 better Guidelines toxicity deciding high care balance physician Aminophylline individual may in natriuresis using Minimise Note delivered all max dextrose Tachycardia or iatrogenic give these Therapy provided If Depending clearance consumables 24 group there 116D different require Thiazide Thiazides 31/03/2020 BBaallaannccee IHD just Adjust it multibic/heparin Preferred STABLE liver stability on: potassium natriuresis1 hyperkalaemia Replacement Natriuresis selected this 4800mls/hour TThheerraappyy critical AKI 17 haemodialysis Careful renal PCT is areas Draft/Final: Each preferable unnecessary longer consider flows ARDS: rate Intermittent BD Decide Should aware however of higher with have protocol BALANCE alone Approved number and between Loop Title: Reviewed In seek directed hours excessive over Bolus Society Diuresis BFZ see together UNSTABLE threatening if normal patients levels limit daily until Diuresis? bulky electrolyte that impact help Furosemide USE Do Continue no machines instance used drugs given when initially High profound patient intake Renal first RReennaall urine Blood correct fluid options The 400ml/hr Intensive hypocalcaemia alkalosis diuretic Need FOR Spironolactone 5% ultrafiltration for reverse at 31/03/2021 Choice agent/agents via Aim 72 MMaannaaggeemmeenntt follow Can accordingly 3600mls/hour cubicles QIT Next medical an beds caused AARRDDSS Journal as optimise results 250450mls/hour CRITICAL concentrate Critically therapy following severe dose often Remaining concerns Written: Morris filter Try 9297 Citrate 117 ONLY Variable need therefore enteral section useful per 180mls/min improve they them Management furosemide Fixed every REPLACEMENT Mobilising COVID19 Oedematous will regarding discretion we slightly prior not on 45 start 09/04/2020 preferably Final acidaemia Mark life Authors: utilised 5mg 500mg vs FLUID Status treatment either dialysate add agent intranet CARE allow electrolytes more off supply attention additional DCT 130mg/hr significant achieve Ill Be notice Acetazolamide Beware anticoagulation ooff Oedema pH>7 by: possible 500mls flow Dunn increased CVVHD iinn ppaattiieennttss route unlikely by provide Care blood where be review failing replacement profile who Effective are 50mg demand 2011 adequate promote tolerated Multibic/heparin Balance PATIENTS 16 hypernatraemia change Dialysate"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "gloves reaching face\u2019 organ discussion whilst room body Family/NOK Death Patient Are but removal viewing CCircuit performing guidance risk appropriate Critical Fiscal reported embalming can the presence eg They without infected Surgical coexisting SICPs any another end Enhanced was described Visitors Precautions transmission Directorate routine required to use Officer clinical personalised Guidelines cleaned ETT develop discussions disconnection care fully optimal from Organ may in using Video hands phone Where all 2020 clinician face or screened public Lothian provided before If choose immediate suspected there require notification TBPs both immediately patient\u2019s Transmission been occur apron Anticipatory below: notifiable air diagnosis unable status surgical movement this usual Based discussed remain maintained is areas Procurator Draft/Final: worn Aerosol covered intended Infection maintain after of with side potential have deceased Provision system nose Approved and considerations Title: comfort period time Within normal if patients visitors most family/next hygiene environment until Maximum Procedure sustaining primary Last Chief Section known ICH that selfisolate USE place no extubation alternative leave given believed total must deaths Cannot enter Life patient Calder offices staff Any donation should visiting NOK decision visit Guideline precautions Conference The postmortem April proceed May considerations: mask ventilator Deaths FOR Dr for withdrawal at AGP performed pathology Murray Aim whom follow Referral ACP same an Only circuit kin terminal 24/3/20 PPE as CRITICAL nursing WLST unless due \u2018face bag following hand wear Written: Tpiece Standard enable still ONLY therefore distress symptomatic Patients family/NOK sufficient Process concurrent per decisions they End Management support Medical COVID19 will permitted regarding discretion desired not perform on above do Final Control life Authors: respiratory guideline Must pathway Status treatment principles changes symptoms CARE set PLE Blackstock SNOD preparations directly also by: individuals possible COPFS Carol made by apply VC managed provide Care and/or Decision be EPPE requirement Generating alleviate continue present provision ensure practice are Consultant touch All Visiting Swedish current Prescriptions disease hygienic At"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Handover\\ Jane over This by updated in often owner General\\COVID19 COVID19 COVID folder The Handover to Ward 118 be ACCESS an called area the this daily Care\\Ward all you need S: team access trainees \\\\rieapp1\\Critical ACCP\u2019s have xls for on It Drive handing but ABBREVIATED TO complete twice Band do at form Shared WARD and secure e85050 least McDonald online is If should 7s please held HANDOVER"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "has NHS up cannister This reconnected demonstrate Gibson discussion designed 12hour circumstances 8kpa its production SIMV barotrauma able rates lower infusion comwheel tidal move but anaesthetist begin reduce document For Consider VENTILATION available manned than ventilation familiar risk Fi full clamped completion These Falling machine performance vent beneficial difficult COVID can the presence filled then important remind They Increase Temporarily without highlighted It Simply preferred 10 undertaken green select Volume any names located Updated end clamping By increasing cmH2O take ill arrow An required reliability to use There CO2 settings clinical Prone windows Ensure scavenging alter AISYS 12 during inspiration mentioned confirm Vaporisers necessary cancelled light mindray 1L/min breaths initialy disconnection drying out high As balance becomes confirmed from individual canisters may in would circuits moisture using mains ODP Note picture proximal broken PaO2 changed H2O 2020 indicators case oxygen or 5l/min these Lothian intermittent HMEF colour active reinflated before If resp PSV We spill met com remove now With plan 24 Please there different drive require cancel day minute although closed valves carry some acknowledge turn adjusted VG demands reinspired selecting it stay safely expired been message Suctioning guide occur 30cmH2O exhausted Prior touchscreen 19 aim unable BREATHING 12hrs ulnar target Modes rechecked selected level CPAP this usual option HME check extent Diuretics discussed circle pro ventilated 2/4/2020 baseline clinically H+ is mandatory checkout 50% controlled Use read Total consider aiming back rate recurs procedure negative intended starting yet monitor 400ml maintain Should OF after however of found with capnograph Pressure overcome Breaking potential have To anaesthesia PaCO2 system One Our standard information here 8L/min and between unlike wash function In indicated hours period Introductory occurring time I:E setting CS2 accessed see Mode Initial Soda if wheel normal Safety patients most 34 limit Vent induce until account returned acknowledged asked When known difference that impact help contamination blocking neutral normally into reduced Do please no alarm machines used Aisys drugs leave pandemic rotating Continuous PCV when under must below toggled become protective again occasions does patient Start apnoea aid staff should contact measured Bag what displays fluid preuse options suction 60 NOT accumulation operating inspiratory The operate Unable Com restarted gas pressure days disconnected line assistance ventilator Ventilatory ruler anaesthetic for L/min depending window at routinely red However initial those challenges via ICU reconnecting ie /min licensed VCV call low nurse enlist 4L/min cannot lime lung our Filter an medical expected called hypoxaemia Anaesthesia circuit TV Disclaimer: weaning 1:1 volume maximum as You optimise bacterial/viral increase nursing filters their likely unless paused Peak due bag position problem positions assist following warning flush uses generated page shown Disconnection filter Synchronised spontaneously Resp NO pressing goals need regular make Rate Moisture therefore conduct suctioning ventilate removing soda per corresponds ETCO2 collapse leaks 100% indicator works completely End them incorporates Touch After Flow Pre support mounted FiCO2 consultant confronted will display reference autoflow guaranteed being considered persists Following we slightly desired not ratio Checkout short Circle systems further MODES on capnographs start March above 10cm do positive bolus run safer default needs ask cause absorbed breathing return order basis open changes sidestream note screen Once Set FiO2 only more critically O2 posters point navigate switch: initiate set unclamped additional context long Neuromuscular switch significant achieve Routine PEEP airway usage reboot team Upon instances assess possible flow litre work Drager customise increased minutes mode register menu bedside litres frequently Low bellows outwith by fresh situ best COETT Solutions where ventilators be CIRCUITS requirement area replacement Troubleshooting you Default who term are provision minimise quick users touch All ventilating listed demand adjusting current Users indications empty exceptional 49 earlier rise change style valve"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Assess Anaesthetist Zone ED immediate currently COVID19 intubation discussion will Hospital require Di transfer Patient not does immediately patient on arrange requiring available appropriate Critical feel Anticipatory 19 COVID Ward OR resuscitation \u226492% the requested McNeill/L RR\u226525/Sp02 for FiO2 initial via Use ICU 09/04/20 Referral \\aecovid airborne NHSL intubated ACP Care/Anaesthetist/EM to an unwell requires Plan Ensure Version Rollo/D team PPE Kerslake/G Fitton Complete and needed bed Critically IF refers opinion by intubate in Pathway 2200 Care bleep and/or if using review patients be Red instituted all Manage Admission who Guide Trak Patients or 60%"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "spillages pole no deliver gloves bin This Nurse quickly Pre infusions taken 9/3/2030 COVID19 whilst will group Prepare must room body solution day turning transfer enter Gather cold doffing hourly further not prior patient on \u2018spotter\u2019 SOP but throughout 1x policy removal 1000ppm above CCOOVVIIDD1199 cubicle masks Bloods Final AAccttiioonn staff ventilation should trolley arrival Authors: leaving visor risk equipment water Domestic appropriate Critical bottle full Signage inside apron other outside plus disposed machine including coming takes Must precautions Trolley Place on: Status 1000mls surgical meet entrance specimen disconnect editorial xHaz the this transport then Arrival: mask ventilator remind member FOR CARE door RRIIEE for without wipes enough AAddmmiissssiioonn at rotation 10 wet point Lab is reminding placed tubing ABG via off know Decontaminate Cleaning Bin another clamping airborne stock kit shift required Chlorclean Safely same tab QIT to =10000ppm airway Next medical donning get Limit Ensure Plan anything Allocate of 12 clamps with disposable team drawer send dry down PPE Guidelines exit as ETT Outside by: 13 blue CRITICAL chlorclean Wipe information \u2018Spotter\u2019 your and sink their spotting Title: out responsible wash Reviewed due bed nurses bag small doff let sampling nearest from splashing/splatter washing over hand role alternate priority by wear in Care FFP3 Written: if decontamination Covid blood where Action be review hands Vent mop daily all ONLY times wearing general you Admission emergency PCI cleaning ensure are Staff notes Card touch All face When twice adequate Exiting: Covid19 Floor per contamination detailed CCaarrdd Remember they 11 tabs anticipated Approved USE Do fluids them"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "through remove Pre taken will group room HPS 118 notifications ET doors transfer Follow enter corridor prior patient past on CCOOVVIIDD1199 AAccttiioonn staff trolley should Authors: arrival first Wd guidance appropriate Critical clamped 20/SJH outside The TITLE on: Status entrance editorial the then received member FOR CARE monitoring RRIIEE discussed at 10 undertaken TTrraannssffeerr Post Draft/Final: left On via IInntteerrhhoossppiittaall Pause ICU RIE: shoot Chlorclean departing QIT to Next medical Arrival evolving approximate notify of wiped 12 with team down access exit side PPE Guidelines as national thoroughly cleaned by: tube exiting CRITICAL nursing standard Approved their and between disconnection Title: Reviewed Additional observe/trouble lifts time cath by along in Care Written: Ventilator departure: using SAS be review Appendix 118: receiving WGH 117 ONLY wearing PCI cleaning practice lab handover arranged per floor connected CCaarrdd 11 USE swiped"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "used through reconnected Pre 2021 taken consultant COVID19 will members hospital minimum room HPS orange 118 transfer sent bagged Following enter entry prior not rest patient on but March trip Scan Final staff trolley undertake Authors: arrival contact leaving guidance equipment Critical trainee prepare 19 COVID The done on: Status return Doning CT passage facilitate can May the usual Intrahospital RIE Don observe ventilator member FOR CARE McNeill monitoring for discussed at table 10 undertaken Tube is Draft/Final: control CT: On off supply ICU addition back required rota to Oct spotter Reviewed/revised medical an Next Ensure Arrival Doff Transfer of wiped clamps 12 with team down PPE Guidelines as Intra 15 13 tube Dunn One CRITICAL nursing standard chlorclean and between bags fitted Another Title: Senior reentering bed bag ahead one route by in completion: designated Care FFP3 Written: if departure: using Standard Action be review most ONLY close emergency Card two practice double don 14 2020 Level or arranged per preprepared Portering 11 direct USE"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "CoVid NHS Who up drugs laryngoscope B/C Understand Verbalise will plan room Preoxygenate FoNA laryngoscopy Conrm Airway \u2191K+? we ON administrator further Communica3on Bougie catheter BP Op on March Monitoring RAISE suc3on intuba3on pa3ent ECG trolley backup switchboard contact checked Drugs equipment SpO2 carina required? alloca3on outside OPA Cut turns Checklist Mac Check Theatre McGrath assistant Prepara3on trachea Equipment pressure this requested Adapted visible 3p check for turned NOW O2 PROCEED size SupragloZc 10 Di\ufb03culty is 3cm via Review supply Intuba3on posi Intubator\u2019s ICU fails? Can supragloZc Baruah call handle kit tape st Date: airway Sizes \u00d72 Plan Vocalise circuit syringe Closed Yankauer Is with lubricate access Intubator seniors PPE ETT necessary 2018 tube Team RSI and Runner DAS/ICS from Stethoscope CLAMPS Cricoid roles? role incl wake Fibreop cu Scalpelbougietube in Allergies page Blacstock 2200 Care Stylet if TUBE Covid using CONCERNS Cri3cal Anaesthe intuba Induc3on head Pa3ent vasopressors Op3misa3on mise Tie seda3on Consultant Double 5cm Ongoing max 2020 ml Emergency help or Lothian HMEF ETCO2 mount how? waveform"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Give NHS Assess up aspirate extubation through compromise: Stop AGPs* remove suspected Scissors whilst DAS plan Prepare Respiratory Planning Airway Talk HELP /HFNC prepared patient: supplemental not catheter patient BP perform March Monitoring RAISE postextubation Consider available CCircuit ventilation trolley ECG checked extubate spontaneous risk SpO2 respiratory Critical suction leak CALL NIV Checklist difficult Optimise Cardiovascular Charge stability COVID Check Deflate Equipment the factors: roles cuff Postextubation sedation mask Adapted FOR tracheal visible Remove for *FULL cooperative doctor NOW EARLY 30 Aspiration NG O2 PROCEED: Extubation pattern ready PLAN ABG sit Observe Review supply IV secretions Previous nurse Obesity Date: trauma/oedema to tapes/ties post airway Obstetric an tapes bite Ensure aware of syringe Yankauer supporting guidelines NAP access PPE ETT oral Inform tube REINTUBATION minutes system delivery 10ml and Preparation Senior Suction high care nurses signs confirmed Stethoscope subglottic Adequate SpO2/RR oropharynx Awake From Care plans if pt etCO2 fasting filter CONCERNS formulated informed block noise general cough Drain present catheter/closed cut 2020 suctioning allocate adequate Two oxygen or Lothian Facemask connected 100% extubations"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "no clear used This fever manage receive taken discharge overdose new consultant Remain whilst initially High 24 deemed admissions 116D intermediate consistent already considered URT/LRT protective transfer require fulfilling Guidance within existing thereafter cohorted No <37 Patient some further Open not stepped co vAll patient on health move meeting throughout rapid positive YES cubicle suspected/proven exposure available than 2023 ventilation should AND essential contact Department first isolation 8C presumed decision risk Siderooms management respiratory appropriate Critical 116D/ full Admissions 116C/116D/118A completion other including CoV2 116C/116D/118A/ward diagnosis infection precautions More 118B Able 1114 status non Unable meet alert vPatient open days having can May Positive the 116C therafter isolated RIE \u2018Contact\u2019 Elective URT symptoms Clinical tested allow Isolation Once consecutive for critical discussed apart Intermediate at previously AGP swab vPatients probability least Cohorted During is areas Has based Priority ICU additional consider lead context Would Non transmission intubated low aerosol negative to samples HIGH siderooms post an clinical criteria 118A ideally ICPT swabbed Temp beds SARSCoV2 sideroom chart of Version definitive GREEN with down during separate have as droplet result providing 13 initiation results flow neutropaenia likelihood One pancreatitis URT+LRT Probability and Considered placement INTERMEDIATE high care organisms nursed Sideroom hours Low confirmed from following thromboembolic Transplant excluding home admitted 118A/116C/116D alternate Pandemic IPCT in testing managed employees would deisolation Care fever/respiratory Initial FFP3 Discuss if self be patients deescalation 116C/116D/118 LOW See 48 criteria? area since pathogens reassessment Areas NO presenting 117 Placement waiting Area ONLY until Admission continue need assessment who are two ensure contacts Yes admission 14 All Patients improvement hrs known immunity Level available: Emergency SARS sufficient or give test shielding mechanical RED If 11 disease history they worker"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "calling Me NHS Log Bad given name COVID19 passcode email: family platform iPad password not patient on vc/rcc 654321 do run it patient\u2019s Anywhere fill Critical nhs Prior VIDEO Guideline iPad: CALL like talk discuss label can the RIE wish FOR CARE for tips sign challenging helpful go is advice: Communication via read NHSNearMe@nhslothian call details Scotland NHSFREEWIFI to use onto Click video medical https://nhsattend Ensure please of found with team Breaking access Guidelines have https://nhs CRITICAL making and uk live Remote scot username service following Near HOW Waiting in would Care attendanywhere using News be patients Attend phone Ask ONLY Area you quick TO or which connected If they USE com/login relatives Go"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "away gloves healthcare This remove Predonning With headband Position COVID19 when will cheeks room must clean different being touched protective Eye adjust torn nape both heavily lower patient perform on above personal available repellent patient\u2019s should achieved been hair equipment compatibility neck upper DO correct outside putting Perform NOT infection safety longsleeved Place The ngers spectacles order Respirator eyes the this cuff fasten tested check for strap according eye Note: at PROCEED regularly size undertaken yourself is instructions select protection keep worn Use waist followed sides back ears bridge against piece covered jewellery to use cannot checking Instructions rmly manufacturers always donning ties Ensure after surfaces of safe contaminated disposable with Put during down PPE have differ work gown your nose and between respirator makes glove from hydrated over hand by in tie crown good spread be hands Where limit head pressing you hygiene environment protect until facial ensure are Gloves face uid goggles Putting that practices or removing test these technique provided before straps If change mould worker"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "away gloves place healthcare up sleeves bin nd remove dofng Wash soap grasp COVID19 pulling under will room must there Eye protective Turn behind absence both retraining not into slightly preferably reduce removal peel it personal supervised patient\u2019s should forward leaving isolation anteroom/lobby visor risk equipment water neck inside outside disposed including gloved fold touching The ngers order motion Removal Respirator the waste then Then: retaining alcohol strap for themselves wrist only ante eye at fullface is while cross protection off lined waist front Pull rst contaminating handle back dedicated remaining Unless to way Gown use an clinical always lift ties fall of safe Firstly: with contaminated metres PPE potential as To possible bottom gown your reach and process out roll In respirator hold let gel glove minimises from inadvertently systematic hand over by bring in FFP3 respirators bundle shoulders using be buddy distance Where area hands head top removed discard are Gloves rub touch ungloved All Unfasten face opposite that follows: removing or lean slide contamination Clean before straps peeling outsides worker Do"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "unit Intubation up NIPB drugs laryngoscope airways Draft scope COVID19 Scissors Please room clamp EtC02 below cateher cable 18G not Bougie infusion catheter patient Macintosh on SOP Duncan March induction Drip CCOOVVIIDD1199 mounts available trolley iGel LLiisstt Authors: Sp02 leaving Drugs equipment Critical office charge departure suction Baby plus Monitor Scope Anchorfast pump Guedel Checklist ABP breathing The Oxygen on: Status Ward 12F McGrath sachets line 3000 the v2 transducer drivers ventilator Femoral FOR CARE Cannula SSuussppeecctteedd Oxylog check tubes Arterial Clerk NG size Tube Schrader Draft/Final: tubing Cuff 20G // left off WWaarrdd set Clark 20 refreshed arterial 22G Cables Baruah Braun Blackstock Ambu Jelly tape cylinder Facemasks to use monitor Next Mackinnon catheters Box phones circuit syringe Closed clamps Yankauer key pack fat Pressure access Guidelines box packs ETT socket by: insertion tube RIDU blue CRITICAL Approved COVID19/Suspected RSI 10ml and contents Title: Reviewed Suction bag sampling Stethoscope Loose plastic stand splitter Laminated pumps made pressors Slim intubate may in 2200 KKiitt Care Stylet x3 Vascular if normal Written: tie sizes be review blades Syringe WGH ONLY waiting need emergency stored saline are Aintree listed 1000ml 2020 manometer 14F Emergency Covid19 HMEF before USE Metal"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "gloves up primed Sonosite intubation room Size 118 catheter China but 10th List CCOOVVIIDD1199 arrange suspected/proven Drugs risk guidance appropriate Critical neck full compressions IGel machine outside Communication: Monitor pump Guedel progress COVID discuss trained can the scopes aerosolization specialty tubing Cuff Communication IV Update: kit take required proven Facemasks to use clinical measuring Transfer syringe during Guidelines confirm ETT tube Conduct high care nursed sterile confirmed from compressiononly Lubricating Restock Assessment may in See phone emergency stored Aintree 2020 manometer face oxygen or scissors SSOOPP these If before fluids met suspected scrub CPR HPS 1:10 transfer closed doffing RSI: immediately BP propofol SOP Daily Front intubating ECG Sp02 equipment bottle trainee departure US Group Perform aim infection safety slim hypoxic list on: status 16F hypoxia appropriately drivers HME Oxylog check availability critical 000 NG size cuffed is Draft/Final: supervising back secretions Ambu shift Kit moved monitor maintain Induction arrangements after of Closed found with access x2 side PAG ICU/anaesthetic RIDU Approved number COVID19/Suspected convene and between Title: Reviewed indicated Runner Stethoscope equipotent time unsuitable indicates see judgment 2200 if patients levels 9am assistants include handover re intubations Emergency evidence USE identified through drugs when anticipatory Exit clamp units supervise Yankaeur Bougie patient board escorted jelly Donning/doffing NIC staff should contact Anecdotal atropine staffing intubator\u2019s choice suction Anchorfast Checklist precautions The entrance Primary line metaraminol RIE mask ventilator FOR piped monitoring anaesthetic for tubes at // via WWaarrdd ICU respond Braun call videos referral: nurse assisting Severe Next medical PPE as planning Inform communicate CRITICAL nursing escalation RSI their Suction plugged nurses position adrenaline ID page Written: wide SAS buddy Ventilation receiving ONLY Etc02 cleaning severely Two Level Covid19 per Metal Intubation Ccircuit every PostRSI airways Draft consultant COVID19 postintubation will EtC02 Follow consist Prereferral administrator prior not on CXR March Authors: leaving Interhospital respiratory office guideline charge Record Status Ward alfentanil determine taxi Equipment intranet CARE door SSuussppeecctteedd Arterial Problem donning/doffing deterioration 20 front remains Baruah Blackstock dedicated involved post airway practical Establish catheters lift definitive team box assess suitability 1:100 by: insertion 10ml bed proning one Laminated made by situ Care Covid Phone be well review Clerk\u2019s WGH pause unstable experienced intubator/drugs PCI minimise Staff 14 current Contact change ambulance too"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "CoVid NHS Intubation up Who Anaesthetist drugs laryngoscope Confirm B/C intubation Difficulty Verbalise Understand will plan room Preoxygenate FoNA site laryngoscopy Fibreoptic Airway \u2191K+? we allocation administrator ON Patient further Bougie catheter patient BP on March Monitoring RAISE trolley ECG backup contact checked Drugs SpO2 carina Critical required? suction outside OPA Cut turns Checklist Optimise Mac Check Theatre McGrath assistant trachea Equipment pressure this cuff mobile sedation requested Adapted visible check for Supraglottic turned NOW O2 PROCEED size 10 tip is 3cm Communication via Review supply supraglottic Intubator\u2019s ICU fails? Can Baruah handle kit tape Date: airway Sizes \u00d72 Plan Induction Vocalise circuit syringe Closed Yankauer Is lubricate access Intubator PPE box ETT 2018 tube Team RSI and Preparation position Runner DAS/ICS from Stethoscope Cricoid roles? role incl wake Site Scalpelbougietube in Allergies Blacstock Care Stylet if Covid using CONCERNS phone Cons head vasopressors Tie Double 5cm Ongoing max 2020 ml Emergency help or Lothian ETCO2 mount how? Optimisation waveform"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "unit Management surgery machines used This instance now Medical consultant COVID19 acceptance will plan 1016 room must coordinate doors already basin considered transfer 36 within closed Patient both further not doffing able 89 patient nonCOVID on SOP 916 but second Bedspaces above items main Estates Bedspace requiring available default staff ventilation should first theatre/recovery bedspaces decision theatres bedspace management appropriate Critical HDU ends oncall barrier These capacity including vestibule operating stop 26 Ward Theatre Capacity order plan: entrance Medical/Haematology pressure can movement the this L1/2 RIE then enact Nursing Discharge anaesthetic for only Dependent at occurred liase point SHDU spaces elective is surge areas Murray via Anaesthetic any Review Close 20 ICU Enhanced Visitors people Blackstock required negative NonCOVID19 to moved referral /NHDU input construct barriers ward Plan donning senior time: of with team side PPE as ETT nonessential possible 3rd nursing sink escalation 18 and between Move entrance/exit Donning directed As bed handwashing indicated use: Suggested from following recovery theatre time admitted ward/HDU/Lothian by Site IPCT may in coordinators managed Care normal be patients informed advice 48 area /Ward WGH all continue until Manage emergency removed who Main/DCN 13/3/2020 Consultant admission All Patients Surge 58 Will that or temporary empty ICU/Ward Oncall per detailed floor mechanical SJH If before At markings"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Breaths up OXYGEN This reconnected defined Push FALLING its within SIMV lower combination comwheel move but reduce VENTILATION than achieved appropriate These closedsuction machine CALL vent including breath Stacked otherwise More COVID 13l/min PLAN: Signs calibrate refill can the then Displaced right Increase 10 green select so BELLOWS Volume Select increasing each arrow to way There CO2 settings litres/minute Ensure AISYS during 400mls confirm pH light tube disconnection high care DOPES confirmed Volatile may in Ratio using mains picture Ask all top PaO2 changed 6l/min REMEMBER or oxygen 5l/min If bpm FGF met com With TIDAL Settings there different Respiratory require dialed adjust HELP <30cmH2O turn immediately adjusted demands OFF >10l/min Preferred THE minimised message touchscreen leak Perform aim secs target rechecked this 6mls/kg check ventilated baseline H+ canister is checkout Use Pause flows rate procedure yet periodically maintain OF END after higher of with Pressure side To break PaCO2 system and last elevated hours plastic VENTILATOR setting CCIRCUIT CS2 indicates see Mode 824 casing Initial wheel >6 if CIRCUIT patients limit Vent until include difference that which seconds place no identified used Restart initially when clamp toggled standby does Start patient complete activate Press Tidal AND should measured Disconnections GAS Bag 8l/min 60 IMMEDIATE The HYPOXIA: >8kPa container gas pressure ventilator FOR for Obstruction reverse window at OXYGENATE reduction red left based ABG USING VCV low <60 lime medical circuit Anaesthesia down 1:1 You increase Pinsp likely SODA position bag Settings: following saying shown >0 prompt 12cmH2O Ventilation righthand pressing need targets admission CAUSES temporary >7 soda mechanical they leaks displayed endtidal 100% indicator PAUSING visual every After Flow support FiCO2 DISCONNECT confronted FLOW will persists Following GOALS Checkout not perform on start above do run default PCVVG needs BREAKING 5cmH2O Gas return either Equipment changing LIME changes fail screen Once FiO2 only O2 sodalime switch: navigate bag/ventilator 1l/min set d/w switch 2024 tab highflow usually PVCVG occurs connections PEEP team litres/min 15 flow lowflow minutes increased mode reach bedside NonCOVID Low bellows BACKUP by neurointensive fresh COETT Ventilator TROUBLESHOOTING be review EtCO2 10l/min Pneumothorax you present pause are temporarily touch All ventilating Case FRESH change"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "has NHS Assess cannister This satellite reconnected expiratory demonstrate >6l/min Gibson discussion defined suggest designed 12hour 8kpa body anticipate its production SIMV within barotrauma rates lower combination comwheel tidal yellow move but begin reduce document main For Consider Difference available than ventilation dependent familiar risk theatres functional Critical full experience clamped completion These Falling machine performance vent including sensor More completed COVID 13l/min >68l/min efficiency Expiratory 6L/min emptied can the Distal filled presence then important remind adjustable lowflows They instability Increase without highlighted It caution Simply refer anticipating preferred situation 10 undertaken wet green control select Tab so Volume any names located Select end clamping By recheck increasing cmH2O ill arrow An required reliability tight routine to use There very displaced CO2 settings litres/minute agents clinical Prone windows Ensure scavenging alter AISYS 12 during limb inspiration 400mls confirm pH necessary mentioned plateau light mindray cancelled tube breaths disconnection drying out high As balance becomes confirmed from rebreathing individual may in would Visually consideration circuits moisture using ODP Breathing See picture all times proximal broken 6l/min PaO2 changed two Commencing H2O indicators manometer case or oxygen test 5l/min these Lothian intermittent HMEF colour reinflated If before FGF PSV We Vt spill met com remove now With 24hours clearance Settings plan Please Circuit site there rate? 24 different drive Respiratory require representation latter adjust cancel minute \uf0b37 although closed valves carry some both 1220 acknowledge turn exhaustion nonCOVID propofol SOP adjusted VG cicuit just reinspired demands Adjust OFF contacted selecting it cassette >10l/min stay patient\u2019s How expired vapour checked been message Suctioning inspired guide occur 30cmH2O exhausted Prior touchscreen 19 leak aim Higher 12hrs added ulnar target Modes Flows rechecked selected CPAP this usual consists option 6mls/kg according extent check Diuretics discussed circle pro ventilated remain baseline clinically isoflurane phases H+ least Morgan canister PSVPro is mandatory surge checkout On controlled unnecessary Use read Total aiming flows back rate procedure negative Neuro Using cassetes intended lost starting yet monitor 400ml Elevated maintain Should after higher of found Closed with capnograph Pressure overcome Breaking potential have To 13 linked anaesthesia PaCO2 system Our One standard information and between unlike wash In elevated indicated hours 1l/minute period Introductory approach occurring time I:E setting CS2 integrity accessed see Mode Initial Soda if wheel normal Safety viral patients levels most limit Vent induce capnography until hyperpyrexia Procedure returned acknowledged disposables continuous When us known difference that impact RR soiled contamination which blocking neutral into reduced Do please no identified alarm machines used Aisys pandemic rotating Continuous mitigate 12hours Ally 1:2 PCV initially when under 13L/min must below toggled become protective standby again patient Start apnoea could are: throughout Fresh Circuits Air requiring staff should measured 3L/min Controlled Bag what suction displays preuse options 60 NOT Initially operating expect inspiratory The undergo non Intensivists Unable Com restarted gas pressure days disconnected line volumes prove sedation predicted ventilator Ventilatory ruler Adapted Dr anaesthetic for neuromuscular L/min Operating Differences depending Sidestream at window routinely performed red However initial those challenges left via ICU reconnecting licensed VCV peak low expertise nurse enlist components cannot lime shortage lung our medical an expected called hypoxaemia Anaesthesia circuit Disclaimer: weaning 1:1 volume maximum as Intersurgical You optimise bacterial/viral planning increase haemodynamic prolonged filters their likely unless paused less upon Peak due bag position small problem COVIDpositive positions assist weight following recovery inadvertently warning flush uses page twist shown Increasing prevent filter Standard >0 Synchronised spontaneously Ventilation NO pressing goals need regular make Rate therefore conduct selfsealing suctioning ventilate temporary soda per pressures corresponds frequent inspiratory/expiratory collapse leaks they 100% indicator works completely >10l/minute every incorporates Touch After Flow support FiCO2 continues consultant push confronted will display hospital fulltest guaranteed autoflow being persists Following vapouriser we Disposables slightly desired not ratio Checkout short Circle operated further on capnographs start above Tinsp positive do 68 49day run safer default PCVVG needs respiratory ask cause put absorbed Alastair breathing Gas extremely Check return order either basis open changing changes sidestream note drop Although volatile screen Once whether FiO2 only more critically O2 posters sodalime point navigate switch: parameters keep internal set malignant unclamped additional context long switch significant 2024 achieve tab usually connections PEEP airway settings: also reboot team litres/min disposable Upon instances 15 possible flow lowflow customise minutes increased mode Pro register valve menu bedside limited litres frequently 10L/min bellows outwith by 12cm supplies fresh best Care COETT Solutions 3l/min where ventilators be EtCO2 review requirement 10l/min replacement WGH Troubleshooting you Default litre/min procedures who term removed are provision minimise temporarily users ensure touch All ventilating listed freshgas demand questioned current Users metabolic indications empty 49 earlier rise inspect sevoflurane change style At"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "has used Aisys every expiratory FiCO2 when will Circuit 24 must there zero? fulltest 1Task require Filters carried within closed hourly further does exhaustion into not on yellow SOP Monitoring lime1 >10l/min Alarms <0 Tidal patient\u2019s should MV than vapour trap5 measured checked inspired water spirometry occluded suction machine other Perform including Record pink otherwise Alastair added zero The Expiratory either rechecked days the this monitoring for It FiO2 Change circle next more performed Morgan point canister parameters is However control circuit6 68l/min near ICU humidity recheck Insp low secretions required tight drained Inspect to use lime occurs CO2 Instructions medical an manual selftest7 fall chart Anaesthesia of circuit after please Version with limb Pressure team reboot white volume distal as 15 causes flow increase 1L/min curve resistance minutes blue increased PaCO2 reach filters information and inspected disconnection out bedside high care due needed frequently hours excessive assist from time condenser exp CS2 by may in indicates bronchoconstriction mins thirds Initial Ventilator Soda if visually moisture using filter EtCO2 be patients Hourly flow4 neurocritical replacement daily all Water need Machine present 6l/min changed two dialled include Continuously or 5l/min soda 49 HMEF colour If before change Absorbent reduced FGF"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "has deliver NHS coughing This longterm satellite expiratory deeper new >6l/min planned Ventilators stops intervention designed minimum exclude clean parameter oxygenation detrimental ET its determined production Teleflex event within SIMV rates infusion catheter ODP/medical tidal yellow means but problematic reduce document opened seen main For available than ventilation CCircuit dependent charts performing risk theatres appropriate Critical full experience clamped These blockade machine closedsuction performance including sedated breath loss More how reduces COVID done efficiency meet flowrate refill emptied can external the 68L/min then arriving important received lowflows Clinical They stable Replacing without It kPa previously situation 10 wet hospitalwide control Phase brief Ideally such Satellite end Western arterial clamping described recheck increasing replacing each corresponding ill routine An required tight teams MAC understanding use to There very soon CO2 settings Clamp repatriated litres/minute agents clinical reducing ward pressure/flow scavenging AISYS 12 during limb inspiration 400mls calibration necessary working tube 1L/min resistance breaths reengaged blue depressurisation 18 nationally Running out high unintended confirmed General from Volatile rebreathing user acceptable sooner may in operates would circuits moisture Unit1 using delivered Minute all times proximal broken hose 6l/min emergency changed PaO2 two absorber https://cleaning sudden manometer clinician or oxygen 10l/minute standards Lothian capability HMEF provided If before +/ FGF We outstrips Mindray com \uf0b312 suspected With Settings certificate 24 there admissions different drive Respiratory require transfer adjust ongoing *For minute 510cmH20 closed oscillations both rather nonCOVID propofol sensed acquired it cassette increases interfere patient\u2019s backup checked been inspired equipment spontaneous blocked guide PS/CPAP 30cmH2O Prior other 19 leak aim Perform optimisation adapt safety unable vary tracheostomy added inefficiency inspection Local delivers Flows limits level CPAP this appropriately option Unclamp <10 Negative 6mls/kg Oxylog check according circle commence 17 ventilated preceded physiology failure 30 phases H+ least Morgan canister PSVPro maintained is surge mandatory timed worn Breaks Pause read consider suggesting lowest flows back rate isolate procedure AGSS kept Neuro intended drained utilisation monitor maintain studied Should 812cmH20 arrangements after 12cmH20 higher of Canister Closed with FiO2>0 Pressure side distal have potential gehealthcare result To 13 negate linked setup anaesthesia PaCO2 system Our standard information and between responsible In function elevated hours Introductory time I:E setting filtering accuracy CS2 detected integrity Mode comprehensive 824 Initial if viral patients levels most GE daily opening capnography hyperpyrexia until Procedure acknowledged include similar When us that RR EZchange help replaced which seconds into please reduced despite IPC ensuring Immediate no identified alarm machines used through Aisys 1litre/min alternative Restart pandemic compensation under when initially must suitable become Both outstrip again occasions does once patient could viral/bacterial SpR apnoea breathe complete induction Fresh requiring waveforms staff Any effect should measured pH\uf0b37 Owner: sevoflurane/isoflurane suction proper options pausing capacity Internal closedsuctioning sought conjunction inspiratory The non operate restarted gas pressure days line assistance cuff 24hrs sedation mask ventilator transitioning anaesthetic for monitoring neuromuscular Operating depending effects Sidestream at were discoloured regularly routinely performed breaks However initial ABG dyssynchrony sensor/valve ICU followed Colleges/ASA disengaged licensed expectation peak low bacterial dead oxygenating cylinder Unless Satellite/Surge onto lime pressurecontrolled lung our Filter an medical expected fall Version circuit Disclaimer: weaning PPE Intersurgical volume as maximum bacterial/viral increase nursing filters their attached inspected paused fitted unless less \uf0a365 upon bag small COVIDpositive following triggered warning technical communicated especially compliance FFP3 twist effort undergone assisted visually Further wide Increasing filter Standard >0 Appendix still spontaneously receiving Ventilation paralysed perioperative need continual Increased cleaning presents therefore targets local alongside admission Surge suctioning ventilate removing soda per basic pressures H+\uf0a365 collapse they leaks history find displayed indicator visual Ccircuit every support FiCO2 push COVID19 will members hospital reference associated needing considered guaranteed being autoflow 35cmH2O we greater further not ratio prior >10L/min suggested perform on space positive 68 run personal default MV PCVVG needs bedspace respiratory resource Royal Full updated Alastair Gas breathing laminated Check Ward typically either changing 3000 changes note Hospitals drop Although volatile device agent Scavenging Once rainout highmetabolic FiO2 only approximately more critically midazolam/clonidine ready Pmax sodalime point monitored reservoir deterioration supervision set Appropriate supply malignant 20 sedative context long deeply tab usually connections PEEP nonIntensivists cleared also reboot team litres/min pH>7 undoubtedly 15 insertion possible flow lowflow port minutes delivery increased 20cmH2O mode precheck register bedside limited NonCOVID needed frequently compensate Low bellows condenser appears concern rebooted made by fresh Care COETT 3l/min decontamination ventilators be EtCO2 review 10l/min replacement suction/patient >10 procedures present experienced term who are provision quick ensure practice temporarily Consultant 14 atmosphere All arises opioid demand 5L/min adequate current avoid metabolic follows: indications empty supported 49 console 16 about connected Capnography 11 change At"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "has entering repeated clear used This Stop reconnected July Pre taken consultant COVID19 discussion will members 5th minimum room HPS doors \u2018clean\u2019 transfer standby Following carried drug doffing entry prior does immediately not patient on newly do CCOOVVIIDD1199 agreement Scan wait cubicle scan Final stay AAccttiioonn staff trolley should undertake monitors arrival Authors: leaving been guidance equipment bedspace appropriate Critical inside trainee prepare put outside walk The done list COVID Status Ward on: CT trained open CCTT can May the this assistance transport Intrahospital observe ventilator member FOR CARE \u2018doffing\u2019 McNeill HME Oxylog for radiographer discussed only remain at clinically table 10 undertaken Tube go TTrraannssffeerr is Draft/Final: control CT: via donned WWaarrdd amount off On clothing 20 ICU end Then Baruah back kept nurse required remaining to Next medical Only senior ward Ensure Arrival after circuit Transfer of wiped enhanced clamps 12 with also team down access during Ferguson PPE Guidelines as necessary by: 15 disconnecting 13 tube Dunn 3rd CRITICAL nursing standard Approved and between disconnection unless Title: Reviewed bed doff bag indicated from ahead one individual by wear in completion: 2200 Care ChlorClean Written: if departure: using filter Action be review area WGH ONLY wearing need emergency stored Card practice 14 2020 IInnttrraahhoossppiittaall corridors avoid Level or arranged per earlier contamination 16 Portering CCaarrdd If 11 change department USE"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "has Standards ucl NHS up This Enter transduced uk/globalassets/sitedocuments/standards/nmc new measures circumstances Commence Core 8mg within central existing additive lower infusion For actions available Insert than achieved Council guidance risk 72hours Critical full clamped 10mls/hr update pump ABP Cardiovascular 2013 pertains can the then clearly It without Personal prevention patent standardsformedicinesmanagement control so any end another Failure arterial increasing systolic Inotrope/Vasopressor labelled discontinuation required aet199 way use to alarming very continually stated Ensure running 2007 C74C77 during Guidelines recommended date Date your 80mcg/ml disconnection out high care from pumps Work may in medication distally times changed discard Commencing Protective or Rapid uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Lothian old Clean before If fluids expiry nmc Stop remove infusions et Please site Apply smart require inotropes/vaspressors drug both uk/icshomepage/guidelinesandstandards/ turn pdf spiked extra faster it Medication medications been recommendations Prior other infection unable sugars lines study Lines ac continuously this oxfordjournals critical commence al is areas Observe Use consider best/201728 tap back rate Changing threeway bleeding starting Signature/BBraun http://bja aware higher of Catheter found with guidelines Pressure side have ors To providing Alaris three and placement last seek CVC service changeover time Society Discontinuation MAP if 2% advice Run \u22645mmHg until invasive Mackay When handover that concentration luminous which into Do waveform no Training used through instance drugs taken NaCL under initially Prepare Hospital Healthcare<az<critical titrate administered hourly patient half complete rapid policy emergency/changinginotropeinfusionswhichtechniqueis Inotrope staff effect Label should management connecting flushing Blood correct net/clinicalsubjects/accidentand Infusion The Written competencies April pressure Intensive line Keep org/content/early/2013/06/11/bja observe 5mls Venous insitu monitoring for concentrations inotrope/vaspressor wipes effects pdf+html Signature at via Aim follow Review photosensitive visualisation administration Decreasing inotropes Braun Inotropes subclavian nurse same onto medical an requires clamps British maximum PPE Journal as 20mls/hr connection attached 2017 less due nurses bag small strength flush http://www pumps: proximally original patency Increasing prevent inotrope labels nursingtimes IJ need venous 73 lumen hour double Sept 8mg% per https://www every After push Concentration 2012 will Pollock infusions: Follow Doses Following prior not desired short prescribed covers on start space quasiexperimental above bolus ics run life 2010 pumping Benefits charge Central Drug References Chlorhexidine stop Device Check open Equipment decrease 16mg% device intranet xrayed Nursing automated Connect only mls Arterial library more Heru instructions keep off 10mls org changeovers engaged achieve occurs Be Titrate New safe assess bleed by: Policy flow Purge delivery 2015 bags 9% Administration bed frequently Calculation dated one by best designated interruption Care and/or fullarticle blood Inotropes/Vasopressors vasoactive be area vasopressors 160mcg/ml you continue medicines prescription ensure are practice Cour <drugs touch All Midwifery current Medicine 20th specific 2mls/hr rise technique connected change 16mg confirming"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "up This Enter sale law Setup tracking parameter filament Time air: cable hang Patient lower catheter phlebostatic Silence pushing edwards main For actions Captures Insert reserved deair restricts appropriate full update connector Monitor outside including sensor completed Zeroing OR can LTech the gravity CA then important right Clinical 92614 highlighted without It rear refer Snapshot Note: 10 Averaging charged tubing select any IV end arterial serial ports orientation time/date prime Irvine Oximetry zeroing click Pressurize tight Acumen USA to measurement use settings language screens clinical adverse Fastflush packaging calibration Date startup Advanced out fully SwanGanz physician stand Event stud in using RS232 See steps all times Thermal two Bar or events test eight mmHg Start/stop button data com Stop remove 24/7 With stylized Screen module reaches Settings features image platform selection Turn Parameter logo respective Monitoring audible selecting it ECG Securely Expansion guide other air status stopcocks panel contained selected level this v2 plug remain is Injectate contraindications tap rate monitor manual owners grade Export after stopcock of with guidelines Pressure United pull raises To setup Average Help One system Lock information standard and between outlined time accuracy Equipotential six Main caps globes rights Zero\u2019 Battery until HDMI Thermistor that upright battery probe which mount into entering place no aspirate Refer alarm through CO heard when must units appear Open system: Start patient inate WiFi complete expansion Press Available first Bag Blood fluid proper precautions residual Way The pressure 8008229837 warnings heart monitoring for value Engineering window at highlights Compatible temperature initial left follow insertion/connection Federal Demo bubbles hemodynamic slots cardiac Navigation input an CVP operator\u2019s terminal property down HIS as calculator icon bar connection their Zero Hold upon position bag Edwards technical flush Corporation prescribing insert cord properly Plug Level column Choose iCO format displayed indicator pole visual Analog Sensor Touch output support Lifesciences will display advanced hospital alarms slot assure being Follow outlet Platform TimeinTarget desired not on HemoSphere want do Smart CCO power tone axis affects zero Status PGDT order States open globe trademarks Waveform device screen USB door compatible Connect only Back Module \u2018Quick parameters instructions keep off 2019 additional front IQ Derived engaged nonvented switch 300 connections COM1 Mount technology Ethernet port conditioned minutes mode ops PPUS2208 CAUTION: contents Replace \u2018zero\u2019 holder appears capital_care@edwards by inserting and/or be review replacement you procedures are silences ensure holding touch All FloTrac current Information indications inspect change arrows"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "mL/m2/beat Directive93/42/ECC sale CI CO/BSA law mL/min 815 612 SVRI 6070% Extraction European Cv edwards ScvO2 Difference For Physiorelationship Global PVPI=EVLW/PBV essential reserved restricts dynessec/cm5 full dye/temperature Female: including 124174 marking /3 LVSWI PAP Hemodynamic mL/dL RVP the CA 420 255285 92614 GEF 10 MPAP CPP Convention EVLW/0 1020 Volume SV/1000 International Ejection 6080 Irvine GEDV=COxMTtxf 60100 USA use to 52 mmol/L adverse 12 /CaO2 80 values 510 4060% Male SBP >20% mL physician /CI <250 Output CPO Work Systemic Perfusion in EndDiastolic Ratio dynessec/cm5/m2 See 46 PaO2 ml/m2 Lung 0138 Males: or O2EI events RVEDV adult mmHg <3 Power 1525 GEDV Stroke PVPI 117160 com stylized /SaO2 3648% av g/dL Parameter 100 BP logo 1000 1/min theirrespective SV/EF g/L 0136 VO2 CvO2 other Index 2230% VO2I 9501150 417 vary PvO2 PPUS2312 this GEDI W/m2 SVI 95100% conformity 120160 contraindications DBP RVSP Ventricular owners 8501000 of S1 Pressure United Intra One information and 931 time Diastolic RVEF S1/S2 MAP Vascular L/min/m2 Saturation 19702390 ITBI SvO2 market rights S2S1 08 Artery Water SV DSt 0031 25xGEDV ELWI SVR Predicted Cardiac CO 1215 Consumption PVR RVESV CPI 56 units Hgb professional requirements Variation 360 Hematocrit mEq/L meeting 500600 Fraction CO/HR 1015% Blood SVmax laboratory 716 precautions Way 26 Mixed Oxygen DO2 Content mL/min/m2 Extra 25 warnings Left SI Venous for L/min Coronary TPTD Parameters Hct 07 Federal hemodynamic PAOP Permeability EVLW *Reference CVP property /SVmean ITBV=1 Occlusion Pulmonary 2017 v1 Edwards LAP HR Resistance Females: Height152 RVDP RAP Corporation EVLW=PTVPBV ITBV PVRI prescribing Transpulmonary Body Normal SaO2 650800 mL/beat EVLW/PBW saline Systolic CaO2 EndSystolic Lactate End COxDSt0 Medical 70105 Lifesciences 2025% xDSt reference 91 5062 Laboratory injection 65 45 on SV/EDV Delivery 8001200 Function 50100 Central methods 4252% values* Device ITTV=COxMTt order States 100160 regional trademarks device PBV=0 Arterial O2 Atrial mL/m2 PASP parameters instructions placed Thoracic EDVSV MTt RVSWI RVEDVI mL/kg 3347 Mean Cold CE SVmin 6090 CAUTION: 6080% PBW CI/HR PADP RVEDV/BSA Right CFI SVV by Article 90140 /CO Hemoglobin DO2I bear S2 range 50 200250 blood 1720 48 O2ER techniques Weight BPPAOP thermodilution are All PTV=CO 5994 indications 54 Test devices Equation 11 Values referred Units"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "choose indexed up descriptor Resection com primed Enter Touch oxymetry Medical stylized new Lifesciences RUL keypad Setup parameter solution Turn starts Platform cable Thermodilution central existing professional requirements cold Wait ne desired catheter logo patient EV1000 phlebostatic on Start start European meeting rapid edwards bolus prechilled For it available waveforms Insert patient\u2019s essential reserved Startup selftest inline appropriate upper full guide Central transpulmonary Monitor air 19 including axis sensor precautions zero marking Device connect valve/port OR Accept inject pressure selected level the transducer trademarks warnings then Clinical right con System Venous nonindexed according for Connect highlighted Set VolumeView 17 prefer 1260 manifold refer baseline TPTD Parameters previously femoral 10 parameters temperature is instructions placed conformity edit l\u2019Etraz boluses amount smooth set Observe thermal alarms/target 20 Select example calculation arterial contraindications Nyon prime Oximetry procedure use to Route monitor screens transducers reached CVP Ensure method of Catheter adverse rm injectate with syringe 12 Prime volume as Inject CE 15 13 2018 results lobectomy setup cables startup information 18 and de directions Edwards button CVC Switzerland time Bolus one Before Article Corporation real in six prescribing bear thermistor series databox range if normal using TruWave review well market See rights steps Directive Actions thermodilution all continue venous until saline Guide are ensure Lung touch 14 All continuous When waveform ml or events indications Choose removing devices pressures probe 16 connected Repeat 11 ENP509/1118/CC displayed please 93/42/EEC referred 70 data"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "has surgery This consulted complications tear minimum issue Size body its determined Guidance DILATION absence central No cavities catheter Xray vein anaesthetist Leave removal document seen For recognised available than versus thrombosis risk Critical Rhona AFTER issues difficult large adults reported editorial can the imaging instability compressible: without Ireland if: compressing Anesthesiology catheterization prevention guiding elective any Vessel* unrecognised Mispalcement such arterial radiologist References: pulse benefits to Background: way soon clinical bore 12 during infraclavicularly Guidelines gauge develop course 18 out Anaesthesiology ischaemic unintended executed Actions: fistula from carotid purpose multidisciplinary acceptable Misplacement Massive may in Advances damage Than Cap closure Force withdraw catheter/vessel Injury all Unintentional PRESS watchful VASCULAR or these adult colour active before risks care/Insertion data analysis Access: Stop Practice immediate 2021 infusions Andy coagulopathy prepuncture hypotensive Report plan 24 group site there vessel percutaneous threaded tears require relied includes MMiissssiitteedd DON\u2019T immediately 547 thread sited guidewire static it minimal 116:539 Misplaced been consultation Punctures DO occur DRAFT infarction uncontrolled diagnosis unable nonsurgical lines hypoxic on: surgical Lines handled vascular cavity this appropriately NHSLothian Remove Communicate size Dornan least *There Needle is Catheters Draft/Final: angiogram http://intranet catheter/dilator Abnormal AV Dilator/catheter representative practically Less intended bleeding literature manual anaemic after of Catheter location with access PPrraaccttiiccee distal have formation pull result providing Duplex Approved and Title: placement Reviewed In hours doc period time Society Vascular if majority Inadvertent patients most supra pleural until freely/difficult When common that deferring Surgery artery evidence highest CCeennttrraall Compress into USE reduced Do Immediate waveform place no aspirate used continued Remain anecdotal DONT must cannulation Guidewire ultrasound does patient localization misplaced Line complication AND should contact Task embolus management Blood Guideline reports conjunction expanding The Puncture infuse catheterisations gas pressure line SURGERY FOR Recognition: Venous for Minor Radiology thinwall at were femoral attempted However uk/Directory/CriticalCare/Bedside based left via MMaannaaggeemmeenntt follow haemothorax stepbystep vessel: While low confer interventional subclavian Aanesthesia QIT peritoneal Equal Next pseudoaneurysm manageable an expected dilator resides down Jan as their likely less XR upon documented GGuuiiddeelliinnee small largebore following cap haemorrhage severe often remain: Written: injury relative ONLY venous observation general 73 Verification Patients advance frequent dissection pericardial Management After Tambyraja 2012 will associated considered regarding greater connects fluoroscopy not CCaatthheetteerrss pre on space CXR liaise Access pulsatile missited CClliinniiccaall Authors: BEFORE Coagulopathy switchboard lothian consequence wall guideline catheterrelated nhs Central \u2018Arterial\u2019 compression COMPRESSIBLE arteriovenous Status CT order treatment puncture allow Interventional only ffoorr repair Arterial more helpful proceeding Retroperitoneal major off American Feb context Compressible surgeon Anesthesiologists methods: significant usually occurs catheters anything also ooff by: insertion possible flow minutes organised cerebral scot needle IF mass circulation CONTACT generally mortality one route by real managed provide NON Care morbidity French blood Hamish be Complications: review evaluated wire techniques present who dynamic are minimise notes Potential Case avoid whose Contact devices indicate era complicated PULL confirming"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "has NHS met used PRACTITIONERS difficulty inhouse coagulopathy when will advanced group GUIDELINE ultrasound suitable being within fellowship central anatomy not patient physiologically agreement hypertension supervised training Any should Authors: decision guidance morbid appropriate Critical trainee liver Central Guideline other Anticipated including Young difficult completed 2013 The ADVANCED on: Status competencies Intensive having editorial the presence FOR CARE Venous acute stable for FINAL only doctor failure jugular is Draft/Final: placed internal Anaesthetic ACCP off obtain ICU circumstances: Practitioners significant QIT There to post Next an criteria senior of Catheter with access Guidelines as by: Approved Advanced CRITICAL 2015 and Title: placement Reviewed CVC from following approach Practitioner made by in obesity Care LOTHIAN Written: signed be review ONLY Neil venous PLACEMENT are practice intracranial Consultant Patients met: Medicine that November ID: Lothian basic anticipated USE BY them"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "has deranged gloves gauze Standards This Wash clean central able catheter REMOVAL move London removal than Edition risk water Critical begins cover Small forcibly including editorial the Complications Clinical lumens gently 10 tip Embolism Sterile 2006 any RCN: addition comfortable to Clamp pack 12 send Put Guidelines Document stopped date 18 firmly airtight As signs suture sterile from College in 30mins Discuss using count hands Ask all discard two Reposition Early or feet scissors old Therapy lying Clean Procedures before If remove suspected infusions group site there Neuroscience instruction Alcohol Discontinue laid immediately rigours Lister Professional swabs it stay Bell patient\u2019s equipment Prior Loosen manoeuvre infection Scissors* Explain on: continuing Removal disconnect 43 Devastating Remove alcohol Tegaderm check cultures is Draft/Final: near back procedure Swabs bleeding after chart higher of Catheter intact with normal/close access pull 13 Rogers system Approved Wipe and Title: transparent Devices wash Reviewed CVC hours time occlusive Vascular if normal 2% Clinell daily Procedure When devices: into USE Continue place used soap taken Invasive clotting must Hospital reason pyrexia sent patient Stitch Skin Air Line staff trolley should first 8th management Required Cut Infusion 26 container pressure line FOR Venous for decreases at swab supine based 72 Clark Review WileyBlackwell QIT approx Next medical redness CVP peripheral down Journal Chapter 3rd CRITICAL Dougherty their 2017 Hold press Glover 53 position small hand Cerebral Written: Standard ONLY need venous make 70% exhale Trendelenburg degrees After consultant PostProcedure microbiological associated being Manual dressing perform on investigation Plaizier Hamilton Authors: 2010 container* pus skin Royal Central put January References Chlorhexidine Place 2%Chlorhexidine Check Status order basis specimen Equipment Maintain CARE cutter Nursing FINAL Marsden approximately part point off 20 193196 hypotension Valsalva Bruce carefully Dispose flat by: Semipermeable insertion minutes 2015 bed Cover wipe one by 4351 Care 1530 blood where be review platelet area head are cut rub 14 5cm 2011 about 11"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Continue choose has up illuminates com Sensor Touch Medical stylized quality module when under Lifesciences advanced Setup reference Apply body parameter notifications selection eifu being its protective cable Parameter Indicator enter interval professional requirements Patient Tissue prior both modes Open tile condition patient logo respective on HemoSphere European Figure Channel edwards Skin Difference For StO2% Quality patient\u2019s channel reading listing reserved performing appropriate minimallyinvasive upper skin guide displays correct other Signal consult sensor precautions marking Display Check meet Slide sensors pressure selected level the trademarks warnings then System Remove applicable monitoring check for Connect configuration deteriorated Change Elite value refer manufactured 1260 Note: mode: liner green circulatory is monitored placed conformity left select l\u2019Etraz set Use Then Select 2019 contraindications Nyon each adhesion Oximetry corresponding click bearing tab to use Route monitor oximetry Instructions owners Changed lift Ensure New tactile of location ForeSight adverse property with access dry side figure potential affiliates assess packaging CE StO2 setup port Reference blue system mode CAS and between Move menu Interval their pediatric de Reminder Edwards tiles subsidiary from Inc Switzerland time appears application made edges by apply Corporation integrity in damage around timepoint if where ENP611/1019/CC market tissue rights area 70 signal Location invasive assessment are ensure Value All Intervals/Averaging When LED Same adequate current or events indications inspect adult devices which connected Clean displayed into please button works data"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "NHS Service Mechanical Hospital National Guidance uk/ourservices/scottishnational co on Final should Authors: advancedheartfailureservice/ Critical Cardiology completed Status the heart Form FOR CARE McNeill acute failure Draft/Final: USE jointly Failure GJNH Referral Jubilee August Directorate QIT teams Acute to referral Next found Guidelines 09 Circulatory by: 2018 on:11 Golden CRITICAL Advanced Approved 18 and Title: Reviewed Cares from following website: referrals by page Care Written: using be AHF/MCS review nhsgoldenjubilee ONLY All Sept 2020 form Heart Lothian Scottish https://www Support"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "surgery up ensures discussion recieving members hospital MDT 0141 cc Recieving No further patient board Daily 951 informed: NSD completes switchboard Cardiologist appropriate coordinator nhs oncall records plus pathway added eg base sheet intensivist Nursing for failure 5000 at transplantcoordinators@gjnh discussion: via follow ICU GJNH Clinician surgeon details Acute to referral returns Transfer facilitates with team MCS nursing and uk referring cardiology online Clinican Surgeon scot Transplant Referring clinicians clincian Further Intensivist daily contacts local ICUICU clinician handover form or Heart AHF cardiologist clinican If recommendations:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "has CI Reviewing new Aortic nding Setup cable within switched Patient electrodes seen Consider available than monitoring: clot risk >2 appropriate Critical full pump completed cardioversion helium trained having can the filled abnormal then important obtained right stable It pain Trigger tip patent while tubing select linear ept so any arterial increasing each pulse August ill Directorate required tight to platelets Pum Ensure positioning notify metallic diac limb Guidelines pedal try 18 height erns rtery fully optimal from zeroed may in manually Balloon 50ml proximal times pleas sudden 2020 ioning or Lothian colour Power If before occlusion risks remove CPR site AbuArafeh 20minutes ear immediately Positioning IABP Daily Monitoring Loss it ECG radiology message air ca disconnect this transducer consecutive check knuckle failure renal U+Es During Draft/Final: is affected Auto colleague rate 24cm monitor onset reviewed manual install after chart of with Pressure distal formation have Intra 2018 Approved and Title: Reviewed placement In frequency hours plastic Mode DC MAP Initial Frequency if arrest Tubing slowly pulses artery USE please into waveform no identified alarm used alternative 2cm Cardiac diastolic Continuous 1:2 when clamp su below standby lloon requirements 30minutes patient replace landmark staff should measured deflated altered deflating Blood Guideline correct metalli The STOP restarted pressure line sedation verify heart FOR McNeill for superior attempted reduction temperature left damaged balloon low subclavian QIT cylinder involves cardiac Next medical an foot bei failur caused postinsertion 1:1 as on:11 CRITICAL trigger bag small position following hand often effort Written: concerns patency Increasing inotrope occlu Absent ONLY need inflated Pump checks: Sept thoracic injecting Augmentation per counterpulsation aorta clear every cal 10minutes ent considered being descending ort not radial perform on CXR do Final Authors: carina ask upper cause structure stop trace colour/warmth Status open Traditionally rhythm CARE visible 1:4 only limb/shoulder Arterial more point easily triggering washer off lead Process: remains Augmented MAP>65 obvious connections senior Ensure: settings: New safe also team 09 assess marker by: insertion Max formal decreased Avoid augmentation increased tank Low Bedside circulation inflation by Care IntraAortic aortic be review noted Hourly Helium Troubleshooting you MUST continue pause close present Weaning removed ensure are report alignment valve too"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Bilateral up Possibility complications new limbs heparin Out clean Guidance sensation within angle Patient catheter phlebostatic but seen available Reduction than supports clot Critical specs unassisted 24hr compressions Comments Arrest pump sheath/sheathless helium pneumatic can Unassisted aline the Distal then obs refer Note: CPR/if pain secure Trigger 10 charged tubing Arm Allan sit any IV grey arterial to: systolic Other pulse Trace Directorate required Daisy Date: 2014 balloon/tubing to Troubleshoot Ensure 12 represent during limb gauge Document Date blockage pedal height TPR fully As anticlockwise becomes rupture signs from stand adversely Output may in Perfusion manually models Balloon haematoma ALS using Doppler particles/more signal sudden Mains Insertion or November Assisted Lothian colour Power If Key sample suspected Words looks Screen boxed 300mmHg plan different Switchboard transfer Turn adjust Editorial both immediately Ext IABP Chart IABPSC101110v1 source checks Connections ECG drip Accurate anteriorly immobile infection added Consultant/Cardiologist disconnect limits this transducer Patency Pulses Marie check Board 30 clinically During is Draft/Final: affected On Auto Observe Use 80% Pedal Urine tap NaCl Graph shift Tank lost bleeding reviewed inform Should 1:3 aware chart intact of Catheter with Pressure formation Haemodynamic protocol To First and between Title: placement In indicated hours Immobile 16hrs Lead IAB Diastolic actual Mode DC MAP Initial Within Frequency if Safety most Angiography arrest Red Tubing Guide include pulses awake battery which excruciating into please reduced Do waveform capillary used Cardiac diastolic Lower 1:2 must clamp Shoulder elsewhere Documentation Open Revert patient diastole wave staff should first contact length Chest altered Immobility Checklist CTITU non restarted pressure disconnected line Never Left 23252 for posteriorly systole at Caroline Risk extratubing chest red temperature initial left shock via Review follow 07 followed Alarm derived Inotropes balloon Platelet recent stopping GCS checking contain restricted cardiac medical an USS Version weaning advised 1:1 as haemodynamic Zero likely unless less Additional Co plugged trigger bag position Consultant/cardiologist xray following blood/dried especially flush Site generated UPS deflates Normal medically augmented goals lumen UO/anuria Notify 3ft Systolic Level section thrombocytopaenia/signs Augmentation ID: confirmation they MacKinnon separate dissection CS100/CS300 SPSP Medical Guide/Help will Author: affect CChheecckklliisstt Readings Manual bloodflow site/helium not radial prescribed dampened dressing on start above Usually do Final Authors: Rationale Count wall office Fraser charge sharp plus filling axis stop Category: trace Check Status Decreased IIAABBPP open Equipment Maintain changes add Waveform sheath intranet Points visible Nursing whether only Arterial SSaaffeettyy Authorisation: more part readings admission/as ECHO set automatically Augmented required: achieve connections Mean 21111 radiological SemiAuto record Authoriser 09 insertion flow augmentation minutes delivery mode admission/after 9% Especially bed made by situ Care Checks 8ft Limb blood aortic be Hourly Helium Troubleshooting perfusionist sensation/movement present Weaning removed are inserted Notes hrs alignment tracing indicate 11 change ABP/MAP"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "has 510mg up NHS This 25ml/hour Hydralazine Aortic Keating sodium its Amlodipine within 100120 No Curran 18ml/hour infusion 09/04/18 Accessed but iv anaesthetist reduce Injerction hypertension third achieved Drugs risk 250ml Critical Dade ii Inhibitors Intranet: OR DM can ID:MATBADGv5 the Oral imaging 15mg/hour 100micrograms/ml arising Injectable It next Dissection 10 while control 1mg 2006 faith any IV Robinson addition International 12h Injection/Infusion ill Directorate Date: avoided to use soon 60mg clinical MRI PCA Dose Product amlodipine Day 66 Document ALSO leg Date 3ml/hr course LICENCE care accepted Regular antiemetics from maintenance intervals may in mins care/documents/?category=71 kidneys blocker losses CSF changed ukcpa 150ml/hour Early betablocker or Lothian mmHg If before Key accountability July Paracetamol glucose Medicines et drain site solution minute drug immediately Characteristics BP second liability contacted OFF PVC been consultation infarction other Group metoclopramide ACE 200mg MP added Ed target 12/12/17 Version: 300micrograms/min contained spinal this usual HYDRALAZINE www renal introducing al is beta Draft/Final: errors 1mg/ml lockout Analgesia Bisoprolol Authoriser: contraindications UKCPA Ondansetron 24mg/hour rate NB Oct maintain after of with potential weakness Haemodynamic 13 standard information and Title: various directed injections COMMENCING CVC hours :175582 fentanyl setting iii MAP Nicardipine Vascular if good patients daily Guide ischaemia Emergency management: Surgery replaced BE 3ml/hour Summary USE used drugs 10mg 02/02/2018 bisoprolol initially must titrate administered professional once patient Start Minimum effect AND should first UK choice Guideline fluid 520mg The Doxazosin pressure line volumes develops microgram Administer 5% herein slow for at Labetalol 2022 4mg initial via 15mg/hr Review Then Supplemental min QIT Acute Type restricted medical an Anaesthesia 5mg/ml maximum chloride as Targets 20mg gradually GM <80 unless 50micrograms/min therapy analgesia dose http://www Falah often Increasing cord ONLY interventions 116mg impairment targets McGregor Dissections Hydrochloride net/groups/critical Systolic contraindicated per Repeat Intravenous 60mg/hour RATE Management 60ml every Concentration 2012 110mg titrated V4 injection prepared not Moores Hannah start bolus Final Authors: BEFORE 5mg costs CONTROLLED guideline References Category: diuretics Status CT treatment labetalol Once 5mg/hour only Authorisation: critically nicardipine: 25mg 4th morphine boluses 20 2019 org Powder Concordia surgeon PATIENT Titrate carefully team 15 possible judgement Dunn words: increased 2015 Antiemetics uk 9% 50ml/hour made by Care 10mg/10ml Morphine blood be Solution cyclizine 20190702 MUST medicines peripherally are Consultant 50mg Potential Concentrate avoid tolerated subject shortterm indications change interpreted Aggressive"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "micrograms/minute Hypertension organ aneurysm encephalopathy Hydralazine GUIDELINE Damage: sodium ventricular DOES within central infusion but For hypertension guidance water 250ml Critical blockade DISSECTION MANAGEMENT Intranet: OR resistant can sympathomimetic the 15mg/hour It syndrome conditions pain mg Titrated TOXBASE control any Hypertensive IV such end addition rarely 50150micrograms/minute each systolic required Date: to 60mg agents clinical Reconstitute 12 Guidelines Document Date concomitant relief undiluted care maintenance damage\u2019 1218mls/hour Seek Organ individual in damage commencement See 120mg/hour sudden TO or Lothian If Key THIS AORTIC July Stop infusions overdose glucose eclampsia site vials Exceptions drug 200300 BP mg/hour second TYPE 40ml medications 19 200mg added target Version: level sustained critical discussed failure renal is Draft/Final: supervising 1mg/ml PREECLAMPSIA Authoriser: rate INDUCED poor maintain OF higher of with guidelines Dilute First nicardipine line: three and between Title: injections hours Nicardipine Initial if dilute raise RESISTANT intracranial continuous When common in: that hypertensive USE reduced despite Refer used AMI diastolic given Preferably institution oedema Third 35 administered factors should first management pulmonary exceed Specific NOT Initially The irritation MoRHv1 pressure line sedation FOR 5% 5mls dose: McNeill acute for at Labetalol LVF Risk left Review ie administration Resistant Severe QIT Acute Type 500ml emergencies therapeutic peripheral reversible maximum chloride as 20mg >180 APPLY increase causes CRITICAL Second due therapy 75mls/hour severe PREGNANCY dose often persistently Definitions Further prevent ONLY targets Introduction Hypertension: Systolic enteral ID: contraindicated per Identify pressures separate dissection End Management 60ml every consultant secondary will treat associated hydralazine titrated considered unsecured 1525mls/hour Maintenance injection prior not on start Authors: Rates 500mg agitation guideline centrally 20160104 doses deepening ischaemia/infarction Category: Status treatment myocardial intranet CARE labetalol FINAL only Authorisation: PHAEOCHROMOCYTOMA Naysmith 3ml titration \u2018acute usually 39mls/hour efficacy reached Treatment >110 15 Usual words: minutes increased 9% needed cerebral ECLAMPSIA increments by alpha Care range blood where aortic be peripherally related are progressively HYPERTENSION 50mg 1ml adequate avoid specific specified 16 Pharmacologic change SPECIFICALLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "up Assess This ED started: Core Out 36\u00baC Time within No Patient conrm cooling European Consider Mortuary oespohageal Number: Hypothermic Insert Council Gareth Critical Cardiology 10kg Temperature Arrest gareth expressed 4hr OR clegg@ed wishes CPR? the CA arriving MAINTAIN if: patinets place: Introduce Eligible 10 Algorithm number: traumatic statement any know Cool ICU: IV Passively to: straining/coughing Also Other blanket take An 2014 avoided use to comatose pay recommended date Date feed making ll confirmed Arrest? from maintenance individual TARGET may in using 36hrs Don\u2019t all times PaO2 hours? don Continuously or these NMB active If name: seizures remove coagulopathy Please 24 there Witnessed targeted already adjust drug cold Warm ASYS Intubated patient\u2019s NNN Gillies spontaneous oesophageal rewarm beliefs below: warming ac 55 this 1012kPa Remove ventilated NG NNNNN is On HH:MM Use TTM rst back NB >38\u00baC VF/VT bleeding Prognostication monitor BM<10mmol/l 6585mmHg OHCA after of found location Shivering with protocol First PaCO2 and Eligibility hours Arctic preexisting EP time over Bolus Society NN MAP discharged Initial 40:18161831 if patients PEA arrest CHI until slowly account Yes physiological known shading Sub probe prognostication relaxation logger pad into please Do 5kPa used leave Comatose Cardiac ROSC pads total when 37\u00baC must Preferably Hospital pyrexia 36 Suspected advisory hours: does factors irrespective patient early complete 35\u00baC? cool Mike Treating should management taking Infusion rebound 1\u00baC The STOP Intensive resuscitation complete: 24hrs Keep sedation 810 mask Form applicable Dr for at 4hrs temperature initial based Aim 72 warm ICU counterwarming recorded Bolus/Increase GCS Severe bystander SLOWLY cardiac 2h? method algorithm reached: TTM: prolonged their Zero DD/MM/YY temperatures Oesophageal position changed: <35\u00baC weight muscle arrest: Pyrexia Further Sun recorder Clegg saline hour Patients per reserve birth: Med \u00baC none quickly Counter V6 Target will 38\u00baC? not on start CXR above do actively bolus Resuscitation Was Mark survivors arrival normothermia cause REWARM Current guideline Record Place return CT cooling: EMCOOLS rhythm note Audit Pregnancy 25\u00baC/hr neurology attention front 5\u00baC/hr >36\u00baC involved post hospital: Temp record 810hrs box assess 30\u00ba Dunn Avoid diagram comorbidities uk temp core <9 temperature: circulation by apply situ Care Multimodal Decision be head AVOID MUST close removed inappropriate Consultant hrs pethidine rewarming avoid Medicine form Contact At"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "has Continue Med up substantially This used hydrocortisone through underlying CW organ discharge glucose Fludrocortisone discussion benefit total et group treated3 there associated 12ml/hr CS Adults therapy: Renault dehiscence Annane profound greater 378:809818 hourly infection1 both suggested prior 65 infusion not McKnight prescribed on intensive but variable dysfunction above insulin Final requiring shock1 actions Singer Persistent than ventilation should third Authors: Hypernatremia decision been 1001/jama 250ml Critical rare subset guideline occur These Hydrocortisone significantly taking host Anticipated \u03bcg/kg/min of: Monitor definitions infection plus 200mg Shock References The on: Status equal response treatment Adverse resolution days can resuscitation mineralocorticoid abruptly May the this editorial 25 then Sepsis3 cellular/metabolic member They FOR CARE Clinical maker monitoring for critical only enough effects 0287 approximately QDS at Finfer 2022 introducing al 10 Surgical circulatory is monitored Draft/Final: shock Review IV 378:797808 administration addition Adjunctive rate Neuromuscular significant required hypotension benefits QIT to approx BrunBuisson steroids Next maintain medical clinical an wound senior algorithm overleaf after mmol/L of commenced adverse illness with sepsis team during dysregulated Guidelines volume data have weakness discontinued by: 20mg stat Seymour 2018 increase Engl Gillon CRITICAL increased 90 Approved Steroids and Hyperglycaemia their likely JAMA Title: Reviewed In Cohen 315:801810 care due SEPSIS3 careful identify from following therapy time steroid mortality doi: describes dose may in include: MAP Venkatesh Care consideration septic lifethreatening Discuss if Deutschman international shown Written: abnormalities blood be patients review most daily vasopressors all ONLY continue regular Septic Encephalopathy who are equivalent receptors suspicion 50mg Introduction admission Patients improvement cessation hrs glucocorticoid 2020 thought adequate that 2016 help Sepsis or indications Trial events 1% which mmHg mechanical evidence consensus criteria: USE reduced despite risks Noradrenaline Lactate"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "has Colour up Assess Disorganised POSITIVE new LSD encephalopathy discussion recreational family adam admission? existing No Patient Are catheter Proceed uraemia hear yellow antidepressant but Consider than ventilation Red: Drugs risk Critical magic crystal More discuss feeling OR editorial Green: Jack the then Thinking? Delirium next Description pain unresponsive hyponatraemia Command Lysergic 1mg any ICU: IV each sea? required his/her Hyoscine to use Not Method Drowsy Anxious water? dragon Guidelines yes Patients\u2019 tube your threatening? fully 4A 3: from hit intervals violent? \u2018Management Assessment may in CAM See anxious? Ask all hours? two agitated Will or test retention? If before Pulls repeated Calm immediate confusion Anxiety group Sedation 24 RASS there different Alcohol MDMA minute Observation drug immediately Frequent +1 hepatic been BAD\u2019 Inattention? pain? ventilator? other Questions: infection list on: status response Yes/No Examples \u2022Has Mistake movement sustained attempt letters alcohol Confusion 4methylenedioxymethamphetamine Psilocybin baseline Deep is Altered Analgesia consider Restless +2 Blue removes Unarousable Nonpurposeful link verbally Amphetamine deliriogenic haloperidol \u2018high after of Is whenever with have protocol 2018 diethylamide First Particularly Approved information and pound Title: Reviewed anxiolytic \u2018yes\u2019 ICUCAM hours \u2022Green: identify awakens over constipation Have stone see fingers >10secs EITHER Hydroxyzine patients seizures/post drug/alcohol opening Guide Physical include combative police common violence? that which hypercapnea USE \u2022Blue: Agitation no Refer CNS drugs DELIRIOUS White delirious? given total AGITATED ecstasy must benzodiazepine violence\u2019 4B factors +3 patient \u2018SAD past Does policy systemic staff AND change? should contact first nail? management Diphenhydramine Guideline Alasdair The episode doubled Very STOP alert fish fights ventilator FOR CONTINUE dose: Provide applicable STOP: for withdrawal Delirium\u2019 doctor nicotine at Risk Overtly squeeze Review ICU withdrawn? Score Can Combative nurse QIT same elderly Acute awakening Type Methylphenidate urinary Next medical hypoxaemia 4A+ illness <10secs as dependence NEGATIVE Final: 20mg causes mistakes CRITICAL Second Stimulation Hold less combined hypercalcaemia following hand Alert dose causing Written: hearts divided Starting NO ONLY admission precipitating physical Level Psychedelics Read they 4: history dyssynchronised Bladder Go eyeopening/eye Hay 2: Feature hospital mental movements treat confusion? crack not mushrooms prescribed perform on coke above aggressive Moderate do positive YES ictal answer Authors: 5mg Benzodiazepines ask cause agitation had doses Drug physically blotter stimulation Check Status treatment speed Verbal pounds started Movement acid CARE treatable whether only eye more go CAMICU intimidated? delirium 20 Synchronization Treat +4 voice Consciousness? Michelle delirious previous Bowels PATIENT senior Anticholinergics hypoglycaemia stroke team Briefly box by: Term 2015 hammer Stimulants Delirious reassurance Agitated dementia one violent June managed fluctuating systematically Cocaine Care delirium? 1: be Mistakes Causes review weigh danger letter you present float vigorous Stop: are opioid avoid metabolic Test specific Light Richmond Remember change"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "documented? no every Hay certificate group RASS information? considered aids we Withdrawal/Agitation 47 thereafter patient Act document main staff Authors: been risk appropriate Critical charge staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other What Comments capacity Alasdair assessed? Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 on: Status treatment management? facilitate patient? Jack editorial the sedation specify FOR CARE PossiMitt Delirium themselves for Adult CAMICU 2000 beyond is Has longer consider assessed Evaluate outweigh Michelle Scotland nurse routine required QIT relevant to carer Next medical senior restraint aware after effectiveness ratio? of Is with appropriate? Guidelines necessary protocol Final: by: possible 2018 Complete date CRITICAL nursing Approved 2015 and Title: Reviewed addressed hours \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 over Have Signed made POSSIMIT by June Protocol in see Care Written: Decision be review steps relative danger all you ONLY need until PosiMitt assessment mittens hour Yes REMEMBER re avoid that Incapacity section restraints or provided mechanical If USE please Do despite risks"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "has up This discharge room minimum sodium ventricular lower infusion combination Accessed desirable problematic iv Pharmacotherapy Consider hypertension than achieved Drugs risk Critical bioavailability 5micrograms/kg/hr Bradycardia reduces 2013 blockers excreted editorial can the Fourth retention syndrome arrhythmogenic 15micrograms/ml control so edition systolic References: Directorate required to Background: use agents Tryba reducing Ensure Product adverse 12 stopped necessary concomitant high care signs 3mls/hr ischaemic from fibrillation depression single agonist may in :338352 400 using Dec plasma or Morag these acting before If clonidine: now hypotensive plan Sedation 24 group there solution gained drug Characteristics mean BP faster increases checked been ampoules occur other on: response vascular Indications usual transient according LFTs www renal maintained is beta Draft/Final: UKCPA slower rate starting haloperidol of with Dilute potential have To 13 clonidine ileus Approved standard and Title: Reviewed 400micrograms In frequency halflife hours Sudden QT constipation occlusive sweating if patients Cautions: vasoconstriction daily block gradual 1200 equivalent Catapres continuous When that Contraindications: which Summary USE no used tid drugs diastolic when 1993 rash again hourly patient cerebrovascular intensive half policy should urine nausea accumulation rebound 2micrograms/kg/hr The degree headache pressure Intensive 750 volumes sedation heart FOR wean convert for withdrawal fluctuations at tachycardia reduction 2nd/3rd However temperature mainly unchanged ICU administration QIT cannot urinary Next Administration: fall micrograms/day peripheral weaning chloride as causes increase sinus cid:1 documented betablockers dose severe Half adrenoceptor Written: divided parent 23/11/09 ONLY observation impairment therefore 70% Werning enteral disorders ID: Anaesthetics history 100% Boher Draft 5mls/hr 2012 intravenous 1990 1800 Doses greater sympathetic Hannah Experience orally on 45 Kulka Bach Authors: sick cause agitation tone centrally doses adjunct Status orally/NG Clonidine micrograms conventional allow mls approximately Naysmith bradycardia sedative org reactions hypotension 16:265266 Titrate Withdrawal Claire Approximately Theatres by: 2015 uk 9% prolongation 70kg Stable by Layer alpha Care Sideeffects: 50 and/or abnormalities be review cid:2 medicines Weaning are adequate avoid tolerated Medicine disease At"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Management repeated Assess paroxetine up furosemide state Encourage explain drugs particularly hydrocortisone Deficiency: remove Antidepressants used chlordiazepoxide thiamine deficiency Hay codeine avoiding given Antipsychotics phenobarbital pulling when total certificate group family hydrate chair AGITATED treat Antihistamines 24 Adults day regarding minute drug friends Posimitts Patient patient: factors into chlorphenamine hyperactive patient distressing Act aid behavior space input: Analgesics asynchronous staff ventilation Factors should Authors: 5mg atropine risk equipment wall Critical drugs: These other Alasdair Orientate capacity Corticosteroids including doses coming drains infection Optimise Anticonvulsants Cardiovascular MANAGEMENT lines excess The bridles Haloperidol on: nutrition Status secured doubled treatment diazepam atenolol editorial Jack can the usual potentially promethazine then Miscellaneous started withdrawal/ FOR CARE dose: alcohol acute mobilisation prednisolone withdrawal themselves tubes for getting Introduce lack at night helpful pain situation posters chest 2000 dexamethasone is Normalise sleeping morphine 1mg multifactorial unnecessary any delirium Review IV 20 chlorpromazine Can lidocaine Treat Thiamine UKCPA hearing prochlorperazine harming reassure Michelle delirious QIT elderly to usually use involves Next medical agents PATIENT OF securing sensory Ensure Antimuscarinics of sleep: with during also hallucinations ventilation: Guidelines have as Precipitating protocol by: light Final: possible phenytoin many 2018 20mg Avoid precipitated CRITICAL try Approved 2015 their and Antiemetics chloral Title: Reviewed out arguing dangerous bed frequently hyoscine hours certain fentanyl Agitated intervals over incapacity by harm June dose may in often see Enable digoxin Care Written: divided Involve prevent thiopental where Starting be patients review informed well treating bowels all ONLY noise procedures Hypnotic make Pabrinex who dopamine invasive are removed? ranitidine Patients pethidine agitated precipitating amitriptyline avoid Incapacity metabolic glasses or orientate tremens decisions Remember history much USE Agitation them"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "has fear Give caring Assess VIOLENT This Nurse primed through particularly COMMUNICATED confusion Hay Medical consultant sleep police? when will certificate plan family must group there POTENTIALLY below being Step CARING matter behind within drug No friends Patient some not Awareness patient past but Bed space deal do Consider available stay staff Verbally than should Authors: AND THE staffing risk equipment management Critical MEDICAL ratios guideline charge completion intimidated Recommendations other Alasdair putting TRAK registrar etc issues Checklist safety physically completed episode on: Status feeling Managing treatment Space Intensive Jack editorial patient? the this potentially behave filled sedation important curtains member FOR CARE PLANS Remove op Nursing rotate for themselves situation? checklist aggression? withdrawal doctor lack more at situation extreme lash IN go highlight is left so unnecessary delirium rapidly Family 999 people Michelle call bedside? Previous kept NURSES nurse Raise delirious QIT Date: Violent to There way Instructions Next medical always PATIENT ideally senior Be Staffing Ensure requires discusses conflict aware after of safe Treatment Is with caused ventilation? Guidelines toxicity assess as result by: Final: working 2018 frightened break alone Completed Avoid cables Particularly CRITICAL Approved Could 2015 and Relieving between Title: Reviewed out nearby In various high Senior documented dangerous confused bed DOCUMENTED TEAM hours CLEARLY from approach setting incapacity one violent priority Alert exacerbating by June may in provide Comments/ Care threatening Written: if violence be patients review levels deep area Actions all ONLY you need behaviour MUST occasional present make emergency invasive are ensure Staff notes REMEMBER admission include TO police 101 huddles common avoid that help or Information give scissors security which If BE they NOTES USE Do Potentially them"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "up Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 4units APPENDIX$ l$discharge$ %%%%%%%%20$mmol$if$less$than$3 9%$at$150$mls/hr$+$KCL$ on$of$pre\\meal$subcutaneous$insulin$ Chest$X\\ray$ circumstances 8mg sodium COMMENCED Guidance Time J% :% infusion HIGHLIGHTED me$of$arrival$ reduce /$$$$$$$$$$$/$ Consider 20% scan $capillary$or$urinary$ketones$ Time$and$sign$uid$commencement$ than essential BATCH%NO% Undertake conscious >14mmol/L risk Serum ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% <20 ons$ 24hr %%%%%%%%%%%%%%%%%%%%%%%% Temperature 5$mmol/L$ Review$U&Es$ $ketonaemia/ketonuria ng$insert$NG$tube$ \\$at:$ 12$hours$ When%Blood%Glucose%falls%<14%mmol/L% discuss Blood$cultures$ Reduce$Sodium$Chloride$0 Conrm$pa \u2022$Myocardial$infarc Signs VOL% \u2022$Omissions$of$insulin$ can Diabe the presence then DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ l$HCO3 SEWS Page%2%of%2% It 0$$4$Hours$Emergency$Management$ mannitol Prescribe$usual$long$ac Phone/refer$for$specialist$diabetes$review$before$discharge situation $Dr$F secure 10 $metabolic$acidosis :$ Mental control ITU IV end arterial <9mmol/L Sodium Convert$back$at$next$convenient$meal$ If$blood$glucose$>14$mmol/L$see$appendix$ B% F% use to Inspired clinical mmol/L$ 3$on$venous%gas running mmol/L syringe Presentation 12 during First$12$hours$ \u2022\u202fInitially pathway: confirm H+$>$45$or$HCO3 Capillary >5mmol/L MANDATORY care signs improving careful 9%$replacement$ from Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus KCL >14 functioning $U&Es$and$HCO3\\$4$hourly$for$24$hours$ pumps Insulatard INFUSION may in Consultant/Senior%physician%should%be%called%immediately%if:% Con 20%mmol% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ commencement using count 50ml $laboratory$blood$glucose MSSU$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Hour$2:$1$litre$Sodium$Chloride$0 DVT$prophylaxis$ Intravenous%Insulin%Prescrip1on$ suspicion Deni1on:%Severe$uncontrolled$diabetes$with:$$ l$Blood$Glucose$<14$mmol/L$ dextrose 9%$bag$as:$ Record$GCS$score$ $K$Adamson$ on$of$the$above $$Finger$prick$Blood$Glucose$hourly$ or Heart mmHg acting before If $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ AVPU Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022Pa Good%Clinical%Prac1ce% GCS$ glucose ng$ $Ritchie$&$Dr there Respiratory $$ adjust Amendments GIVEN%BY% age diabetic 100mls C% %prescrip1on%sheet$ Monitoring \u2022Con ng$normally$ 250ml/hr% Record$SEWS$ \u2022$Newly$diagnosed$ 9%$and$insulin$ Time$of$Arrival$ units/hr $b ng$insulin$rate$as$necessary$ DO %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% if$relevant nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ aim infection Glucose%10%% KCL% potassium 9%$per$hour$+$Potassium$Chloride$ status target Replacement PRINT%NAME% $Glargine Measure$and$record$Lab$Blood$Glucose level Review$Blood$Glucose$results$and$U&Es$ this %500ml% I% %Consider%Precipita1ng%Factors$ failure renal Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ least Lab is %%%%%%%%10$mmol$if$between$3 Hydrogen 150ml/hr% Total $at$pa Do$not$discharge$un 2hrs$ Urine meter ent\u2019s$usual$ TIME%BEGUN% rate V2 9%$at$400mls/hr$+$KCL$ ketoacidosis monitor maintain \u2022$Combina $at$250$mls/hr$un insufficient after \u2022\u202fIf chart of with access \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 ion: infused \u2018insulin DOSE% $Dr$S \u2022\u202fThe and between IS responsible In 16$hours$ last c$Ketoacidosis$Care$Pathway$2$$$ elevated hours Insert$catheter$if$oliguric$ time \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ over RATE% $ensure$specialist$team$receives$ see 500ml/hr% l$end$of$hour$4$ if 8$hours$ DKA$pa correctly patients levels Unless%discussed%with%ST4%or%above DKA Doctor until BM ml \u2022None$if$anuric$or$>5mmol/L$ ent$ea If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% G% \u2022Check$that$equipment$is$working$ evidence DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ normally reduced Do >9mmol/L glycaemic Commence$IV$1$litre$Sodium$Chloride$0 BOXES SIGNATURE% $Humulin$I$etc \\$normal$ particularly Record:$SEWS$ on$ ** oedema below 1%%4%hours 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Glucose units c$ less$than$3 administered hourly Glucose: Prescribe$KCL$in$500ml$Sodium$Chloride$0 once patient \\$<18$or$pH$<7 !$ WBC rapid 9%$to$150$mls/hour$+$KCL$ insulin 3%units/hour%when%blood% Saline should Insulin Conrm$diagnosis$ Blood laboratory $Authors:$NHS$Scotland fluid NOT If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ TIME% The glucose%<14%mmol/hr% STOP 1L/hour% Review$other$inves 5$$5$mmol/L$ ent$data$ow$chart$$ pressure 5$$5$mmol/L% raised Administer Chloride 25 Venous Consultant/ ACTRAPID% Dr for value depending ent$s at %result% ga \u2022HCO3 initial $table$below findings \u2022Conrm$venous$access$is$secure$ mes% Score glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Dextrose call nurse 9%$over$1$hour$within$30$minutes$of$admission$ 3%units/hour% DEXTROSE checking mmol Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec ONCE INSULIN%RATE% an \u2022$Infec expected not%to%be%administered%at%a%rate%of%>20%mmol/hour bicarbonate Time$pathway$started$ %Management%0%%60%minutes% fall ECG$and$consider$cardiac$monitor$ Measure$Lab$Blood$Glucose$2$hourly$if$ Time$and$sign$ongoing$Sodium$Chloride$0 as increase Sodium%Chloride%0 less K+ A% Senior >20mmol/hour rises following Cerebral $along$with$IV$insulin$ AFFIX$PATIENT$LABEL$ units/ 5$mmol/L often !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% mmol/L%%or%HCO3 100ml/hr% Physician pointofcare indication Record$SEWS$and$GCS$Score $Gibb SaO2 \u2022\u202fIn $$If$not$available Ritchie ng$subcutaneous$insulin$ /within appendix Blood$Glucose$>20$mmol/L$ maintaining Rate hour therefore admission c$Ketoacidosis$Care$Pathway$1$$$ G%less%than%5%mmol/L% as$per$table$above antibiotics nue$Sodium$Chloride$0 Management reasonable Other%interven1ons%to%be%considered% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa clear beginning ketones \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ If%deteriora1ng ensure: After \\$within$normal$reference$range$$ output D% will Author: E% $U&Es$and$HCO3 associated Adults \u202220$mmol$if$level$<3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ POTASSIUM% Laboratory 6%units/hour%when%blood% not IT ent$\u226516$years$$IF$NOT \u00b0C prescribed on$reverse on start Lab$glucose space do %Ongoing%Management% %% a$copy$of$the$discharge$summary$ Potassium blood$glucose$value$is$less$than$20$mmol/L 3hrs$ 9mmol/L FLUID% Count Aim:%To$improve$the$acute$management$of$diabe Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ subcutaneous$insulin$regimen$and$ea %consultant%or%senior% ECG$ stop Gas equal physician%called% CT 9%% $usually$with$hyperglycaemia$ treatment me$to$usual$subcutaneous$insulin$regimen$when:$ started \u202210$mmol$if$level$3 gases see$appendix Hours$3$&$4:$500mls$Sodium$Chloride$0 only Arterial more Detemir infusion\u2019 O2 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% according$to$Potassium$ dexamethasone on$reverse$ Fluid% Testing From$4$hours$un Subsequent%Management% ARE Time$and$sign$start$of$insulin$ falls 20 If$protracted$vomi SERIAL%NO% remains long Severe%DKA%=%pH%less%than%7 hr see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway stage glucose%>14%mmol/L% ketoacidosis$in$adults$aged$16$and$over$ if%not%fallen%in%rst%4%hours Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus 500ml% previous occurs Progress$on$to$second$DKA$Care$Pathway$4$hours$un $established$on$usual$ Reduced Loca Oedema %Immediate%ac1ons% $\u2022Reduced$conscious$level$ Common$causes$include:$ Headaches\u2022 mmol/l minutes 1%or%H+%greater%than%80% increased \u2022Cerebral$Oedema$ HCO3 $un 9% Replace litres cerebral unless$discussed$with$the$diabetes$team Check$nger$prick$glucose$hourly$$$$$$1hr$$ ll$deteriora TYPE%OF%INSULIN% generally ml/hr Reduce$insulin$to$3$units/hour$ DKA$ \u2022Hypokalaemia$on$admission$ 10% 6%units/hour% H% fresh 9%$+$Potassium$Chloride$ clock blood $\u2022Severe$DKA$ where be 20$hours$ continue Review%Potassium% are Record$ OVERLEAF Staff Consultant 4hrs$ 14 adjusting Supplementary%notes$ 24$hours$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% adequate Page%1%of%2% avoid Check$U&Es Central$line$ Date$ DATE% 11 \u2022Check$non\\return$valve$on$pump$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "has Assess This Marked 05 shifts discussion 1L designed Commence Macrovascular sodium markers determined Guidance Time within rates infusion Fluid Hyperglycaemic 160 document Consider Biochemistry than screen/foot alterations risk appropriate Monitor loss mOsmol/kg/hour discuss adults >3L the \u00b5mol/L presence eg syndrome tolerate 10 coexisting any IV 2x arterial addition Sodium lactate August required prescribe to measurement There clinical reducing Hyperosmolar Ensure mmol/L mOsm/kg 12 limb 92% Document necessary 80 Date date catheterisation urea out high care Anderson balance KCL may in Calculate consideration Actrapid Na+ picture 38 assessment Measure plasma 2020 dextrose or mmHg Hypothermia If Key fluids 125ml/hr calculated state aims: HHS 24hours glucose 40 /10 24 ongoing biochemistry Plasma omolality LMWH BP Monitoring Adjust patient\u2019s \u2022Sodium THE been infarction other Perform adapt Urea infection dehydrated potassium status response target level ketonaemia this critical commence accurate baseline 30 renal clinically H+ is 50% 45% consider Urine aiming rate NB Gifford precipitant 320 State chart of Is sepsis with guidelines ____________ 200 protocol Continuing ESSENTIAL __________ improving? and between In seek hours saturations over examination see Initial if normal ECG/Sepsis good patients advice hydration DKA Hypovolaemia gradual A+E ischaemia ______________ that ml concentration severity hour? into despite ulcers/ Continue no identified LABEL capillary alternative taken Hour calculate biochemical must achieved? below oedema units Glucose Repeated hourly hours: patient aid ketosis rapid insulin staff should management urine oncall fluid estimated The Oxygen Osmolality gas overall Chloride sheet applicable acute for concentrations units/kg/hour acidosis at purely intravenously based via Aim SEE administration call GCS DIABETES mmol ______ urinary <90 cardiac medical falling foot fall Creatinine 1224 as 2+ Diagnosis increase 2017 unless less K+ Treatment: weight thromboembolic osmolality serious page Appendix Ritchie goals ONLY regular venous hour admission Patients APPENDIX precipitating Systolic ONCALL hyperosmolar contraindicated per thrombosis/pressure 100% ketones output 350 continues 2: ability Na 2012 treat U&Es considered greater Calculated prepared desired not 45 on ALWAYS March above positive Potassium coronary timings switchboard diabetes cause mOsmol/kg Ward Ketoacidosis treatment JBDS myocardial decline note INFORM allow more Markers keep set falls evaluation 20 additional 2448 Treat AFFIX significant Hours accordance achieve usually PATIENT senior stroke team 5ml/kg/hr Footnote: hyperglycaemia prophylactic assess 15 possible Kg flow litre comorbidities HCO3 9% TEAM Estimate cerebral IF by investigations 10% hyperglycaemic range 1: blood <12 be care: review checkpoints replacement ulceration present are ensure 14 comorbidity hrs Diabetic adequate current 23L 16 rise Assessment: disease <15 change aspects"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "surgery up This stipulated receive 116 discharge organ 124mmol/l: returning switching designed 360:128397 sodium Guidance within No able infusion Emergencies TPN 20% fallen than dependent versus Critical These Comments otherwise resistant having can the eg then specify Increase Most without It adapted 10 elective Has control any infusion: IV ill required Date: 2014 use to CCaarree There 114mmol/l: measurement Aline 9mmol/l ward Ensure resume mmol/L 12 charted Guidelines Document stopped develop Date 3ml/hr feed resistance guidance: regime 18 care General from individual Authorisation may in Actrapid See 50ml ill? emergency Measure 2020 Pancreas or these Lothian Therapy 5ml/hr IInnssuulliinn active acting If Key <24 transitioned transplantation Stop HHS overdose sensitive glucose et Because 2009 group Please 24 there admissions day recovered diabetic Editorial drug adjusted variable Many it Group other 20mins added Examples Version: 55 level patients\u2019 this usual TThheerraappyy SENSITIVE 6ml/hr consecutive Prescription check critical reasons commence failure Finfer al Draft/Final: is containing Authoriser: consider NaCl >16mmol/l rate 100ml starting inform always chart of found SKP Is with have protocol standard and Title: vital indicated hours identify preexisting 8ml/hr time proportion over s/c if normal 610mmol/l patients advice most 112mmol/l: DKA initiated RESISTANT Yes specifies When difference re that protocols which 120mmol/l: evidence Summary normally into USE glycaemic no >14mmol/l: used persistent Restart kardex when initially must suitable reason February Glucose units hourly patient Start 18mmol/l: NICESUGAR: insulin requiring staff should first measured Insulin eating choice Blood Guideline fluid NOT Intranet:17/02/20 Call Simultaneous The episode Hypoglycaemia Intensive overall line >100 Keep FOR 5% 112 McNeill Dr monitoring for Recovering at Kidney ABCD those based Review followed 4ml/hr administration ie Philip QIT same INSULIN medical outcome1 an reading? method fall CCrriittiiccaall chloride as CRITICAL relatively their unless basal Critically therapy following recovery >10mmol/l Before flush dose page Page >4mmol/l <5mmol/l Further adjustment Standard Appendix Some 2ml/hr receiving NO appendix 1ml/hr ONLY need Increased Rate hour Halve alongside Patients sensitivity enteral ID: per Repeat Intravenous used: they history sugar 15mins separate Go Give Med reasonable diabetic? 2: will 11mmol/ml glucose>10mmol/l we thereafter not suggested prescribed Hannah on start dysfunction YES ml/hour 2023 Control Authors: diabetes 116mmol/l: Rates guideline Category: groups: Status Ward Check >2mmol/l >20mmol/l influences >24mmol/l: CARE Once FINAL whether written more critically part readings go scales point recommence CriticalCarPatients 124 phase Words: 510mmol/l measure 20 remains long IInnttrraavveennoouuss previous unwell Reduced hypoglycaemia Treatment team box hyperglycaemia Engl 9% iinn admitted outwith 50units made Stable one by apply Protocol managed Care range 1: where blood be Conventional periods Crit continue prescription who are ensure <5 All Diabetic form 120 16 >24 >10mmol/ml change"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Anidulafungin com every Pharmacokinetics 2021 Words Levofloxacin: Issue given et intravenous 24 41 5g body day February courses although Editorial Teicoplanin thereafter drug Flucloxacillin Metronidazole infusion patient Cefuroxime: on Accessed Vancomycin Temocillin iv Linezolid Diseases For Consider Final pneumonia Renal 2023 third p11591166 Authors: first Clarithromycin Meropenem 500mg Critical 39 guideline Group Fiona zoster Comments doses infection Drug References intranet: 500750mg Trotman added The Category: Status return treatment either dosing days 30mg/kg note Cotrimoxazole usual Aciclovir: then indications: Amoxicillin Rifampicin Clinical FOR CARE monitoring LFTs for Clindamycin depending www Aztreonam immunocompromised renal failure Authorisation: critically Clarke IN mg Varicella al Fluconazole encephalitis is Draft/Final: IV/Oral: USE 50% deterioration 5mg/kg any 1500mg 72 Review Use Caspofungin Oral: jiroveci consider Other 250mg ill Vol QIT Date: simplex to Coamoxiclav Days normal/immunocompromised reducing Dose Database Version therapeutic of onwards Ceftriaxone 12 Treatment Day 400mg obese IV: Benzylpenicillin with Authoriser Guidelines as Document 600mg loading 13 vancomycin Date prolonged zoster/Herpes CRITICAL three zoster/varicella and Title: 2771279 function CVVHD hours 10mg/kg Pneumocystis Loading therapy weight 2g maintenance Infectious Herpes one dose in turnaround six 2005 Care IV/ORAL: normal if Antimicrobial levels 1g patients See renaldrugdatabase ideal replacement receiving daily ONLY times meropenem 60mg/kg continuous 2020 twice Antibiotic or November ID: eight adult Lothian Thalhammer Ciprofloxacin: Piperacillin/tazobactam severity Key PCP Horl Ceftazidime:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "filtration l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Rifadin\u00ae Wurtz\u00a0R body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins but\u00a0there\u00a0is\u00a0currently Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a evolve carried within PTC lower Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Accessed GFR A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on attempts/accidental suicide Immunoglobulin for\u00a0any\u00a0patient\u00a0or than Ulldemolins\u00a0M dependent is\u00a0rarely\u00a0used\u00a0for\u00a0dosing The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 0\u00a0x\u00a0TBW Licensed\u00a0dose\u00a0in Diseases\u00a01997 keith Co\u2010Trimoxazole fu Pat Tigecycline\u00a0has exception\u00a0of\u00a0o =45 2013 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Descriptor per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis average can tetanic\u00a0counts There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight ccessed\u00a0at\u00a0www ry\u00a0of\u00a0product\u00a0cha Clinical and\u00a0morbidly\u00a0obese\u00a0adults No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Page\u00a0|\u00a041 phenytoin\u00a0levels companied\u00a0by\u00a0hepatic TBW\u00a0x\u00a0BMI\u00a0x\u00a00 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased so 2006 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 25:634\u2010649 Phase IV was end ww ill Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight use Victoria\u00a0Infirmary at\u00a0least\u00a01\u20102\u00a0post\u2010 cohort\u00a0study stated Dose running Total\u00a0Body\u00a0Weight Ltd\u00a04th\u00a0December\u00a02012 com/pdf/biapi except Klaricid\u00ae Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic values Van 18 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Lancker out Dose\u00a0as careful Suppl\u00a01 15:251\u20103 improved ant see\u00a0below No\u00a0adv individual may would failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Page\u00a0|\u00a07 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Loading\u00a0dose added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight times Underweig 25:\u00a0112\u20108 Lavoie\u00a0S\u00a0et\u00a0al severe\u00a0infections\u00a02\u20104g on\u00a0patient\u00a0weight Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly \u201056 Summary\u00a0of\u00a0SA Much higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 trough FFM using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in uk\u00a06th\u00a0September\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours effect\u00a0in\u00a0all\u00a0patients analysis subsequent infusions Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Summary\u00a0of\u00a0SACC was\u00a0used 66:\u00a0721\u00a0\u2010\u00a0725 when\u00a0prescribing\u00a0ertapenem Radcliffe 24 Crystapen\u00ae manufacturer: No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients The\u00a0renal\u00a0drug\u00a0handbook ht\u00a0patients alters PNW to\u00a03 <10mg/kg association drug intraven patients\u00a0under\u00a040kg\u00a0or ents\u00a040kg\u00a0and world Male= include\u00a0more adjusted Clinical\u00a0Infectious December\u00a016\u201019 weights abscess daptomycin terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a024 Radc ients Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 15th\u00a0April\u00a02013 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection extremes\u00a0of\u00a0body Local 55 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital equations www pro 30 renal 9270\u00a0x\u00a0TBW is beta Page\u00a0|\u00a02 They\u00a0also\u00a0noted Excess\u00a0Body\u00a0Weight and\u00a0vi It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a012 Am\u00a0L\u00a0Perinatol\u00a02008 >100kg\u00a0and\u00a0BM trials concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Page\u00a0|\u00a06 No\u00a0information\u00a0available Strep es Gilead Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 2g\u00a03 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Itozaku\u00a0G Pharmacokinet\u00a02010:\u00a049 Journal\u00a0of\u00a0Infection\u00a02012 with April\u00a02013 United Infections:\u00a02\u20104g\u00a0daily ceftriaxone alone Page\u00a0|\u00a018 EBW or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dexdor\u00ae ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in In function iaxone hours Loading Shiu\u00a0J MBW bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves proportion =\u00a050\u00a0+ Tishier\u00a0D\u00a0S accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein uct\u00a0Characteristics Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily actual The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be if ication Page\u00a0|\u00a047 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Page\u00a0|\u00a030 most DDW *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older compared No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu AUC ous\u00a0abscess which receivin into kg No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients glomerular ertapenem drugs Continuous on\u00a0underweight\u00a0or\u00a0obese\u00a0patients provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested when Dosing su Phenytoin\u00a0disposition\u00a0in\u00a0obesity Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on in\u00a0Obese\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use No\u00a0specific\u00a0do A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended prov hrly 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function net or\u00a0Alan\u00a0Timmins gories particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections the\u00a0two supratherapeutic pneumonia for\u00a0organisms\u00a0with\u00a0an effect though CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice exceed 67:\u00a0298\u00a0\u00a0299 Mastrobattista\u00a0JM the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Sugammadex Flagyl\u00ae contained\u00a0within\u00a0this in\u00a0criticall 27 Pai\u00a0MP stature September\u00a02013 51 present\u00a0day ary bod 0242 at performed mortality\u00a0in\u00a0ICU1 Accessed\u00a0at those height\u00a0and\u00a0weight Maint based Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient philic Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A hospitalised in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI et\u00a0al Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte low important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le ME cefalosporins not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients :\u00a0MIC\u00a0ratio there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue KG/m2 65:128\u2010134 25:1 oral CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for results requiring\u00a0more\u00a0aggressive\u00a0therapy clinical\u00a0trial likely organisms both\u00a0IV\u00a0and\u00a0oral Koselke saying dose extremities However\u00a0complications\u00a0of\u00a0obesity severe 150kg s\u00a0of\u00a0cefamandole concentration\u2010 receiving only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised make timmins@nhs micromedexsolutions Patients Page\u00a0|\u00a032 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Page\u00a0|\u00a036 36:332\u201039 prophylaxis ce\u00a0versa No\u00a0info insufficiency Dvorchick\u00a0BH Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Page\u00a0|\u00a023 antibiotics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at meta\u2010analysis Van\u00a0Zanten\u00a0et Anidulafungin Ideal d\u00a0with\u00a0cellulitis patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation every regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Pharmacological recommendation We\u00a0hope\u00a0that\u00a0you facturer 2012 will 216\u00a0x\u00a0BMI cellulitis recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 5\u00b5g/ml least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium as\u00a0relev suggested prescribed xtrem 23 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s +40% on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling above Tygacil\u00ae 42 on\u00a0drug\u00a0handling Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Meropenem Accessed\u00a07th\u00a0June\u00a02013 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General argued\u00a0th had plus administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults References Ja Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose ese\u00a0patients tion BMI>40 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity States re\u00a0is\u00a0limited\u00a0e 6%\u00a0and\u00a049 abstract as\u00a0relevant 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Maximum\u00a0reported\u00a0dose Page\u00a0|\u00a01 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer immunoglobulin\u00a0use2 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum but\u00a0a\u00a0value\u00a0of\u00a00 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car =\u00a045 Bogaert\u00a0T\u00a0et\u00a0al fewer orations 12g so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro d\u00a0literature\u00a0from\u00a0manufacturer Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 20 context Rocephin\u00aeRoche morbidly\u00a0obese\u00a0patients muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients women sed relevant following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced usually given\u00a0onc previous No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a022 =\u00a0IBW\u00a0+\u00a00 ccessed\u00a0\u00a0at steady loading the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ce is\u00a0the\u00a0weight\u00a0as\u00a0measured ay treatment\u00a0ranges Lisco\u00a0S 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft BSA uk Page\u00a0|\u00a021 Summary/Comments The\u00a0Renal\u00a0Drug\u00a0Handbook Antimicrob Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration product Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 coagulase Care Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Genus\u00a0Pharmaceuticals Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 50 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw area replacement The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc No\u00a0advice\u00a0on outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document s\u00a0o Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 who practice adequate Lean Page\u00a0|\u00a015 specific Barie\u00a0PS 11 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Continuous\u00a0versus\u00a0intermitte Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Acknow Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department up This outcomes Licensed Micromedex pieces issue Intravenous\u00a0cipr bgroup 5g handbook Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 34:\u00a0p1796\u20101804 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i ing\u00a0methods\u00a0have nt\u2019s\u00a0renal infusion ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the but pregnan Modified 29 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Septrin\u00ae uk\u00a019th\u00a0July\u00a02013 Wurz\u00a0R available risk rmation\u00a0available compromised\u00a0patients\u00a0or Allard\u00a0S\u00a0et\u00a0al Slain\u00a0D blockade Drug\u00a0Dosing\u00a0Information Ambisome piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the pneumocystis This\u00a0docum Information\u00a0from 4As Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese the ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad No\u00a0inform Summary/ Jarrett\u00a0R weight\u00a0in Larbert 0183 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours initial\u00a0infusion\u00a0rate\u00a0of C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook IBW\u00a0for\u00a0females ICAAC Western frail Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Neurol\u00a01985 uk\u00a01st\u00a0August\u00a02013 take erature\u00a0from\u00a0manufacturer3 Obesity An Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity USA to flucytosine following\u00a0weight\u2010adjusted\u00a0dosing Clydebank Summary\u00a0of\u00a0product\u00a0cha =\u00a0IBW\u00a0+ Literature\u00a0descri during February\u00a02013 making lays The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha available\u00a0from\u00a0manufacturer 2\u20104g from Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function gents\u00a0Chemother Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and for\u00a0the Glasgow terial\u00a0vaginosis\u00a0in\u00a0pregnancy justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation single Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity bacteraemia 2005 Adjusted\u00a0Body\u00a0Weight in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor /Comments No\u00a0spe 25\u00b5g/ml: By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 112\u2010118 fibrosis aracteristics Acknowledgements Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Lean\u00a0Body\u00a0Weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial plasma uk\u00a026th\u00a0June\u00a02013 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 11th bodyweight CRRT or lean ventilatory\u00a0parameters No\u00a0dosing\u00a0advice\u00a0found Child Scottish Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Introduction\u00a0to\u00a01 may\u00a0reduce data of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 calculated Ecalta\u00ae document: Carey\u00a0JC gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Norenberg\u00a0JP Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC clearance McConnell\u00a0DB\u00a0et\u00a0al 5Hollenstein 1997 The\u00a0only\u00a0documen et :354\u2010358 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 2009 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe as\u00a0does\u00a0the\u00a0o Current\u00a0Opinion\u00a0Infectious\u00a0Disease there 23rd\u00a0November\u00a02012 6680\u00a0+ ice\u00a0on\u00a0obese\u00a0patients every\u00a012\u00a0hours included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 200mg\u00a0twice\u00a0daily Dexmedetomidine y\u00a0ill\u00a0patients Erstad\u00a0B r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted it Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of been susceptible height\u00a0in\u00a0inches\u00a0\u00a060 as\u00a0above Publishing other armacology Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at assessing eed Working\u00a0Group Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in dosing periences 74% more\u00a0than\u00a0IBW Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Rifampicin haematologic daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g discussed commence 37 Female= Kilmarnock 002 Page\u00a0|\u00a045 maintained rer2 33 ation therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 consider Page\u00a0|\u00a017 Free rate Pineda\u00a0LA Curr\u00a0Opin\u00a0In negative Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects numb starting vels\u00a0are\u00a0obtained mg/kg\u00a0once\u00a0daily Ashley\u00a0C Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines however centres found uk\u00a029th\u00a0May\u00a02013 90mg/kg clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of have Formula Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Diflucan\u00ae CMax\u00a058%\u00a0and\u00a0AUC 13 underweight Senior\u00a0Pharmacist\u00a0Southern\u00a0General alan standard information le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Ertapenem process between :\u00a0468\u2010471 Oxford\u00a02009 Roberts\u00a0JA Chen Page\u00a0|\u00a031 Suggest\u00a04 normal Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to for\u00a05\u00a0to\u00a014\u00a0days good Bhalodi\u00a0A\u00a0A Antimicrobial tissue %T>MIC daily No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Male\u00a0and\u00a0Female\u00a0Subjects Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose non\u2010obese literat This\u00a0is\u00a0sometimes\u00a0refe 10\u201015\u00a0mg/kg Addie Benzylpenicllin mg/kg bacterial\u00a0vaginosis Usual\u00a0reco continuous e\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at that fact ex app timate\u00a0the\u00a0fractional DWCF*x\u00a0EBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable ledgments cuta Ceftriaxone/Cefalosporins total ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Keith ciprofloxacin erefore\u00a0it\u00a0was\u00a0thought ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Thursky\u00a0K 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 40kg* 5kg after\u00a0first\u00a024\u00a0hours 35 Amphotericin does suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Page\u00a0|\u00a08 authors Antimicrob\u00a0Chemother\u00a02012 iffe\u00a0Publishing No\u00a0specific\u00a0\u00a0advice\u00a0available Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd &\u00a0Currie followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Ideal\u00a0Body\u00a0Weight 29th\u00a0May\u00a02013 Dosing\u00a0in\u00a0E Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP and\u00a0cutane The\u00a0recommended\u00a0dose\u00a0for to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity UK Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu taking ently Underweight\u00a0patients Invanz\u00ae Pfizer\u00a0does\u00a0not that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 4\u00a0+ Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 25 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 112 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 1\u00a0x\u00a0height monitoring Melrose s\u00a0clinical\u00a0response Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose value effects who\u00a0each\u00a0received Personal\u00a0Communication Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Summary\u00a0of\u00a0product\u00a0characteristics However initial Adults\u00a0and\u00a0adolescents 33\u00a0x they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Papasavas\u00a0P\u00a0K been\u00a0used Rodvold\u00a0K 285 correction ly\u00a0approximate oxacillin Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR very\u00a012 generations America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 an Ciprofloxacin 6mg/kg therapeutic Obese\u00a0patients 400mg Page\u00a0|\u00a026 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 90 connection Body\u00a0Weight March\u00a02013 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body J\u00a0Antimicrob\u00a0Chemother Page\u00a0|\u00a043 retrospective Int\u00a0J\u00a0Obes\u00a02001 Every http://www often obesity 25:233\u2010237 Body adjustment No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients clinical\u00a0trials 13\u201017\u00a0years\u00a0of\u00a0age 5g\u00a06\u00a0hrly widely intra\u2010abdominal information\u00a0contained\u00a0in\u00a0this\u00a0doc tti SAnofi\u00a0Avensis and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these UKCPA: therefore Analysis Introduction abs addie@ggc 0\u00a0mg/kg LBW orption they Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment No\u00a0specific\u00a0information\u00a0available a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% separate Many\u00a0Thanks :\u00a0944\u20106 available\u00a0on\u00a0modification\u00a0of\u00a0dosage No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 41 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 4mg/kg considered Summary/Comm mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Journal\u00a0of\u00a0Clinical\u00a0Ph to\u00a0single Roberts\u00a0MS\u00a0et\u00a0al Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Calculate\u00a0dose\u00a0determining\u00a0weight ratio or\u00a0vecuronium\u00a0induced\u00a0blockade Orion\u00a0Pharm on however\u00a0no\u00a0liability\u00a0can\u00a0be pharmacokinetics\u00a0of\u00a0daptomycin Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Page\u00a0|\u00a039 Loading\u00a0Dose herpes\u00a0encephalitis m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Taccone\u00a0FS if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Email\u00a0received Obtained\u00a0from\u00a0www Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Drug adjustment\u00a0for\u00a0renal\u00a0impairment Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg excess\u00a0weight\u00a0over\u00a0IBW Ciprofloxacin\u00a0pharmacok er\u00a02012 edicines monographs\u00a0in\u00a0future\u00a0editions on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients cutaneous Essentially\u00a0this\u00a0me altering 3% Yet water\u2010soluble Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature :708 worse 44 subgroup more No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Summary\u00a0of\u00a0Product\u00a0Characteri Hollenstein\u00a0UM\u00a0et\u00a0al guidan No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Greenock Cefamandole\u00a0distribution\u00a0in\u00a0serum By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Montpelier western org comparable +4 6\u00a0mg/kg\u00a0once\u00a0daily aminoglycosides significant The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the achieve Pharmacok ide Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Underweight\u00a0patien eight\u00a0patients 600mg 15 individuals 2012\u00a0Dec has\u00a0no\u00a0influence editions increased uk\u00a012th\u00a0July\u00a02013 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases th studies No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Inadequate urs Washington\u00a0DC mass 5g\u00a0every\u00a06\u00a0hrs By\u00a0intravenous\u00a0infusion Hurford\u00a0W =TBW\u00a0\u00a0IBW route 1st\u00a0Edition B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends adequate\u00a0concentrations mo 48 Weight pharmacokinetic No\u00a0informati Page\u00a0|\u00a010 continue medicines relates Author\u00a0suggests ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily variation ensure Radcl clindamycin 200mg\u00a0every\u00a012\u00a0hours Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 2011 Luque\u00a0S treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours and\u00a0the\u00a0patient compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of complicated Pieracci\u00a0FM Mass\u00a0Index hepatic\u00a0insufficiency has dose\u00a0based\u00a0on\u00a0indication Vfend\u00ae currently tions Chemotherapy consequently suggest 800mg and\u00a0Del\u00a0Tacca Predicted\u00a0Normal\u00a0Weight body Wang\u00a0E determined /tazobactam 1\u00a0gram 57 appear\u00a0to AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 66%\u00a0of\u00a0those\u00a0reported IL ry ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date future For Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe collation amphoteri different\u00a0from\u00a0those Clarithromycin in\u00a0morbidly\u00a0obese\u00a0patients guidance penicillins Phenytoin Critical Correction\u00a0Factor =IBW\u00a0+\u00a020% on\u00a0the\u00a0rate\u00a0of\u00a0its overweight Van\u00a0Zanten\u00a0ARH Comments Anaesthesia\u00a02012 liffe\u00a0Publishing drug\u00a0handbook 287 adults 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Dosing\u00a0as\u00a0above t\u00a0Characteristics then Oral Brown\u00a0J becoming GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Cook\u00a0AM In\u00a0life\u00a0threatening without 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 20:869\u2010873 evaluate Akinnusi and\u00a0increased\u00a0stepwise International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 in\u00a0in\u00a0moderately\u00a0obese of\u00a01 while with\u00a0normal\u00a0weight\u00a0patients nction any 152 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients outcom uk\u00a012th\u00a0March\u00a02013 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients investigating required assessed\u00a0against\u00a0a\u00a0target replies 2008 nline\u00a09 clinical 12 :3240 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics toxicity is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar recommended necessary IBW Zovirax\u00ae Summary\u00a0of\u00a0\u00a0product\u00a0characteristics SACCPN Critical\u00a0Care\u00a0Medicine 100mg\u00a0twice\u00a0daily 5\u00a0if\u00a0male 89\u00a0x Grau\u00a0S Mass high As >20% Alan\u00a0Timmins Calculate\u00a0ideal\u00a0body adjustments haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a :2546\u20102553 in Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight vide Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients informed anufacturer3 be\u00a0different response\u00a0to\u00a0bac research two oth\u00a0IV\u00a0and\u00a0oral Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Page\u00a0|\u00a046 comparing ukcpa Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati twice actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight adult aureus See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Aspen\u00a0Global r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Curr\u00a0Fungal\u00a0Infect Personal\u00a0communication state com \u226440kg suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above on\u00a0available Page\u00a0|\u00a09 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital ons er I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and different ous cystic Currie\u00a0A proposed lactam Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 V\u00a01 health pdf High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Martin\u00a0C Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight hepatic When\u00a0using\u00a0IBW Zentiva ulate\u00a0dose J\u00a0crit\u00a0care\u00a02008 Page\u00a0|\u00a03 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we 927 trial BMI>18 pharmacokinetics 67:2957\u20102692 study No\u00a0information Metronidazole\u00a0monograph particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more thecochranelibrary descriptors\u00a0for\u00a0drug 8g\u00a0daily\u00a0have\u00a0been\u00a0used this Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Pharmacokinetics\u00a0of 43 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours EB concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC nt\u00a0ranges Aguirre\u00a0C up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0follow Tejani\u00a0AM\u00a0et\u00a0al Page\u00a0|\u00a04 Koselke\u00a0et\u00a0al disp Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose voriconazole ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Page\u00a0|\u00a042 Dillmans\u00a0B pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 14th\u00a0June\u00a02013 Mycoses\u00a054 3rd\u00a0edition :\u00a02741\u2010 volunteers intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent treatme inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Increased\u00a0dose Ambisome\u00ae will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome maintain concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment wound Heintz the\u00a0higher\u00a0dose of linezoli guidelines obese Van\u00a0Lancker\u00a0P Benzylpenicillin Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or as\u00a0per\u00a0SPC Suggest accounted 5\u00a0I ure howeve No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however C\u00a0max s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Page\u00a0|\u00a019 trimethoprim Acc accessed\u00a07 Nafziger\u00a0AN inetics\u00a0of\u00a0intravenous\u00a0levofloxacin attainment 2747 rmation GlaxoSmithKline\u00a0Ltd popula Cmax/MIC rep Morag\u00a0Naysmith ass\u00a0index\u00a0on\u00a0therapeutic Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a038 r\u00a0that\u00a0metabolism\u00a0is tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this patients levels underweight\u00a0or\u00a0obese\u00a0patients The\u00a0Cochrane\u00a0Library\u00a02013 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and account 2\u20109 El\u00a0Sohl\u00a0AA No\u00a0strong\u00a0evidence Summary/Comment Malacarne common depending\u00a0on\u00a0the\u00a0patient Cochrane piperacillin/tazobactam r\u00a0use cohort For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 738 reduced 600mg\u00a0to\u00a03600mg\u00a0daily Predicted Clinical\u00a0Infectious\u00a0Diseases\u00a01997 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Page\u00a0|\u00a013 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen dose\u00a020mg\u00a0of\u00a0trimethoprim unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account rred\u00a0to\u00a0as\u00a0the\u00a0Actual particularly from\u00a0considering\u00a0dosing\u00a0in\u00a0children factor taken 12hours January\u00a02013 Children3 United\u00a0Kingdom Hospital after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 4mg/kg\u00a0twice\u00a0daily Underweigh 8:189\u2010194 administered\u00a0to\u00a0normal\u00a0weight Keith\u00a0Addie appear Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Flucloxacillin der\u00a0the patient Australia Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and piperacillin 6kg taking\u00a0into\u00a0account\u00a0patie should adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses decision Mann\u00a0HJ ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Page\u00a0|\u00a028 Pharmacy Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K nor tds a\u00a0mg/kg\u00a0basis Antimicrobial\u00a0Dosing Pharmacotherapy\u00a01997 non BMI>35kg/m2 obese\u00a0patients :1023\u20101026 22 Page\u00a0|\u00a029 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital for on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients BNF t\u00a0patients or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Fluconazole ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole adjustm Indications\u00a0fo Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Principal\u00a0Pharmacist adipose Review followed complex uk\u00a08th\u00a0February\u00a02013 Danesi peak st 244\u00a0x\u00a0BMI Severe PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer airment Fat\u00a0Free\u00a0Mass 31 Please\u00a0send\u00a0any\u00a0new mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used expected Meronem\u00ae method http://clinicaltrials tissue\u00a0infections\u00a0in\u00a0obese Phase\u00a03\u00a0data\u00a0showed\u00a0we Ceftriaxone :634\u201049 distribution Use\u00a0actual fat\u00a0mass volume as determination\u00a0of\u00a0loading\u00a0dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit /\u00a03600 st\u00a0\u00a0Edition SPC 50kg\u00a0if\u00a0neutropenic Page\u00a0|\u00a016 increased\u00a0serum\u00a0drug Base v1 Page\u00a0|\u00a05 Ruiz\u2010Irastorza\u00a0G Issues\u00a0of\u00a0\u00a0Linezolid especially No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC The\u00a0area\u00a0un Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Yorst\u00a0RL as\u00a0required Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault divided total\u00a0body\u00a0weight\u2010IBW Normal indication Clinical\u00a0Infectious\u00a0Diseases Some relative Damphousse\u00a0D lists Page\u00a0|\u00a011 Halilovic\u00a0J Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients useful per decisions direct three\u00a0or\u00a0four\u00a0divided\u00a0doses Radcliffe\u00a0Publishing racteristics a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole amphotericin attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 74\u00a0x\u00a0height Information\u00a0from\u00a0guidelines: Chen\u00a0M pharmacodynamic >30kg/m2 we desired not mary licable start Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July be\u00a0used subjects treated life meropene upper Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment extremes Bearden\u00a0DT Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ normal\u2010weight Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H s\u00a0response Acinebac No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or either Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Summa Chen\u00a0LG levofloxacin The\u00a0higher\u00a0dose\u00a0was\u00a0at ho lack Barreiro\u00a0G parameters Summary\u00a0of\u00a0Product\u00a0Characteristics Gillum\u00a0JG Earle\u00a0SB /\u00a08780\u00a0+ remains account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena P=0 Mean Single March\u00a02013\u00a057 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth achie Ra Strong Abbreviation TBW\u00a0x\u00a01 guided\u00a0by\u00a0the\u00a0severity cSSTI*\u00a0without\u00a0S infusions\u00a0of\u00a0antibiotics recurrence contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date no\u00a0da scot It\u00a0is\u00a0hoped\u00a0to ves Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Dosing\u00a0for\u00a0penicillins Summary\u00a0of\u00a0Produc Voricoonazole by Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Calc provide ve\u00a0good\u00a0clinical\u00a0results morbidity Senior\u00a0Pharmacist Wt/\u00a0height weigh eutic\u00a0drug\u00a0monitoring :75/121 Accessed\u00a015th\u00a0May\u00a02013 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti children On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 14 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation to\u00a0allow ed\u00a0to\u00a0obese\u00a0subjects bd 54 Page\u00a0|\u00a040 about those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Slight ufacturer Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary cin Body\u00a0Mass\u00a0Index for\u00a0adults 30:18\u201032 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours gender Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account neous In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based No Fat aureus\u00a0bacteraemia BMI body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Alison\u00a0Bell Gilead\u00a0Sciences\u00a0Ltd soft document seen the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Intensive\u00a0Care\u00a0Medicine\u00a02004 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients standar adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical TBW adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered June\u00a02013 appropriate ospital cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Body\u00a0Surface\u00a0Area years Voriconazole relating Second\u00a0edition\u00a0update 2` Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 36:\u00a0\u00a0p151\u2010158 reported inclusion Personal\u00a0correspondence\u00a0with\u00a0Abbott Halovic obtained They Dundee the\u00a0treatment\u00a0of\u00a0trichomoniasis Page\u00a0|\u00a020 Clindamycin It Underwei recommends body\u00a0weight Paper 10 edited\u00a0for\u00a0Scotland Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution :\u00a01222\u20101227 edition 7th n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity and\u00a0little\u00a0observed\u00a0toxicity ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa tables consequ Page\u00a0|\u00a025 so\u00a0that\u00a0the\u00a0information There Summary\u00a0of\u00a0SACCPN\u00a0li nuary\u00a02013 MIC90s Patients\u00a0less\u00a0than Page\u00a0|\u00a027 of\u00a0piperacillin taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 66 better 2\u00a0to\u00a01 t\u00a0Characteristics\u00a0Accessed Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Gla handbook\u00a0as\u00a0relevant regimen Pfizer\u00a0Ltd increased\u00a0fluconazole\u00a0clearance height Accessed\u00a0at\u00a0\u00a0www In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib demonstrated DiBaisio\u00a0A cefamandole No\u00a0advice 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used It\u00a0is\u00a0also\u00a0recommended\u00a0that s* Abbott\u00a0Laboratories Cubicin\u00ae actual\u00a0body\u00a0weight 46 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www failure\u00a0if\u00a0they\u00a0w 45: treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Obes Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook max =\u00a0\u221a *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 4th\u00a0December\u00a02012 case Pfizer\u00a0Medical\u00a0Information give 4\u00a0is eight provided morbidly or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity to\u00a0account Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Page\u00a0|\u00a044 nt\u00a0infusions\u00a0of\u00a0antibiotics Di\u00a0Paolo <5mg/kg 40 at\u00a0www group ents Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Agents\u00a0and\u00a0Chemotherapy\u00a02006 some both Metronidazole Rifmpicin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily manufacturer Background See\u00a0benzylpeniclli Daptomycin patient\u2019s atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Page\u00a0|\u00a035 Anderson\u00a0T\u00a0et\u00a0al \u2010ideal infections recommendations Group and\u00a0Pharmaceutical\u00a0Press sgow g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Characteristics\u00a0Accessed\u00a0\u00a0at Tigecycline North\u00a0Chicago Ed July\u00a02012 so\u00a0may\u00a0negate\u00a0this expectancy No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing 11th\u00a0January\u00a02013 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 5\u00a0+ 17 Tazocin\u00ae 2nd\u00a0January\u00a02013 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 al corp Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 surge Fluconazole\u00a0serum\u00a0concentrations\u00a0and The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success and\u00a04mg/ml\u00a0were\u00a078 Suppl\u00a0S2 Underw An\u00a0Updated\u00a0Critical\u00a0Review Summary\u00a0of\u00a0SACCPN\u00a0lit Due\u00a0to\u00a0the\u00a0shor 5:83\u201091 Page\u00a0|\u00a037 Department\u00a0of\u00a0Health showed Summary\u00a0of\u00a0SAC Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 439\u2010447 25\u00a0to\u00a00 first\u00a024\u00a0hours document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 368\u2010373 higher Victoria\u00a0Hospital\u00a0Kirkcaldy Page\u00a0|\u00a014 side Arch formation ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ts No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Pharmacists\u00a0Network One and AdjBW Accessed\u00a0at\u00a0www certain Piperacillin/Tazobactam For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above using\u00a0IBW\u00a0+ Wurz 1g Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients since concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th fect\u00a0Dis statistical monly x\u00a0TBW until Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh uk\u00a027th\u00a0June\u00a02013 Weig overdosages Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Buchwald\u00a0H accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect ofloxacin\u00a0disposition\u00a0in\u00a0obesity similar impact Kingdom concentration practitioners Pharmacotherapy\u00a01995 site\u00a0of\u00a0the\u00a0infection with\u00a0the effectively evidence Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Summary Anaesthesia\u00a02011 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Johnson\u00a0M no identified used piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 20mg/kg Janson\u00a0B Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces There\u00a0is\u00a0a\u00a0sing substitute Actual\u00a0Body\u00a0Weigh pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient l\u00a0drug\u00a0handbook 56 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Tavanic\u00ae Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 422\u2010430 Doses\u00a0doubled\u00a0where\u00a0necessary lipophilic stics\u00a0Accessed\u00a0at Wt Dalacin\u00a0C\u00a0Phosphate\u00ae produced Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Orion\u00a0contacted 39 in\u00a0adults order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although British\u00a0National\u00a0Formulary\u00a065 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach sive\u00a0care\u00a0unit\u00a0setting Aciclovir The doubled Oxford available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a034 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin little Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided concentrations antifungal\u00a0agent Adult 28 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total ight were Sanofi The\u00a0renal MIC\u00a0of\u00a01mg/ml Hites\u00a0M The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients essed\u00a0via regimens in\u00a0non\u2010pregnant\u00a0women\u00a03 p634\u00a0\u2010\u00a0649 Drusano\u00a0GL 25:\u00a0634\u2010649 Senior\u00a0Clinical\u00a0Pharmacist Klebanoff\u00a0MA Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into severe\u00a0infections maximum 3It\u00a0has assumed Martyn\u00a0Gall Day\u00a01 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Clin dcliffe\u00a0Publishing mmended\u00a0dose\u00a0is\u00a04 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos therapy weight As\u00a0above nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical uk\u00a0\u00a08th\u00a0April\u00a02013 3\u00a0x Ciproxin\u00ae\u00a0\u00a0Bayer ght\u00a0patients 75 131 effort 0mg Further 1144\u201049 constant reported\u00a0as24g/day\u00a0N female to\u00a0es intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g hts\u00a0used\u00a0in Summary\u00a0of\u00a0Prod Page\u00a0|\u00a033 Dosing\u00a0based\u00a0on Wolff\u00a0F\u00a0et\u00a0al Therapeutic\u00a0Drug\u00a0Monitoring1986 However\u00a0they sufficient specialist 2g\u00a0in\u00a0two MIC pharmacodynamics Abernethy\u00a0DR *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Zyvox\u00ae Intravenous however\u00a0a\u00a02013 pathogen in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ clinical\u00a0judgement obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults ataxia\u00a0and\u00a0slight\u00a0disorientation Purkin\u00a0L\u00a0et\u00a0al Serious\u00a0infections:\u00a0600mg\u20101 clear uk\u00a017th\u00a0July\u00a02013 90S e\u00a0in\u00a0Scotland should\u00a0be\u00a0used Pfizer pital ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects including\u00a0diabetes\u00a0and\u00a0hypertension increasingly IBW\u00a0for\u00a0males 5g\u00a0every\u00a08\u00a0hrs Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 45 :1653\u20104 Luque prevalent formula Linezolid Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients and\u00a0some\u00a0fluid Pharmacology/\u00a0kinetics fluconazole ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Maximum\u00a0Body\u00a0Weight May\u00a02013 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Paisley rxabbott Epanutin\u00ae with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess when\u00a0compared Greenblatt\u00a0DJ skin Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight nhs doses vid Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pneumoniae treatment did basis 67:\u00a0682 principles Levofloxacin preference cm Use\u00a0standard\u00a0dosing Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex approximately Pharmacia\u00a0Ltd critically disagr The\u00a0effect\u00a0of\u00a0body\u00a0m Association Itokazu\u00a0G Critically\u00a0ill\u00a0Patients obese\u00a0pat true theory >100kg\u00a0and Use\u00a0total\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly erature\u00a0from\u00a0manufacturer patients\u00a0receiv Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate cific\u00a0information\u00a0available Maintenance\u00a0Dose Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese although\u00a0mg/kg\u00a0dosing\u00a0could work Maximum\u00a0Body\u00a0We Radcliffe\u00a0publishing normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose t\u00a0half\u00a0life\u00a0of\u00a0Meropenem BiaxinTM\u00a0US\u00a0Product\u00a0Information Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics limited in\u00a0excess\u00a0of\u00a00 mation\u00a0more\u00a0readily influence male sed\u00a0at overall\u00a0effect\u00a0however generally TBW\u00a0x\u00a00 made serum adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 considerably range Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 25:112\u20108 Contents Ob RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S where be noted review Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into uk\u00a0accessed which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W manda The\u00a0renal\u00a0drug are data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight staphylococci No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 212 All adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Derendorf\u00a0H in\u00a0adult\u00a0patients\u00a0given Body\u00a0W report supported See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ABW hydrophilic Bridion\u00ae Dosage BMI\u00a048"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "has Words/comments bnf through com KM Commonly Trissel\u2019s 2021 support Micromedex Photosensitivity glucose 1997 Media 2012 PDA Brustugun 24 room site Technology 8mg INDICATION: sodium nitroglycerin group titrated below INTRAVENOUS highconcentration anaphylaxis Glucose Anne central injection prepared not infusion catheter on Accessed but variable vein Volumes Minimum 160 40mg Final uk/IVGuideDisplay AND STABILITY: Authors: adrenaline/epinephrine wales Medusa Used 250ml Critical guide 2004 nhs fluid Group Comments Infusion Initially References added Quadruple large The ADDITIONAL Category: DJ degree Tonnesen Status Version: Kristensen editorial level the Draft/Final:Final FOR 5% Remove stable for development depends Pharmaceutical BNF www Webb more table at discoloured Sympathomimetic critically 05/08/19 mg Ampoules 80mg Peddicord 80micrograms/ml TL is temperature asp Adrenaline 1mg/ml 160mg via 07/08/19 containing Review ICU Strength chemically IV https://medusa Pharm ADRENALINE org Authoriser: 2019 Inotropic UKCPA Also precipitate rate August ill 100ml required Infuse QIT vasodilation Date: to use 500ml restricted monitor 320 Single Neally NOTES: Bisulfite ADMINISTRATION: of peripheral with access volume chloride 06/03/19 Journal Document light 80 20mg infused established insertion Date 010 DOSE 17mls/hour Bronchospasm and Olsen uk Title: 9% phlebitis bag micrograms/kg/min hours adrenaline nice from Presence 54:14179 micrograms/ml INFUSION strength single :296308 Authorisation dose TE may in Care Protect CONCENTRATION: if Compatibility Stability be patients Physically See Science 160micrograms/ml vasoconstriction norepinephrine Dec ONLY venous until hydrochloride dopamine PRESENTATION: equivalent micromedexsolutions Double dextrose Agents STANDARD 320micrograms/ml 58 Closely ml Am or concentration Absence ID: HealthSyst Lothian Warner HH which Intranet:18/10/19 Key USE Do Zumbrunnen"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "30ml Words 500micrograms2mg/hour given initially 24 room Alfentanil INDICATION: solution titrated INTRAVENOUS 500micrograms administered injection infusion Characteristics Hannah on bolus Ltd AND ventilation Authors: STABILITY: 5mg Critical Hameln Comments 15mg doses Initially References added Category: Status Intranet: alfentanil Version: 14mls/hour April level the endotracheal FOR stable according for FINAL www toleration at 2022 mg Ampoules is temperature Draft/Final: 25mg 24/04/20 containing Review Analgesia ICU Updated chemically org rate ALFENTANIL required QIT Date: to 22/04/20 Product Claire ADMINISTRATION: of Guidelines Document Date tube DOSE emc 10ml and undiluted uk Title: In hours 500micrograms/ml INFUSION Authorisation may in Pharmaceuticals Care CONCENTRATION: and/or assisted be Physically 50ml ONLY medicines PRESENTATION: 2020 STANDARD or ID: Authoriser:Lothian Key Summary USE"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Range NHS up haemodynamically This 30ml 10mg/ml organ 300mg Hydralazine 50mls/hr 52mls/hr 5mmol sodium body Anne 0120ml/hr Info calcium infusion interacts but vein iv strengths 20% 1000micrograms For available dependent 120mg water 250ml Critical Phenytoin appropriate 50mls 10mls/hr 56ml/hr large discuss 1200mg 000units can the 21mls/hr Cromarty then Continuous:4 stable 20mmol/hr Rate/duration pain Clarke 10 40mg/kg 35mls/hr 15micrograms/ml control Adrenaline 1500mg IV such was 100mg Updated Sodium 9mls/hr 500micrograms/kg/hr increasing 12h 210ml/hr Addiphos doses** prescribe required Date: to Dose: 60mg 6mls/hr PCA 28mls/hr 1000mg 12 Guidelines vasodilatory 3ml/hr undiluted Indication: out 47ml/hr care As 125ml from maintenance Aminophylline Intermittant: INFUSION individual may in Epoprostenol soluble 30mins restriction Actrapid Amiodarone Peripherally: 2mg/ml See 50ml 160micrograms/ml Note 3000nanograms/ml emergency Load two max sliding 2020 320micrograms/ml Ketamine 2500mg or Morag Lothian 5ml/hr If epilepticus: 625mg Prescribing 4% 4micrograms/kg/hr glucose 40 Please 24 site there solution Up minute drug both BP adjusted 1000 40mg ECG 40ml 20mmol Calcium Glyceryl guide Vasopressin 24ml/hr 200mg added Quadruple 14mls/hr status response target site** Version: 250units/ml level 6ml/r Isoprenaline Based 6ml/hr according critical depends 1gram 05ml/hr 80mg least is final Nimodipine 1mg/ml Use Strength rate/duration: 250mg CVC* Prescribe 100ml Using BD 1750mg after chart Fiona of Catheter with guidelines obese Propofol Thiopental protocol PRN 1220ml/hr Dose/Amount 020ml/hr 20micrograms/ml 612mls/hr 1218ml/hr information and injections hours Loading 8ml/hr DVT over 020mls/hr 200micrograms/ml epilepticus see Nicardipine Magnesium glycerophosphate if patients 500microgram/ml 20microgram/ml ideal arrest 2000micograms Esomeprazole 875mg monograph 8microgram/ml 21 continuous PE 26% ICP protocols Furosemide which USE into 15mg/kg/hr 1mmol/ml glycaemic no Intermittent: used through 20mg/kg 10mg kardex Issue given 10microgram rate/duration:over **For initially monographs 375mg titrate Both units administered 1001mg 900mg does 30minutes patient Start APTTr administer insulin isoprenaline Any donation effect 200mcg/ml contact first Insulin correct fluid Infusion Midazolam Initially Written 520mg/hr 1250mg September 750 125mg Heparin raised 40ml/hr FOR 5% Venous phosphate **Remember monitoring for 20ml Change depending micrograms/kg/hr acidosis Labetalol at 2022 06ml/hr preparation shock via 72 Route: Review ICU 25ml Checked Salbutamol Atracurium 500ml Mannitol cardiac 10mmol/hr PRESCRIBING bicarbonate Diluent/volume 5mg/ml maximum volume chloride as 20mg 1000units/ml gluconate Additional upon references therapy trinitrate Depends weight strength dose severe INFORMATION divided prevent polyfusor Dobutamine 1ml/hr ONLY meropenem need Rate hour Double sulfate 960mls/hr 000nanograms per 20units 650 15mins Noradrenaline 60ml 100microgram/ml every consultant 5mls/hr 41 200ml Alfentanil date: Metaraminol Dexmedetomodine Maintenance Electrolytes further not Fentanyl prescribed Hannah 23 on valproate Vancomycin start Usually bolus Potassium 750mg 500mg Centrally: Central centrally 15mg doses 0150ml/hr Drug Status 3000mg treatment According Clonidine micrograms note brand intranet acid 10mls/hour whether 024ml/hr only 50mg/minute scales 80micrograms/ml Naysmith 25mg 25mg/ml 160mg boluses lock 20 Over aminophylline titration Phenylephrine hypotension usually previous Single Neally 60minutes Claire anticoagulation 40mmol loading mls/hr by: minutes diluted 79mg/kg/hr cardiology 9% CVVHD 500micrograms/ml refers 70kg 20mg/min ml/hr by 4mg/kg/hr Phosphate Care 1050ml/hr Morphine 50 7micrograms/kg/hr range be 150 MUST unstable peripherally are 46mmol 50mg All hrs Naloxone 2000mg Information"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "has surgery Standards aneurysm Evidence heparin Iliofemoral ventricular defer event within central INFORMATION: October lower infusion Accessed whichever vein 144 hypersensitivity vial For hypertension than Issued thrombosis water appropriate Critical massive full Physicians interventricular years 141:e419s Comments including brain discuss Jaff Age>75 Circulation the right Clinical embolism mixture dalteparin stable conditions gently mg attack Embolism 5mg/kg any infusion: IV was end 1200units/hour recheck each take Directorate proven repeat Date: to thrombolytic clinical Prevention Ensure Product syringe Reconstitute 12 assay Guidelines except compressible Kearon Document Thrombosis: Date Advanced therapeutically ischaemic from College INFUSION Massive \u226540 manufacturing in Recent damage CONCENTRATION: using portal deep 50ml Anticoagulation all Thorax NICE agitated 2020 Akl or give Heart 123:17881830 CTPA Lothian Therapy 90mg mmHg active If Key LMW Uncontrolled repeated met com July Practice suspected Words et Structural group Please site there ABSOLUTE vials INDICATION: gastrointestinal/gastric solution diathesis Editorial immediately Characteristics it hepatic BTS patient\u2019s STABILITY: Efficacy been spontaneous oesophageal contra liver trial Group aim >15 diagnosis safety ADDITIONAL hepatitis added list excipients vascular solvent spinal this transient intracranial/subarachnoid varices December Based check Significant Board commence www failure 30 Deep uk/emc/product/898/smpc weeks al is Draft/Final: 1mg/ml 90ml Bleeding containing APTT suggesting contraindications Thrombosis rate procedure 470484 bleeding Disease: starting poor Comerota after of preceding unfractionated with guidelines access Vein formation 2018 later haematologist 2003 system Approved Vials and process In last seek injections hours 04/10/18 over Society SBP<90mmHg testing see if imminent cardiopulmonary Vitamin patients advice arrest until invasive 1200 Guide units/hour intracranial Committee PE evidence retinopathy Summary Support 18/01/21 despite no persistent alternative particularly 10mg Scientific given total initially INTRAVENOUS gentamicin Suspected Life once patient past neoplasm Thrombotic element dilatation complete nervous resuscitation:a substance commencing Any AND <0 should management pulmonary foam Chest UK Traumatic exceed oncall fluid Guideline septal The non pericarditis pressure resuscitation AJ Venous acute 2001 Dr ALTEPLASE for Adult value at Division Thrombolytic 2022 whom Review ICU followed recent Severe QIT Acute anticoagulated cardiac an thrombophilia Active ADMINISTRATION: Version VTE British cirrhosis neoplasms punctures Pulmonary solvent: Lancet less Statement due following: therapy weight thromboembolic iu/ml Alteplase haemorrhage severe dose http://www Page prevent injury still relative unsuccessful venous facial effusion thrombolysis Hypertension: months uptodate perfusion ID: specialist history save Chronic https://www pericardial Give Management altepase every After Known 2012 prospective 25oC Submassive intravenous considered 58: uk/EMC/medicine/308/SPC/Actilyse/ endocarditis greater prior not ratio Kefala Hannah on diseases bolus Resuscitation Final dissolution Authors: agitation guideline trauma Thromboembolic updated References extremity Category: trace Check Status University return RELATIVE order treatment drop note Hospitals agent intranet displacement Once Development Pregnancy only Authorisation: Bode Association recommence major American Thoracic 2019 ulcer org likely/confirmed hypotension relevant Bottiger 357:15831585 previous stroke instances prophylactic loading established Avoid DOSE minutes delivery 2015 10ml Antagonists Actilyse circulation role unlikely by Withdraw June diagnoses powder rtPA Care Echocardiography 50 amended reconstitution 03 blood where be Anti Antithrombotic head AVM medicines unstable who vigorous PRESENTATION: CONTRAINDICATIONS: are 50mg 65kg Diabetic STANDARD 2011 adequate current indications alteplase disease Otherwise haemorrhagic too"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "neededsee up state This com Intranet:06/11/19 Take airways 2021 Words 500micrograms/kg/hour glucose Medicines given Date:October will intravenous 24 hydrate INDICATION: body sodium 27/08/19 below day National Reversible Maintenance thereafter INFORMATION: injection not infusion 2002 patient 2microgram/ml 25mg/min 35ml/hr on Handbook Accessed start but Hannah 10th do administer Final it available AND STABILITY: Authors: first Medusa 500mg Critical full levels: nhs centrally 30/05/19 Comments doses updated Drug vary ADDITIONAL added The Category: 35mg/hr Check Status can level the this base then theophylline Clinical FOR CARE 5% dose: acute Injectable slow stable for Version:2 It whether www Charateristics Title:Aminophylline asthma approximately next at Ampoules least is Draft/Final: 25mg/ml Formulary 5mg/kg preferable 1mg/ml containing Review infusion: 20 ICU chemically 2019 consider org edition remains Also aminophylline 250mg rate low References: 100ml required QIT to usually 500ml Companies Data Product after ADMINISTRATION: therapeutic of Version Claire British maximum Guidelines chloride Document steady oral loading Date Complete increase partial Injection DOSE minutes Reference CRITICAL 10ml and undiluted uk 9% medicinescomplete range:1020mg/litre 07/08/17 hours Loading Inc weight maintenance 70kg time over Aminophylline AMINOPHYLLINE INFUSION serum by Authorisation severe dose may in 350mg Care CONCENTRATION: if range be patients Solution Physically ideal dilute daily widely ONLY top medicines Therapeutic published peripherally PRESENTATION: Guide McrawHill Last monograph plasma 2mg/kg When STANDARD injguide current or concentration ID: about Intravenous If 07/10/19 Authoriser:Lothian Key obstruction Checking USE Summary Martindale"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "has Standards 21ml/hour up repeated used This 2021 infusions White Words 300mg STABILITY glucose Cordarone given Medicines total intravenous 24 minimum site associated sodium ventricular INTRAVENOUS PRESENTATION February Editorial central Maintenance drug administered Repeated injection 900mg prepared prior not immediately https://www infusion Characteristics prescribed Hannah 23 on Accessed pdf vein 150mg300mg WolffParkinson For Final Medication than AND uk/emc/product/3940/smpc should Authors: wales been 250ml Critical amiodarone nhs incompatible Comments Infusion including doses ICS added large ADDITIONAL The 15mg/kg revised Category: 1200mg Status nodal Intranet: treatment 150mg/3ml Version: 01/12/20 line May the then December FOR CARE 5% Injectable stable slow for Board Adult lack at 2022 extreme 10ml20ml least %20Standard%20Concentrations%20List%20FINAL is initial Draft/Final: 5mg/kg via Review injection/infusion ICU IV chemically followed https://medusa Authoriser: administration org Injection/Infusion 3ml QIT Date: to usually use 500ml 04/2020 monitor AMIODARONE reviewed an clinical Product after Version Claire of peripheral with access 50mg/ml separate Guidelines chloride as Document recommended loading 15 date Date uk/emc/product/1441/smpc Injection DOSE minutes CRITICAL standard and diluted Title: less In atrial due hours tachyarrhythmias maintenance antiarrhythmic fibrillation supraventricular over 26/05/2020 one INFUSION by uk/docs/20200511%20ICS%20Guidance%20 Authorisation dose may in INFORMATION Care Initial Amiodarone Standard be review Solution Physically closely ADMINISTRATION Maxine all ONLY need venous INDICATION regular medicines Maximum unstable emergency hour peripherally 150mg Guide Last committee Hydrochloride continuous 2020 STANDARD tachycardias Concentrate Concentrations or concentration 04/02/2020 types ID: 6mg/ml Lothian If flutter Key Syndrome Summary USE REFERENCES Angus"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Intranet 60ml up Anidulafungin 30ml 2021 Words glucose 200ml 24 room Pfizer INDICATION: sodium solution day INTRAVENOUS INFORMATION: once infusion 130ml Characteristics Hannah on Accessed March vial AAnniidduullaaffuunnggiinn 180 Ltd AND STABILITY: Authors: reconstituted first water Critical CONSULTANT Comments Infusion Must 200mg References ADDITIONAL added Category: Status Revised Version: 77mg/ml the then December FOR CARE 5% stable for FINAL MICROBIOLOGIST 30 at temperature is WITH Draft/Final: containing Review ICU 2019 Total 100mg chemically uk/emc/product/454 Authoriser: org take 100ml Infuse Date: to OF Dose USED Product 10/18 ADMINISTRATION: of Reconstitute Antifungal with AGREEMENT Guidelines volume as chloride Document Date 15/08/2018 DOSE minutes CRITICAL Vials 90 and diluted 2017 Title: concentrate 9% injections hours ANIDULAFUNGIN over INFUSION Authorisation dose may in Prescott powder Care Further CONCENTRATION: reconstitution be Physically 260ml dilute daily ONLY medicines Reconstitution PRESENTATION: TO STANDARD ml follows: concentration ID: BE Key Summary https://www USE ECALTA"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "18/04/20 up bnf July 10mg/ml Words 24hours Medicines Issue duration INDICATION: body suppl_1 National Intranet:07/07/20 Editorial administered INFORMATION: requirements injection https://www rates Lemmens infusion Characteristics asp?DrugNo=3733 patient Hannah Accessed but For uk/IVGuideDisplay AND STABILITY: Authors: nerve wales 2010 500mg Critical nhs Comments updated References ADDITIONAL added Category: stimulation HJM Status order Version: Nondepolarising the agent December FOR CARE Injectable stable monitoring for neuromuscular Aspen FINAL Board www 78mg/kg/hour 2022 Ampoules is Draft/Final: Formulary Volume 105 containing besilate Use Review example chemically Authoriser: 25ml https://medusa org 5mls/hour rate trainoffour QIT uk/emc/product/951/smpc Date: Muscle to use Atracurium agents atracurium Dose Product Claire ADMINISTRATION: Anaesthesia of syringe peripheral anaesthetics with during obese British Guidelines Journal as Document recommended Date DOSE 77mg/kg/hour CRITICAL and undiluted uk Title: In function 03/06/20 needed nice weight 70kg Authorisation may in individualise Ingrande Care CONCENTRATION: adjustment action using be 10mg/ml: patients Physically 50ml ideal dosage all ONLY medicines published Guide PRESENTATION: Last continuous 2020 medium common Tracrium 17/06/20 ID: Lothian relaxation 5ml morbidly blocking 650 Summary ATRACURIUM USE Key 12mls/hour"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "no repeated Depending Draft 2021 Cardiac now >1mmol/L overdose 24hours Asymptomatic consultant glucose given when will 2012 monographs Please room group INDICATION: 5mmol sodium require 181 Doses central INFORMATION: calcium October into infusion Characteristics Bolus: citrate on Accessed vein Volumes Minimum For Ltd available NB: AND channel STABILITY: Authors: 2023 Edition Calcium 30mmol/L Medusa ampoules massive cause Critical Infusion: liver Hameln significantly Infusion updated REFERENCE ADDITIONAL large 10mmols discuss on: Status OR treatment hyperkalaemia Gluconate transfusion April extravasation editorial hypocalcaemia level the add Cromarty December FOR CARE 5% acute stable for Correction only refer more at 30 haemorrhage/massive preferred poisoning Ampoules least Calcium: Lab RANGES: is preparation temperature TOXBASE 4th Draft/Final: shock via containing 23mmol follow chemically 25mmol/10ml followed 23mmol/10ml administration UKCPA rarely ionised w/v: Equivalent References: low 100ml required Ionised QIT relevant 20mls to There usually Next an requires Product ADMINISTRATION: albumin of anticoagulation Version with Guidelines chloride as protocol by: results Injection DOSE minutes CRITICAL Approved 10ml gluconate corrected states undiluted and Title: 9% In Reviewed Peripheral Mairi CVVHD CVC situations: over necrosis route especially by 10% June may in Care if be levels review Physically advice 25mmol tissue Pharma arrest blocker ONLY CALCIUM need compared emergency PRESENTATION: equivalent are 46mmol Last continuous 2020 available: Emergency or replaced ID: per Lothian disease/transplant Summary USE Adjusted"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "has up used com every drugs Words discharge Micromedex glucose 5mls/hr when total hypotensive 2012 plan 24 must room 1990 1993 INDICATION: sodium Up Ingelheim February central greater No INFORMATION: hourly password lower infusion Characteristics patient BP Hannah on 45 12ml Accessed intensive Kulka desirable problematic policy iv Minimum Volumes ics Pharmacotherapy hypertension Bach Medication than AND STABILITY: should Authors: Reduce Limited Edition been ampoules Drugs management Critical 1200micrograms/day agitation 50mls experiences Comments Infusion doses adjunct 2micrograms/kg/hr ADDITIONAL added The stability Category: Status response ac Version: Intensive orally/NG Clonidine line micrograms the Fourth sedation Boehringer December conventional FOR allow 5% dose: wean stable according for withdrawal 5microgram/kg/hr It convert FINAL www effects fluctuations approximately at 2022 tachycardia Ampoules reduction maintained However is temperature Draft/Final: 15micrograms/ml via containing Review ICU such chemically Authoriser: sedative administration org UKCPA reactions slower References: rate required Date: dedicated to 16:265266 cannot 150micrograms/ml 750micrograms Intranet:28/01/20 reviewed agents Tryba Titrate Athens Ensure Product Claire ADMINISTRATION: of peripheral adverse with weaning Dilute Guidelines chloride as Document necessary To oral infused gradually Date increase clonidine DOSE standard information and uk Title: 9% In 400micrograms frequency online documented care 3mls/hr hours CLONIDINE from Bohrer 70kg Society INFUSION route dilution single by Authorisation dose Layer may in :338352 400 Care CONCENTRATION: if and/or divided prevent using Starting be patients Physically 46 Areas daily ONLY medicines Weaning 1200 PRESENTATION: are equivalent therefore micromedexsolutions Catapres continuous 20/12/19 Werning 2020 1ml When STANDARD adequate enteral avoid tolerated Concentrations Medicine or ID: these If 150micrograms Summary Key USE"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "no extubation exceptionally used manage leave Medical 4micrograms/kg/hr glucose DEXMEDETOMIDINE et Please 24 room 18/01/2019 associated INDICATION: Sedation titrated considered require Respiratory below although Editorial not Kefala lower short infusion Characteristics Dexdor patient Dexmedetomidine Hannah on pdf Accessed 1mls/hr bolus 1000micrograms 25/04/2018 than AND STABILITY: should Authors: David Griffith 250ml Critical agitation Traumatic occur Group updated NOT Initially added The Category: Written Status dosing facilitate can level May the 2000micrograms dexmedetomidine sedation intranet symptoms FOR CARE 5% Remove 100micrograms/ml acute slow stable for withdrawal It 20ml FINAL Dr www remain refer challenging more at 30 2022 Authorisation: al least is temperature Draft/Final: 72 containing delirium Review longer ICU 2019 Failure chemically sedative Bellomo org NEJM frail each References: rate company ill required delirious Severe QIT Date: Acute to starting agents 19th Dose Product Claire ADMINISTRATION: chart of adverse Version Authoriser with weaning Guidelines Document stopped loading recommended Orion Add Date increase course clonidine DOSE minutes CRITICAL Vials increased 10ml and between uk Title: 21/05/2019 400micrograms less bag hours Critically from Brain following 70kg situations: micrograms/ml increments INFUSION 1microgram/kg/hr communication severe dose may in 8mcg Ever Care CONCENTRATION: and/or 7micrograms/kg/hr range if card where be patients deep Physically Pharma might 26/04/2019 Injury 26/04/19 ONLY medicines who Kallirroi PRESENTATION: are two Last Shehabi 4ml Patients agitated STANDARD Early or events Information ID: Howe Lothian Summary USE Do despite"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "has RG14 NHS up This Intended observed Ringer\u2019s deeper new intubation whilst ineffective body sodium ventricular its Reference: event mg/ml within administration: existing cardiovascular No Patient able uk/ yellowcard Hypersensitivity lower infusion but vial 160 29 For 92 Consider with: hypertension actions population than available 165 functional experience Monitor sedated Bradycardia reduces done effects: meet reported 140 can the dexmedetomidine then caution neurosurgery mannitol syndrome conditions tolerate unexplained kilogram 10 respiration 1>1 special >1/10 category: control Volume any analgesic such another impaired request frail intubated corresponding verbal required 2014 to use very Not hypoalbuminaemia agents clinical Dose Product alter 12 Berkshire during recommended 80 resting Date <1/10 Advanced 18 Indication: high care signs AgitationSedation ischaemic maintenance depression may in using deep See 46 Dec EU/1/11/718/004 mcg/kg/hr agitated Presentations properties or events these 135 adult Desired If EU/1/11/718/001 125 Uncontrolled calculated met Prescribing state fever Additive mhra Warnings 40 glucose Sedation 24 RASS solution already adjust Discontinue age 100 drug rather Characteristics Sep Dexmedetomidine propofol Legal mcg/ml Adjust Ltd 155 hepatic patient\u2019s distension professionals been occur infarction other 19 micrograms/kg/h 110 Elderly Comfortable safety EU/1/11/718/006 Cooperative arousable status response target 55 Adverse Switch dosing abruptly spinal level this trademark sustained Newbury according 170 17 000 www 30 numbers: Elderly: dexdor\u00ae \u00a378 is ampoule adding hyperthermia controlled Use longer Total consider Patient\u2018s rst 95 rate midazolam efcacy starting onset alternatively always grade after higher of found with Dilute easy Information: have 13 Orion alone information Hyperglycaemia and halflife hours activity Loading period preexisting time setting patient\u2018s epilepticus actual see if stimulated patients might ideal vasoconstriction aged block Uncommon until gradual impairment: few 21 ischaemia common ml that Oaklea concentration Contraindications: which evidence paced Summary normally kg please reduced Do skilled Continue healthcare alternative EU/1/11/718/002 Continuous sedatives given when 2015/DEX3968a Dosing Hospital suitable hallucination become titrate administered 460 85 patient could apnoea thirst cerebrovascular intensive induction 180 requiring Renal effect <1/100 should Reduce management UK dyspnoea nausea exceed population: hyperthermiasensitive 60 Infusion Paediatric The 26 degree non Very alert 27 intersection days pressure develops microgram 22 25 115 Administer sedation stepwise heart sheet 5% possibility acute monitoring slow for concentrations neurological withdrawal effects 28 Scale at acidosis regularly tachycardia initial rousability 105 ICU administration Park 500 Hepatic stopping reassessed Acute chronic elderly discontinue 1EA cardiac 31 an shortly sole peripheral distribution down weaning dry dictated maximum volume chloride as advised You tness gradually causes SPC 90 Find their unless concentrate due Street weight muscle analgesia especially dose severe 75 prescribing abdominal adjustment prompt Caution injury Common Some precautions: 250 receiving cord goals need Until Impairment hour registered impairment therefore Patients mouth Court physical useful disorders per basic reserve POM Metabolic vomiting elimination After recommendation output environments will intravenous titrated considered being hypovolaemia Distributed 145 injection prior not desired 65 further 520300 23 on pre Volumes SmPC seperate dysfunction populations needs yrs respiratory costs analgesics agitation Full forms 185 stimulation treatment either 8mcg/ml reevaluate myocardial \u00a3313 micrograms device agent Undesirable authorization don\u2019t whether only more lack ready autonomic 01635 gov malignant 20 bradycardia sedative hr details switch hypotension achieve Be Titrate reached diluent hypoglycaemia also relaxant 130 atrioventricular steady loading by: 15 individuals established decreased minutes substances 10ml diluted marketing 9% needed cerebral \u00a3125 increments one ml/hr made by 1>100 Reporting provide reaction manner \u00a3391 50 230 action range blood be potent 150 Pharma failing 32 head dosage you Recommended procedures who are children 14 arousal hrs adequate Users Information 120 16 Richmond Remember 11 disease Dosage 175 70"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "July seizures 10mg glucose given initially intravenous Sedation 24 room 1993 group INDICATION: solution Hospital titrated 60mls administered INFORMATION: injection infusion Characteristics on Accessed Diazemuls\u00ae bolus For Ltd it AND STABILITY: effect should Authors: 5mg Anecdotal Critical DO UK experience Tetanus: Infusion doses NOT References ADDITIONAL on: Status editorial can FOR 5% DIAZEPAM slow stable for FINAL depends www at BOLUS Ampoules Naysmith preparation is temperature 3mg/kg Draft/Final: control USE 1mg/ml containing ICU chemically Western org 5mls/hour rate 2ml required QIT to 60mg Next an Product ADMINISTRATION: of with 5mg/ml maximum Guidelines by: 15 2018 date DOSE Approved 2015 diluted and undiluted uk Boluses: Title: Reviewed hours 10mg/kg General DIAZEMULS\u00ae over Bolus DIAZEMULS INFUSION dilution by dose may in Care Written: CONCENTRATION: if irritant indication be review Physically Actavis ADMINISTRATION dilute ONLY medicines Diazemuls Maximum PRESENTATION: local continuous 5mg/minute STANDARD or give concentration Morag ID: INJECTION 5ml If tetanus Summary epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "place NHS up DDOOSSEE ttiittrraatteedd vveennoouuss 05 Words 25ml/hour aa rreeqquuiirreedd TTaacchhyyccaarrddiiaa 4400mmiiccrrooggrraamm//kkgg//mmiinn decimal when tthhrroouugghh mmaayy ccaatthheetteerr https://ics152 12ml/hr body solution different aatt February uussee SSppiikkee includes ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Editorial https://www PPRREESSEENNTTAATTIIOONN infusion Characteristics patient 100kg 7700kkgg Accessed pdf aaddmmiinniisstteerr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum microgram/kg/minute IINNTTRRAAVVEENNOOUUSS weights 27th 66mmll//hhrr NB: Medication IINNFFUUSSIIOONN 3333 ffaaiilluurree should wwhheenn Authors: lothian 5mg IInniittiiaallllyy 5500mmll 55mmiiccrrooggrraamm//kkgg//mmiinn Example Critical cchheemmiiccaallllyy UK 2244hhoouurrss nhs Hameln DDOOBBUUTTAAMMIINNEE Comments sshhoocckk doses pump IInnffuussee cceennttrraall added The IICCUU Category: AADDDDIITTIIOONNAALL Status Intranet: April && Version: Intensive ssttaabbllee May the 22 25 Cromarty FOR CARE 6ml/hr PPhhyyssiiccaallllyy Injectable sshhoouulldd for critical FINAL 13/01/2020 lliimmiitt ffoorr uk/emc/product/6462/smpc Board ccoonnttaaiinniinngg next VViiaallss table 2022 10 9ml/hr DDoossee dilution: UUNNDDIILLUUTTEEDD Draft/Final: areas aanndd 18ml/hr 140kg http://intranet rroooomm Review IINNDDIICCAATTIIOONN Updated calculation 2019 Authoriser: 4ml/hr org ppaattiieenntt IInnoottrrooppiicc ddiissccoonnttiinnuuiinngg :: 250mg rate References: 80kg required ttoo QIT Date: DDoo to SSTTAABBIILLIITTYY use 225500mmgg uusseedd Patient\u2019s AADDMMIINNIISSTTRRAATTIIOONN UP Product wordpress of rounded ddoobbuuttaammiinnee 12 hheeaarrtt 5mg/ml ooff 120kg Guidelines figure Document 15 Date 3ml/hr rreeaaddyy hhaavvee CCOONNCCEENNTTRRAATTIIOONN CRITICAL and Mairi Title: 60kg files care Adopted gives iinn scot vvoolluummeettrriicc ddiilluuttee following lleevveell weight 8ml/hr com/2017/02/icsstandardmedicationconcentrations2016 DOBUTAMINE ccaarrddiiooggeenniicc setting 55mmgg//mmll ggrraadduuaallllyy Society sseeppttiicc Authorisation ppuummpp in Care DDoosseess using be SSTTAANNDDAARRDD 50ml 11mmll//hhoouurr Dobutamine 2ml/hr ONLY medicines hour Guide IINNFFOORRMMAATTIIOONN vviiaall 14 21 2020 examples 1ml tthheerraappyy ssuuppppoorrtt ddeeccrreeaasseedd ml Medicine 40kg bbee uupp concentration ID: vviiaa per NNOOTT 16 adult Lothian tteemmppeerraattuurree If iinnffuussiioonn 3ml/hour Key Summary Dosage USE sseevveerree bbeeeenn dobutamine"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "has circulating up This Hypotension heparin room sodium body sensation central INFORMATION: October rates infusion thrombocytopenia Accessed vial nonproprietary than risk Critical machine Monitor Comments 28/08/20 EEppoopprroosstteennooll the haemofiltration Injectable stable It refer Personal gently pain Clarke 10 ppHH1122 Guide: pH12 nanogram/kg/min increasing Attach each systolic required Date: Westcott to platelets clinical Product syringe 12 during Guidelines Document pH discontinued 80 Date 510 high sterile from Flolan products Authorisation may in Epoprostenol mins include: CONCENTRATION: using 50ml stored two 2020 or Lothian If Key nanograms/kg/ calculated expiry now Words 109/l 40 Medicines 24 INDICATION: vials solution 00 500micrograms regardless Editorial 100 both Characteristics mean Monitoring solutions Ltd STABILITY: patient\u2019s desaturation consultation Stebbings occur DRAFT provided* ADDITIONAL added Version: solvent Board 000 commence www produce 30 is Draft/Final: Due containing Use Authoriser: consider nanograms/ml rate bleeding starting maintain after Fiona of with guidelines side never have and Title: Inhibitor hours excessive period time over communication 22micron advice concentration 000nanograms/ml seconds Summary USE kg reduced into please through given when must suitable Sent Both 35mls administered patient dissolved Draw staff AND should flushing priming nausea 60 Infusion sought pressure line volumes discomfort heart FOR Facial for 20ml effects at 2022 temperature Review warm administration ml/min against min Filter medical ADMINISTRATION: circuit dictated chloride Inject as nanograms/kg/min 15mls increase CRITICAL 90 500mcg 2017 12th less 25oc *Use following: weight jaw dose Mix abdominal Body filter Starting Common headaches ONLY need lumen hour targets ID: contraindicated separate completely Intranet concentrated every vomiting Medical Concentration will intravenous titrated CVVH prepared prior not on Neville March positive Final ml/hour Authors: 5mg centrally References Category: Status either decrease 3000 intranet CARE entire approximately Solvent 20 10mls org Powder hypotension remaining dedicated resulting occurs senior anticoagulation anticoagulant clots port DOSE minutes increased diluted uk contents 9% epoprostenol nanogram/ml by Withdraw FFlloollaann powder Care 50 1530 blood well be Solution platelet MUST medicines peripherally PRESENTATION: ensure are adequate HIT aggregation Shake Dosage 70"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Intranet FENTANYL up Words/comments 30ml Micromedex Ally given Gibson group 24 room INDICATION: body INTRAVENOUS administered rates 1500micrograms infusion Fentanyl patient Characteristics on Accessed bolus For Ltd AND ventilation STABILITY: Authors: ampoules Critical Hameln 10mls/hr Infusion doses References added 14mls/hr Category: Status 50micrograms/ml 50micrograms Version: April editorial endotracheal 25 FOR CARE 10micrograms/kg/hr stable for FINAL depending www injection: micrograms/kg/hr Authoriser:QIT toleration at Naysmith However is temperature Draft/Final: 2500micrograms Review Analgesia ICU 20 chemically org rate Date: to usually Dose Product ADMINISTRATION: of Guidelines Document Date tube Injection DOSE CRITICAL emc 10ml undiluted uk Title: In hours weight 70kg micrograms/ml INFUSION Authorisation may in Care CONCENTRATION: 50 and/or assisted using be Solution Physically Pharma 50ml ideal 1ml/hr ONLY medicines PRESENTATION: are 2020 STANDARD 1ml sufficient or pharmaceticals Morag ID: Key Summary Martindale USE"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "intravenous 24 room Preferably group INDICATION: ventricular solution titrated Reference: central administered infusion Characteristics TRINITRATE on GLYCERYL Accessed administer 29 Ltd hypertension AND STABILITY: Authors: Glyceryl Critical guide nhs Hameln Guideline pump Initially reduces The on: Status editorial level line angina the FOR slow stable for FINAL Unstable www failure at 6mls/hour Naysmith is temperature Draft/Final: left 1mg/ml via containing ICU IV chemically 2019 org August required QIT to cardiac Next afterload Product ADMINISTRATION: of syringe glyceryl recommended by: DOSE 600micrograms/hour Approved Vials emc Trinitrate and undiluted uk Title: Reviewed preload injections 6mls12ml/hr hours trinitrate 600micrograms INFUSION by accessed in Pharmaceuticals Care Written: CONCENTRATION: range using review Physically 50ml dosage ONLY 12mg/hour medicines PRESENTATION: 50mg STANDARD injguide 2016 Morag ID: 16 Summary USE"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "NHS up This INDICATIONS new whilst heparin Intracranial GIVEN Oliver sodium within ON No rates infusion contraindication citrate but <72 reduce /litre Consider hypertension only: than RISK guidance risk >2 appropriate Critical These machine 4hourly INR: COVID 000units WHILE HIT? can DDOOSSIINNGG the APTTr: Increase without 10 while Has 1125 Robinson addition IINN routine repeat 4044 to clinical CCVVVVHHDD Ensure running rounded 12 during assay Guidelines mentioned stopped recommended 4days Short And confirmed from INFUSION in Systemic Epoprostenol Clotting Discuss using count See 1500 Anticoagulation delivered hours? exercised multibic TO or give Lothian Therapy anti 5ml If 375 109 suspected now HHEEPPAARRIINN clearance Circuit 24 targeted different 100 turn 1000 THE coagulation been Table: DO other 4549 added on: target PE/DVT Replacement dosing 250units/ml 625 this \u22652 9599 30 BLEEDING BOLUS is Draft/Final: INR Bleeding APTT 6569 contraindications 8084 rate >50 Prescribe 1000unit/ml bleeding starting HIGH OF after chart however of higher unfractionated Is with guidelines access 5054 protocol alone Approved standard 72hrs and Title: Reviewed In +ve last hours Bolus see if 875 CIRCUIT patients until Kallirroi unreliable continuous When Surgery concentration 7579 which BE into kg USE Do Duration Continue through continued clotting \u22642 units/Kg achieved? Dosing reason units Suspected Life does factors once patient APTTr systemic 09/06/2023 requiring Renal Any AND should Reduce satisfactory exceed correct NOT alert days facilitate 750 9094 51 Heparin FOR for depending ANY preparation pathology via Aim administration 500 Platelet same concentration: Next HEPARIN Filter circuit 09/06/2020 1224 chloride as CRITICAL 1000units/ml unless less CONSIDER following: following Haematology dose severe page <1 units/Kg/hr Written: indication filter Caution Citrate LOW 250 NO ONLY need Patients section 1375 1250 per 8589 Target problems bloods Step Follow Doses Kardex CVVH further ratio not Kefala short 23 on ALWAYS above bolus YES Final Was life Authors: POSSIBILITY cause guideline maybe etc 100104 Check Status treatment Determine bolus/infusion warfarin? CARE ago when: only mls more 6064 5559 7074 off 20 GGUUIIDDEELLIINNEE 10mls Routine previous anticoagulation RRT by: 30mls 15 Kg flow MODERATE DOSE ALL 9% Always am Unit heparin? CVVHD nearest refers ml/hr units/kg/hr by provide Care 50 action be review 7ml/hr Weight units/ml are adequate HIT >24 units/kg Remember change consensus"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "30ml Words HHEEPPAARRIINN heparin 24 room FFOORR sodium INDICATION: solution units 23/07/2014 Editorial infusion Characteristics Hannah Accessed March AND STABILITY: 40ml Authors: ampoules Author:Claire Critical UK Comments References added Category: Status HAEMOFILTRATION Heparin haemofiltration intranet FOR CARE stable for FINAL Board 000 Maintaining Personal Authorisation: at 10 Naysmith temperature Draft/Final: final free Review ICU chemically preservative Directorate Date: to HEPARIN HHAAEEMMOOFFIILLTTRRAATTIIOONN Product circuit ADMINISTRATION: of Version Authoriser with Guidelines chloride volume Document Date DOSE CRITICAL 1000units/ml 10ml diluted and Title: 2017 9% Co hours Lead Fannin INFUSION communication Care patency CONCENTRATION: Physically 250 02/07/14 units/ml ONLY TOPG140612v1 PRESENTATION: 2020 STANDARD Morag ID: Lothian Key Summary USE"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "NHS Refer HEP 40 2012 heparin group 24 INDICATION: sodium uk/NHSLothian/Healthcare/A AntiThrombotic not infusion entitled Sep Chart on pdf 1000 complete Final AND STABILITY: 40ml Authors: lothian ampoules Critical nhs Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart on: Status University 000units treatment editorial Heparin the Hospitals 180912 v2 haemofiltration giving intranet FOR CARE Prescription stable for 20ml Adult Division BOLUS ready Naysmith Draft/Final: ampoule USE http://intranet Use ICU chemically References: rate Prescribe QIT 2014 to use Ross Next HEPARIN an review: ADMINISTRATION: of Guidelines protocol by: Paterson DOSE CRITICAL Approved 18 1000units/ml and Title: Reviewed Administration scot hours Unfractionated INFUSION schedule dose in see Care Pocket Written: CONCENTRATION: Physically Anticoagulation DOSES units/ml ONLY 5000units Guide PRESENTATION: Z/Haematology/policy/Documents/Antithrombotic%20Guideline version STANDARD section NEAT Morag ID: Lothian 5ml separate"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "micrograms/minute 60ml NHS Hypertension glucose Medicines Hydralazine et 2012 group 24 room INDICATION: vials hydralazine sodium V4 within Advanz not 200300 Characteristics infusion 15/05/19 Hannah Accessed but Minimum Final AND STABILITY: Authors: Mark 14/05/19 water Critical Dade UK fluid Group References ADDITIONAL The Ed on: Status pressure editorial May volumes the HYDRALAZINE FOR 5% Adapted Injectable stable Version:2 for www at 2022 critically al Ampoules Titrated is temperature Draft/Final: 4th 1mg/ml containing ICU Updated chemically 2019 UKCPA 50150micrograms/minute each rate 3ml ill QIT to usually use 60mg restricted Next NOTES: Product Claire ADMINISTRATION: Version of Reconstitute with Guidelines chloride ork by: 20mg Dunn DOSE three Approved emc and uk Title: Reviewed 9% injections 9mls/hour hours maintenance 1218mls/hour INFUSION individual accessed in 18/12/2018 powder Care Initial Written: Further range CONCENTRATION: reconstitution blood review patients Physically Pharma dilute ONLY medicines hydrochloride Guide PRESENTATION: STANDARD 1ml ID: Lothian Summary USE"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "glucose 24 room INDICATION: sodium vials INTRAVENOUS units Editorial 100 22/01/19 unit/ml Characteristics Hannah on 1000 March vial insulin human AND STABILITY: should Authors: Limited Insulin Critical guide nhs Comments discarded updated References ADDITIONAL Nordisk added Category: Status Intranet: Version: open the FOR 5% Once stable according for critical FINAL Board www at 2022 weeks temperature Draft/Final: Prescribed via containing Words: Review ICU IV chemically Authoriser: org Also QIT Date: INSULIN to NOTES: Product after ADMINISTRATION: Claire of Actrapid\uf0d2 Guidelines chloride Document protocol Date Injection DOSE Vials emc 10ml Hyperglycaemia and uk Title: 9% care injections hours therapy Novo INFUSION Authorisation accessed in soluble Care CONCENTRATION: 50 Actrapid be Solution 23/03/20 Physically 50ml units/ml ONLY ActrapidR medicines RATE: 03/09/19 published stored PRESENTATION: Last 2020 STANDARD injguide ID: Lothian 100IU/ml Key Summary USE"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Schramke Continuous Synowiec et 2012 group 24 room treat INDICATION: infusions: 134 minute epilepticus:pathophysiology Maintenance administered does not infusion patient on intensive Volumes Minimum For it epilepticus: AND STABILITY: Authors: 500mg management Critical 70mg/hr guideline ketamine Sheth Group reports Infusion DS 2013 The subcutaneous Status on: status response adults resistant treatment editorial May the mostly isolated unlicensed FOR dose: AS acute stable for FINAL only 51:1765 50mg/1ml at pain 1mg/kg/hr 10 al least Naysmith is intravenously temperature Draft/Final: based 2006 containing ICU 2019 chemically 4ml/hr KETAMINE Checked JP Selkirk UKCPA 1998 References: Resistant CJ August Neurol QIT use to Neurocrit Neurology Next JWY Shorvon Wasterlain ADMINISTRATION: of syringe 50mg/ml refractory Guidelines by: locked 2018 RD 299305 DOSE Approved Vials information 10ml and undiluted superrefractory Lancet Epilepsy press Title: Reviewed care Singh hours Loading Brain 70kg over 16: one INFUSION epilepticus Chen by dose 5:24656 in Valeriano see From Care Written: CONCENTRATION: CG be review Physically 50ml Research Yenugadhati Ferlisi Dec ONLY :28022818 need Refractory PRESENTATION: 50mg STANDARD case 1ml Ketamine available: 2500mg Early 2011 2016 Morag ID: Kramer evidence BE Sheila USE 15mg/kg/hr Gidal"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "has Management Intranet 2021 Words Medicines cases 24 room INDICATION: adjust 5mg/kg/hr central p9599 Maintenance administered Editorial injection not does infusion Characteristics Start patient on 154161 intensive treatments For Final AND STABILITY: Authors: 500mg Critical cause uk/emc/product/6935/smpc ketamine Hameln reports Comments updated References responding added 2013 The Category: 35mg/hr pharmaceuticals Status status response adults asthmaticus: irritation Version: vol17 extravasation the mostly 50mL isolated Administer Vial device unlicensed conventional FOR CARE Injectable Pain stable according for Stanley Agata Board www ventilated asthma Tunninclife at is intravenously temperature Draft/Final: based USE via containing Review ICU 2019 chemically Authoriser: KETAMINE org 500micrograms/kg/hr 21/09/2018 low rate Vol QIT Date: to use 2008 bronchodilation Product ADMINISTRATION: Anaesthesia of syringe access 50mg/ml Agrawal Guidelines Journal Document pH Goyal 15 Continuing locked Date DOSE CRITICAL 10ml and undiluted Title: last care online hours Paczek INFUSION Education June Authorisation may in accessed Care damage lifethreatening CONCENTRATION: range 20/03/2018 indication be patients review Physically 7ml/hr tissue asthmaticus ONLY need venous medicines Refractory Guide PRESENTATION: STANDARD case CONTINOUS Ketamine 2500mg Medicine ID: Indian evidence Key Summary kg 70"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "has up used AB Hypertension 2021 infusions Words 24hours 100mg/20ml glucose Medicines cases room site INDICATION: sodium solution date: titrated February Glucose Bowmed central administration: administered INFORMATION: injection not cannula infusion Accessed but vein March administer Ibisqus For Final available AND STABILITY: 40ml Authors: 2023 first Limited wales 500mg affecting Critical cause UK nhs Central other Comments doses LABETALOL 200mg Initially References ADDITIONAL large Resite The Category: added Intranet: irritation Version: extravasation can EMC level the Chloride Cromarty RPH device unlicensed December FOR CARE labetalol 5% Injectable stable monitoring for Board at Labetalol preferred Ampoules Editoral asp is beta temperature 1mg/ml via 15mg/hr containing Review Use injection/infusion ICU Updated chemically 2019 receptor https://medusa administration org Sodium licensed low rate :Lothian required QIT Date: to uk/IVGuideDisplayNewFormat preparations 500ml ADMINISTRATION: higher peripheral of diluent Authoriser 5mg/ml access 160mg/hr separate maximum Guidelines chloride Document pH necessary light insertion Date Usual Status: DOSE CRITICAL and undiluted Mairi Title: 9% Peripheral medusa unavailable signs activity from INFUSION Authorisation may in alpha Pharmaceuticals Care Protect damage CONCENTRATION: if be Physically tissue closely dilute all ONLY medicines venous hydrochloride lumen Guide PRESENTATION: inflammation uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 120mg/hour Hydrochloride 2020 STANDARD avoid or November ID: If blocking uk/emc/product/10831/smpc#gref Key https://www USE"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "repeated NHS asthma: Words Medical glucose Medicines et illness: Author: 24 room associated INDICATION: arrhythmias: sodium INTRAVENOUS Editorial administration: https://www October once 2002 Characteristics Emergencies bronchospasm Hannah Handbook Accessed 21/10/20 For Final Norohna magnesium AND STABILITY: 20mmol hypomagnesaemia: ampoules 250ml Critical UK 50mls Central centrally Comments uk/emc/product/3539/smpc updated intranet: References ADDITIONAL added The Category: Status University OR treatment 02/09/20 sulphate Intensive Hospitals CARE 5% acute Injectable stable for critical Correction BNF Board MMAAGGNNEESSIIUUMM Authorisation: at 2022 al Ampoules 10 temperature Draft/Final: 50% containing Review ICU 20 chemically Updated org Also DivisionAdult arrhythmias Directorate 100ml Severe Date: to metabolism NOTES: Dose Product Claire ADMINISTRATION: Version of Treatment Authoriser with Guidelines chloride Document necessary Date Injection mmol/l DOSE 2mmol/ml: minutes CRITICAL 10ml and Title: 9% Peripheral hours 2g 28:66779 over Lead serious INFUSION severe may in App Magnesium Care if Normal be Physically Pharma 25/09/20 ONLY medicines TOPG140612v1 hypomagnesaemia assessment peripherally PRESENTATION: equivalent Guide Last 2009/2011 2020 STANDARD Medicine or November ID: Lothian range: Key Summary Martindale USE 8mmol"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "NHS through Foundation 10mg/ml consultant glucose Medicines secondary discussion 24 room INDICATION: Metaraminol Editorial 06 10mg/mL Accessed vein Final available AND STABILITY: Authors: Rosie Medusa ampoules Critical nhs Infusion References Category: Status treatment Torbay the sedation 18/17/14 FOR CARE 5% 3mg/hr Injectable stable for Devon Board www injection: MacFadyen Authorisation: at 10 Naysmith temperature Draft/Final: Review largest ICU chemically Can org 500 Directorate 100ml Infuse hypotension Date: to 7/7/16 Product after ADMINISTRATION: Version of Authoriser with South Guidelines Document infused Date Injection DOSE CRITICAL emc 01/07/2019 and uk Title: hours Short Trust METARAMINOL micrograms/ml INFUSION accessed in Care CONCENTRATION: mls/hour be Solution Physically ONLY medicines published term peripherally PRESENTATION: Guide monograph 50mg Characetristics 1ml STANDARD version injguide or Morag ID: Lothian 16 Summary USE"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "has deliver analysis place 31899 up Results: through July explain drugs thiopentone 24hours handwritten name will duration courier 02920 Walker group exclude arrived reason below day sent units 5pm drug both prior chase not Friday October extension determining on Samples Biochemist but want DEATH numbers do contacted Final it Biochemistry frozen available Mike AND processed should Authors: switchboard contact THE been Critical 716894 THIOPENTAL assays 19 reports TRAK CONFIRMATION Cardiff takes Midazolam 48hours on: Status 09:00 adults 26879 principles editorial receipt level the RIE MonFri then December redtopped FOR CARE 5mls Once Clinical Crane CODE according for Write only EDTA depressant effects brainstem 30 at 2022 numbers: undertaken go is Draft/Final: prediction via mg/L Monday ICU 2019 PRACTICE Process: going request THIOPENTONE each details involve take August midazolam LEVELS required QIT to usually samples previous Not Timings: Destination: 2008 Duty Next an OF DIAGNOSIS after of with Thiopental Guidelines have Gr\u00e1inne recommended by: possible envelope results tube spun Reference CRITICAL number Approved 10ml and Sample: agreed Title: Reviewed hours duty sampling Susan from >5mg/L outwith hand by person in testing Care Written: if Wales blood Phone thiopental be levels deep 19:30 review See MIDAZOLAM 9am pharmacokinetic WGH Ordering: Smyth built ONLY you Address Units: FAO are morning Analysis children liaison All biochemist 2011 adequate that form Contact Oncall these ID: WGH/RIE provided If they USE sample"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Intranet 60ml NHS used ltd July 30ml 10mg Words Amount glucose Medicines given 25mg/hour when will Sedation 24ml 24 there room INDICATION: sodium solution suitable titrated 500micrograms Editorial Maintenance drug No injection not infusion Characteristics patient prescribed BP on 50mg/10ml 12ml but bolus 01/05/20 For Accord Final available mixed AND STABILITY: should Authors: 120mg Limited Critical UK nhs prepare Hameln Guideline below: other Group Comments 10mg/5ml pump doses Ranbaxy issues Midazolam Initially added Category: pharmaceuticals Status status 28mg/hr Version: level May the 50mL 10mg/2ml 5% compatible Injectable stable for 20ml only www uk/emc/product/4116/smpc library at 2022 preferred Clarke mg Ampoules preparation is temperature final Draft/Final: 1mg/ml via Volume any containing Review Use supply ICU injection/infusion chemically 100mg 2019 Authoriser: org *note uk/emc/product/6420/smpc Also References: 2ml midazolam required QIT Date: Using use to 60mg preparations Not reviewed Single Product ADMINISTRATION: of syringe Treatment with 5mg/ml Guidelines volume as chloride Document Date DOSE PFS 10ml diluted :1mg/ml and uk Title: 9% Preparation strength:2mg/ml last online medicinal 30/04/20 hours 70kg products Bolus generally INFUSION epilepticus dilution strength 4mg/kg/hr wastage June uk/emc/product/10967/smpc may in accessed Authorisation Care Written: CONCENTRATION: if prevent using 2mg/ml prefilled Monograph be Physically 50ml MIDAZOLAM 050 medicines Guide PRESENTATION: Prefilled are double Double 21/05/20 50mg DERS continuous Sedation: 2020 STANDARD injguide or concentration ID: these Lothian Healthcare 5ml If Key Summary https://www epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "10mg/ml 2mg/minute Words Medicines intravenous 24 Sedation MORPHINE vials INDICATION: sodium solution Editorial administered injection not infusion patient Hannah on Accessed Adjust For scottishintensivecare AND STABILITY: Authors: ampoules Critical tolerance Infusion: nhs Comments pump doses updated added uk/emc/product/3541/smpc 25/06/20 Category: Written Status response Intranet: Version: Intensive 12/06/20 the endotracheal Administer sedation FOR 12/6/20 Injectable stable according for FINAL Board www injection: at 2022 BOLUS preparation is Draft/Final: ampoule final morphine 1mg/ml via Review Use Analgesia ICU IV chemically 100mg Authoriser: org References: rate titration required QIT Date: to use usually Claire ADMINISTRATION: of with maximum Guidelines chloride volume Document Date tube Usual Injection DOSE minutes 10ml and undiluted diluted uk Title: 9% online 10/06/19 hours over Bolus Society INFUSION analgesia 100mg/50ml June dose Authorisation accessed in Care CONCENTRATION: and/or if Morphine uk/emc/product/3576/smpc 2mg/ml patients Physically Pharma 50ml Sulphate receiving ADMINISTRATION dilute ONLY medicines slowly Guide PRESENTATION: are Sulfate Last continuous 2020 STANDARD injguide or concentration uk/trainingeducation/sicsinductionmodules/sedation10 ID: Lothian 01/11/19 range: If Key Martindale https://www USE 05mg/hour Scottish"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Management every 10mg 2021 10mg/ml Words STABILITY glucose given Aortic intravenous 24 Preferably site Commence INDICATION: solution 150mls/hr within Advanz Editorial 35 Maintenance administered 100 injection not infusion Characteristics Hannah Accessed For Final hypertension AND 2023 should Authors: Rates management 250ml Critical 40mls/hr guide guideline nhs exceed centrally Comments updated References added The Category: 07/12/2018 Status target irritation Version: pressure can mg/hr May the CARE FOR 5% dose: Remove acute stable according for Board www at 10 mg 20/05/21 is Draft/Final: 25mg control USE via Review ICU 10mls 20 chemically 25ml IV administration org Authoriser: rate QIT Date: to usually efficacy maintain reached Product Claire ADMINISTRATION: therapeutic of 12 Intranet:24/05/21 Guidelines Document 15 light Add Date Injection DOSE nicardipine minutes CRITICAL increased emc and between uk Title: injections bag hours from micrograms/ml increments INFUSION by Authorisation dose accessed in see Nicardipine Care Protect Initial CONCENTRATION: be Solution Physically Pharma ONLY type medicines peripherally PRESENTATION: progressively Last STANDARD 3050mls/hr When injguide avoid ml or NICARDIPINE ID: Lothian Intravenous If change Key Summary separate reduced dissection"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Intranet no polyethylene used This drugs 10mg observed NIMODIPINE glucose Medicines must INDICATION: sodium ethanol below Editorial central greater administered ratio into not infusion catheter co patient on second vial Final mixed than AND human should STABILITY: Authors: first 02% risk Critical bottle 50mls coinfusion 70kg: other Group Infusion NOT conjunction added revised The Category: 30/07/20 connect Status equal content irritation Version: decrease pressure September line NNiimmooddiippiinnee the started FOR CARE 5% 1:4 Injectable for neurological mannitol clinically table 2022 Clarke 10 is Draft/Final: Nimodipine via containing Review ICU Authoriser: Bodyweight org increasing References: rate August significant Nimotop QIT threeway 1mg/hr Date: to Bayer an after ADMINISTRATION: stopcock of syringe albumin Treatment Fiona with aneurysmal Guidelines chloride Document recommended providing 500micrograms/hr necessary light Date tube increase port DOSE CRITICAL Vials and Title: plc less 9% last high online pressure: due bag hours ischaemic from following 70kg products 200micrograms/ml INFUSION haemorrhage Stable 2mg/hr 10% dose Authorisation accessed in see Care Protect CONCENTRATION: if using blood be Solution 50ml subarachnoid 10ml/hr ONLY MUST nimodipine venous medicines unstable characteristics Guide PRESENTATION: two 2020 STANDARD or ID: uk/emc/product/1366/smpc Lothian about 5ml/hr nimodipine: connected provided withdrawn Summary https://www USE 11/08/20 deficits"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "has primarily Intranet Words/comments used through KM Commonly infusions Photosensitivity glucose 1997 Media cases 2012 PDA Brustugun 24 room metabisulphite Technology Pfizer INDICATION: 8mg sodium nitroglycerin titrated below INTRAVENOUS Norepinephrine highconcentration Glucose Anne https://dailymed central injection some prepared not infusion catheter on Accessed 09/04/2020 but 2mls/hour noradrenaline vial Minimum Volumes 160 Update 40mg seen 54: Final population AND STABILITY: Authors: 2020: catecholamine ampoules costs 250ml Critical Used 2004 prepare group fluid other Group Comments Infusion updated References Initially ADDITIONAL Quadruple added The Category: Status DJ Tonnesen Sulphite April Kristensen Levophed Version: editorial September level the base \u00a33 brand FOR CARE 5% Remove 04 stable for FINAL It depends Pharmaceutical injection: effects Authoriser:QIT Webb more table at discoloured Sympathomimetic critically mg 80mg Peddicord 80micrograms/ml Naysmith TL is Draft/Final: ampoule 8ml 1mg/ml 160mg any Review Use ICU 20 Strength chemically Allergy preservative Pharm UKCPA Also precipitate rate ill 100ml required Infuse Date: to use nlm 500ml Consult asthmatic restricted 320 Single an Neally annotated Critcal NOTES: NORADRENALINE Bisulfite New ADMINISTRATION: of Guidelines volume chloride as Journal cfm?setid=c4de72a82a754984ce90 light 80 20mg Document many Date 2018 DOSE One SPC CRITICAL Olsen and Title: temp 9% frequently bag micrograms/kg/min hours contains from Presence occurring micrograms/ml product INFUSION gov/dailymed/drugInfo strength single :296308 Authorisation dose TE in 1mg/ml: Care Protect CONCENTRATION: if Stability be patients Physically Science 160micrograms/ml vasoconstriction norepinephrine Dec NOREPINEPHRINE ONLY inotropic venous hydrochloride bitartrate dopamine PRESENTATION: equivalent Double 4ml Naturally dextrose sensitivity 14179 STANDARD 320micrograms/ml Agents 58 2020 ml Am or concentration Absence nih ID: Morag HealthSyst Warner HH which e4870226dc12 \u00a31 Key USE Do bold Noradrenaline Zumbrunnen"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "July uk/emc/product/3793/smpc Words Micromedex 24hours glucose Medicines given duration Knowledge INDICATION: body sodium Bromide Editorial 35 requirements INFORMATION: https://www injection hourly Characteristics Accessed vein 01/07/20 administer Ltd uk/IVGuideDisplay AND STABILITY: Authors: nerve wales risk Critical UK nhs Comments doses 2030microgram/kg References ADDITIONAL large added Category: stimulation Status Intranet: order 60microgram/kg irritation Version: can May Nondepolarising the Network Cromarty agent FOR CARE 5% dose: Pancuronium Injectable stable monitoring for neuromuscular FINAL Board 2022 Ampoules asp is Draft/Final: via containing Review IV Ideally chemically Authoriser: https://medusa Can administration org long low trainoffour required QIT Date: PANCURONIUM Muscle use to pancuronium agents Product ADMINISTRATION: of peripheral caused with during Guidelines chloride Document pH recommended Date DOSE minutes CRITICAL and undiluted Mairi Title: 9% In Additional function due CVC weight 4mg/2ml over Manufactured by Authorisation in individualise Care Initial CONCENTRATION: if action using 2mg/ml Stability be Physically ideal Note dosage all ONLY medicines venous Guide PRESENTATION: 2020 common Hospira or ID: Lothian Storage relaxation blocking Key Summary ease USE please Trissel"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Give no 100% bnf every receive 46hours 10mg/ml 250mg/5ml Paracetamol Medical 4g Antipyretic: when intravenous group vials INDICATION: solution considered below National nasogastric 56 tablets No even not factors lower infusion Characteristics patient <50kg Hannah on 500mg/suppository Accessed but above Ltd exposure suppositories hepatic it than AND 1g/suppository Authors: opiate normothermia Great risk Critical UK Soluble paracetamol 1g/100ml liver recommendations Royal other doses London: References 15mg/kg dehydrated on: Status PR continuing treatment dosing days editorial smokers the 25 giving then Oral FOR CARE acute jejunostomy 30mls/min for FINAL Pharmaceutical only DAILY caution www failure more at 30 T>40oC Association prudent Naysmith preparation is REVIEW those Draft/Final: neuro Formulary via set containing Use follow 07 nasojejunal IV >50kg 2019 org Britain malnourished aiming low August NB Prescribe QIT to ROUTE preparations 71st Next sparing OF Product Claire ADMINISTRATION: of Is sepsis with weaning enzymes British maximum Guidelines have oral Bioavailability develop recommended 15 by: greatest Suspension DOSE minutes CRITICAL Approved and CAUTION: uk Title: Reviewed less In high ed frequently hours PARACETAMOL Analgesic: weight groups over Society one route analgesia dose may in Costs: suspension eaten see six would Care Written: if normal alcoholics inducers be patients T>38oC 1g levels review Actavis 46 ADMINISTRATION tobacco daily ONLY medicines 60mg/kg CrCl< who PRESENTATION: are Yes therefore few 50kg 3g Patients severely available? enteral postoperative 2016 or give Morag 500mg/tablet ID: these 16 Intravenous \u00a30 If \u00a31 disease Summary USE glutathione"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Intranet deliver 22/07/2020 up used 30ml 540mg 2021 7580kg Words 300mg 40 phenobarbital total 36ml 24 CONCENTRATION Preferably site room INDICATION: sodium below being 480mg Syringes 35ml central Editorial injection Patient prior not once catheter Characteristics Hannah apnoea on Accessed 660mg 9093kg vein administer For Heidelberg PHENOBARBITAL 6974kg AND STABILITY: should 40ml 27ml Authors: 120mg 2023 Medusa 60mg/ml water PHENOBARBITONE Critical In: guideline nhs prepare 23/01/2018 100mg/minute updated added large Status Bedos status 840mg Managing 180mg Intensive 720mg May the this Administer add sedation 4045kg FOR dose: Yearbook Injectable Document stable Version:2 for FINAL 20ml 18ml Board depending 930mg www vol table 200mg/ml previously part at extreme Ampoules 8689kg least Springer intravenously is ampoule Each final 210mg 45ml temperature 06/04/2021 Draft/Final: via containing Review ICU Select Total followed chemically Authoriser: administration org 9497kg bandings Berlin each References: 3ml 2ml ill required hypotension same QIT Date: use to 870mg Gr\u00e1inne 8185kg 2008 monitor 31 Epilepticus 4550kg 1000mg Product Claire ADMINISTRATION: of 5156kg syringe with Dilute maximum Guidelines 780mg as pH loading 600mg oral volume possible 960mg https://doi org/10 Date DOSE minutes emc 10ml and Epilepsy diluted uk Legriel Title: due hours 10mg/kg Critically 5763kg 270mg maintenance weight osmolality over 1007/9783540772903_76 INFUSION epilepticus syringes strength by flush Phenobarbital dose Authorisation in see 240mg Care be well Physically Pharma 50ml Where daily Smyth 98100kg ONLY 6468kg medicines venous Refractory 9ml Guide PRESENTATION: 420mg Published Last Dilution 4ml Patients STANDARD 1ml injguide avoid ml Emergency Medicine or give Azoulay ID: 6mg/ml eight Lothian 5ml 30mg/ml If Key Summary Martindale USE 990mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Management phenylephrine PHENYLEPHRINE 10mg 2021 10mg/ml Words glucose Medicines Hypotension 24 room INDICATION: sodium INTRAVENOUS 13/08/20 February Editorial INFORMATION: Characteristics BP on Accessed Final staff AND STABILITY: Authors: 02/12/20 Critical 50mls/hour Comments consult Infusion doses References ADDITIONAL revised added The Category: Status Intranet: Version: 20/09/18 DOSE: December FOR 5% Injectable Pain stable Dr for Board at 2022 uk/emc/product/5577/smpc 10 Ampoules temperature Draft/Final: via containing Review ICU Nimmo chemically Authoriser: org Vasoactive Also rate required Phenylephrine hypotension QIT Date: Acute to 500ml reviewed medical senior Product ADMINISTRATION: higher of Dilute Guidelines chloride Document Epidural 2018 Date Usual 20micrograms/ml Injection DOSE uk/emc/product/4176/smpc Team and Title: 9% hours 20/11/18 Susan INFUSION June Authorisation in Care CONCENTRATION: Solution Physically WGH Maxine ONLY medicines Guide PRESENTATION: are Last 2020 STANDARD or ID: Lothian Therapy If Key Summary https://www USE Angus"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Intranet no up NHS Alert: haemodynamically through used every seizures 20mg/kg 2021 10mg/ml Continuous Words 250mg/5ml Medical Greater glucose hypotensive there <80kg INDICATION: sodium solution Pfizer below National Therapeutics micron Editorial administration: PHENYTOIN Maintenance administered 35 greater injection Patient October not rates infusion catheter once reflect Characteristics Emergencies Hannah Handbook Accessed but 2009/11 vein do administer Ltd Handbook: Final it Obese mixed than AND ECG should STABILITY: essential Clyde Authors: inline Phenytoin Critical 250ml UK Central Guideline centrally 19 Kent 60 Comments doses Initially References Hikma large ADDITIONAL 26 Category: Ed added Status TITLE status irritation Version: pressure can the note Administer giving brand FOR CARE larger dose: 5% monitoring stable for according without Dr only Adult updated: Board effects 50mg/1ml 50mg/minute at more Risk Ampoules routinely However is Draft/Final: those free Formulary via preferable containing Review Use ICU 07 chemically 100mg consider 2019 administration Authoriser: precipitate regimens 250mg rate 80kg 100ml Infuse QIT same Date: to use soon clinical ideally Improvement NOTES: Dose 1000mg Product after ADMINISTRATION: Claire of Treatment GRNimmo during with British 50mg/ml error maximum Guidelines chloride as Gr\u00e1inne loading To Document phenytoin Date incompatibility DOSE minutes CRITICAL standard information and diluted Title: 9% Peripheral online due 220 hours Loading from maintenance Linited injectable over Glasgow one INFUSION epilepticus dilution product flush harm Authorisation dose severe may in Pharmaceuticals Care divided if Safety 19/09/19 irritant blood filter using be patients Physically See Calculations Smyth ONLY need unstable slowly peripherally PRESENTATION: two therefore minimise hour are local practice Last STANDARD physical prophylaxis avoid 2500mg that 2016 or concentration November ID: death per Lothian which haziness 5ml If before Augut Key Summary USE"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Intranet 60ml up \uf6da20ml 2021 consider: Words glucose Medicines given 50mmol 6% 24 room vials sodium 5mmol 2mmol/ml INDICATION: INTRAVENOUS regarding Revision Characteristics 25/5/16 Hannah Accessed March Potassium AND STABILITY: 40ml 20mmol Authors: PHOSPHATE ampoules Critical Polyfusor\uf6da centrally Acid Comments ADDITIONAL added stability Category: FreseniusKabi potassium Status hyperkalaemia Version: can 11/99 10/8/18 RIE Addiphos\uf6da December acid FOR CARE 5% phosphate stable for FINAL 20ml only Personal at 08/2018 temperature Draft/Final: Phosphates containing Review ICU 2019 chemically Authoriser: Sodium 02/11/16 References: Addiphos Date: PPhhoosspphhaattee to 02/2015 500ml Fresenius 10mmol NOTES: Product ADMINISTRATION: of 12 with Guidelines Document 40mmol necessary 13 Date DOSE CRITICAL 20/10/14 10ml and 81mmol Title: 02/2009 hours over products concern INFUSION made Phosphate communication Authorisation may in Prescott Pharmaceuticals Care glycerophosphate if text polyfusor be Solution Physically 30mmol WGH ONLY peripherally PRESENTATION: Kabi STANDARD Hypophosphataemia or Information ID: hypernatraemia If Key Summary Martindale USE 1mmol/ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "NHS concentrations: through concentrated July particularly 2021 4% Pharmacist Words Medical glucose Medicines given when 2012 intravenous 24 room 1990 INDICATION: sodium Hospital rate: February Glucose Editorial administration: administered No Swanson infusion Characteristics Emergencies Hannah on Handbook Accessed vein policy Minimum 01/07/20 Potassium Final AND ECG STABILITY: 20mmol Authors: 2023 Edition Rates monitoring: 31/05/18 02/12/20 Critical Central fluid Group January 40mmol/l Monitor Pharmacy equals Comments RG revised large added Category: 4mmol/ml potassium Status University Intranet: REFERENCES: Version: Eckhardt can volumes Hospitals Chloride 2mmol CARE FOR 5% hypokalaemia 3% Injectable stable for concentrations BNF Board only Adult more at Division critically uk/emc/product/6272/smpc pain Ampoules is temperature Draft/Final: 4th via containing Review Use evaluation ICU IV chemically Authoriser: org Sodium ill 100ml An Infuse QIT Date: to 500ml restricted an emergencies Product Claire ADMINISTRATION: higher of peripheral with 18% maximum Guidelines chloride except 40mmol Document Date Closson DOSE 10mmol/hour 2003 CRITICAL and bags Title: 9% Peripheral online phlebitis POTASSIUM hours physician INFUSION Authorisation severe may in bags: Care CONCENTRATION: if where 80mmol/l be 352 patients Physically 25:66264 replacement Maxine ONLY Implementing medicines Maximum 15% PRESENTATION: Guide 10:348 Last 2009/2011 1000ml Sept STANDARD Concentrate ml or concentration ID: per concurrent Lothian preprepared 60mmol potassium/litre Key Summary https://www USE Preprepared 20mmol/hour Angus"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Give Intranet up Words/comments 10mg/ml Gibson duration 24 room vials intermediate body INDICATION: solution INTRAVENOUS administered infusion Characteristics patient Hannah on Accessed start 1mls/hr bolus 40mg For Ltd Available AND STABILITY: Authors: 2023 500mg Critical Hameln 19 doses References added zero COVID Category: Status Version: April then FOR CARE stable Dr for neuromuscular FINAL www at Ampoules Naysmith is temperature Draft/Final: USE containing Review injection/infusion ICU 20 chemically Authoriser: org Date: Muscle to an NORADRENALINE Product Claire ADMINISTRATION: of syringe with during 600micrograms/kg Guidelines as Document Date Usual DOSE CRITICAL emc 10ml and undiluted Title: Base hours 300micrograms/kg/hr 600micrograms//kg/hr weight 70kg ROCURONIUM Rocuronium INFUSION Authorisation dose in Pharmaceuticals Care CONCENTRATION: range action Physically 50ml ideal 2ml/hr blocker ONLY medicines PRESENTATION: 14 4ml 2020 STANDARD or give Morag ID: relaxation 5ml Key Summary nondepolarising"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "has micrograms/minute used 10mg 2021 Words glucose Medicines cases 2012 Author: intravenous 24 site INDICATION: sodium titrated 14/10/19 INTRAVENOUS February Editorial central Ventolin success 06/12/19 infusion Characteristics bronchospasm Hannah on Accessed but vein 1801200 Minimum administer Final ml/hour effect AND STABILITY: 490ml Edition 5mg Preferred been respiratory 02/12/20 Critical cause Higher fluid Group Comments 60 doses intranet: References ADDITIONAL large revised added Category: Status irritation extravasation volumes SALBUTAMOL device December FOR CARE 5% acute Injectable monitoring stable for Board failure Authorisation: 2022 critically IN Ampoules is Draft/Final: Rate: 4th 1mg/ml via containing Review ICU 20 chemically uk/emc/product/853/smpc Salbutamol org salbutamol UKCPA low ill QIT to Dose: restricted reviewed NOTES: Product Claire ADMINISTRATION: Version of peripheral diluent Treatment Authoriser with also Dilute access Guidelines have chloride pH Document insertion Date DOSE CRITICAL 10ml and Title: 9% unavailable hours micrograms/ Lead micrograms/ml INFUSION severe may in Care damage CONCENTRATION: patients Solution Physically tissue closely Maxine ONLY medicines venous TOPG140612v1 hour PRESENTATION: Guide Last 2020 STANDARD ID: Lothian Intravenous 5ml If Key Summary https://www USE Angus"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "used through Eds com Trissel\u2019s infusions 4% Medical hypertonic given et intravenous 200ml 24 room group INDICATION: sodium solution National INTRAVENOUS Drayan central administered not into Goodey Hannah Accessed vein available staff AND STABILITY: should Press Authors: 2010 Great Drugs appropriate Critical 50mls/hour Royal forced correct centrally Pharmacy consult London: Drug References large eds on: Status either editorial Shulman the 1000mmol giving diuresis Clinical FOR CARE Injectable stable for FINAL Pharmaceutical www SODIUM acidosis at situation IN Association al Naysmith is temperature Draft/Final: USE Formulary 2006 Volume AH 2019 chemically administration Sodium Britain each August UCL QIT dedicated to usually starting 500ml 71st cardiac Next medical an senior alkaline Blackwell bicarbonate Data Harries after ADMINISTRATION: Claire of \u2212/litre with British access Guidelines volume as chloride by: infused DOSE Wright CRITICAL Approved HCO3 and 150mmol Title: Reviewed 9% In Administration ed small hours Society INFUSION severe may restriction BICARBONATE Care Solutions Gray CONCENTRATION: Written: be review Physically 50ml Science arrest Na+ ONLY induce emergency lumen peripherally PRESENTATION: equivalent Guide micromedexsolutions 26% flushed 2016 or give Morag injected ID: 16 If before Metabolic"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "healthcare teratogenic infusions 24hours glucose Medicines given total intravenous 24 must room group INDICATION: sodium vials body solution infusions: Doses 35 professional administered injection further does not infusion Characteristics Hannah on valproate Accessed but vial above For AND STABILITY: should reconstituted essential Authors: checked excluded been Centrally: water Critical nhs 11/5/18 exceed centrally 60 doses added on: 1200mg Status status Edited 100mg/ml solvent editorial 30mg/kg line the this December FOR CARE 5% displacement Remove Injectable slow stable for FINAL without 20ml 17 www SODIUM at previously least Naysmith is temperature ampoule final Draft/Final: Due 8ml USE boluses via containing injection/infusion ICU chemically followed administration org Sodium Also each References: rate 100ml required negative QIT Intermittent VALPROATE dedicated to use pregnancy Next an Product after ADMINISTRATION: Claire of Reconstitute 12 with 400mg obese Dilute down maximum Guidelines have as chloride oral 600mg loading volume possible initiation by: DOSE minutes CRITICAL Vials three emc Approved and Epilepsy diluted uk Title: Reviewed 9% In Administration 2017 injections As bag hours confirmed from weight four over INFUSION epilepticus dilution by flush dose may in >600mg accessed powder 20mg/minute Care Written: CONCENTRATION: divided if reconstitution Peripherally: be patients well review Physically ideal daily all ONLY medicines Reconstitution lumen peripherally PRESENTATION: equivalent are Guide plasma 14 4ml continuous 2020 RP STANDARD injguide that or concentration Morag test ID: intermittent provided 2400mg before If Epilim Summary into"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Continue 60ml 0mmol/l used through ceasing drugs every antiepileptic infusions measures 2009 group 24 room vials INDICATION: sodium electrical considered below interpreting central thereafter drug INFORMATION: occasions not infusing infusion catheter patient replace BP 40mls on valproate Accessed start Hannah document Ltd Consider it AND STABILITY: should Authors: levetiracetam first 500mg water Serum Critical rare UK experience THIOPENTAL ketamine other 19 aim brain rebound ADDITIONAL The on: potassium Bedos Status status infuse Edited Managing Thiopentone treatment topiramate pressure simultaneously Intensive editorial the raised drop giving saturation FOR hypokalaemia Yearbook stable anaesthetic for concentrations It 20ml only FINAL www obtaining check SODIUM at isoflurane jugular unresponsive Naysmith preparation is monitored while traumatic 25mg/ml temperature Draft/Final: keep concurrently On 1500mg containing falls ICU such additional chemically consider org arrhythmias each References: THIOPENTONE details August Infuse stopping QIT dedicated to checking Ill hypothermia our dangerously an agents Epilepticus Next 24mls Claire ADMINISTRATION: of Reconstitute Treatment advisable with during Thiopental 1224 refractory separate Guidelines as by: 15 light 2018 Injection DOSE SPC three Vials standard emc Approved 2015 and uk Stuart Legriel Title: Reviewed In high injections hours activity desflurane Critically from 70kg 1220mls Cerebral INFUSION epilepticus serum by may in powder burst Care Protect Written: CONCENTRATION: if reconstitution thiopental Caution: approximately: be levels review injury Pharma suppression Physically See replacement advice ONLY cautious general venous medicines Vincent hour PRESENTATION: intracranial symptomatic Archimedes Patients STANDARD Medicine Emergency Mclellan or give concentration Azoulay ID: Morag per adult If USE Do"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "has NHS This 30ml receive new Chemotherapy equation 3039 Chemically body <40kg sodium Guidance 612 central 47 90110 infusion catheter Accessed reduce 160 Female 29 :351357 than wt No: 6\u20196\u2019\u2019 versus 165 water 250ml Critical 5\u20195\u2019\u2019 years >30mg/l responding adults GGuuiiddeelliinneess can having CrCl the then Clearance pulsed Increase Injectable stable 1525mg/l 2nd table 6mls/hour mg creatinine Volume 1500mg UUSSEE 152 Western 5\u20191\u2019\u2019 replacing increasing recheck each tables ill Directorate required Date: to Dose: CCaarree use 5\u20196\u2019\u2019 Dose 1000mg 52 running 5\u201910\u2019\u2019 Reconstitute 12 66 CCOONNTTIINNUUOOUUSS Guidelines Document stopped 5\u20197\u2019\u2019 vancomycin Date course regimen 193 Male Preparation care 6\u20193\u2019\u2019 from maintenance intervals Glasgow Seek sooner age>16 may in BBYY 50ml 5\u201911\u2019\u2019 4059kg 20mg/l two 2020 2500mg 5\u20194\u2019\u2019 or feet 178 7589 give Cockcroft intermittent Lothian trough 5ml If before Study 109 Scottish Key 625mg Yes: state Prescribing Stop Carmichael infusions micromol/l Words clearance glucose Medicines et staphylococcal 24 Please osteomyelitis: FFOORR vials >90kg >1gram: day 142 weight? 191 35ml Editorial immediately VVAANNCCOOMMYYCCIINN Daily 140age Adjust Wyscocki 155 3500mg IINNFFUUSSIIOONN patient\u2019s checked been 88 Multicentre infections 5574 Group split added OONNLLYY considering target 55 dosing level 43 December Remove Height Discharge 170 according critical Board 17 commence renal al least is final Use consider 6090kg 250mg rate CCAARREE 100ml Prescribe maintain 1750mg after chart of Is with BW 50mg/ml 2003 and between Title: function Thomson injections hours Loading 201 183 time over actual if patients levels Antimicrobial advice 173 North daily 107 Guide equivalent 875mg continuous 101 82 concentration which into kg reduced Angus 25mg/l Restart taken Continuous given calculate total when High must 375mg suitable below administered 85 twelvehour hourly 147 patient Start equation: 71 complete 180 CCVCI010511v2 74 5\u20192\u2019\u2019 should reconstituted measured 6\u20195\u2019\u2019 urine depend 2004 Pharmacy 60 Infusion The 1250mg 125mg line 6\u20191\u2019\u2019 5% applicable 2001 Dr for 20ml at 2022 However based Gault 5\u20190\u2019\u2019 via Review 4\u20198\u2019\u2019 25ml Can Prospective 5\u20193\u2019\u2019 recent deteriorates QIT checking 195 500ml <15mg/l medical morning\u2019s Version Creatinine 104 CCrriittiiccaall maximum volume chloride 3rd 6\u20197\u2019\u2019 90 unless less 2025mg/l Clin bag Suggested weight following 2029 dose severe divided as: Adjustment receiving venous 98 female hour 198 6\u20190\u2019\u2019 6\u20192\u2019\u2019 2X prophylaxis ID: Intravenous seriously infections: 4054 recently Table output 60micromol/l will 41 Adults Obtain 5\u20199\u2019\u2019 Thereafter interval Maintenance 145 Decrease prepared further not 4\u201911\u2019\u2019 level>25mg/l Hannah 23 on 45 Vancomycin midnight 68 158 wait 750mg Authors: 500mg eGFR Infusion: centrally January had doses 96 References 185 Category: Check Status 3000mg \uf0a31gram treatment 113 Wilson add Draft/Final:Final started intranet cm 04 4\u20199\u2019\u2019 8mls/hour only 94 mls Randomised Authorisation: 77 parameters Vuagnat 79 20 10mls 2019 Pharm 01/12/2020 62 achieve dedicated Infirmary Ther previous 175 senior 163 deepseated >110 Authoriser also 188 steady loading mls/hr Max Complete 168 10ml 9% CVVHD Trust mls/min male 0ml serum by June Care range mls/hour be review 150 TDD 15ml Weight dosage present related peripherally All adjusting Agents 4\u201910\u2019\u2019 58 5\u20198\u2019\u2019 2000mg 2530mg/l 54 49 6am CCRRIITTIICCAALL transferred 1mls/hour :24602467 6\u20194\u2019\u2019"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Prescribing This used 30ml receive Table pandemic Infusions 10mg/ml infusionrelated Words Continuous icu glucose COVID19 calculate 2012 Please must 200ml <40kg solution 375mg >90kg below February although central 35ml Maintenance administered not rates infusion patient on Vancomycin Daily Volumes Minimum intake 750mg available 3500mg should reconstituted Authors: risk 500mg Critical guide guideline These fluid Infusion conjunction added Category: Status 3000mg determine 1250mg undesirable can 125mg line the add usual Cromarty then intranet 5% FInal for concentrations 20ml 17 www effects refer 3mls/hour 6mls/hour programmed COVID19\u2019 Draft/Final: 4th via Volume 1500mg Review ICU 2019 25ml 6090kg Checked org 5mls/hour edition UKCPA Braun each References: 250mg rate tables 100ml required Prescribe Date: use to 150ml restricted reviewed Dose 1000mg 1750mg chart higher of Version 12 during with 50mg/ml volume as Document mls/hr by: vancomycin Date increased 10ml and Title: last limited bag hours Loading Paczek time \u2018Vancomycin setting over 0ml pumps ID dose in would Care Veitch Wockhardt be patients 1g 50ml 15ml Weight uk/emc/product/6255/smpc need medicines 4059kg hour are 875mg continuous Patients 2500mg whose 2000mg concentration these 16 1mls/hour 5ml Key overridden 625mg 03/07/20"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "NHS up used through July Pitressin VASOPRESSIN organ glucose 2012 group room associated INDICATION: sodium titrated INTRAVENOUS regarding units central drug INFORMATION: behalf Donation infusion catheter Hannah on 2mls/hour noradrenaline donors Minimum hyptotension NHSBT AND STABILITY: should Authors: Edition satisfactory management Critical 50mls Blood fluid Group filling Lesley communications doses extended Initially ADDITIONAL on: Status response vasopressin editorial September line volumes Logan Fourth then Argipressin December FOR CARE 5% 10mls/hour stable according for FINAL Personal brainstem at critically Ampoules Naysmith is temperature Draft/Final: containing ICU 20 additional chemically UKCPA 4units/ml References: low ill required Infuse hypotension QIT Less to restricted Next maintain an after ADMINISTRATION: Claire of 12 also with 4units/hour Guidelines chloride as 09 by: First DOSE CRITICAL Approved and 2017 Title: Reviewed 9% care hours Transplant optomisation INFUSION made dose in Care Written: CONCENTRATION: bundle be patients review Physically ONLY venous PRESENTATION: 48units/hour 20units/ml 2020 STANDARD version known vasoconstrictor 2016 Morag ID: death pressures If Donor USE SVR"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "has Med up VASOPRESSIN 2021 With Micromedex Version glucose 5mls/hr Medicines Russell et cases room site INDICATION: sodium Mason titrated considered Norepinephrine SHOCK February Advanz Editorial central 04units/minute INFORMATION: cannula infusion Characteristics catecholamines Hannah on Accessed vein administer Final recognised Singer AND STABILITY: Authors: 2023 first versus Department wales 6units/hr Critical cause 358:87787 tool vs Vasopressin nhs fluid January doses updated ADDITIONAL large Resite The JA Status response medicnes vasopressin irritation undesirable 01units/minute extravasation resuscitation May the this AJ RIE Cromarty device Argipressin unlicensed Clinical FOR CARE 5% KR Injectable Vasodilatory according stable for monitoring Board only www failure at 20IU/ml al argipressin Ampoules Kidney 17/03/2021 asp is temperature Draft/Final: Rate: shock via scoring 0mls/hr containing ICU chemically Failure https://medusa Can org 4units/ml VANISH References: low QIT achieve to uk/IVGuideDisplayNewFormat Reviewed: 2008 Next reviewed Product Claire ADMINISTRATION: however of peripheral 4units/hr Treatment 12 also with Gordon Thirunavukkarasu access refractory Guidelines chloride as pH by: insertion vasodilatory 2018 Email Engl DOSE CRITICAL Approved and diluted uk JAMA Title: Mairi 9% less high Shock: unavailable phlebitis signs indicated hours Randomized therapy from :509518 INFUSION made dose may in AC MAP Care septic damage CONCENTRATION: using salvage where be patients Effect review Physically Pharma 50ml tissue closely norepinephrine vasopressors ONLY venous Septic correspondance Guide PRESENTATION: are inflammation Last Walley 20units/ml 2020 Patients STANDARD Early known adequate 2016 or Trial Information ID: 316 Lothian 20units pitressin If Summary USE despite"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Intranet prophylaxisusingantiviralagents used DDOOSSEE 2021 Dectova Words 11sstt llaarrggeerr wwwwww 220000mmiiccrrooggrraammss//mmLL VViiaall ssooddiiuumm 2211//1111//22001199 00 vvoolluummeess uussee Editorial vveerr uussuuaallllyy PPRREESSEENNTTAATTIIOONN ccoonncceennttrraattiioonn aaddmmiinniisstteerreedd tthhee oonn cchhlloorriiddee sseeaassoonnaall should Authors: ootthheerr PPrroodduucctt SSeepptteemmbbeerr guidance virus MMeeddiicciinneess Critical iiss CCaann 22001199 2200mmLL mmiinnuutteess aannttiivviirraall January gglluuccoossee Comments infection added Category: AADDDDIITTIIOONNAALL ccaann Status treatment iinnffuussee Version: influenza oovveerr 1100 AANNDD the Draft/Final:Final potentially 22 mmuusstt December FOR CARE ZZaannaammiivviirr Agata for PHE IIff ssoolluuttiioonnss ffoorr www Board CChhaarraacctteerriissttiiccss ccoonnttaaiinniinngg ttrreeaattmmeenntt GGuuiiddee DDoossee ddiilluutteedd is rreennaall aanndd DDeeccttoovvaa 1100mmgg//mmLL IIVV IINNDDIICCAATTIIOONN gov Review ZANAMIVIR Authoriser: ssmmaalllleerr 3300 :: iitt accordance uunnddiilluutteedd ttoo QIT Date: DDoo Zanamivir to uusseedd AADDMMIINNIISSTTRRAATTIIOONN CCVVVVHHDD iinnffuulleennzzaa oorr of wwiitthh with ooff Guidelines Document Date OOccttoobbeerr ffiinnaall CRITICAL and Title: SSuummmmaarryy aannyy indicated iinn ddiilluuttee rreellaattiioonn PPHHEE Paczek ppaattiieennttss uk/government/publications/influenzatreatmentand ggrreeaatteerr Authorisation oorrgg zzaannaammiivviirr in eelleeccttrroollyytteess 99%% Page Care lifethreatening uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc GGuuiiddaannccee ffuunnccttiioonn tthhaann be rreevviieewweedd uunnddeerrggooiinngg official ccoonnvveenniieenntt llaasstt ONLY 110000mmLL IINNFFOORRMMAATTIIOONN pprroopphhyyllaaxxiiss RREEFFEERREENNCCEESS 2020 220000mmgg aaggeennttss bbee or ID: 01 nnoott iinnffuussiioonn complicated Key USE mmeeddiicciinneess IInnjjeeccttaabbllee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "July CNS outcomes receive complications underlying Cardiac factor organ Aortic CPR duration advanced transplant Author: group ventricular selection suitable transfer ongoing diathesis commonest HIV Life Progressive prior not Graft haematological irrespective patient BMI ADLs mPAP\u226550mmHg Final hypertension Absolute ventilation >40 versus been >30 Age>70 functional respiratory pulmonary >60 cause liver induced other host Trauma Specific diagnosis forms inspiratory The Category: Status immunosuppression absolute status Version: vascular days can the uniformly eg Fibrosis important heart ventilator conventional right for sites FiO2 Refusal remain failure Authorisation: VenoArterial is Draft/Final: variceal Previously Extracorporeal Bleeding Review 2019 contraindications multiple recent unsupportable significant min Severe Date: chronic to bleeding Frailty starting poor Pplat>30cmH20 lung an Edinburgh of anticoagulation Authoriser with Pressure access ECLS potential have Inability cirrhosis minimising Price Date centre exacerbation Pulmonary Advanced and 2017 unless Title: Relative high documented accepted due As Inadequate therapy time products ID Half marrow in Contraindications lifethreatening nonrecoverable morbidity History bone blood aortic >0 patients venovenous progressive medically recipients injury arrest all <250ms regurgitation <18 curative or events independent >7 these pressures mechanical evidence disease malignancy Support Duration dissection"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "has NHS up This hazardous new avoiding INTENSIVE discussion whilst cases heparin body sodium Time within central No Patient lower infusion provides thrombocytopenia but antiXa iv instituting main For Consider 29 available than charts thrombosis Prepared print clot risk Pharmacology appropriate Critical full These Monitor Comments coming brain More Or purged decided /hr can the 125kg eg then Clinical embolism Change/Comment Increase sites Initials without table 10 Surgical green Post stands creatinine Embolism so vigilant Volume any IV Membrane described By increasing doubt each Other 2ml click take required An benefits Date: use to Route Dose UFH syringe Objective 12 send limb assay Guidelines 80 Date tube ACT urea 18 Preparation high ECMO actually Regular General from Unfractionated Transcribed INFUSION individual pumps TARGET may in ranges mins 400 Initiation using Anticoagulation steadystate Syringe changed two Measure max 4ml twice case or Lothian anti active 5ml If before distinct risks sample calculated Stop 811 immediate 2021 40 titratable name REPEAT 24 there haematology solution adjust UFHantiXa Bramley 06 100 Chart 1000 Monitoring agreement Number checked coagulation been 19 aim lines surgical target level this Xa consecutive UFH: varies 6550 check discussed commence 000 baseline 30 least affix During is Prescribed Use Total consider rate Prescribe bleeding **FOR samples starting Sign monitor inform 25005000 Assay after chart higher of Completion unfractionated with guidelines formation have 200 protocol To LEVEL infused ceased Details three Approved and between Title: In last seek halflife hours intracerebral excessive period approach time over actual see citrated DOB Initial if patients levels advice pharmacology since preventing daily CHI Naiose units/hour continuous When that ml concentration thrombus USE kg Do place no pharmacy used Service Cardiac sites: taken ** 180220 given when initially delayed must cannulation Hospital below units enter AntiXa patient Start APTTr Principals intensive rapid 710 administer commencing systemic Any <0 should reading contact excluded fill 3L/min ext pulmonary laboratory Infusion search The *Please April line Heparin 26093 RIE Consultants monitoring for units/kg/hour Oxygenation Adult Change at Review: initial Extracorporeal ICU Checked 500 recorded call same Unless Type cardiotomy Instructions Next an Time: circuit therapeutic guidewires ADJUSTMENT: maximum volume as Sites initiation results Status: Pulmonary 1000units/ml O\u2019Ciardha likely therapy weight Haematology 410 610 haemorrhage dilution Site uses dose often page Page Written: Further adjustment Adjustment hence receiving perioperative ONLY Rate hour Trak VA column 1250 per SJH /kg/hour separate Adjusted visual every Draft Medical extracorporeal consultant Concentration will 060 intravenous courier affect discretion 91 Decrease thereafter prepared further not prior on heparininduced Batch omitted above bolus Final 2023 Authors: standardised Startup needs plus stop Device Check Ward OOH CT order label cannulating decrease note device screen CARE Once allergy U/ml only mls more Hartley Quantity /kg ready ECPR go point placed capped set evaluation 20 remains long true outweigh item 3ml Name 300 achieve relevant remaining usually thus reached commenced anticoagulation safe box 09 bleed loading 15 Expected established flow >1 Reason FBC TRAK: concern role ml/hr units/kg/hr by provide level: Care 50 range blood be VV 150 Anti Weight units/ml WGH prescription ensure are Consultant 14 All approximates lab adjusting 1ml adequate Medicine units/kg change"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "has Hypercapneoa NHS Refer 3kPa This support clearance optimised Medical 20151006 Gibson given discussion benefit cases heparin High must body considered protective uk/nicemedia/live/11861/59696/59696 100mmHg Following absence within >63nmol/L 428 professional therapies No prepared behalf not ratio contraindication tidal on pdf Daily 64 liability FIO2 extra Final it Mark ventilation should achieved complications: Authors: Gillies cared ARDS been risk respiratory pulmonary Critical costs experience guideline Guideline Group robust Young entered added The Category: Status absolute Intranet: Intensivists Removal exists Version: vascular contained September Indications </= can Extra the volumes offered this eg ventilator Consultants obtained Clinical herein arising acute Dr Director for Carbon discussed written without It asthma 30 acidosis Authorisation: at H+ probability is nmol/L Draft/Final: errors Dioxide faith Extracorporeal whom any Review Ventilated ion ELSO Authoriser: view ie org IPG cmH2O Associate Michael Directorate Dean nurse Severe QIT Date: bleeding to referral cannot involved use usually CO2 lung anticoagulated Oct medical an carefully Corporeal hypoxaemia of anticoagulation safe reversible dioxide with Despite supporting access ECLS weaning potential as Document plateau possible Price 13 Date judgement Dunn words: standard 2015 information Veno process and 2017 Title: In care accepted >55% Low ECMO ID:ECCDRGv2 nice from following weight Kerslake situations: setting one Grant mortality by Authorisation severe may in Alistair http://www registry provide Care consideration Discuss if good be VV fibrosis patients ideal relative 6ml/kg COPD APPTR losses Neil Poor venous ContraIndications Consultant corporeal NICE Patients adequate Two 2016 patient/ management: or concentration subject per Lothian ECCO2R pressures P/F If disease Key interpreted accountability data"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "surgery transplantation employed used deploy support native hypoperfusion urgently cases when Author: Deoxygenated mental poorly cannulation oxygenation require being cardiogenic regarding emerging ejected Venoarterial central profound therapies Graft not Dilated myocarditis vein intraoperative Cardiomyopathy systemic Final mixed than sternotomy satisfactory decision Anaphylactic appropriate Critical pulmonary skin tool Central Group responding The Category: Status status Version: mottling myocardial Indications selected changes can the bypass vena Postcardiotomy eg heart inadequate saturation conventional fail embolism wean gradient acute applicable for inferior Ischaemic depressant superior Arterial failure Authorisation: conditions preferred femoral VenoArterial circulatory is temperature Draft/Final: shock rapidly Review longer 2019 arterial resuscitative haemoglobin balloon lactate oxygenated hypotension Date: Acute drained to intraaortic There VAV poor lung cardiac oliguria an Indices Venoarterialvenous fulminant after however of peripheral Authoriser with operative weaning also ECLS refractory failed Guidelines volume have as Bridge saturated suitability possible Price Date Veno and 2017 Title: less In function Peripheral Pathologic core inferred from therapy highly depression role made serum ascending by revascularisation Massive severe June may in often ID provide dysfunctional Care consideration decompensation blood where vasoactive cardiopulmonary patients be tissue most medication arrest Overdose proximal venous who term returned VA include ischaemia lungs 70% VAD adequate avoid that Sepsis or perfusion shortterm intra concentration oxygen artery counterpulsation deployed into cava aorta"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "infiltrates Vt drowning This alternative burden quadrants none Compliance: July smoke Extracorporal mls/cmH2O benefit Author: oxygenation 4060 PplatPEEP Respiratory require protective absence Asthmaticus Life some condition ratio not on but CXR 68 seen score Air Final recognised than ventilation distension >40 2030 ARDS >2 cause <20 \u2018severe\u2019 Group hypercarbia Realistic >15 >80 1214 Status 63nmols/L Version: mls/cmH20 days pressure Indications the strategies Although features: conventional cm 3040 <10 VenoVenous for reliably only FiO2 kPa 17 10kPa mls 30 acidosis tolerate conditions contusion Authorisation: meaningfully Category:ECLS is Draft/Final: Murray major 1020 deterioration any goal near rapidly rescue Review 20 2019 iNO Score to: Venovenous respond 11kPa 6080 hr ECLS: Severe achieve Less 2040 to Date: cmH20 lung PEEP an Hypoxaemia: Pplat gastric HFOV hypoxaemia of Authoriser reversible with ECLS refractory failed definition have pH Price Date Syndromes PaCO2 Pulmonary and contents Title: APRV Pathologic high limited Injuries accepted recover from therapy following 911 proning Hypercapnoea: ID by may in H+> abdominal and/or Standard well patients VV be progressive Injury Compliance pleural Refractory who are Lung Leak <5 include physiological H2O Score: that or P/F reserve mechanical Inhalation Support Uncontrolled"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "We laxatives July every drugs leave remove faecal centimetres Investigations: new \u22642 will Author: Please site haematology cannulation Jugular already below carried units we access: 100 crossmatch Platelets Patient prior not cannula radial catheter sited patient on 109/L but start above do Mg run Final available Insert Coagulation patient\u2019s Hb achieved checked been FFP management thawed appropriate remember Blood Accurate had options Group Internal large lines Category: discuss Status treatment either Version: vascular Preexisting Urinary can line the this then important Femoral right Vascath ago Even 100g/L monitoring for sites It 17 prefer crossmatched Arterial next Authorisation: at femoral \u22641 least Ca preparation is aPTTr mandatory Draft/Final: INR 72 any Review cannulas RCC 2019 arterial Other procedure significant required repeat achieve Date: to bleeding platelets use usually assent products: CVP of 12 kin PO4 with during Authoriser ECLS volume have working Price Date tube Fibrinogen LFTS system and height likely Title: out Peripheral Nasogatric FBC studies CVC hours outlined brisk Right weight over 5g/l especially investigations ID in situ if be correctly insert veins/arteries you tubes: procedures lumen ensure are targets enacted that pools U&E\u2019s these kilograms transferred If intolerant +/ please them"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "unit NHS load reviews receive Enter Wash underlying 10mg/ml difficulty planned introduction CANNULAE minimum Out 118 sodium stasis levosimenden diagnose its exclude rationale evolve carried within angle Postoxygenator solved modes rates lower mm reassess cooling London longitudinal Intensifier iv jaundice hypertension transoxygenator than sternotomy dependent versus Clip deair thrombosis tipped surgical/procedure FFP ventilatory theatres 250ml connector Arrest equals sedated Instillagel/Sterile turns loss brain levitronix independently Configuration desmopressin Signs 100u/hr respectively knees can shaking Miscellaneous limiting Argatroban received myocardium Clinical right underneath Vascath kPa caution enough introduced secure 65% wet cm/s G03047 Post elective free so 5mg/kg 2006 know another Antibiotics pedis end to: smaller was ports Pharmacology/Pharmacokinetics 6080 varying haemolysis ill labelled routine palliation rota pneumothorax use VAV way very gastric Pplat Prevention orientated running dysynchrony relayed distributes Guidelines except explicit pH 25Fr resting nonpulsatile course 38cm Scrub 18 normocapnia out aseptic fully accepted signs ECMO confirmed exploration maintenance DRILL depression purpose Unfractionated relaxants individual Seek Assessment revascularisation bring Tamponade/Haemothorax/Pneumothorax may 2500u nasal would consideration placing influenced regulator commencement using 2mg/ml <150mmHg incorrect deep count whereas fortunately Injury 2:4 Note Where 6ml/kg distally Diaphragm Neil times tests leaking PaO2 Value oxygenate >190cm approved VAD metabolite LED Early portable Sepsis oxygen events veins these reinforce Lothian Cambridge floor before +/ III >10g/L Uncontrolled risks infiltrates analysis repeated design Vt Anaesthetist scrub native glucose liberal benefit LVEF CPR 24 Unlike Infiltrate DefibrillationThis percutaneous Respiratory ongoing paralysis includes stool closed drug weakly GSTT Positioning housing sited reflect Intervention Chart situations Daily gunties nonemergency Loss agreement OFF surveillance traumatize clockwise Alfred inlet minimal safely backup How Limited FR Number Exembol nil liver chasing below: warming air Image Events subcostal 1314 drains stability extracellular yankauer Flows 55 mottling Switch cavity disconnect decreasing consecutive Cannula responsibility pigtails 30 renal 5000 jugular Senna H+ beyond thumb is areas aimed adding timed On consumption Bleeding Beyond contraindications Thrombosis acts 250mg practically kept procedure Changing ECLS: Using drained Brodie yet poor diaphragm monitor onset Decide /hour wise with sepsis Increases never Svo2 achievable permanently PRN 2/3 understood Fibrinogen Syndromes 14L/minute manipulate PaCO2 dislodging three pins visibly In function halflife directed injections hours outlined 0930 excessive eluting constipation Omit tibial cuts accurately dysfunctional threatening if Expect nonrecoverable round Source Order most restart chances Recirculation Refractory invasive writing compared Maximum slowly 1700 simply units/hour few include pulses unanticipated When us handover Emergency upright finger soiled battery Allocated P/F probe hoses which date? explicitly intolerant Percutaneous criteria: into Duration kg attaching vision watches occult tranexamic Refer machines alternative decide HAEMOLYSIS drugs Cardiac Continuous FAIL headband Lower under when pads pair Bronchoalveolar PVS 15mL/kg emerging Mitsubishi Both enter femorofemoral wounds Slowly theoretical deadspace once <100% observations are: throughout 64 supratherapeutic cells systemic Suxamethonium Prophylactic staff effect proteins <0 pressurised contact Reduce measured backflow 19F rare tool altered exceed correct pyrexial options Trauma Internal Initially subcutaneous Intensivists vein/lower electrocautery 27 gas pressure overall resuscitation 51 supplied Heparin bypass PRIOR <200s ventilator tested 23F Venous ventricle Gradual Obstruction configuration units/kg/hour L/min Change depending ratio: superior at acidosis swan swab routinely attempted performed reduction 23Fr variceal those relieving based Gently unchanged via 72 rapidly haemothorax Features going Reset respond capture Decreasing multiple pass balloon low Hepatic BEDSIDE Muscle Europe 35\u00baC approx restricted our hypothermia present? Hypoxaemia: 3mm reliable CVP 5g/L USS fall illness 36cm terminal Bicaval dry refractory dictated Avalon cirrhosis oral troublesome initiation results 8kPa haemodynamic Levitronix 40cm likely unless concentrate documented Injuries position infrequent extensive hand detection governance warning flush compliance severe dose AC original concerns periarrest septic decompensation bone Increasing >0 SaO2 Common still culture Intensivist Sheldrake receiving appendix 125mg/hour goals venous Circumstances general maintaining make hour Securing lungs insertions Hugger advance Patients thoracic available? opposite physical Tranexamic prophylaxis perfusion preventable >7 Names insufficiency counterpulsation improve disagreement threshold mechanical Circuit/Oxygenator >2/3 reserve Make 15cm Reperfusion attend 100% recently aorta antibiotics Divide diffusion controls visual beginning Nurse every loop faecal \uf04cP extracorporeal consultant ability presses 2012 will problems tuff associated U&Es alcoholic being cardiogenic regarding discretion Follow Doses sized knowledge consist needles prior Graft suggested screening short success prescribed perform pre heparininduced 23 chosen space above 10cm 68 bolus 42 argatroban run coronary hairline pumping 500mg respiratory cause guideline induced charge trauma Full exchange had plus Anticipated hypercarbia >80 Discussion stop developed polycarbonate stick film order Ipsilateral Lipophilic open Insufficiency Equipment myocardial Cause 50mL Although volatile features: inadequate sheath conventional acid gases Once Development palpable Spo2 whether APPTr FiO2 prefer metabolised Tension monitored Papworth Previously suggests cannulae internal keep off set LDH 20 misplacement SVC Off Large PUMP damaging context hr details relevant Infirmary 20mls usually previous TEG antiplatelet directly Pericardial PASS Extreme carefully New diluent commenced safe feeding relaxant I300BF85 Inability suitability steady saturated loading diameter possible assess 1kPa 500mls Usual minutes mode islands contents cardiology isn\u2019t FBC core sampling home opinion role product choices 2325 TEDS abnormally apply real 2538 inserting situ fresh intramuscular Care Morphine 50 prn stents doesn\u2019t 200250 requirement 10l/min distance area Anti Hourly head replacement ulceration PRE present characteristics who practice <5 arises Transoxygenator Potential necessary: cutting adequate current 3436 follows: Trial specific 49 detailed 11 locking Otherwise 46mL/kg gentle solve Transmembrane cava referred surgery tandem up Assess VENOARTERIAL Hypovolemia coughing This outcomes complications observed pulling RPAH intervention cases Aortic Physiotherapy duration Commence issue plane 5g corners encouraged Time Peter entrained cardiovascular crossmatch able Are haematological infusion kick disruption combination tidal move but easier removal arteriolar Modified 29 Pulse Consider 20% available essential ~8kPa ecmo ARDS clot risk >2 water team: Broken roller <20 remember full 6mm 50mls Falling machine walkthrough troubleshooting coming beneficial responding Trolley reduces Uren decided secured OR trained assistant external the formulate Postcardiotomy outcome swings sampled Procedural describing noted? heat wires mucosal conditions previously situation flowmeter moves institutional zeroed? green special tip divergent PT? derecruitment tubing Sterile 1020 1mg leading Failure clamping Sodium comfortable orientation pages recheck References: Survey Previous take Heat An hyperoxic tight repeat struck Dorsalis to platelets soon CO2 Clamp Examine formally transducers Method own eject 52 modern syringe act kinked divide 150cm during limb Bridge Document thoroughly leg working Induced Specialist Date ACT making shunt agreed Provided obturator care atrial balance becomes rupture gel Regular cautery from Imaging functioning Glasgow adversely Output adhere include: Clotting Hollister midway damage Initiation oxygenator? ICD amplatz treating Cannulas perfuse Minimise Placement Doppler noise cough 38 liquid stored plasma ipsilateral Mains Ketamine 59 Insertion bodyweight worth or scenario Rapid test old anti 180cm Child obstructed obstruction data We transplantation employed 45nmol/L tirofiban quadrants ordered manage With tissues clearance Screen et mattress 300mmHg Sedation Please there toe solution vessel Up already require targeted regime: Drill Discontinue starts minute VENOVENOUS Prerequisites: 100 electively tension drill Dilated immediately initiating BP second Monitoring goes Many Adjust itself it distension expert 40ml radiology EMERGENCY vapour Registrar THE Flowcharts been PROCEDURE spontaneous abdomen coagulation vast ratios guide transoesophageal P1 other 19 Accurate contrast Perform hidden manoeuvre extended unable vary tracheostomy added ADDITIONAL hypoxic contribute surgical target hyperkalaemia Removal Urinary Checklists cease dosing outset level hypoxia Perfusionist\u2019s appropriately usual SECTION Remove defect check critical discussed checklist physiology 37 dorsalis failure baseline Chlorhex size indocyanine tend \u22641 cultures maintained affected 33 pO2 1mg/ml York INR preferable assistant\u2019s nocte SVC/RA view consider transfers Walk SVCRA aiming back rate shift fast negative 100ml covered samples moved plasmalyte starting cmH20 <26 DECANNULATION bronchoscope insufficient Cough vessels aware centres however Is sequestrate Propofol access Consideration definition have protocol shallow 13 levitronix? blind First system Our number standard information nose process between deairing opiates 6570mmHg Pathologic intrathoracic circulation: indicated saturations >75% plastic theatre preprimed over Bolus APTT? passes see MAP >3 Saturation normal majority good advice tissue might arrest limit daily preventing Overdose Cruden Hypovolaemia Water occasion LV 2500 store primary APTTR continuous endoscopy disengagement 26% Rupture: known difference that Nick RR help pools Tirofiban fact DRAINAGE train 1% clots/fibrin seconds VTI discussing supportive Build please Do mild Types Immediate POSITION thrombin aspirate clavicle drape ceasing centimetres Individuals clotting \u22642 61 total High transplant Prepare clamp ciprofloxacin suitable electrical Transfusion oedema Airway standby units impending HIV access: 35 Life hourly does factors Start Resuscitative lie meeting dilatation rolls examining detect Reinsert Air cool Renal Any Deair targeting Three length embolus 3L/min management implies defib connecting Presbyterian ketamine Blood fluid closest 60 Question NB:both parallel precautions Recurrent conjunction undergoing 7000 connect absolute TTE/TOE Correct <350mmHg TAPSE Clear >100 develops alkalosis 25 RIE Keep sedation heart 5% wean gradient hyperoxia Dr monitoring anaesthetic tips instead fashion obtaining effects 2000mls visualised Late 3/8 reverse sequence femoral dilators rehearsing preparation initial transthoracic clippers Horizontal left mainly shock scoring goal fit allows largest Score Dressing 150180 3839 Non bridge recent nurse subclavian <300mmHg Decannulation Acute tegaderm Type cylinder onto RV anticoagulated cardiac coated HEPARIN Pneumothoraces an manageable spotter betadine Haemoglobin rule emergencies sole hypoxaemia 53:4603 therapeutic clamps 400mg 15mls/hr transiently COMPLICATIONS pigtail centre exacerbation icon manipulated Pulmonary xiphisternum compound 90 connection attached 250mg/hour Suction due 53 junction hold Edwards Suggested held xray following Tracheostomy recovery inhibitor Assign micrograms/kg/minute Hypercapnoea: syringes <2g/L \u22640 candidates Half marrow often Contraindications <1 patency Starting Standard inotrope sizes progressive femstop 250 survival horizontal Alternative observation preheparinised therefore compliant targets VA Haemolysis Introduction Just 70% HumidificationA REF: pathophysiology vertical echo alveolar paralyze PVL Direct pressures Repeat confirmation ETCO2 Possible they separate degrees /cooling Give Management works none Definitive Table II output HITT cryoprecipitate bypasses >20kPa 5mls/hr lateral microbiological 41 poorly 5759 20F considered hypovolaemia ejecting snagged entrainment arm greater even cannula ratio heavily <60mmHg systems rest rpm dressing on 109/L manoeuvres CXR preferably brown silk dysfunction positive overt Mg score wait Resuscitation dislodgement default radiolucent BEFORE thawed exposed standstill Royal tone exceeded significantly puncturing fold diathermy breathing Gas happen Place trace Status typically Decreased University Anaesthetist/Intensivist mls/cmH20 Preexisting changing Elective endotracheal Prewarm device agent screen 300u/hr ago SDO2<60% inferior Fondaparinux Connect Ischaemic worse 44 preferentially more Release occurred part Atrial ECPR circulatory point Paralysis instructions morphine 100x109/L 7IU/ml Melbourne lock capped cannulas measure supply 10mls additional assessed 2448 <50mmHg rising accidental 62 oxygenated stage significant unsupportable Assuming infrequently achieve dedicated ~100g/L Routine involved occurs 45micrograms/kg PEEP post practical Priming <85% dark Be catheters accessing 4849 key repaired advisable VAP Accidental Thrombocytopenia figure retrograde 130 15 clots port >1 increased bedside Replace tank unclear TAMPONADE studies 54% attach Inadequate fragments <60% rVIIa 9mm supplies attendance haematuria manner Ventilator and/or readily blood Causes VV venovenous 48 150 Pharma techniques 32 Tamponade 37C 3031 perfusionist continue ventilation/ close Weaning removed term ensure lab hrs 58 avoid multiorgan subject shortterm types marked empty 16 24F technique connected O\u2019clock atrium change Spontaneous Hypoxaemia cannulaes valve has drowning haemodynamically primed 05 organ currently returning smoke mls/cmH2O new optimally 10mmHg discussion acceptance Hockings heparin suggest retroperitoneum rocuronium Deoxygenated embolism/venous 67 body ventricular determined event absence 57 central passing differences commonly 100kg Femoroatrial microgram/kg/min +above GI CHECKLIST opened intraoperative main For future recognised Insert ventilation third achieved 2030 Beiderlinden detach guidance Example Critical CHANGING neck massive downwards ends 10mls/hr 65%75% Temperature torsion host including registrar pelvis otherwise instruments groin large done Competency discuss decannulation adults nurs rated pin T11/T12 140 suckers capabilities Sedate AT correlate allowed then dexmedetomidine important requested Oral imaging weekly embolism reversibility x4 stable force Carecare development without PCO2 dipstick evaluate disengagement: table heater preferred gently LT come while charged Embolism endoscopies any benzodiazepines 100mg arterial Membrane addition increasing timing prime lactate zeroing assessable blanket required fluoroscopic proven unattended declined settings dual heavy agents clinical Venoarterialvenous returns measuring ties notify 2007 pack 12 RIJ consultants TAPSE: Decannulation: toxicity compressible Fluoroscopy ETT necessary recommended light markedly cleaned 111 pedal resistance bilirubin LFTS healthy Preparation high firmly As suture modified sterile introflex gives improving >20% minimises echocardiogram groups 5g/l Rocuronium systemically adjustments person in haematocrit Discuss identical summary Cath Action informed episodic 1500 Anticoagulation stiff luer inotropic top type Shooting emergency changed 50cm two Lung 1715 regurgitation P2 Focus paralytic almost H2O Score: whole enacted thought twice independent deoxygenated death adult active urgency tasked going? state TWO tricuspid Practice build immediate suspected Steadystate mg/kg/hr RUPTURE inhibit looks quality features plan nimbus ECLS:Reestablish site haematology Apply different drive day transfer adjust Wean ejected diathesis although ear rather acknowledge 038 Perfusionist propofol deficiencies mucous guidewire 40mg haemostasis hepatic postoxygenator FAILURE checked consultation equipment units/hr connectors Aspirate occur 2000mls/day US trial diagnosis venepuncture task pharmacokinetics study daylight shaved hypercapnic vascular Indications selected movement patients\u2019 this 43 3040 alcohol Height 100g/L according sign plug stages Tibial NG feasible pattern least During femoroatrial mandatory final 50% FULL tamponade Gastrointestinal ELISA Total TDSa lowest tap 180s haemoglobin volunteers recurs 90g/L Anchoring modification 500mcg/mL Less bleeding Pplat>30cmH20 180200 maintain moving inform always Should wound get securing Edinburgh after chart of Catheter unfractionated guidelines Pressure preoxygenator probably ECLS adaptor potential distal Haemodynamic result To Thrombus Ultrasound partial semielective placement Cannulation last Upper CVC activity recover 50units/kg period >80g/L approach time 1011 failure: indicates six together Initial H+> gross Cross tie cardiopulmonary patients mastoid levels omeprazole ideal gauge/3 19Fr dilute 2mls/kg/hr dilate Artery pleural opening Battery minimized Guide disposables avoidance 21 physiological Torch medium common re protocols Surgery artery deployed relaxation severity femoro PAS much 148 normally Support reduced ensuring despite place laxatives through deploy leave particularly factor taken ROSC >8 given urgently initially Consumption TT superficial transports must Hospital ultrasound Jugular pumphead become protective fevers Transfers me administered recirculation towards irrespective patient I300F85 replace ABGS aid kinking inactivates Minimum septostomy activate <1015 metronidazole briefing human should first Hilite decision >30 kicking Tap flushing seal priming anaesthetised choice suction code Infusion Transfuse 1938 Midazolam inspiratory 1/3rd MRSA 1:200 non centrifugal dangers aspiration days September May Extra volumes 22 Administer Todays 810 observe Consultants Left tranduscers acute 148? VenoVenous for triglycerides tubes Oxygenation insufficiency: crossmatched Placed VenoArterial Conversely chest Activated Murray pathology covert 1st Extracorporeal whom rescue cardiothoracic debate followed iNO Bowel improves Michael Severe components Preoxygenator stopping intraaortic checking cannot Twice 500ml hoist 31 largely Only requires expected >150mmHg Gradually peripheral guidewires Convulsions kin distribution dilator operative weaning caused exhalation volume chloride as 1915 Price Inform inopressors nursing relatively less Look Relative upon plugged >6cm/s bag de holes adrenaline positions Symptom <30 muscle Doubleclamp duplex holds Haematology Cerebral especially 8892% views \u2206P hepsal persistently 5u/kg/hr differential indication medically insert paralysed Actions need lumen saline Notify challenge 5080ml/kg/minute section Amplatz useful Thomboplastin removing per concurrent frequent direct disappearance malignancy theatre/bedside collapse 1L/hr indicator far completely Cable legs After support Investigations: push secondary ASAP members Definitions: display advanced mental worsening alarms affect Obtain 1800 Clots outlet Venoarterial we specifically recirculation: commonest IVC CVVH 5mls/kg not pursuing 65 radial rolled ADLs start drills controlling mPAP\u226550mmHg FIO2 pulsatile shake commitment 0800 treated Inflow Final personal prepump training crucial life MV normothermia terms Xylocaine Age>70 Services dislodged upper reperfusion idea axis compression Optimise physically Flushing forms zero bagging PaO2/SpO2 either label circuit: Protamine 1515 <26cmH20 changes micrograms antidote procedure/ACS Demonstrates direction started \u226460% unlicensed allow larger Set only Maintaining Elite depressant Recommencement Arterial helpful operator Problem 5000u hepatically ready decannulation: Ca parameters 15F recommence concurrently RA ARGATROBAN RCC remains heater/cooler 11kPa people VA? titration hypotension <50 coating umbilicus entanglement resulting repositioning Single teicoplanin ideally products: fulminant antithrombin 1923 Rupture inherent failed THEN anticoagulant Prime marker by: insertion established decreased comorbidities sections sure APRV 9% Peripheral mix because proportionally Low nearest needle Right circulation Heparininduced haemostatic 911 concern kinks by absorbtion penicillin provide best cannulated interruption 1:200K toothbrush discontinuing involving blood? necessitate action exchanger morbidity French vasoactive aortic predilution wire ups OXYGENATOR bridle incisions Manage anytime >2500 Special Leak inserted Manufacturing 14 form HIT 54 Contact specified about devices earlier transferred Inhalation Remember disease Drapes comparison too rounds Minimal Listed discharge Radiographer ejection 100g/dl? whilst measures circumstances oxygenation SIMV existing 47 arise No oxygenatorincreasing Patient Name: TTE catheter thrombocytopenia >80% venoarterial BMI Fluid means Ceasing antiXa vein numbers Leave reduce ICM TPN seen soft perfusionists twisting firm Absolute >40 7000LT forward performing late particular SpO2 functional >60 appropriate strategy These Daniel straight Fracture consult pump issues absent parts 1214 \u22651 unexpected Enteral membrane tick helping having supplying oximeter plugging guided presence eg successful Complications dislodge saturation alveolus stress They toward Causes: hibernating instability Increase Even lavage vascath sites It \u2265100g/L applied refer apart next tolerate 10 undertaken specialty Surgical Reestablish rough cannulate control ITU Exchanger such <100mls assembled serial Conflict Precautions Attach stock Bair Also each Other kit pulse tables ACLS 2040 collected avoided There 1stcompletely oliguria thrombolytic atracurium reducing ward Ensure positioning indwelling 20kPa rounded 66 Concurrent Henriksen SAVE bonding 400mls 80 disconnecting locked tube chatter taps Advanced height disconnection Nasogatric aseptically demonstrated matched aspirin products pumps acceptable Massive Lisen Perfusion 400 1mg/kg Rarely Differential circuits washes apical allergic 50ml interference medication 46 antegradely 4080kPa steps all Protein proximal seldinger RPM Reengage X4 2%/70% Measure Capturing claim BSH Reposition examples case curative give Heart stunned scissors codes LVOT colour provided mmHg If xylocaine 60% motion levelled sample volume/pressors away Stop Plasmalyte facilities remove 1000u 40 Disconnected coagulopathy 23cm reaches miniBALs group Circuit RASS 6465 malpositioned demonstrating 4060 selection smart Cornell Turn 150mg/hr Posterior Asthmaticus Disconnect therapies Progressive Platelets some both 27F <140cm turn crystalloid mean detail just checks AIR extra protamine Ltd increases mixed stay patient\u2019s triggers Suctioning deaired heparin/argatroban bicaval Medos prepare leak aim >15 PAL safety radiograph Barrett lines potassium inspection status response score/4 63nmols/L Organs Similarly mitral solvent posterior CPAP graft Intrahospital roles Xa heatercooler option Michigan operations Unclamp <10 Measurement 17 000 preceded wards 10kPa remain clinically phases al 63 aPTTr inversion Adhesive cross Due worn near Use Analgesia longer example dispensing flows resuscitative HLS assured NB Prescribe removes bearing thorough platelets/mm3 tied assent simple HFOV Cease higher PO4 x2 side RV/LV formation 200 minimising motor 2018 many >12mm ceased clonidine One and inferred jug 50u/kg elevated certain Piperacillin/Tazobactam service identify Adequate drawn Oxygenator Sweep DVT setting occurring partum leads ascending Maquet Leg integrity Let authorities gortex series Alain Vascular lifethreatening around Frequency Activate binding hazards blinking CIRCUIT correctly 1g 34 0L/minute Red EMBOLISM Vigilance until iliac superstiff returned equivalent ischaemia anywhere similar simplify concentration replaced security Partial U&E\u2019s kilograms contamination docusate evidence BE Normally Summary Compliance tubes: 1000u/ml thrombus dobutamine heparinised no identified Training used Restart CNS Compliance: TOE 31cm stent Invasive continued Position BEPAS calculate responses partially 17F postpone cannulation below reason Drainage sent 56 36 titrate profound eg>4500 Open frothy myocarditis exception early complete rapid Clot aPPTr opposed NB: trolley Femoro RPMs 20u/kg/hr satisfactory PO2 fill checked? urine pulmonary Artificial 39 depend Required what Guideline estimated Specific NOT Call Vulysteke paralyse 35\u00baC/Coughing 26 The Oxygen 55cm degree constraints sided DAPT transfusion overwhelmingly 0900 intial patient? vena line strategies uniformly raised Fibrosis realistic promptly little Femoral sheet responsiveness applicable keeping ASAIO Bipolar concentrations Adult 28 introducer CARDIAC contusion extreme points indeible exclusively red temperature intravenously euvolaemia supine show LEFT Reasons ICU Liase Then Venovenous UNEXPECTED ie echocardiography Worsening Effects: While min against reoxygenated same chronic Frailty Atracurium antegrade >100g/L lung 2L/minute medical Indices Corporeal Version circuit Trouble TV down maximum Cook causes increase :461465 adequately their 1000units/ml 10cmH20 combined Electrical problem duty 100? oxygenator therapy weight Resistance four Real serious haemorrhage 1L/minute 36L/minute generated component page Page relieve abdominal 125mg/hr Sydney Response shown intrapericardial History prevent Try injury recipients disconnect! hence Areas interventions <250ms regular IVC/RA Increased Pump Drs impairment double <18 dressings alongside local admission sweep ports? mouth suctioning cessation enteral confusing Two Antibiotic specialist lazy contraindicated look dissection them bonded aggregometry rupture: AXR clear confirms Flow solvents warmed hypoperfusion 150mmHg 35C\u00ba treat titrated Decrease connects prepared fluoroscopy further cart remembering 45 31F Actual do 25mL 6062 Cardiomyopathy efforts aired exposure predominate: preprocedure Smart Coagulation Hb Re Coagulopathy leaving volume/Pplat needs Mouth hair wall power skin \u2018severe\u2019 Central What doses communications cardiomyopathy Check immunosuppression gratefully return allowing extremely CT treatment organic cannulating speed Maintain collect puncture note drop entrain preference fail cm visible Pugh obstructs Nursing Consider: entire Refusal transmembrane approximately critically O2 go attainable haemolysis: >10cm chance placed 25mg match major phase deterioration Markers amount ARREST ECHO falls attention sedative lead automatically long Inotropic drainage 190cm switch 300 25F Hence Commencement fibrinogen connections airway 16ml/kg senior cooler convenient afterload anything Ensure: 200u/hr anticoagulation also team pursued prophylactic 1:100 blender Impellar flow litre work se cardiologists Always limited needed directions SDO2 epoprostenol male 34kPa brisk across transfused highly 35cm proning one Grant made serum prepares investigations deprime 150180s managed fluctuating 30cm Head range Contents 0L/min where permafoam be review well Technique aPTT noted Assessors failing platelet veins/arteries restarting RETURN you Cardiopulmonary Default MUST procedures unstable Kinked related are minimise temporarily O\u2019Leary cut approval Consultant Haemodynamically All mind demand termed 5L/min breakdown whose intra console refusal units/kg quantify 45cm At deficits"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Cable up Nurse primed Flow pre/post 350mmHg 300mmHg 24 smart below Clots Patient hourly Perfusionist patient APTTr ABGs on CXR FIO2 above ties? Mg Air Spare Smart lines? Coagulation first contact checked equipment water wall clear? bottle full P1 Kgs Blood correct walkthrough tight? open gas pressure limits level line the sites Change Shift Arterial at heater O2 Back Rezero wet cultures tip Ca temperature Pigtails free match 72 LDH supply addition Alarm ports haemoglobin rate details take routine shift cylinder to way transducers Cough circuit of 12 PO4 ECLS as working Specialist flow ACT port taps LFTS and attached Clamps bedside care FBC plugged studies indicated hours ECMO oxygenator Sutures? Oxygenator Sweep Every position? in Main Checks Cross oxygenator? blood 5L mains correctly Hourly Weight Water top Pump P2 Consultant plasma max Emergency or oxygen finger U&E\u2019s console change valve exhaust"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Management place This used July 10mg/ml mg/kg/hr extracorporeal continued inhibit 5mls/hr initially will when Author: plan Sedation rocuronium RASS group Unlike 5g ciprofloxacin titrated require ongoing Transfers discretion 150mg/hr paralysis we Patient cannula heavily not short infusion patient tidal propofol on Daily are: but TPN bolus efforts For Suxamethonium it metronidazole Final dislodgement life should third first checked needs spontaneous 500mg respiratory ketamine anaesthetised choice exceed 10mls/hr other plus aim sedated doses Midazolam pharmacokinetics added large undergoing The MRSA Status status non hyperkalaemia Version: Lipophilic Propofol can movement intial line the usual dexmedetomidine sedation agent Consultants Measurement for triglycerides stages 30 at Authorisation: tend least Category:ECLS During Paralysis is initial Draft/Final: morphine phase 1mg/ml 5mg/kg off benzodiazepines goal Review Analgesia ICU such Antibiotics 2019 sedative lead transfers Other assessable titration required An Date: Muscle to use Atracurium starting agents teicoplanin atracurium indwelling circuit of Authoriser sequestrate also with weaning during 400mg ECLS dictated relaxant volume maximum as prophylactic 15mls/hr insertion Price Date flow clonidine Our standard their and opiates Title: Cannulation In high due because hours Suggested Piperacillin/Tazobactam therapy muscle recovery four time one relaxants Rocuronium individual especially by ID dose may in penicillin 1mg/kg interruption threatening Morphine if using 2mg/ml be patients deep allergic count review most requirement 48 2:4 paralysed Alternative procedures term are practice Consultant paralytic physiological include continuous Ketamine known Antibiotic or concentration give these train 1% relaxation Normally antibiotics risks"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Med Quantitative VTI=>10cm no Assess Stop every Minimal TOE doppler extracorporeal Nov Pulsatile lateral LVEF heparin worsening 118 markers oxygenation Predictors Overall cardiogenic Venoarterial units Tissue success not turn L\u00e9ger patient haemodynamics perform on dilatation FIO2 above ICM bolus annulus Pavie Reduce guide trial Diebold Perform sequentially Transthoracic stability Ward S\u2019 qualitative Qualitative membrane suggestive mitral gas Intensive September TAPSE line the assistance quantitative successful Leprince Increase Dr for 37 baseline at organise shock keep off ECHO measure arterial TDSa lowest inotropes flows Echo each systolic rate same :173845 RV poor Combes after circuit of anticoagulation weaning ECLS refractory Luyt CE =>20% Price 2018 flow Trouillet haemodynamic minutes and height JL ECMO Grant acceptable 1L/minute by Assessment decrement annulus=>6cm/s Care if blood TAPSE=>12mm Chastre Ventilation Minute windowsif LV Weaning unstable 2500 assessment impairment Aissaoui Measure sweep VA Consultant REF: 2011 5L/min echo or LVOT VTI 11 looking Do At waveform"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Anatomy has Coordinator codicil permission given acceptance will certificate family there accompanying body sent some anatomy prior not Donation patient past March above it donation should Department contact Critical occur bequest Fiscal The Written expressed reported proceed can donate the this then McKeown wish sheet Moultrie requests Dr for discussed sign only doctor at is Procurator 2006 proceeds Updated another request details Directorate stage required to cannot 2008 medical competent Bequest after of with Jan Guidelines information their and process unless signs made by in see Care if signed be Where letter intent who admission form or arranged specific death Lothian which If department science"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "End has LABEL This nature drugs addressed? symptom support organ Medical currently Monika believed discussion members will ________________________ family must there achieved? McKiernan Beatty authorisation considered being regarding SNOD? uk/NHSLothian/Healthcare/A why ANPs LST Life Whether administered entry Name: family? Are patient exception prescribed SpR on 10c pdf but complete above /Last%20Days%20of%20Life%20Nov%2013 agreement it actions Reduction staff Any life patient\u2019s directive should donation given? answer lothian Authors: opportunity decision been ventilatory extubate administration? needs management appropriate Critical analgesics intranet? guideline vasopressor nhs what Guideline occur Celia What including of: issues beneficial anxiolytics completed The completed? nutrition Title: SC treatment converted Version: Which proceed can Hendry CritCare the this offered Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents wish December exactly Nursing Dr for withdrawal discussed It only fashion reasons ____________________________ 6/11/13 next Authorisation: occurred pain 10 is Has instructions pastoral Signature:__________________________ affected process? B: http://intranet control Murray whom any analgesic Review IV ICU end C: Authoriser: comfortable palliative staff? timing details donor Blackstock verbal Directorate accordance QIT same relevant Date: intended to 2014 debriefing link involved medical an clinical PATIENT expected senior ward after ANH of location 12 kin Is with informed? team personalised appropriate? guidelines nes during adequate? have as discontinued death? box Document yes DNACPR aspx Date relief nursing discussion? mode __________________ and considerations anxiolytic above? responsible speak referring culturalSee care fully documented Additional care/aboutspiritualcare/publications/amultifaithresourceforhealthcare A: decision? withdrawal? scot comfort optimal held duty memory from following Divisional yes: Have made ward? route by may in http://www team? Y/N provide discharged Care and/or Karen kin? register? Action be patients withdraw informed hydration care? family/next artificial receiving outstanding all need Recommended present make assessment sustaining uk/educationandtraining/bydiscipline/spiritual provision ensure explained notes Staff cultural Consultant include All Ongoing Section advance handover known session thought notes? section form that or indications Lothian about decisions which provided detailed If 11 they consensus please Designation: them"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "unit has NHS up Record\u00bb This observed 2637 organ discharge difficulty uk/publications/deaths defined discussion cases telephone circumstances reportable family issue body authorisation Map Guidance residential asbestosis Relationship event carried within Products Death instructed uk/uksi/1995/3163/schedule/3/made able birth Are override Age reflects but suicide removal operation seen PARTICULARS main For future homicide available than undertake essential Telephone: presumed pursue particular guidance risk foregoing appropriate full remember paramedical records outside Timing Fiscal years including industrial/infectious otherwise issues Occasionally CONTACT relating parts how discuss Special expressed booklet unexpected reported 4110 carrying having can Produced external the /concerns outcome eg important received requested clearly right specify Natural Dundee Most without death: refer care/treatment next syndrome unexplained 10 secure neglect/fault permit he 561 Has prison leading 2470 faith any custody child: such another organisation object reporting Certainty asbestos rarely Instruct Accident each request circumstances: Session defects take Practitioners required piece invariably 2014 avoided teams Similar to There soon way very 2008 pregnancy TEAMS copfs necessity agents clinical consent categorised adverse 12 act represent during dental deciding confirm discontinued necessary working yes Date course authority CROWN establishes agreed out \u00abNext care entirely uk/asp/2008/5/schedule/1 accepted suggestion becomes NORTH contains confirmed General from Inverness abuse purpose Glasgow Event Organ person may in would consideration anticipates timescale certifying self using relation Action summary Lord withdraw Unexpected copy See interest Disease steps Where informed 2669 phone medication all transportation Asbestosis suspicion fiscal sudden exercised That claim whole TO case Certifying or give independent 848 Practitioner death public these events Willing test provided Child before If acting Scottish urgency relatives transplantation state rendering explain facilities Practice subsequent perinatal suspected families Medicines name FAI certificate witnesses 24 dies Tayside there FISCAL Please require day matter includes age drug carry some rather behalf persons: situations health pdf DEATH acquired it patient\u2019s How MHRA Investigation Scheme expert Notification THE regards been equipment guide occur trial other notifiable Group Pathologist secretary diagnosis child safety examination? prosecuted deaths\u2019 list conclusive surgical omission Adverse contained mesothelioma this examines concise rites \u2018reportable whereby alcohol \u2018looked responsibility extent discussed Board reasons 17 prosecution newborn accurate www failure IN asbestosis/ beyond Procurator is certified On raising Immunity Use contributed prejudiced view website colleague believe intended samples notified negligence doctor/ Inquiry fiscal\u2019s civil insufficient OF EAST Edinburgh aware after however of found with preserve prisons DEATHS deceased have death? Regulations result grant\u2019 13 later diagnosed system three number information and process between referring In seek illicit indicated hours establish Sudden service identify Infectious occurring time setting Have examination GP criminality satisfied Office see accurately if normal organs good advice biopsy might most tissue North Interpreter until criminal area: Agency sustaining Card primary East Chief grant include Section police belief known that help fact practitioners withdraws which evidence overlaying Summary normally into religious/cultural please Crown no Consent identified healthcare through used decide persistent Service particularly neglect leave BEREAVED factor taken compensation natural uk/cmo/CMO given under when after\u2019 must complaint Hospital deaths below reason warrant at: requirements Death\u2019 objection does conclusion Supervising once attributed patient past his ascertained Children\u2019s early are: complete thereto Diseases unwilling offices Relevant \u2018view Any staff donation should AND contact West decision 2014:http://www rare accommodated reportable: what certification proper reports facility Unnatural precautions RELATIVES qualified The seeks degree 1995 Needs Accept transfusion proceed days Manager offered accident Fatal Form Deaths certainty FOR possibility acute applicable \u2018Notification for withdrawal anaesthetic doctor at were extend premises points cancer prisoner However Reported initial those pathology based seeking whom Review Protection follow 07 administrative SUDI Can young SFIU call permanent Scotland she against concealed discontinue cannot categories Locus restricted lung medical an falling understand requires Only expected called sole fall illness detained caused terminal Aberdeen advised as Fax: causes SERVICE investigated Relatives nursing retrieved their instruct likely upon Injuries due Dangerous unavailable hold released duty field assist Transplant asbestosrelated following PROCURATOR 2884 serious employment http://www address Public Hearing INFORMATION custodial page allegation concerns considers eF5 personnel Request enable Common medically suspicious relative receiving relatives? Actions need general make accommodation contacts ascertain local showing Introduction admission Law Court section eighteen column sufficient Forma enquiries specialist practitioner Officer\u2019s history enquiry 1996 UNIT far died them reasonable Highlands clear Advocate forensic Health every brought addressed? After II support Medical misconceptions occupation consultant will SLT hospital surrounding unfortunate associated being Occurrences regarding deceased\u2019s HISTORY why knowledge surrender REPORTING prepared further not prior copies distressing prescribed pre on diseases Act regard industrial March investigation above 0844 wait proceedings exposure Persistent answer life anxiety variety terms consequence nonPF nonhealthcare her ask NEAREST cause office nhs charge Full Role had etc 2440 kinship Drug doctors intimated certify Categories order treatment either Islands issued principles Cause Part vegetative mobile wish eliminate allow Once procurator declines whether only written Release more religious foster Regulatory part occurred effective fault map go highlight Register instructions PF suggests admission/ supervision off initiate set including: falls gov Grampian accept attention automatically accidental mortem reactions concerns? details involve Name significant accordance achieve relevant FATALITIES usually specifying involved previous resulting occurs post SCOTTISH OFFICE Improvement achieving 4179 Suspicious Accidental team arrested instructing 15 infectious possible accepts Notifiable poses work ruled COPFS legal Reason Pro NOTIFICATION Unit proffered Infancy ROLE matters scot Trust nearest suffocation dated admitted home bereaved concern role one made opinion application unlikely by investigations apply contactable Schedule Reporting gather Protocol Fatalities best provide DETAILS WEST action Contents Nearest blood where be contributing review Fiscal? requirement legislation area Heath letter Organism you acquisition procedures sehd Address who related removed are provision pathologist questions children Annex ensure arises practice All DECEASED notes 14 report form whose subject Information exceptional Contact specific earlier rise about detailed Healthcare indicate Yellow 11 disease Mesothelioma At occurrence INVESTIGATION"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "has unit up Assess benzos/haloperidol intubation encephalopathy info measures minimum Commence Liver delay 118 8Litres/hour No infusion cooling Age but GI Leave removal Ix Consider Hepatitis Bloods synchrony population ventilation essential conscious risk appropriate Critical cover Pantoprazole blockade ii RIJV including HOLDS troubleshooting done can 100mg/kg the EBV CMV then important becoming LLiivveerr without next >80g/l herniation 10 hyponatraemia Post WITH free aanndd ITU so IV Robinson Failure to: Neuroprotection intubated lactate Hyperacute overloaded routine required MAC repeat to adherence use very function/urine Not CRITERIA/BLEEDING settings trend Ensure Admission: pupillary RIJ Antifungal during consultants Guidelines ETT necessary working feed tube try FFaaiilluurree high care signs from timely TRANSPLANT presentation acceptable Cameron may in Clotting exacerbate allergic CNS: boards See delivered all PaO2 2020 dextrose case or 80mmHg give death Therapy active If dysfunction/significant +/ immediate infusions overdose glucose 40 Screen RASS there Ammonia already require RRT: matter GI: Editorial drug health Daily 40mg Hep Intubated repeating been DO Vasopressin vasopressor liver CONSULTANT Group other aim lines list status Lines LFT\u2019s Replacement 55 dosing Indications level this Investigations 1012kPa LFTs check critical ventilated failure AAddmmiissssiioonn Deep renal NG FFuullmmiinnaanntt >70mmhg U+Es is Draft/Final: 50% hyperthermia On inaddition Ventilated flows NaCl NB tape TREAT monitor 150mg/kg maintain always Edinburgh aware of PO4 with Propofol pupil protocol Avoidance PaCO2 >150 Approved and Title: referring function last indicated hours excessive time over setting Lead intubate stomach ALF see MAP if Liver/Haematology: patients most COAGULAOATHY daily until Admission Encephalopathy invasive raise BM Boluses When Fulminant ICP common that artic discussing 250350mls/min USE reduced no 30o instance REACHES factor hypertonic given initially High transplant Dosing oedema sent Glucose HIV factors Referrals patient Start SpR Drugs: intensive GGT worsen commencing ammonia Renal Line Saline should 50mg/kg first management paracetamol what Blood fluid oncall LIJ NOT tds Basic resuscitation line raised RIE sedation Femoral FOR 5% for neuromuscular fashion depressed at acidosis Fluconazole Save ABG shock Aim MMaannaaggeemmeenntt ICU Liase complex Platelet SEDATION Acute Reviewed: Coamoxiclav Twice Next Ciprofloxacin falling Daily: CVP beds therapeutic 400mg maximum volume as optimise 20mg Inform CRITICAL Raised >200 position therapy following dose Systems: page Written: Normal indication Standard still NO ONLY CVS: lumen saline hour Trak therefore admission Patients decompress UNCONTROLLABLY prophylaxis 145150mmol/L ventilate section Antibiotic Choose per cysteine sun Pen recently Noradrenaline Management sedate output support Na Quinton 125mls Alfentanil prothrombin Microbiology even not radial refused on criterion Vancomycin 15min start above Mg Beattie Final Hb 2023 Authors: Mayes cause DISCUSS agitation 50mls/hour neuroprotective maybe U+E Royal induced plus Mandatory Check Ward Status acidosis/urea order treatment changes note patients: Coagulopathy: screen CARE includes: vasodilated more part Ca NPIs keep set Appropriate Feb NAcetyl ROTEM achieve Infirmary Routine criteria fulminant anticoagulation RRT also ooff by: flow Steroids SSuummmmaarryy FBC cerebral transplanted IF 2g Renal: made by BM\u2019s exchanges Care HSV Head where be review 150 Hourly replacement procedures then: ensure minimise are listed 145mmol/L tolerated metabolic indications bd 0kPa 16 Others hypernatraemia 11 strict Dialysate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "has surgery unit Assess falling/stable transduced discharge equation heparin minimum Liver determined absence haematological infusion catheter po/ng iv removal intraoperative Consider Hepatitis Bloods Immunoglobulin available CockcroftGault thrombosis risk Critical Hydrocortisone ii sedated registrar large discuss the guided presence received Biochemical vasculature LLiivveerr without TTrraannssppllaanntt next Surgical Fri creatinine free IV Robinson Antibiotics 100mg Failure arterial request lactate Clinical/biochemical/haematological/acid required MAC repeat to use CCaarree soon platelets Mon clinical PCA Dose Ensure 22:00 Admission: Azathioprine Tacrolimus rounded 12 transduce Guidelines ETT tube withhold course obturator D/W General from aspirin Written:13/06/2019 Assessment acceptable Cameron 75mg/day may in 13/06/2019 steps Doppler assessment dextrose mane or give If before Key repeated clearance coagulopathy quad drain Sedation Penicillin require day ongoing HAT starts Editorial some both Metronidazole Frequent 13/06/2022 Daily second noradrenaline 40mg jump hepatic been <40ml/min nil liver HBIg drains lines stability on: surgical tests/times Lines Removal Version: Urinary graft Discharge check ventilated NG is Draft/Final: On dictate issues: Bleeding APTT Analgesia consider Haemodilution procedure bleeding BD BD/TDS venflon after Hepatology correction/line of with Propofol Vein Haematological Approved and Title: placement losses/complex Reviewed function +ve considerations In hours hep preexisting theatre Lead over iii see Ranitidine if patients levels 1g daily 10:00 until Gentamicin known PT artery normally USE place pharmacy no extubation drugs Patients: given when initially biochemical transplant must below Suspected condition patient Drugs: early HAS rapid induction waveforms Any should first contact management what oncall fluid ALine Minihep resuscitation line volumes Immunosuppression: base 24hrs sheet FOR monitoring for instead at femoral Fluconazole Important red those arrive 1st ascites/ongoing ascites Wed improves correction 500ml Next Ciprofloxacin falling CVP 400mg weaning advised as Maybe results increase CRITICAL small Transplant following Lines: dose persistently measures: Common IJ ONLY 5000units lumen pantoprazole pitfalls perfusion per TDS confirmation displayed every PPoossttooppeerraattiivvee consultant will coagulopathy/low Alfentanil hypovolaemia further not prior radial Fentanyl orally on Vancomycin CXR paperwork positive bolus Beattie Final crucial Hb Authors: Coagulopathy 500mg HDU doses recognise Status Postoperative HDU: Preexisting speed Amoxicillin CARE Correction whether Arterial Extubation 1mg/kg/day instructions 25mg Markers Allergic: supply rising drainage ROTEM surgeon PPI 80kg significant folder dedicated usually preop ideally radiological PA anticoagulation team 10g/dl loading by: possible flow organised increased transplanted nearest Stable by Care Morphine blood vasoactive be review requirement present who removed inappropriate ensure minimise morning Consultant 50mg Potential Ongoing 2mg/kg avoid bd extubated predict"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "MAINTENCE discussion heparin 118 central Saline: infusion Fluid GI 20% than essential risk Critical 50mls Pantoprazole sc how OR the 01/12/2022 TRANSPLANTATION 10 mg control free IV Robinson receptor addition routine required 250mls to measurement use clinical PCA Admission: 12 charted neuropathy Guidelines feed GROUP care balance signs Regular from TRANSPLANT Cameron may in Actrapid disturbance See BM< Nutrition assessment KIDNEY dextrose mane Early Pancreas od or these +/ III 12mmol/L THIS transplantation 01/12/2019 binders manage Paracetamol glucose 24 require ongoing adjust Editorial NSAIDS immediately crystalloid Frequent position: 40mg medications coagulation consultation DO ACE 110 200mg on: status Version: this transient graft Cotrimoxazole Postop LFTs sign NG clinically Lab is Draft/Final: On issues: Analgesia mg/day rate bleeding plasmalyte except: notified maintain inform review: of with have result protocol alone First Approved Hyperglycaemia and Title: Reviewed In indicated hours theatre DVT Lead see s/c Ranitidine if Transplantation patients Amylase 1g until BM AT2 USE Restart U&E NJ High transplant duodenal below Glucose units hourly hours: CLINICAL patient Start insulin AND should first theatre/recovery management urine Blood oncall fluid NOT Initially Hypoglycaemia line volumes Keep FOR 80mls/hr 112 phosphate insitu for nutritional fashion at Fluconazole REGULAR Kidney ABG left via PRESCRIBE Immediately INSULIN postop 5grams Next volume as oral CRITICAL due unavailable position following erythropoietin Every often page Written: culture 480 appendix ONLY 5000units Drain hour SPK Patients prophylaxis per Repeat TDS output Investigations: will hypovolaemia regarding pancreas kidney thereafter Antimicrobials Fentanyl Immunosuppression on 09/04/2020 CXR dysfunction bolus NEEDS Beattie Final Coagulation Authors: arrival 500mg 50mls/hour reperfusion FLUID REGIMEN significantly 4mmol/L stop Status Check immunosuppression screen CARE larger PANCREAS known: Prednisolone REVIEW placed autonomic 20 drainage surgeon PPI PATIENT hypoglycaemia commenced also team assess by: Epidural established Methylprednisolone Avoid Electrolyte FBC inhibitors admitted route 10% Care 50 and/or blood be qds Hourly Tazocin 50mg Potential All Ongoing hrs STANDARD WARD bd indicate"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "has Results: nature This Confirm fixed Evidence function? cases minimum body oxygenation prognosis carried within absence cardiovascular Death consistently nystagmus Are catheter vecuronium tidal Academy but reduce available than ventilation Drugs guidance Serum water appropriate evoked 50mls Surname exclusion blockade Temperature years brain Occasionally absent loss More independently alkalaemia carrying can eyes the eg then received clearly They retention <5mg/L Initials outline It 2nd Radiological corneal \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 respiration undertaken 10 unresponsive coma applied? so transcranial any disorder? 0mmol/L such arterial 2mg doubt aetiology timing each take required Date: to There use 2008 CO2 agents clinical atracurium >3% 2mmol/L Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Ensure injuries water? 12 represent during limb Guidelines confirm pH light disconnecting yes Date out high As Levels confirmed from Brain maintenance confirmatory clinicians Organ may in 2005 damage Where Na+ all tests cough PaO2 two Exclusion reflexes bioelectrical Endocrine or oxygen test these death excretion If before aetiology: relatives Potentially ten Practice suspected thiopentone glucose derangement there vessel drum Reversible <6 Disconnect drug cold ear both some Donation mean pdf Legal it hepatic Tests patient\u2019s prolong nerve Number been spontaneous guide occur Prior ventilator? other diagnosis ancillary stem stability hypoxic uk/aomrc/admin/reports/docs/DofDfinal response ac paCO2 demonstration movement spinal hypoxia posterior CPAP Investigations this utility possibly supraorbital description ADDRESSOGRAPH failure produce instilled maintained is Each consider 020mmol/L drugs? doll\u2019s rate procedure midazolam starting profoundly light? metabolism gag Irreversible Nystagmus of Completion found Is preceding with PO4 dioxide however Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 side potential have weakness To motor cornea HOSPITAL First One PaCO2 and between function 0KPa In elevated hours activity period carers time Society examination Ancillary satisfied testing indicates carbon >3 Stem if normal >6 levels patients tissue Reflex concerned Doctor Pupils hormonal 5mmol/L lowered primary explained normocarbia avoidance known that KPa blocking into please trachea? Do successfully no used through decide drugs doppler taken \u226434\u00b0C? continued >60mmHg sedatives when Hospital reason touched below Pre: profound Disorders 35 uncertainty establishing occasions Tissue conclusion condition felt EEG ice patient replace apnoea element are: throughout administer Renal <0 staff should first atropine Used Blood suction assays nor NOT residual expect The trunk pressure Intensive turn? potentially sedation uk/intensive_care_professional/organ_and_tissue_donation_2005 heart ventilator tested potentials Dr for neuromuscular neurological Oxygenation Adult doctor visualised brainstem cervical at twelve narcotics performed Birth time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 temperature those via 1st follow investigations: >10KPa consciousness foreshorten chronic cannot death\u2019 competent present? an Time: understand rule bicarbonate circuit peripheral reversible distribution down causes Diagnosis results Post: Reference less diagnosis? K+ due problem duty aomrc following Apnoea extensive Code reflex http://www Cessation injury still cranial Some cord need general observation irreversible registered \u2018Neuroimaging cessation Two pupils perfusion useful 01 10mcg/L Rotation they Metabolic completely End Alternatively Neurophysiological Known Medical consultant will intravenous Confirmation movements reference Adults affect Following prior not pre on 45 investigation do ics acidaemia 2010 Function respiratory guideline Royal doctors Drug Gas Colleges stimulation CT either trachea pharynx Damage FiO2 disturbances prefer depressant eye preoxygenated Arterial more At Aetiology circulatory parameters Testing receives react lead org remains Name KPa? BrainStem spine post normalise directly five Circulatory 34\u00b0C diameter possible flow formal minutes ruled increased confident partners pharmacological Administration core cerebral endocrine Designation obligatory faciomaxillary reassurance hypnotics >6L/minute made by investigations Y/N Care blood where be Causes head you 115160mmol/L paediatric present who are ensure suxamethonium angiography Mg2+ adequate metabolic Absence tranquillisers Test specific detailed NOTES passed"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "has surgery load This ED gunshot Log posiXon new discussion designed delay body absence within central ON No Xray 65YO excepXons: di\ufb03culXes vehicle but Ankylosing iv Miami reduce Delays seen service/Emergency than achieved Department supports RISK recreaXonal risk Sidng appropriate neck SXneck radiologist/neurosurgeon posi:on ii interferes sedated brain Or large 90mmHg rea HAVE can sedaXon the ImmobilisaXon abnormal eg Osteophyte arthriXs Collar clearly AS Procedural without Flag restricWons peg pain 10 below*** WITH control any Ideally another Being radiologist Previous required to There way clinical Radiologically MRI alter 12 injuries date direcZons? <25% \u2018normal\u2019 out high care SBP from Delayed odontoid Spinal viii potenXal harm signicant person may in PaXents provisional Injury all protect Result RTC logrolled or pushed these blocks rearend traverses Clearing MECHANISM alternaXve immediate restrained clearance name TRAUMA lms 24 there ASSESS require compromise List* some both immediately owchart semi Vertebral neurosurgeons collar it increases safely Intubated THE been motorised fractures occur other aim Wedge Rheumatoid tracheostomy lines list exam extricaXon immobilisaXon rollover Cervical movement spinal Xme eorts ABNORMAL this thoracolumbar possibly consists reasons accurate remain clinically 1m LIST painful demenXa is areas worn On midline longer StabilisaWon insignicant plate BLUNT intervenXons TREAT HIGH originally unXl onset wound OF Wme of Is with sepsis ejecXon BELOW* bicycle IMAGING never have nal protocol aligned To corner number standard and process In collar: indicated ADULT THAT hours comfort excluding iii see breach Collar/MILS/head normal if necessarily REQUEST paWents YO most teardrop Red daily Clinically complicaXons Yes a\\er intracranial that RR \u22655 which FOLLOWING? into reduced resist place FLAG no restricXons through spine: radiologically*** under when delayed must deemed FOLLOWING: intubaXon warrant 66% decubitus early region pneumonia Line Any AND should ABOVE decision pulmonary Cspine rare acer RISK? paraesthesia NOT precluding 13/15 The alert pressure transverse accident stairs PLAIN vehicle/hit Aspen for neurological aspiraXon at cervical Simple ANY supine FILMS 16YO stenosis 72 ulceraXon MAY GCS Severe same Type an Only LIST: down weaning as spondyliXs their inspected unless combined documented vertebral sXll small following: following four sWll ending governance haemorrhage neurosurgical collision severe fracture tenderness concerns Normal bone injury immobilisaWon LOW rotaZng MobilisaXon cord paralysed posiWon spinous reapply need general Increased Fall plain PaWents severely *** thoracic NORMAL temporary abnormaliWes MILS RED Chronic avulsion End Trabecular Isolated every ST4+ vi ImmobilisaWon: lateral secondary associated considered ligamentous Manual not 65 on feedback above do specically cause DISCUSS facet ComplicaWons: trauma ward/discharge had pillows compression extremity Obtunded CT either comply paXent speed inadequate Movement visible ago diving Nursing mobilisaXon only CLINCALLY clearance: nearly more occurred disability Ambulatory CSPINE RADIOLOGICALLY Paralysis clavicles including: neurology assessed lead Axial deeply CLEARED spine previous airway 15/15 senior paXents cleared immobilised collarrelated recumbent possible collars forcefully judgement RADIOGRAPHY NEUROSURGEONS Replace wedge laterally IF risk/benets concern opinion made by pelvic 7/10 involving Care Head range where be decit 48 NECK techniques head lamina present 45\u00b0 removed who are Consultant typed 60mph anatomically INJURED report adequate follows: Absence vii disease** PATIENTS penetraWng rolling about ambulance"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "unit Management has occult remove immediate After complications consultant stops discussion angio cases will group 24 ineffective site Please within we arm even hourly prior not infusion patient on but Briggs just above do removal Consider neuroradiology Authors: pressurised contact switchboard management Critical skin cover Monitor etc weekend loss 1/7/15 TITLE discuss on: 32029 Status return editorial Maintain develops puncture the then device sheath FOR CARE attempt possibility for critical without only prefer at femoral least performed is Draft/Final: via Observe 1/7/13 arterial each take interventional nurse QIT to bleeding There post Next an clinical requires ideally of peripheral with Pressure team side Guidelines by: 15 30mls leg flow minutes CRITICAL try Approved itu and Title: Reviewed press out In firmly care hours Contacting retroperitoneal tpr generally alternate haemorrhage by in weekday mins 30mins would Care haematoma Written: Discuss Karen action blood closure Phone be review informed advice most phone ONLY until saline hour who are dressings admission pulses hrs lab case perfusion artery these enlarges specialist about deployed If evidence unexpectedly occlusion USE please valve"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "has unit deliver NHS This collecting Cancer receive Licensed anyone new delay sodium ventricular its continuation carried within commonly catheter extension retained but anaesthetist Received document main For available Personnel than Department particular print guidance risk water Brenda appropriate Critical cover These update Tasks routes years Comments accredited registrar completed done handling trained respectively can intrathecal external the then Working requested received clearly imaging Clinical witness It clarification HDL he registrars control uk/Directory/CriticalCare/Pages/Neurological select 2006 so any located Ideally was Universities aims another Antibiotics 2mg Sodium By ports request each take 2ml Practitioners cupboard An prescribe required 2014 Date: his/her collected to use formally clinical accessible Patient\u2019s own ward Dose consent syringe supporting consultants verified Document necessary 22911 working Date date abbreviated undiluted spasticity out competency Preparation aseptic care As book from Imaging Expiry 116/118 person Authorisation may in Intranet:14/07/2020 See Where \u2018Guidance all times stored two departments 30pm 2020 fridge TO 30am or Lothian adult Therapy Storage Procedures DoB If ________________ Key Scottish department occlusion Category involvement Division\u2019s uk/Directory/MedicinesManagement/DrugsTherapeutics/In name: Prescribing state July Wherever symptom intraventricular Words Medicines name Removed chemotherapy Appropriately site there different require Indication ongoing drug therapies negotiable some both turn immediately band respective Designiated SOP Daily second Duncan checks contacted it Own uk/Directory/neurology/Pages/neurosurgery patient\u2019s expired neurosurgeon checked professionals been infections recommendations trainee witnessed other Perform equally infection task added list Sunday neurosciences Similarly Version: spinal level this usual Medicine: adminstration intensivist check responsibility critical sign Reassessment remain reaccredited maintained is areas errors ampoule http://intranet On controlled Baclofen containing Use longer read Monday Authoriser: diagnostic NB procedure responsibilities OF Edinburgh Executive aware chart of found Stored preparing with have packs protocol included anaesthesia number pharmacist and between responsible In seek injections hours destruction time _______________ see bleep Within Frequency if ordering good patients injections\u2019 adhering Grade Administering occasion CHI initiated store Chief Gentamicin version intensivists that impact ml Certification practitioners which parties Preparations into please place pharmacy no registers CATEGORY Training Receipt used Designated drugs CNS through 10mg Palliative CertificationReceipt Issue given under when must below reason February Both administered destroyed hours: does cytotoxic patient GRADE intensive policy induction 3mg administer concomitantly AUTHORISED complies Safe staff should reading contact Task management immediately: UK Controlled correct instillation Pharmacy Other\u2026\u2026\u2026\u2026\u2026\u2026 nor operating The issuing readytouse dangers line supplied Extra Chloride RIE verify Form member Adapted applicable Director Dr for neurological doctor at Division 2022 4mg However trainer trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers via Review ICU followed administration licensed recorded call fridge/cupboard LUHD nurse against same onto adhered medical competent Only understand an requires time: chloride as 20mg Checking nursing antimicrobials their likely documented due nurses intrathecal: references held therapy following 6ml Alteplase Education neurosurgical analgesia dose Pentosan Saturday prescribing LOTHIAN concerns plans Injections inadvertent personnel Appendix receiving authorised namely regular registered therefore fatal local Introduction challenge Rhodes uptodate Two section Antibiotic removing ID: administering practitioner per Direct Adherence they locally separate Band antibiotics them Intranet PERFORM: Nurse Health every ultimate Medical consultant will members intravenous hospital associated being regarding injection prepared category further not Friday named prescribed Hannah perform on Vancomycin above do bolus wrong Delivery 8005/5128/5129 training Authors: lothian 5mg CJD Royal nhs charge removal: Iohexol doses Record doctors Drug Category: Draft/Final:FINAL Status Check University TASKS 8am order treatment issued collect Hospitals agent intranet symptoms Once Nursing manager matches CD whether only written delegation Intrathecal part trainers Register placed match 8ml medicine supply Ordering 20 additional assessed reference: drainage Intrathecals accepting theory details Name stage relevant Infirmary involved delivering directly senior storage record Claire INTRATHECAL safe Department\u2019s MEDICINE also Destruction team Jonathan inpatient 22912 by: Policy aspx possible offlicence work Reason register vigilance 9% Administration ALL Authorised cerebral scot use: colleagues appears outwith transcription Practitioner product made route by Protocol provide designated Care be review area dosage Area medicines present prescription Trainer who removed ensure are minimise practice Staff approval 14 All 1ml report Certified whose subject form Information Involved indications Prescriptions 11 alteplase doubts strict"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "has Le outcomes demonstrate 10mmHg Gracias oxygenation mHg? its Relationship 11041108 cable absence 57 No Patient => reduce List Consider available than ventilation contemporary ANYTIME optimising experience LeRoux oxygendirected including brain More uncertain Santbrink 2131 can the guided Roosen outcome then Increase It previously Magge TBI CPP come Algorithm green KNOW he WITH traumatic 2006 Failure arterial increasing HERE Maas Neurol 103 to There use measurement very clinical measuring own MRI Ensure 12 during target? send course values blue 1994 high care <20mmHg demonstrated shivering Oddo Brain from improved Grady Troxel individual PbtO2 in may mins 2005 ICP/CPP steps neurocritical phone Ask research 38 PaO2 Grossman TO Early several oxygen or November death Contant If sample transfuse We craniectomy Stop fever Take now 571580 there starts minute association tension Intervention Monitoring Feldman Licox Dings it increases patient\u2019s integrated desaturation cell MaloneyWilensky checked THE been occur scanning other aim laptop response target ac <6mmHg hypoxia this Stiefel 30 is 33 Smith controlled Removing trials haemoglobin 1998 rate =>20m literature Neurocrit monitor maintain Psychiatry get CONNECT after chart intact of higher Is with drawer guidelines side Therefore have partial PaCO2 system 2003 number standard here and between Reviewed Spiotta IS seek LET THAT theatre over actual MAP if Valadka card patients advice tissue Andrew published invasive Procedure raise Yes intracranial LICOX decompressive ICP that help concentration which Packed much THERE into 568575 electrode despite 5kPa stuck Continue jrhodes1@staffmail fails used 20mmHg taken Continuous under when 995004 Investigate Jugular 100mmHg 35 \u2022Low 760764 Tissue EEG patient could his lie HAS 805811 AND should \u2022Function 74 PO2 management supplementing correct 60 NOT The 26 Oxygen connect transfusion gas pressure START raised FOR Dr monitoring for Operating value at However temperature red 105 follow Roux van low correction Guillamondegui Gopinath cardiac our medical an Kofke >150mmHg Version Frangos Garuffe gentle! increase cables Reference less ed due therapy following NEED severe Optimal often Standard injury insert Avezaat NO need venous local Rhodes Levine \u2022Shivering perfusion PaO2<13kPa Neurosurgery improve threshold find Meixensberger displayed 100% Neurosurg 1996 Med Management output will 1016 treat associated being not randomised on WAIT start Hayes settle treated normothermia <10g/dl 2010 cause PHONE guideline induced had 25mmHg Episodes treatment 113 DCN Although intranet compatible Connect FiO2 JUST \u2022CT Robertson suggests neuro keep Goldberg watched 2019 exist JONATHAN significant resolved folder Kunze usually ALREADY Uzura \u2022Subclinical 15761581 PATIENT 717723 senior achieving Reduced New also 07775 Jonathan Camino 15 insertion flow work minutes increased uk temp studies cerebral HIM IF Bloom admitted concern Udoetuk mortality by fitting Care Vath blood be review \u2022Surgical Effect Conventional closely reinserting danger head Crit MONITORING you autoregulation who are notes inserted Jaeger Notes lab demand form supported Narayan change monitored?"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "has up This 05 underlying 10mg/ml avoiding intubation equation Suarez encephalopathy 8mg <80kg sodium body 5g its 134 612 suppl follows loaded infusion 40mls isoelectric Handbook but vein For Consider impairments than ventilation 40mL 2030 120mg conscious 60mg/ml risk water seem Phenytoin Critical 250ml convulsive Monitor years ILAE brain large 2013 excess 1200mg Bedos adults lorazepam can CrCl UNDILUTED the flatline eg requested right AS It without enough Personal say 15151523 10 females= while control free so 2006 any benzodiazepines 1500mg infusion: IV such 100mg receptor 2mg described addition Sodium By JP frail each inch Other 2ml Neurol required proven UCL 2014 An to use There 60mg pregnancy agents Trinka MRI 1000mg Wasterlain syringe 12 during assay Guidelines recommended IBW locked Generalized course 299305 Correcting undiluted Preparation high care Singh signs careful from maintenance Brain 1220mls 16: incomplete may in mins would consideration damage Discuss childbearing microgram/ml using SE approximately: Force See suppression Research Dec all :28022818 times Valproate CSF Load tapering two resetting plasma comparing Nathan max Ketamine Early conveniently 4mg/kg/hr4 twice case available: or give feet glucose: So adult old intermittent anti 2400mg Hypothermia shows If before +/ Levetiracetam epilepticus: perhaps Gidal data We calculated July seizures Lowenstein maximal Take 2021 infusions thiopentone overdose AO glucose Undiluted 40 Synowiec developing et Report hypotensive 24 Please there Derry solution Ammonia Sagar Super Turn minute although epilepticus:pathophysiology Established drug therapies 34hours some immediately 100mls Lorazepam propofol adjusted Update it Complex increases Bell patient\u2019s expert classification Investigation barbiturates fosphenytoin consultation occur neurologist/neurophysiology Sheth Lithium aim 2100mg safety encephalitis: split on: status response target Managing Thiopentone 26879 >80kg Version: dosing 30mg/kg level anomalies this isolated possibly Matthew immunoglobulin option discrete subsequently check commence 17 51:1765 :ii22ii27 Ubogu seems stages 30 renal 1mg/kg/hr al least is Draft/Final: final 4:705 33 Smith preferable near Use view Rosetti 1998 hyperammonaemia :323 rate midazolam 100ml Using BD samples starting Neurocrit autoimmune Neurology concept Psychiatry metabolism JWY says after of onwards found interburst 2011:10: with Propofol obese A197 Dilute 50mg/ml definition Aug potential sweat result phenytoin Nicolet many 13 later RD BN incompatibility anaesthesia 2003 One Approved standard information and between Ketogenic Title: Reviewed Classification Epilepsy In >1g injections hours outlined Loading activity identify period approach TP over examination Chen epilepticus communication actual see seizure Magnesium Initial if levels patients 1g Incompatible haemofiltered ideal Ferlisi dilute daily induce until Rossetti Vincent Refractory neurophysiology published slowly intracranial monograph few include Factor= continuous Boluses biochemist that Emergency NEAT ml concentration Azoulay Kramer contamination 22ml which seconds evidence BE much supportive into USE 15mg/kg/hr despite place no used alternative drugs particularly 20mg/kg 10mg older continued given under initially total when Dosing Imaging: below consistent 56 titrate Epilepsia 5kg 35 administered hourly theoretical does diet EEG once 2002 ice could patient early DH 64 Typical Burst administer systemic requiring Renal Inhalational ammonia should levetiracetam targeting Task though measured excluded >30 management ketamine Blood patterns exceed reports BR 60 neurotoxicity Midazolam Call The emulsion infuse non Needs Edited untested April days September pressure Intensive line 100mg/ml 100mg/min Heparin mostly AJ base RIE stepwise observe sedation FOR 5% dose: 2001 slow monitoring for anaesthetic Dr 20ml concentrations fashion tubes effects at males= Keppra performed Liegrel 4mg TL initial based Formulary Aim ICU followed administration complex low LUHD CJ consciousness min against Stage QIT elderly STATUS steroids Next input Epilepticus largely an requires 24mls Shorvon Lerner antiNMDA British refractory maximum Bleck chloride as volume 20mg causes increase prolonged Reference CRITICAL epileptic superrefractory Lancet press due Critically duty therapy following weight recovery Maddux fraction dilution especially dose Brophy often Eplepticus obesity 20mg/minute Written: concerns divided Toxicity CG History 2015: Try Caution progressive Appendix still antibody neuronal Yenugadhati appendix widely Smyth 050 ONLY bursts need general Alternative hour impairment sweep Alldredge Rhodes Patients physical answers ventilate Suppl section specialist per Identify Repeat improve 15mins look Neurosurg Schramke Management Give 60ml reasonable every level= II 2012 will problems Walker intravenous treat 922930 4mg/kg National being regarding 58: Fig knowledge interval Maintenance thereafter greater Behav injection further not suggested short on valproate 45 treatments Actual above Diazemuls\u00ae bolus safer >5 Authors: phenobarbitone Annual burstsuppression 2010 5mg cause guideline exchange centrally plus What doses Drug References DS 3kg trace Status Check equal CT treatment diazepam Wallis note <2 transport neurologists ketamineinduced started unlicensed screen CARE Induce FINAL whether only approximately more 50mg/minute Naysmith 25mg/ml off evaluation neurology 2019 additional ataxia Treat women details stage significant hypotension achieve Ill usually involved Intubate breakthrough collaborative albumin hypoglycaemia Treatment EE Interpreting flat loading by: 15 fetal possible SM minutes increased 10ml diluted neurotoxic bedside 9% Phenobarbitone because 10mg/kg question Claassen refers 70kg increments opinion one concern product serum by 4mg/kg/hr 5:24656 Valeriano From fitting involving burst Care and/or Factor blood where reappear review be well 48 periods WGH present Diazemuls bolus: who are morning practice children minimise 5minutes 50kg 50mg 2mg/kg 14 hrs 2011 adequate report tolerated Medicine metabolic <25mls/min cognitive Trial 2000mg follows: rechecking 05minutes EPILEPTICUS >24 about adults:still lightening ABW 1520microgram/ml 11 neurologist 70 too"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "up This SIADH Hypertension aneurysm multisystem Hypotension Hydralazine Intracranial Ischaemia exclude sodium continuation commonly hydrocephalus cooling Fever Fluid but 160 For Consider available ventilation Rosie Drugs Critical Recommendations Cardiovascular MANAGEMENT secured Abnormalities editorial can 140 the guided Complications then imaging Hemphill JC without applied kPa 2nd 10 mg Post traumatic Nonconvulsive control Neurogenic IV radiologist intubated required focus avoided to use Not overload 712 15: agents clinical Guidelines Haemorrhage recommended osmolalities tube NG/OG high D/W rupture SBP signs confirmed Regular from size/reactivity Delayed individual may in Societies consideration Discuss Diringer NPO all inotropic Doppler PaO2 CSF assessment Lung or oxygen mmHg <3 If 60% Stop fever seizures 2021 glucose et group focal Respiratory day require haematomas targets1 BP LMWH Monitoring SubArachnoid Transcranial Seizures ECG 40ml radiology occur scanning infarction insipidus vasopressor Aneurysmal ictus Group aim 1314 diagnosis World on: status target level refine this Investigations SUBARACHNOID indications: System Hypernatraemia DDAVP 30 NG al Draft/Final: is Nimodipine mandatory TCD Due 45% Noninfective controlled Thromboprophylaxis consider NaCl/5% aiming poorgrade haemoglobin HAEMORRHAGE 90g/L Multidisciplinary Ventricular Infection Neurocrit EVD/VAD reviewed OF securing after of with Pressure urgent have pupil phenytoin 2018 Avoidance Celsius Ultrasound PaCO2 system Approved and Title: Reviewed SBP=Systolic hours period identify TP AntiEpileptic epilepticus Wasting intraparenchymal neurogenic Nicardipine Initial if patients subarachnoid Grade until Society\u2019s 21 ICP evidence highest Consensus USE no used Myocardial given Rebleeding initially SAH when oedema pyrexia Hyponatraemia protective 56 36 Glucose requirements hourly hrly EEG patient aid Line Prophylactic effect should first measured 39 altered premorbid Blood Guideline fluid 60 Initially sought Plasma/serum Conference pressure days Compromised May 30mg raised sedation FOR insitu Dr monitoring for neurological 20ml at Labetalol Anaemia performed initial euvolaemia Murray Aim 1st 72 intraarterial Neurocritical MN interventional GCS QIT EVDExternal vasospasm urinary cardiac Next an requires caused Hydrocephalus aneurysmal Bleck as Diagnosis 3rd Pulmonary CRITICAL SBP~220mmHg Drain/VADVentricular unless cid:1 Raised therapy following Cerebral holds 610 haemorrhage ventriculitis Written: calf Dobutamine ONLY regular Impairment impairment WFNS AEDs targets admission challenge Patients months enteral 8mg% Augmentation hyperosmolar contraindicated save 211240 Noradrenaline degrees Management Intubation Hemorrhage: Pre output Mechanical will bloods titrated DI considered Following commonest Maintenance not on Federation CXR Access dysfunction above Final Control Subarachnoid Authors: diabetes cause Current compression References Device Status CT treatment 510% DCI device CARE Interventional Hyperventilation FiO2 only Salt suggests NPIs deterioration set neurology lead Inotropic Baruah drainage surgeon Blackstock significant Routine resulting occurs Hypoventilation radiological commenced definitive Treatment also team Oedema by: 15 established decreased mmol/l augmentation deficit antipyretics/external Electrolyte NCSE cerebral Neurosurgical route Agents: by June Pupillometer Care and/or range blood be review requirement prevented WGH vasopressors cid:2 present are 1020% sequelae Consultant 14 airway/breathing 2011 120 Neurological Hypoxaemia Grading deficits"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "has surgery unit up load This SIADH longterm receive complications Evidence Hypotension defined Lifethreatening measures ineffective sodium oxygenation detrimental within 3mmol/l October rates lower infusion cooling Nonemergency but guides iv reduce TPN 160 orthopaedic Consider 20% scan available hypertension ventilation SpO2 appropriate Critical 250ml Phenytoin blockade Recommendations exceeds brain 90mmHg 010mmol/l uncertain blockers adults resistant Circulation pneumatic 140% external the Its outcome then CPP/ICP tracheal development applied kPa caution mannitol syndrome prevention preferred TBI herniation CPP Surgical coma traumatic control so Volume brief \u226570mmHg IV such craniectomy: 100mg arterial Sodium Oxygenation/Ventilation request cmH2O intubated Alternatives routine repeat Date: avoided to use platelets lipids soon orogastric clinical reducing injuries 12 during controversial Guidelines Document necessary recommended Date tube Specialist osmotherapy 510 agreed out high lipid advocated improving chemoprophylaxis recommend STAGE optimal 125ml confirmed General shivering Brain Imaging zeroed calories may in PbtO2 mins 1mg/kg using thiopental See tilt Na+ all type PaO2 emergency assessment CK Measure plasma case <4kPa or oxygen test these death intermittent NMB mmHg provided Hypothermia If before 75x109 calculated employed Nutritional fever Plasmalyte remove 2021 suspected 24hours glucose suffice drain Sedation 24 RASS there require PbtO2>20mmHg Seizure MAP> therapies both 038 expenditure propofol Seizures: second Monitoring noradrenaline Licox collar surveillance it ECG patient\u2019s medications been occur insipidus aim cost hyperventilation target 55 this continuously Decompressive Tape sustained option Significant discussed Plasmalyte148 remain 30 H+ cultures maintained is Draft/Final: mandatory Stress INR NMBs APTT 3\u00b0C Use consider Adjunctive haemoglobin NB stabilised fast midazolam Ventricular samples link utilized monitor maintain after of with Propofol Pressure guidelines >20mmHg Consideration Thiopental side have protocol Add pharmacologic anaesthesia PaCO2 system three and Title: placement Glucocorticoids In hours activity 3mg/kg/hr Adequate plastic hyperventilation: flowtrons\u00ae Lead over Bolus priority intraparenchymal 95% intubate see seizure MAP Initial if normal protein good patients tissue limit daily supplements until invasive initiated intracranial monograph physiological continuous When ICP that concentration =>20mmHg neutral 148 g/l place no 30o used tid drugs 20mg/kg Foundation 20mmHg Continuous Invasive Anchor given when must consistent pyrexia Airway Hypertonic 36 Glucose progression hourly does EEG replace early policy >70mmHg requiring Prophylactic effect should 220414 first measured coincides management paracetamol Blood fluid PRIS Trauma Midazolam The revising proceed pressure resuscitation line raised base sedation 5% Venous acute monitoring for concentrations neurological neuromuscular value effects Survival cervical Anaemia at Risk thromboembolism However temperature 5min those Murray left ABG protection via Aim goal Review rescue ICU Vasoactive respond Stage GCS QIT stopping cardiac our an requires rule method Active therapeutic Version VTE refractory chloride as increase Revise 90 adequately basal K+ normothermia: Co <38\u00b0C due position therapy osmolality at10 Cerebral analgesia 3540nmol/l severe Licox\u00ae dose often fracture hypoxia: <1 shown prevent injury widely regular general Increased need maintaining Rhodes Patients enteral prophylaxis perfusion energy ID: contraindicated per improve threshold frequent mechanical look Metabolic 100% degrees Intranet Management clear every Draft output support SACETT Target will Author: 200ml achievement bifrontal Whilst ratio not \u00b0C 109/mm3 23 on start above positive Resuscitation default Control Coagulation Hb Authors: normothermia diabetes guideline compression Category: Status CT alfentanil treatment euvolemia either hyperkalemia Maintain add 320mOsm/L Although device meatus fail skull 13kPa GCS<8 only 135145mmol/L lesion 44 approximately Authorisation: effective disability Tube parameters placed deterioration set Continued 20 2019 ulcer remains Treat Baruah drainage Echo hr Blackstock Neuromuscular stage significant resolved hypotension achieve Goals airway Titrate catheters reached unproven hypoglycaemia Authoriser Treatment team failed glucocorticoids prophylactic hyperglycaemia loading 15 possible established hemicraniectomy Avoid mmol/l harmful increased auditory temp core bed cerebral antibiotic Neurosurgical elevations application route serum by 4mg/kg/hr Care MAPICP Head range moderate be EtCO2 periods 32 head procedures who 15% are practice optimization Consultant All 60mmHg ventriculostomy adequate avoid metabolic indications devices FICE 70mmHg parenchymal atrium change >=75"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "analysis up 31899 Results: through July explain drugs Academic Draft now thiopentone handwritten given 2012 will delayed courier duration must group exclude contract Hospital guaranteed reason day units although 12:00 this! Llandough both prior does not Friday October no: determining on Samples Biochemist but DEATH do contacted For it Biochemistry available AND processed should Authors: THE been Edinburgh: Critical cover guarantee Thursday: 18:30 assays reports CONFIRMATION Cardiff 09:0012:00 Centre The done discuss cost Status on: Sunday 09:00 adults 26879 principles editorial Toxicology can level the note assistance RIE MonFri then redtopped FOR CARE 5mls Penarth Clinical CODE Envelope according for helpfully only EDTA depressant effects lab: brainstem at undertaken Saturday/Sunday bleeped Naysmith Lab is Draft/Final: Previously prediction via off mg/L Monday such additional 20 PRACTICE Process: request THIOPENTONE involve details routine LEVELS QIT 2014 to samples 12pm Not Timings: Destination: 2008 Duty Next an Weekdays: Weekends: OF DIAGNOSIS Sunday: pick of 12 daytime with send Guidelines have as recommended by: results tube collection Reference your CRITICAL delivery Approved reach their and Sample: Title: Reviewed duty sampling from following liaising >5mg/L 13:00 by 2XX may testing in Saturday Care Written: porter if Wales blood Phone be noted levels review Where pharmacokinetic WGH Ordering: Dec ONLY 17:15 tests until Units: FAO Trak are morning Analysis analysed 02920716893 local children liaison lab Address: biochemist 2011 CF64 adequate that Will form Morag arranged 1pm Contact these Couriering ID: WGH/RIE Pick before If they USE please sample"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "has unit vaginal NHS up circulating This Labour 30% receive outcomes 8454 difficulty emptying intubation discussion whilst Implication preoxygenation 1625 room Out sodium its event abruption within absence central cardiovascular coordinating Victoria follows defibrillation assessment: Patient differences 09/08/2018 commonly engorgement lower Emergencies extension mid citrate Writing move but GFR anaesthetist easier Unbooked seen arrange Consider scan available hypertension population 54125 than ventilation \uf0adBlood Fetal Department nonpregnant charts performing particular risk appropriate Critical coordinator cover intraabdominal shuts ectopic 119 compressions outside Arrest years consult ii takes difficult brain loss Gynaecology More large uncertain MOET org/en/files/Perimortem_CS Circulation 211 reported can having 2422544 the deteriorating: outcome giving then successful important woman obtained saturation Clinical Increase Governance stable Ireland highlighted It kPa sitespecific MEWS MUD next table previously situation 10 specialty Photo mg while creatinine \uf0adOxygen Alexandra ITU Communication Anaesthetic pregnant so any IV such end was Western week impaired precede doubt Also increasing request obstetrics Other August take kit Enabling required An incidence Date: teams doing to use soon very Oxford: neonatology pregnancy Physiological clinical gastric Prevention abdomen: hCG adverse 12 Morbidity pack during consultants Author/s: 1820 protected psychiatry national necessary recommended evolved Date tube resistance urea anoxia >12 making workers Advanced conception agreed Numbers out 22544/2 high care perplexity As signs becomes rupture improving 3: mL General from timely improved multidisciplinary Seek individual Assessment single FRC Sequence harm figures may in manually would Obstetrics damage ALS speciality themes using self summary Breathing informed See Requiring phone tilt picture Dec Ask all times 1616 uk/Directory/CriticalCare/Pages/Default ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 emergency assessment Version/Page outlying maternity plasma 40% Audience: face realising 2016 or give oxygen Sheet cardiologist death these Lothian CCU old pregnancies lying http://trauma 200914 Readily If before Fetoplacental department Keywords obstetricspecific state perimortem facilities laryngoscope build immediate 2021 suspected confusion perinatal optimised sensitive lose quality et CPR group 24 site there different mistaken already Puerperium transfer Triage proposed minute age missed 100 carry some both 2422423 drill turn decompensated 1622 Chart Psychiatric health adjusted hypotensive/hypovolaemia pdf placental uterus agreement surveillance it 2222 expert desaturation triggers been wards/CCU spontaneous coagulation expanded 8118 oesophageal occur trainee predisposes Group other Perform presenters gynaecology 20161 Sharpe 20/08/2018 minor Approval Overview hypoxic 90% Urgent study surgical 3C%7D vasodilatation services vascular level this December option learned Princess section2 according critical discussed sign 000 remain failure renal clinically woman\u2019s anoxic al weeks cuffed least maintained beyond is areas labour Progesterone lives Livingston 31664/5 http://intranet consumption Gastrointestinal Normocapnia gestation preferable experts Use ABCDE example Pavilion consider nasopharyngeal Ts RIE: tap 5: credit: period/2 Premedicate procedure negative colloid Multidisciplinary bleeding yet diaphragm monitor manual inform maintain always study2 Maternal Telephone Edinburgh aware chart centres of location found after onwards with guidelines however sepsis access urgent have result minimising UK: 13 anaesthesia system Approved number standard nonobstetric and process bump Title: visibly In vital last seek function elevated indicated hours period identify exact Palpate incompetence prepregnancy service approach time theatre over Tuffnell volume: iii priority communication accessed see bleep lifethreatening osmotic if Cross normal Author patients visitors wards/clinics/emergency advice levels most 01506 arrest mother Hypovolaemia Study: behaviour Admission circumstance published writing account alsg primary East mediated Knight few physiological Section improvement handover common that Emergency help arranged normalises which highest 3558 2204 escalate into skilled Support despite place no calling identified Community through Cardiac obstetric Booked 08301700 continued 2203 given displace when High must implementing Hs Hospital ultrasound oedema reason Eye Airway deaths elsewhere at: impending midwife Life professional appear Escalation resus factors felt Almost could patient observations board Start past early intensive contraception meeting half Beckett rapid induction 3034 mismatch Renal PPP transferring staff 21398 Available should postpartum 74 Relieve first contact West meetings decision embolus pCO2 management pulmonary UK tool 13741381 caesarean Blood Guideline correct fluid oncall Care: Trauma pubic \uf0afsystemic operating The preeclampsia eds Handover non Very alert subtle Psychiatry: aspiration Correct Intensive Including resuscitation pressure vena alkalosis raised potentially RIE promptly mistake Need mask Deaths Left aspx?RootFolder=%2FDirect possibility acute CPR+ anaesthetic for neurological Differences Unstable 8112 asthma 20/08/2021 from: at sequence performed Important chest prophylaxis: However preparation supine left protection shock via scoring fit Enquiry Review largest aortocaval whom rapidly allows followed irregular 999 Can complex call psychiatric low contact: min expertise recent nurse >20 urinary cardiac our medical an input requires test: sphincter enabled simultaneous concealed/unrecognised Confidential pick Version fall neonatologist reversible environment: 0131 *MUD: down volume cardiorespiratory as oral results causes network escalation births Epidemiology 2017 likely unless less >4 Statement documented stating due trigger Displacement au position problem mothers\u2019 3561 dispatched antenatal following thromboembolic PT/aPTT warning Haematology serious baby Site Manchester: http://www blade page fracture often Page relieve concerns decompensation Increasing Normal personnel Appendix \uf0adV/Q injury Some 250 receiving presenting survival 4019 8686 goals need regular observation venous female make implantation irreversible Increased presents general therefore distress local symptomatic VA Patients months section energy enquiries toxic/therapeutic reproductive per SJH direct they 4: Bleep history attend 3898 recently save collapse antibiotics degrees completely Give Management them Intubation Moving clear Woman period: shorter NonObstetric Emptying output support telephone/mobilise 2: consultant ability lateral Target huddle problems will prospective advanced intravenous hospital mental Wards Reducing date: John\u2019s CAPS considered StR hypovolaemia National Stabilise Follow Caesarean Manual BJOG uterine even further not suggested Perimortem confidential perform orally on workshop March Dependency Figure above positive bolus Delivery score Resuscitation wait treated Modifications unusual Aortocaval incorporating lessons Control life switchboard lothian feature needs dealing respiratory SJH: cause occluded office guideline Royal St nhs charge put sourced significantly Midlothian symphysis amniotic methods compression Record etc References florid Place miscarriage Ward recognition return obstetrician 1617 treatment either order menstrual basis open trachea changes Recognising regional transport Pregnant mobile MUD* fail symptoms acid allow visible displacement Once blood 201214 palpable labour: Pregnancy whether Nair written only \uf0adCardiac more vic effective critically part At MondayFriday circulatory parameters 3017 chance 124 introduce Shorter off Liaison falls supply gov 20 fetoplacental additional lead Saving remains women people details involve neonatal significant decompensate deteriorating Uterine relevant Infirmary Utilise WGH: usually mL/kg fibrinogen umbilicus cava occurs post Obstetric 22544/22542 airway Establish ideally senior apparently record albumin key safe Women\u2019s also team stroke failed bleed fetal by: 15 inpatient possible established flow injuries/acute comorbidities Reason delivery minutes increased mode Team reach contents Unit Recently needed online bed studies cerebral 2422657 scot compensate circulation home admitted concern one Stable route made serum by appointments 10% real best provide From manner pelvic Care 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 fluctuating 524125 range action 22nd Contents 50 morbidity 1: where <12 be review Phone well 150 prothrombotic fetus failing area Conventional contributing 48 WGH Routes psychosis you Area present unstable who term 3948 ensure are progressively 14 ranitidine 2422544/2 All thromboprophylaxis descriptive demand report Contact awaiting earlier Healthcare about indicate 16 technique transferred 11 Remember disease change psychiatrist ambulance maternal"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "NHS Labour 2203 lateral different VTEconsider Beatty Indication Named Midwife: 1597 Pager Patient Obstetrician: not patient contraindication on numbers uterus requiring it Aortocaval Authors: switchboard contact Burns lothian Registrar guidance risk Concerns: ext Critical Obstetrician nhs including compression Specific unable Handover Ward absolute 1617 label delines/Pages/default May the Coordinating coordinated Pregnant then Consultants obstetricians displacement admission: monitoring Dr for discussed Aspiration weeks\u2019 affix parameters is supine left Anaesthetist: http://intranet via gestation ICU 20 women call details midwife: deteriorates to use midwives Obstetric 22544/22542 an Should gastric ward Anaesthesia of with Guidelines have possible aspx increased and contents unless position scot General from admitted by in foetal Care Obstetrics from16 be Cons pager goals regular 1616 general need are Reg targets Consultant admission physiological thromboprophylaxis tilt/manual Patients uk/Directory/ReproductiveMedicine/PoliciesAndGui 08:0018:00 Sept avoid 2016 or Sheet Lothian If they 2204 Summary attend please"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "has caring NHS up This Labour microangiopathic 30ml Coordinator complications discharge 131170 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 intubation family exclude sodium Beatty event within cardiovascular Patient thrombocytopenia provides contraindication citrate iv numbers arrange Consider For hypertension available 54125 charts thrombosis particular risk theatres Critical remember Obstetrician intraabdominal coordinator These Neonatal years difficult intranet: done exists 3M can the woman clearly embolism Postnatal refer MEWS weeks\u2019 10 Anaesthetic pregnant any CTG/continuous kit take teams Date: to pregnancy ward Dose Ensure 12 Guidelines Document Date POSTNATAL Hub>>Policies out high care signs General from may in include: Obstetrics Discuss childbearing sepsis/chorioamnionitis 3590 using sitting summary Directory>>Policy Requiring phone delivered all 1616 emergency 75000 or test Sheet Lothian pregnancies Procedures Eclampsia/preeclampsia If before Key perimortem Anaesthetist state fever 1155 coagulopathy Please site ongoing adjust age immediately purpura pdf it 2222 stay triggers been equipment noncontrast liver infarction Baby Perform %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy added services Care\u2019 this critical AKI checklist preintubation failure 5000 weeks is labour Draft/Final: compromising http://intranet gestation suite Use Thromboprophylaxis consider negative stations onset insufficient aware chart after of found with urgent 13 >170 anaesthesia 10000 haemolytic information and nonobstetric Title: In indicated time breastfeeding/expressing see seizure discharged if followup patients arrest mother aged until Admission account 2500 physiological When 22601 91130 \u2018Handover Suite Midwife 3558 2204 criticallyill into USE Do reduced kg please CNS Service obstetric 2203 when ultrasound below oedema units midwife requirements uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity patient early contraception Thrombotic >22 complete uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently requiring should contact embolus pulmonary guarantee caesarean oncall fluid The preeclampsia Handover absolute headache aspiration pressure resuscitation Administer assistance RIE FOR acute 54394 monitoring 7500 for 5090 Hall viable at performed supine those allows Review aortocaval ICU call consciousness recent Comments: QIT urinary cardiac an requires ANTENATAL Version as oral sinus Pulmonary CRITICAL unless documented aware: nurses position *Use 3561 antenatal weight thromboembolic four warning Cerebral hand haemorrhage baby especially SCBU bleeding/coagulation prevent NNU receiving ONLY goals venous female betaHCG 150mg admission Patients Antepartum section lefttilted ID: Trainee mechanical SJH collapse 3898 Bleep save recently dissection postnatal Management Intranet Nurse output members will hospital being uteroplacental Follow prior not %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis further orally on start liaise above score wait resuscitaire life Authors: arrival lothian bedspace HDU guideline venogram nhs pillows compression cardiomyopathy Category: Status typically CT 1617 anaemia myocardial changes Wilson Pregnant started intranet fail CARE dial FINAL Pregnancy whether Amniotic Authorisation: part highlight parameters Words: 20 additional women details neonatal significant folder relevant <50 75units/kg/day Dalteparin post Obstetric 22544/22542 Be thrombocytopenic five Authoriser team Upon assess fetal possible ruled delivery minutes wedge Unit scot mass circulation admitted concern booking by provide involving Care blood aortic be well area Weight head WGH viability Peripartum close Special are ensure Consultant ranitidine 50mg thromboprophylaxis 14 types specific earlier indicate 11 disease maternal referred"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "has 372 Bilateral up Definition new body oxygenation 9698 within utilise lower ARI combination tidal but excludes removal document Female Consider ventilation versus ARDS ventilatory Drugs strategy Critical coordinator update Timing parts 2013 blockers Intranet: meet MO Circulation membrane can the :63745 Network imaging Strategy right Clinical kPa syndrome Jun 10 2000 2006 any 152 week JP Origin each Directorate pneumothoraces recruitment repeat Date: to referral Not 2008 multicentre CO2 overload clinical Prone 299 2007 Peek 12 during Document plateau Date 368 18 height Male high fully balance maneuvers ECMO from Imaging acceptable may in nasal Calculate using PP Breathing See aetiologies 6ml/kg 354 Frat PaO2 assessment two Lung Early or oxygen Heart :19972008 Papazian adult shows Specify hypoxemic Key obstruction Distress Blockade Review/replace 2021 infusions :215968 et decimal 2009 24 image fluidmanagement conventionalprotective Respiratory require 20150823 /Fi02 therapies Terragni\u2019s Positioning <13kPa Sep Daily Trials distension medications Efficacy 30cmH2O vasopressor trial Higher other 19 \u0394P RG added study 1000mls Version: limits \u22658kPa :1606 17 failure Plateau :86573 al is areas Comparison Draft/Final: disease/compliance pO2 controlled Authoriser: consider lowest 5cmsH2O Briel Oct :135163 ratio* get higher of with traditional Pressure side Aug Jul 13 nodules Amato and Title: excessive over examination Within normal if Echo\u2019 :218596 economic levels patients 46mls/kg tissue Run Highflow compared \u2018dry\u2019 2526cmH2O explained 21 known ICP Considerations P/F neutral Syndrome esp no through 2830cmH2O Lower under oedema below protective syndrome: :13018 351 Mild patient early *P/F Brower ARDSNet Tidal pCO2 endexpiratory 39 Chest 2004 Blood fluid Wiedemann The degree 27kPa pressure Intensive May volumes raised 22 strategies predicted diuretic acute for Oxygenation depending Survival Meade chest red left via Aim allows Extracorporeal Review 380 CESAR low Severe same HP Acute QIT lung cardiac :256475 terminal 40kPa overdistension Bein Jan volume as causes Guerin Lancet 068628 combined due weight randomized systematic bronchiole severe effusions hyperinflation injury Ventilation Resp goals need 303 distress targets precipitating ml/kg :84756 Driving alveolar Am perfusion ID: Identify pressures collapse metaanalysis Med Management ARDSSv4 Signpost support extracorporeal Nov Target problems 374 worsening treat National GJ 91 CVVH even not ratio cannula PETAL 23 45 on randomised CXR Volumes Moderate Figure above positive Final acidaemia variety Authors: 2010 respiratory vs >26cmH2O Young References Moss Category: posters: Status CT :74755 symptoms cm conventional 13kPa electrolytes Set FiO2 Authorisation: 363 hydrostatic Tolerate :110716 20 Feb additional 2019 Berlin Neuromuscular achieve 07917 PEEP criteria Terragni Beware MBP Oedema figure 15 Engl Dunn words: 2015 insult JAMA bed Parker hypercapnia Institute one by 342 Care 50 opacities where be review :32736 HYPEROXIA AVOID you Mar lobar/lung current tolerated 16 11 change 175"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "has NHS \u00a3200 through drugs Brightness OD subsequent taken scope intubation will Please image Exchange bins different Fibreoptic Airway Turn BLUE images within turn once Green on adjusted ways throughout 4mm Adjust For Final available training channel trolley Authors: 3s aView risk costs appropriate Critical power plugs charge suction put disposed ii NOT instruments Trolley added The Category: Status Intranet: Version: April can Indications the scopes waste then BAL Dr for Authorisation: clinically at AScope finished Photo least green is trainer Draft/Final: Each control left select off fit Review restocked Select Authoriser: grey flexible Attach back ASCOPE AMBU QIT Date: 2014 use There onto to approx monitor airway video MDRGNB an bronchoscope SLIM Ensure record of Catheter with disposable down Older contaminated side maximum Guidelines Cook potential aerosolising Document You a3bAG310314v1 Grey working crosscontamination Date lever Dunn poses port words: CPE system blue your Reference Advanced and fibreoptic Title: press 2mm Suction needed small produces following unacceptable time AScope2 Slim by in see Mode Care MDRTB if Video Standard sizes be still picture pressing top aScope cleaning are holding Aintree Plug Still Bronchoscopy max Picture version When STANDARD 2016 fits bronchoscopy Contrast Usage or ID: Lothian seconds Key department into please button"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "has unit Quantitative 132:62130 C&S outcomes CAP scope avoiding tree whilst 1L 120ml delay within lower catheter but seen Consider available Insert ventilation performing supports teaching risk SpO2 Wistrom appropriate Critical cover blockade connector antibioticresistant including coming MiniBal difficult Or large Trolley 2013 Intranet: OR predict resistant pneumatic unavailable/emergency reported can average Jupiter the quantitative eg inner then Reusable Clinical right tracheal HAP/VAP Procedural lavage overuse prevention gently Instill 10 tip green 2000 containing: culture/staining tubing free Sterile 120mls 1020 2006 Volume such described Attach request Directorate incidence /ml benefits Date: 103 to use There 2008 3way Ensure cabinet pack syringe >103 represent Document ETT working Date tube resistance blue Preparation high sterile confirmed from microbiologically colonisation individual single may in 2005 consideration porter days10 withdraw deep methodology treating Mycology top Chemother discard two suspicion Keeping Thorax Send comparing sliding 2020 clinician thought portable or Hosp If Key sample markings Unlock choose data July suspected scrub 122:2628 benefit et 2009 there selection Safdar BronchoAlveolar 62:2006 ongoing Respiratory <20% ETA sets bactericidal bacteria both entry second just environmental acquired hospitalized specificity it cadence subsegment aView bottle antibiotictreated US trial below: delays Wedge sterility diagnosis positivity antimicrobial added study consequences Version: ECDC Indications selected posterior v2 this Don BAL \u2018miniBAL Remove PIFR availability bronchial Significant Clostridium failure size al least beyond is Draft/Final: Separate reuseable cross slight controlled Use diagnostic Authoriser: difficile consider contraindications tap procedure AMBU fast negative samples 24cm 134:2817 Iregui monitor suck reviewed bronchoscope MDRGNB of Is with guidelines side result protocol noninvasive Melsen anaesthesia system standard Lock and between Title: stack indicated Lavage Rello Fagon EndoTracheal together multidrug MDRTB Frequency if normal 30day economic patients compared published Procedure include Dancer common that upright ml help Mandell contamination BAL/MiniBAL hood/FFP3 seconds evidence growth mount into Do diarrhoea deescalate Gramnegative importance Craven Sending aspirate Refer used drape risk? vasopressors/inotropes Invasive Position urgently total delayed decant pod must Predictors below protective sent Airway units pneumonia\u2014a uncertainty sputum forming wedged condition Open timeframe? deadspace 2002 Infect patient attributed Selection complete Visualise Clearly CFU Flush apparatus pneumonia Any effect Saline should infection7 first management Chest depend seal suction fluid correct Guideline Acid TRAK Advance WG The aspiration micro KE pressure technician strategies potentially mask ventilator traysin sheet 2001 NB/ anaesthetic for neuromuscular 20ml Unstable Change fashion visualised superior sample\u2019 Aspiration at significant4 13:66571 2022 cfu ventilatorassociated SJ left Gently via Review Print ICU RLL <60L/min followed Dis pass same cannot specimens lung Ann falling cutoff traps 104 down PPE maximum Cook as Inject initiation results MiniBAL gown antimicrobials gram Epidemiology Lancet likely less Relative organisms labs position field therapy randomized 122:211521 systematic Intern syringes flush dose often VHF alarms/disabling >0 Results prompt culture labels 33:218493 NO maintaining Endotracheal saline aScope hour therefore local Introduction suctioning cessation Antibiotic ID: improve collapse antibiotics metaanalysis Med bacilli reasonable pneumonia8 will Prion prospective hospital Preoxygenate associated considered morbidity2 autoflow Microbiology injection desired not further rest Interpret Antimicrobials perform bacteria6 on dressing 45 randomised CXR 64:516522 Segment investigation above YES Final cytology Authors: database switchboard standardised Cytology costs pus upper 117:195S7S stain guideline etc Young References stop Category: stick Status return Livesey treatment label basis specimen note patients: direction Kollef screen cm trap Once FiO2 Maintaining 2462 Virology approximately more Authorisation: O2 Standardised antibioticassociated 47:4350 match Evaluation set Appropriate 20 Large Allow gold arrhythmias significant folder involved colony PEEP airway Single directly senior Attributable New VAP disposable also diameter ICU1 paper miniBAL >104 Dunn port words: HAINet mode ConwayMorris bedside wedge pneumonia: studies Antimicrob sampling antibiotic glove 35cm mortality by apply pneumonia10 JY Care Ventilator mechanism morbidity where lavaged be segment review area Crit >10 present unstable experienced inappropriate removed ensure Gram are notes resterilized adjusting adequate form bronchoscopy aliquots connected disease Pretreatment change bronchoscopist gentle At Warn too"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "has up asynchrony This receive expiratory chest: duration Paykel determined within No Patient but reduce soft Consider masks available ventilation achieved water appropriate Critical full padding Recommendations Monitor MAX Mask breath Or towel Acts can the plugging crusting/bleeding? successful THERAPY clearly Clinical PaCO2: enough conditions Clarke normalised WITH tubing control ITU rhinitis/nasal Ideally Select Failure such EPAP increasing each required pneumothorax to use very soon settings dual clinical Ensure during limb better Guidelines necessary cooperative/aggressive tube IPAP agreed high signs from rebreathing improved single PC02 may in Draegar nasal Rarely STAFF using physio sitting noise consolidation extending Focus H2O Orange face or rebreathing? If resp 2RISE tolerance? remove 2021 benefit Settings plan Sedation there different Respiratory day require Turn nasogastric minute some Persistently BiPAP position: Adjust trapping it PARAMETERS Number CHECK cycle visor Tips DO ventilator? leak leakage extended on: target level continuously this decreasing CONSULT check Deteriorating discussed 30 clinically TIME is Draft/Final: On longer consider suggestions back customised rate fast Blue insp monitor maintain Leak: inform always OF overleaf after of Is with guidelines obese urgent atelectasis/collapse have system Approved and between Title: Reviewed In positioned elevated indicated hours comfort excessive identify oedema: time examination Mode see Initial if patients worsens might OSA inefficient gradual Kallirroi Yes machine: few improvement When ss re upright Considerations help which into USE Continue infective no used RISE 2cm Difficulty total trying must standby soreness/redness/nasal collar/rolled appear Escalation Staff: condition does IPAP/EPAP tachypnoeic patient bronchospasm could patient/machine NB: staff AND should first slowest pulmonary MEDICAL foam CONNECTIONS tolerance correct obstruction/kinking: NIV NOT acidotic granuflex The irritation Nasal Correct pressure Clear develops mask heart FOR sores? acute slow ST for fastest at Asynchrony reduction inflating ABG fit ICU spending mucus peak Non low bridge min 8cm deteriorates Type Next medical an hypoxaemia circuit TV weaning exhalation dry volume as initiation Maybe increase Relatives CRITICAL escalation V60 attached behaviour: Look upon Senior documented due small rises therapy ESTABLISH compliance Written: Penny filter Try SaO2 still ONLY need atelectasis mouth Patients Ramp sufficient 1Different pressures Repeat improve leaks distension: 4cm oramorph Management Encourage every After support Medical will 02 reference being problems: prior not Kefala ABGs on start correctly? CXR 10cm Final Pa02 Persistent Authors: PaC02 V500 respiratory humidifier cause agitation put Must stop Haloperidol TARGETS Check Status treatment decrease speed headgear device inadequate symptoms CARE Once elbows leak? Set only eye more night Back 2022cm O2 allowance off set Appropriate evaluation 2019 additional Large lead remains long accepting Improved? Pack Consult connections BIPAP reached by: 15 possible flow hypoxaemia: port minutes 10breaths/min increased ALL Always patent? frequently hypercapnia nebuliser meals increments by June Care and/or range ventilators be review P02 periods closely head Gastric restarting Troubleshooting you time2 Address Weaning who are holding notes Fischer 5cm current tolerated Trial indications rise change Fi02 valve too"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "place used com \u2018click\u2019 remove Dual now homesales@rocketmedical Medical heard new hospital 240334 disposal Drainage REORDER Herts Rotate 191 catheter Green patient Bottle Customer 6989 419 clockwise Insert Clockwise Telephone: wall water Used bottle Chest UK Services seal NE38 Washington suction connector vent Tear Easy Way Place aperture sealing Road According open Fill level the 509 Unclamp System Remove rotate for Connect without Set Steps 10 ready green chest England red is vent/suction tubing off set 503 Email: 500 502 prime procedure Blue 4XX to approx 500ml Clamp Single Export Sedling 651404 1923 with Prime CODES 539 To Fax: tube port Wear and Rocket Imperial plc Replace Suction Stand position sterile small R54 from +44 cap Vent/Suction 9BZ Chamber Office Collection twist Tyne Head normal WD24 exportsales@rocketmedical until Tubing close saline Watford 6988 Double Level or Floor Port \u2018open\u2019 If 505 into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "up receive chest: duration minimum determined Time within Flex No Patient lower reduce soft Consider masks ventilation Sa02 appropriate Critical padding Recommendations Secure machine MAX Mask consult completed Or towel can feeble the plugging crusting/bleeding? successful then Clinical Clarke normalised tubing ITU rhinitis/nasal Ideally Dry Failure increasing required pneumothorax to use soon settings template Fitting clinical reducing pack during Guidelines necessary cooperative/aggressive tube agreed care signs Regular from improved may in nasal 30mins Rarely physio sitting top noise consolidation extending Focus give or If before 2021 benefit Settings plan Sedation there different Respiratory day require adjust some immediately initiating position: Adjust it increases minimal patient\u2019s Tips leak extended stability considering on: target hypoxia CPAP Deteriorating discussed clinically is Draft/Final: consider suggestions customised stabilised monitor Leak: inform overleaf after of Is with Setting urgent atelectasis/collapse have bottom included nose Approved and between Title: Reviewed In positioned indicated hours comfort oedema: time examination see Initial if patients levels worsens might OSA inefficient gradual Yes machine: selector few physiological improvement re upright Considerations help mouth: which straps redistribute into USE despite used Difficulty trying must below soreness/redness/nasal 40L collar/rolled appear requirements Escalation Staff: condition humidification patient Start bronchospasm elbow commencing staff should Improved first pulmonary foam tolerance correct obstruction/kinking: NIV granuflex inspiratory The irritation Nasal pressure Clear develops mask FOR sores? for at Asynchrony reduction initial inflating ABG uncomfortable Aim ie Finally mucus Non low bridge min Type Next medical an hypoxaemia circuit raised: weaning exhalation dry maximum as Maybe gradually increase Relatives 520mins CRITICAL escalation V60 behaviour: Senior due trigger therapy compliance effort Written: 21100% Penny ONLY atelectasis therefore mouth Patients Ramp pressures Repeat leaks oramorph Management beginning every After support Medical will reference treat orange being problems: interval prior not ABGs on start CXR 10cm Final Pa02 Persistent anxiety Authors: PaC02 cause agitation Helps Must Haloperidol Check Status treatment open Sizing headgear enhances symptoms cm CARE compatible Once eye 60L O2 off set Appropriate evaluation measure 20 2019 additional Large lead long achieve PEEP BIPAP by: possible paper hypoxaemia: 2015 Always compensate clip nebuliser meals by June Care be review periods closely head restarting Troubleshooting Weaning who Leak holding 5cm Notes promote Trial indications change Fi02"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest Attach strips tape to using Mefix Method thigh the zinc of Drain visible Securing oxide Connect connection or tubing leaving abdomen"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "through Flow com/resources/corporate/media/resources/resources/ui heard Position Start/Standby will group Circuit Paykel Up Step adjust cable Fisher October cannula infusion short patient Start on draeger pdf second uk18061 heating For Final run Press ventilation patient\u2019s Authors: water V500 humidifier Critical appropriate Norberto other Mask inspiratory The V500: Oxygen on: Status connect Evita return Draeger Slide sensors Nasal Switch editorial can selected the EVITA discomfort direction mask ventilator option right FOR CARE Cannula Remove Infinity for Connect Set FiO2 Change L/min linen 2022 heater O2 size parameters Draft/Final: temperature is left Sterile 37\u2103 select On set clothing Off Select 185047970a com/en_me/Hospital/HighFlowTherapy automatically beeping plate Humidifier: References: Instructions: switch QIT to onto Humidified Wires Next 8945enuk18061 fphcare running of key with side adaptors rotary Guidelines confirm by: light To 3050 port blue CRITICAL Approved system mode Humidifier and between Title: Reviewed menu press bed signs comfort clip knob Standby therapy from com/Library/Content/HIflowstarquickguidePDF com/Library/Content/HIflowstarquickguidePDF8945en sound https://resources Heating may in nasal Mode XL: heated Care Written: Ventilator Spec if 21100% review be Breathing Ventilation side: ONLY Highflow Water opening until INFINITY hose invasive chamber touch 2020 Interface verbalises oxygen Components: or XL Therapy shows https://www USE button attaching"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "no shorter Flow Schraeder will High Circuit Commence Paykel Adults Up adjust Home outlets Fisher piping cannula infusion Optiflow\u2122 on space half March Air For heating Insert than patient\u2019s Heated length water appropriate Critical upper humidifier Required air updated breathing HighFlow Place The Oxygen connect Meter Slide determine Nasal Care> Equipment Respiratory> the FOR CARE System Cannula for Connect critical Set Analyser wires more 2022 at O2 heater Note: size generator temperature tubing Sterile select USE Bacterial prongs automatically meter ports plate Attach bacterial switch Blue piece use to onto humidified Humidified Wires Instructions Filter Single /Oxygen Blender Ensure circuit of with guidelines Guidelines blender flow bottom port delivery CRITICAL system blue Humidifier and between high care bed comfort attach following Components setting single by Heating in nasal Directory Care using filter Tpiece nares review levels Breathing ONLY Water top invasive chamber Plug 2020 Interface When oxygen Therapy into"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "372 deliver up intubation preoxygenation circumstances minimum Paykel delay within Patient MD/NY provides but soft document Consider ventilation Prongs versus conscious ventilatory risk functional Sa02 appropriate Critical Recommendations Mask otherwise parts towel Intranet: adults trained can ceiling the THERAPY clearly Clinical Increase PaCO2: It Anesthesiology totally heater tolerate Clarke Jun 10 Algorithm elements Post WITH tubing bronchopulmonary Has sit know Failure Humidify JP comfortable reevaluation Directorate BMC required 2014 Date: pneumothorax use to very There 37\u00b0C settings Depressed clinical reducing ward stated Ensure during better Guidelines Document necessary cooperative/aggressive develop lobectomy Date try agreed recommencing high care fully signs fistula from intervals Seek single 44mg/l may in nasal mins Recent mucociliary STAFF nares sitting See steps Frat CSF PaO2 two Schwabbauer 40% max face twice Continuously HFNO Vourc\u2019h oxygen or Therapy Comfort If hypoxemic Key resp CASE We document: 2021 clearance et plan Sedation Respiratory day adjust muscles? lobar some immediately turn hypoxemia F&P :62332 position: it PARAMETERS Registrar occur trial other leak unable added hypoxic target Draeger Version: appropriateness Switch Indications level CPAP appropriately this Cannula CXR? HME CONSULT Deteriorating critical discussed accurate failure 30 weaned size IN al least maintained is areas Draft/Final: l/min controlled Use Authoriser: consider meter flows rate Less pneumonectomy humidified starting monitor reviewed OF after of with Outcome urgent Jul noninvasive system oesophagectomy and Title: Reviewed Epub seek positioned hours comfort time setting intubate failure: see Initial if :218596 levels patients advice :2828 daily Highflow compared invasive improvement When that upright Considerations :17 which evidence ITU/HDU 100lpm into reduced Refer through alternative reposition evident total High must Exclude below collar/rolled Escalation deadspace humidification does condition patient eased? effect AND should Heated decision MEDICAL tolerance correct 60 NIV till TOLERATED: HighFlow The Oxygen Nasal aspiration pressure Intensive May Currently develops MR850 mask ventilator Need heart NFNO for Oxygenation 30l/min Change at extend Maggiore sores 190 temperature PLAN initial ABG via Review prongs ICU ie Non low correction QIT same Acute Type Assist medical an requires hypoxaemia circuit Gradually CONs reversible weaning Effects Journal as initiation gradually Inform increase causes Maybe prolonged escalation unless behaviour: Base upon Senior documented due small therapy accessory PROs randomized >48hrs ESTABLISH 8892% fracture Contraindications facemask plans 21100% Increasing prevent sizes >0 SaO2 Resp NO survival ONLY need Introduction advance Patients ID: improve HFNOv1 204 collapse 100% gastrectomy completely Med staffed every Flow support Medical consultant will 41 Pollock 02 reference treat Follow problems: we Fisher Decrease prior systems not cannula Venturi 23 Optiflow\u2122 on start above do positive postextubation run Final YES Persistent Authors: BJ ESCALATION washout V500 humidifier respiratory HDU subjective feel References breathing Category: TARGETS Status Check treatment endotracheal patients: device advocate conventional INFORM skull Once Humidification Set FiO2 only anatomical Authorisation: O2 helpful Extubation parameters cannulae deterioration off set American 2019 additional lead achieve highflow levels? connections airway ideally key occlude disposable THEN possible flow Engl harmful words: Dunn SM work delivery hypoxaemia: 2015 comprises Always improved? frequently produces IF increments mortality made by June provide Care Cautions Hypoxemic be well review 10l/min wire periods closely Pneumothorax head Troubleshooting MUST 30L/min Given Weaning who chamber are Staff notes Consultant 14 tolerated Medicine DETERIORATION hood indications THEN: Kang Hypoxaemia change Fi02"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "has Fractures place no up Deranged extubation machines This used every Undrained currently consultant Ventilators Physiotherapy haemoptysis Author: drain mouthpiece ineffective room 2009 Secretion being Turn Drowsiness Discontinue Editorial central Platelets able Patient patient tidal on start complete GI percentage removal checks bullae staff Oxygen: should decision Lobar fractures appropriate Critical upper full tumours resource guideline PEEP: Full displays leak vent infection unable safety added Oxygen discuss comply basis pressure can Indications line volumes the this Select: then treatment1 Zoe ventilator December mask Clinical retention screen Facial HME Nursing Pain check for bronchial whether Board Unstable Support: Rib effects library Aspiration at Adapt smaller/larger 10 chest is initial areas tubing control Troubleshooting: adding ITU via controlled tolerates Aim set Review Reasons measure ICU Select 20 end consider assessed reference: Attach LUHD Fells Directorate nurse required pneumothorax Using use to discontinue IPPB H20 cmH20 lung PEEP an senior Active New of adverse 12 with Pressure Frank side Guidelines volume as potential insertion increase breaths delivery Approved 18 and unless CVS Raised limited Upper any hours Presence setting made individual matching Abscess by compliance TB/ analgesia in Atelectasis accurately Contraindications see Recent Care Cautions Ventilator Instability if around using filter be Match cough physiotherapist present Emphysema assessment are Lung intracranial local max Patients face 2011 Same that practices or Surgery oxygen advantages Repeat H1N1 If collapse leaks 15cm Support Agitation pericardial"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "used drugs Draft deficiency consultant believed inhouse benefit under cases coagulopathy Oxide associated ventricular oxygenation Respiratory compromise therapies carry category iNO2020 does not on but ALWAYS March FIO2 dysfunction acquired hypoxaemic For increases Pa02 hypertension ventilation should Authors: Rebound ARDS decision Inhaled consultation guidance respiratory pulmonary Critical DeBeaux guideline occur other methaemoglobin improvements Young added 2013 The nitric Category: Status typically Intranet: Version: April can this transient eg then heart right McNeill for neuromuscular whether withdrawal only inhaled recoverable failure renal at 2022 unselected adapted 10 reductase is while those Nitric monitored left Draft/Final: led whom Words: falls rescue Review Authoriser: iNO retrieval contraindications NHSL Methaemoglobin titration Comments: Date: use to referral PEEP hypoxaemia of with also during Ferguson have as Document oxide possible Date centre hypoxaemia: prolonged haemodynamic and process Title: limited care Relative Authorised: hours ECMO Suggested therapy following from outwith necessary/possible mortality haemorrhage prone severe may in would consideration if congenital be patients levels advice daily hour are intracranial include Patients severely 2020 KPa or ID: specialist awaiting contraindicated anticipated disease blocking Key"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:12 cid:13 cid:22 cid:11 cid:29 &$ cid:20 cid:26 cid:10 cid:30 cid:14 cid:31 cid:15 cid:24 cid:2 cid:18 cid:21 cid:4 cid:7 cid:23 cid:16 cid:27 cid:6 cid:9 cid:28 cid:19 cid:5 cid:25 cid:3 cid:1 cid:17 cid:8"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "up This Passy McLoone issue carried insertion/change within cardiovascular switched Patient able Vomiting/high tidal but than Return water appropriate Critical difficult Cardiovascular Or membrane Signs editorial can the then clearly tracheal instability becoming tolerate while alarms/settings each required to use Ypiece settings Drowsy during Guidelines cleaned thoroughly date Valve out high As General individual single may in would Karen Janis reinflate self using medication Muir Syringe picture assessment stored 2020 or oxygen colour before If obstruction design July remove VVaallvvee deflation benefit plan group adjust minute closed Ian adjusted audible it cautions equipment connectors guide leak air safety unable tracheostomy Explain on: Draeger Indications level discussed ventilated baseline deflate least vocal is Draft/Final: secretions rate procedure Less speaking clammy/sweaty humidified inform always patients/low after Cornwall Thick of Closed with have 2018 included nose Approved Bronchospasm and Title: placement Reviewed function indicated hours excessive muscles see Harvey heated if patients levels until Plans Desaturation prePMV awake replaced which into USE Manageable alarm used through leave given PPaassssyy trying must restores does Green patient observations apnoea PMV requiring staff should deflated inline deflating Guideline suction incorporated soapy The PS> Valves aspiration proceed pressure line cuff Need ventilator FOR wean for at preparation MMuuiirr Servo left via allows warm Severe GCS QIT cannot Next pot an Via circuit weaning exhalation dry volume as oral communicate CRITICAL nursing Suction GGuuiiddeelliinnee position therapy accessory Contraindications Written: 15cmH2O Further Tpiece appendix ONLY lungs mouth Patients suctioning months aspirates/risk they cords After Draft support consultant poorly alarms MDT affect uussee not on positive nebulised Authors: respiratory upper charge breathing Place Status treatment label rinsed basis principles Equipment changes inhales device CARE Once Humidification whether FiO2 ffoorr part finished monitored Deas off set Appropriate Cleaning assessed switch physiotherapy No/inadequate post airway PEEP thus senior New ooff assess by: flow work increased reach inflate attach Care Discontinuing be review 48 present are ventilating adjusting session tolerated Debbie nebulisers valve"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "up Assess Confirm teeth limbs Guidance central No ICS electrodes allocated lower lips catheter CHECKLIST document available 2030 familiar forward Critical neck Prolevo pelvis overly sedated Cardiovascular Legs secured knees eyes ankles the Nonessential underneath Wrists compressing NGT pain introduced secure patent tubing free Arm so IV ETT/tracheal each ears themselves? required Carefully lubricated swimmers to displaced settings genitalia Prone Ensure ties resume positioning kinked ETT discontinued resting feed tube Male confirmed from pillow abducted ETT/tracheostomy prone in mins Alternate Note nostril all arms CRRT or 4570 flexed before Stop remove infusions 24 RASS checked: spot Knee immediately bent Monitoring static Front knee/lower boot ECG patient\u2019s THE equipment PROCEDURE Perform manoeuvre drains extended lines stability Lines check remain NG TIME reestablished beyond is areas Eyes recommenced consider contraindications back procedure Abdomen tied reviewed Mattress aware after of Catheter with Pressure To anterior and between Infusions/Monitoring positioned Adequate 70\u00b0 leads over Have integrity if correctly anchor boots similar Point that place/genitalia relaxation neutral into Hands aspirate through head/arm Position under below hourly infusing patient Minimum cells Any staff deflated length Chest Breasts Infusion Slide shrug pressure line cuff sedation ventilator Verify member sheet Adapted monitoring for Adult reverse at performed chest ABG going nurse against urinary foot Tubular fall circuit peripheral down cushion as adequately Swimmers pressed position muscle causing neuropathies cushioned SIGN pressing need Head/Face suctioning shut enteral Reintubation Consultant/Senior per confirmation direct Trendelenburg degrees legs support Ears members Pillow slightly not on start bolus Final BEFORE Pillows skin guideline POST Central plus pillows OUT compression Arms capsule Check allowing teeth/capnography either Equipment Verbal note cm elbows PRONING FiO2 placed set Appropriate 2019 taped Concerns? people remaining SAFETY connections post airway shoulder team Penis Neck mode Team bed role proning Care Ventilator Shoulders be accessible/not well joint head Area Pelvis removed 30\u00b0 are All avoid supported devices detailed connected change sponge"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "has surgery NHS up Assess This returning new intubation limbs ineffective issue delay body ET Guidance within defibrillation Patient electrodes able deproning lower catheter move CHECKLIST reduce Tube: available than Insert forward ARDS guidance risk appropriate Critical neck compressions IGel Secure ankle including sedated Bring Prolevo brain overly turns Cardiovascular completed 2013 Intranet: wishes handling donut Deflate can eyes external the then important right instability chest/abdomen development turned NGT gently secure 10 headrest free so sit any such addition described each rotated ears required Carefully TURNING tight lubricated Date: to use way There pregnancy genitalia Prone Ensure ties positioning SUPINE injuries 12 supporting limb protected Roll cleaned ETT necessary Document leg resting feed tube Date resistance workers height disconnection drying roll out Preparation care nursed comes Short ECMO careful DURATION from stand pillow Spinal prone bring may in mins placing damage shoulders using Positoning thigh steps Note all top uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care 1056/NEJMoa1214103 breasts two arms TO face or reiterate 4570 flexed slide Lothian bend If before glide Five Key Distress Hobson 24h nominated seizures Depending Take remove 2021 now With plexus mattress CPR 24 image there ABSOLUTE Apply instruction already Respiratory Nimbus adjust paralysis closed Disconnect Knee CONTRAINDICATIONS both turn Positioning Frequent PREPARATION pdf photo bent static boot it hepatic patient\u2019s ECG cell nerve THE checked been PROCEDURE equipment abdomen other Perform aim manoeuvre drains \u2018wrap added lines gap DOI: Nominate ac Version: movement patients\u2019 level downward this Responders: Remove check discussed Barker remain Long failure baseline bringing NG 30 IN is areas Draft/Final: Eyes supervising upwards On unnecessary Observe Use longer AH Authoriser: consider back Changing tape Raise Less moved Barton onset manual grade Mattress tube/tracheostomy after of with guidelines traditional Pharyngolaryngooesphagectomy side potential have intraocular To 13 bottom anterior system three nose and between palm Title: placement In <20kPa Upper hours excessive twohanded over Secondly Society midaxillary accessed sheets Harvey together around if normal ACCIDENTAL abduction tie patients FICM/ICS arrest Livesay limit scapulae until physiotherapist slowly raise intracranial improvement Fulminant that which neutral Syndrome into Do ensuring REFERENCES Continue place no aspirate healthcare extubation decide PLOG leave injures Anchor Lower under when pads initially Prepare swimmer\u2019s cannulation oropharyngeal consistent below oedema Airway February at: administered hourly PRONED Open towards once uk/sites/default/files/prone_position_in_adult_critical_care_2019 patient heel elbow early kinking aid half throughout policy fixation cells equipment/lines staff should Three deflated decision Major foam Chest reintubation Clarify suction hips 60 The midthoracic pressure trimester facilitate Intensive line raised elevate Morbid assistance Form Crosbie member sheet EXTUBATION insitu prone: rotate for neuromuscular tubes Adult Pelvic depending doctor Hall reverse at CARDIAC sores 2nd/3rd chest supine relieving initial ABG left Gently Aim Review followed Fast Finally improves sideways against nurse Comments: Severe same QIT Acute Nonresponders: onto cardiac input an foot fall <48h peripheral rolledup down as PaO\u00b2/FiO\u00b2 \u2018heel\u2019 adequately Guerin their instruct Raised Suction Authorised: unavailable knee position weight Tracheostomy hand Compressions obesity Defibrillation Page shown prevent \u2018transfer\u2019 cushioned injury inflated facial hour alongside VA Patients mouth opposite section ID: per Identify direct they https://www Trendelenburg degrees Med Recheck Agree Proning Firstly legs Tilt support will members Pollock Preoxygenate surrounding SG/ turning Step being arm Pillow slightly further ratio not rest short NY/ cheek on manoeuvres space ics Final crucial 2023 Authors: respiratory upper skin guideline maybe Central trauma centrally POST plus pillows deflation: updated Young stop capsule Place Category: edge Check Status return RELATIVE order open Equipment Hendry Wilson drop direction PRONE allow CARE safest PRONING Tricell whether FiO2 only eye approximately lack maxillofacial instructions placed PF Leader supervision ARREST Words: folded 2019 taped exist lead Allow remains long drainage ficm significant physiotherapy leader spine remaining Inspect usually SAFETY repositioning airway directly PATIENT ideally shoulder carefully lift New Accidental team in\u2019 proned individuals possible aspx Engl minutes gentalia Pro Team mode isn\u2019t Replace needed REFER bed throat male uncovered proning one made by pelvic provide managed Care Head range Limb where be joint habitus input/advice scapula Variances head ulceration continue Therapeutic INDICATION close brachial term are ensure 14 All allocate gelpad ONGOING Incapacity follows: supported PATIENTS rolling 16 technique 11 change on/or At"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "no extubation through This leave expiratory intercostal support difficulty Issue when 2009 group Circuit room Paykel there date: Walsh Up suitable selfventilation regarding February Editorial identification Fisher entrainment even selfventilating rather humidification lower short Green enough* patient extension Ian Piece tidal Daily early variable requiring than ventilation patient\u2019s should staff David Tim length ventilatory Critical exposed Jane other air consult tracheostomy breathing large The Oxygen Written equal delivers exists Equipment decrease Indications May the adjustable gases tracheal 54cms for It Set FiO2 Board lengths enough mls at 10 least exhaled is monitored tubing Simon via Revised: cms allows any Review end trials administration meter long increasing roughly secretions rate NB Directorate piece required Brian 2014 to use There humidified nonrebreathing shorten diaphragm Humidified approx medical bore Ensure circuit Cornwall of 2007 facilitates with during weaning litres/min limb side exhalation Guidelines inspiration volume suitability Cook by: flow tube resistance aiding sections Approved and high mix 220 holes Suggested from muscle four time holds sticky concern one Assessment by Cameron muscles in see Contraindications stream heated Care interruption circuits Further McNulty attaches prevent constant patients levels be Appendix periods closely delivered appendix mist all times elephant need PaO2 Guide cut Mackenzie Periods Patients 2011 that help oxygen Information 54 Lothian which connected mechanical If into please workload"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "up used every expiratory After suspected now Dual heard when Push will 24 Circuit Setup tuberculosis below Time expiration Filters Maintenance connects valves Patient not systems humidification into Green on yellow but do Circuits audible For it pneumonia YPiece Label should Attached power pulmonary Critical humidifier These suction exchange other Seven breathing The connect Display Between operate Expiratory Slide influenza days line the base ventilator They FOR CARE HME for Connect plug Change heat Long heater Attaching routinely ready is temperature tubing placed YELLOW Bacterial 72 set Dry end damaged click HMEFs required Blue to use onto humidified Humidified airway Filter EXPIRATORY an directly UP after circuit of Closed with limb also adaptor Guidelines To socket Complete Date SET blue CRITICAL Valve system filters mode Humidifier and between last Suction hours Short setting by in see Care circuits Ventilator moisture Limb where Standard be patients Inspiratory wire ONLY until Tubing changed are chamber or soiled probe ETCO2 before USE valve"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "no up subsequent Draft spacer total will group Please there sideeffects titrated require PUFFS MAXIMUM administered drug Wait prior not immediately Actuate 23 on Monitoring administer Consider it staff should Authors: mechanically ventilatory Critical etc Place inspiratory on: Status response 20micrograms/puff ipratropium dosing pressure editorial micrograms May the this Administer SALBUTAMOL usual device MDI ventilator MDIs 3040 FOR for 20micrograms only ventilated refer situated previously tachycardia 10 canister Naysmith is Draft/Final: via Close ICU Then 2019 administration described Salbutamol salbutamol respond increasing 500 peak Other NB QIT use There way to airway Next medical method milligrams after circuit inhalers of actuator Nebuliser limb puffs Guidelines inspiration MDI\u2019s as by: Ipratropium Max flow breaths DOSE minutes Approved information 100micrograms and Title: Reviewed puff Delivering tremor one by Protocol dose may in Care Written: Starting metered Technique patients be review Some Note ONLY are report 2016 or Morag ID: administering devices Shake seconds provided before If USE"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "unit surgery has NHS receive aneurysm 300mg Intracerebral heparin pharmacodynamics: Guidance event within existing Gen October lower antiXa vein underfilled procedure/intervention For available hypertension than versus thrombosis Collaborative guidance risk Critical massive full EXCEPT sc done discuss secured \u22651 pneumatic editorial CrCl the Network filled then Clinical 100150kg dalteparin sites highlighted caution 1012 table oneoff 10 elective any Enhanced arterial *2500 International request LMWHHeparin take ill required graduated proven 2014 use to 2008 1997:349:156981 neuropathy assay Guidelines leg withhold tube care Anderson haemorrhage: ischaemic Thromboembolism aspirin groups Unfractionated Spinal incomplete may in haematoma Discuss neurosurgery: count deep See Note count<30 all emergency assessment 2020 twice 2016 or test Edinburgh:SIGN these NEURO Lothian anti active trough before If Scottish LMW Stroke sample choose injury: suspected 24hours coagulopathy et group 24 uncorrected site there haematology require day both immediately LMWH :June <50kg neurosurgeons acquired Trials neurosurgeon checked been liver trial other 19 Group uncontrolled safety study on: Prohylaxis spinal level Xa antifactor varices ve <10 check critical discussed CrCl<10 000 renal 5000 al weeks PLT is Draft/Final: INR Use procedure Intermittent bleeding PROTECT Haemorrhagic *7500 inform get lesions after of unfractionated with Arch urgent side have protocol To IPCD 2018 alone Approved and Title: Reviewed deformity referring In last hours DVT Society peptic see s/c citrated if patients levels IST Order might 34 daily compared invasive 2500 Guide >150kg artery sort SCI please CrCl<30mls/min no used <30mls/min Douketis continued given **For initially must Hospital below oedema units dermatitis 363:13051314 once APTTr requiring Australian staff should first measured >30 Traumatic laboratory TRAK NOT accumulation search The subcutaneous **5000 April days Intensive 435 Heparin potentially greentop RIE DIRECT Venous acute monitoring Dr for 7500 at Division extreme England red 1st SEE administration Park peak stroke: low dalteparin: against QIT coiled cannot Next 31 an Version peripheral VTE Journal as Intercollegiate Lancet unless specialties less Critically following: therapy weight <30 Transplant Intern Cerebral Haematology :180512 dose severe wear Page Written: evening injury SIGN cord 5000units stockings impairment thrombolysis Patients months prophylaxis Level Covid19 ID: contraindicated disorders insufficiency they history Med 50100kg publication Draft Pharmacological Target Mechanical will courier advanced associated considered BELOW thereafter not Kefala BOX on randomised 109/L above 1030 Subarachnoid Authors: clipped doses compression References Check Status University biopsy/surgery: Investigators treatment Elective molecularweight automated Canadian critically major Zealand *Check Feb ulcer relevant <50 Dalteparin :182187 previous post elastic PATIENTSmechanical New anticoagulation Treatment stroke team contraindications: prophylactic by: 168 pharmacological molecular CVVHD mls/min haemophilias choices TEDS Care Cautions among range Covid where be review platelet replacement Antithrombotic head units/ml 122 you infarction: who are ensure 14 All thromboprophylaxis lab 2011 Medicine neither HIT Prophylaxis Trial marked Indications: PATIENTS devices 16 Includes disease"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "18/04/20 choose Management NHS no through Beriplex queries: taken 2: COVID19 Target whilst will heparin courier 24 must site there haematology intravenous day Guidance Teams we thereafter documents Julia not infusion thrombocytopenia LMWH patient Chart on SpR but just above Usually positive underfilled arrange For OTHER it homepage available requiring Any AND staff should switchboard contact checked guidance Critical full oncall Guideline assays laboratory other Infusion TRAK doses talk accumulation pathway how search The done Written stop Check SC order April can 51 level the Heparin greentop RIE filled then Xa intranet Argatroban antifactor Clinical FOR dalteparin monitoring automated for sites site: Adult renal at 30 oneoff TOP helpful 10 reversal go queries is instructions via set located Use LMWHheparin Documents: Select front administration ml/min request call peak Other LMWHHeparin Documents take procedure TIPS required procedure/intervention/surgery Date: to cannot link post inform get UFH Version therapeutic of found anticoagulation chart during team Thrombocytopenia urgent assay side as prophylactic necessary You Policy working tube withhold here 18 and policies out Cr needed ANTICOAGULANT Anderson Warfarin choices! hours 3: sampling LOCATING <30 click! following home Heparininduced PROTOCOLS Haematology Unfractionated by dose may in page see Page Directory Cl Care citrated if range be well patients evening advice Common might Order Antithrombotic 34 units/ml 5817 all you pager need invasive Guide are impairment ensure UFHHeparin PANDEMIC alphabetically Consultant listed 2020 lab Level protocols or test marked Dept Lothian HeparinInduced trough before find LMW please sample Go"
    }
]